| Age Category | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 58,451 | 59,286 | 22,335b | 24,627 | 36,116 | 34,659 |
| 18-25 | 11,536b | 12,583 | 4,376b | 5,210 | 7,160 | 7,373 |
| 18-20 | 4,362 | 4,499 | 1,567b | 2,024 | 2,795 | 2,476 |
| 21-25 | 7,174a | 8,084 | 2,809 | 3,186 | 4,365 | 4,897 |
| 26 or Older | 46,916 | 46,703 | 17,959 | 19,417 | 28,956 | 27,286 |
| 26-49 | 29,150 | 30,160 | 11,668b | 13,045 | 17,483 | 17,115 |
| 26-29 | 5,935 | 6,195 | 2,254 | 2,700 | 3,682 | 3,494 |
| 30-34 | 7,484 | 7,912 | 3,217 | 3,478 | 4,267 | 4,434 |
| 35-39 | 6,274 | 6,271 | 2,487 | 2,742 | 3,787 | 3,528 |
| 40-44 | 5,082 | 5,371 | 1,904a | 2,419 | 3,178 | 2,951 |
| 45-49 | 4,375 | 4,413 | 1,807 | 1,705 | 2,568 | 2,707 |
| 50 or Older | 17,765 | 16,543 | 6,292 | 6,372 | 11,474 | 10,171 |
| 50-54 | 4,332 | 3,770 | 1,569 | 1,201 | 2,762 | 2,569 |
| 55-59 | 3,460 | 3,235 | 1,240 | 1,551 | 2,220 | 1,685 |
| 60-64 | 3,488 | 3,587 | 1,222 | 1,582 | 2,266 | 2,005 |
| 65 or Older | 6,485 | 5,951 | 2,260 | 2,039 | 4,225 | 3,912 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Age Category | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 23.0 | 23.1 | 18.1a | 19.7 | 27.7 | 26.4 |
| 18-25 | 34.5 | 36.2 | 26.2b | 29.8 | 42.8 | 42.6 |
| 18-20 | 33.4 | 34.8 | 23.2b | 29.5 | 44.2 | 40.9 |
| 21-25 | 35.2 | 37.0 | 28.2 | 30.0 | 41.9 | 43.6 |
| 26 or Older | 21.3 | 21.1 | 16.8 | 18.0 | 25.5 | 24.0 |
| 26-49 | 28.5 | 29.4 | 23.0a | 25.4 | 33.9 | 33.4 |
| 26-29 | 34.0 | 36.4 | 26.0a | 31.4 | 41.9 | 41.5 |
| 30-34 | 32.9 | 34.1 | 28.4 | 30.1 | 37.4 | 38.1 |
| 35-39 | 28.2 | 28.4 | 22.0 | 24.6 | 34.5 | 32.4 |
| 40-44 | 24.9 | 25.8 | 19.3 | 23.1 | 30.1 | 28.6 |
| 45-49 | 22.5 | 22.6 | 18.6 | 17.9 | 26.2 | 27.1 |
| 50 or Older | 15.0 | 13.9 | 11.2 | 11.3 | 18.5a | 16.2 |
| 50-54 | 22.1 | 19.1 | 16.6 | 13.2 | 27.1 | 24.0 |
| 55-59 | 16.2 | 16.2 | 11.3 | 15.0 | 21.4 | 17.5 |
| 60-64 | 15.7 | 15.8 | 11.5 | 14.0 | 19.5 | 17.7 |
| 65 or Older | 11.8 | 10.5 | 9.1 | 8.0 | 14.1 | 12.6 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 58,451 | 59,286 | 11,536b | 12,583 | 46,916 | 46,703 | 29,150 | 30,160 | 17,765 | 16,543 |
| GENDER | ||||||||||
| Male | 22,335b | 24,627 | 4,376b | 5,210 | 17,959 | 19,417 | 11,668b | 13,045 | 6,292 | 6,372 |
| Female | 36,116 | 34,659 | 7,160 | 7,373 | 28,956 | 27,286 | 17,483 | 17,115 | 11,474 | 10,171 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 49,640 | 49,836 | 9,280a | 9,903 | 40,360 | 39,933 | 24,524 | 25,219 | 15,836 | 14,714 |
| AIAN | 425a | 243 | * | 66 | 285 | 178 | * | 133 | * | 45 |
| Asian | 2,452 | 2,587 | 591 | 754 | 1,861 | 1,833 | 1,325 | 1,291 | 536 | 542 |
| Black or African American | 6,609 | 6,095 | 1,206 | 1,308 | 5,402 | 4,787 | 3,187 | 3,257 | 2,215a | 1,530 |
| NHOPI | 163 | * | * | * | * | * | * | * | * | * |
| White | 38,374 | 38,875 | 6,931 | 7,285 | 31,443 | 31,590 | 18,911 | 19,655 | 12,533 | 11,935 |
| Two or More Races | 1,617 | 1,778 | 364 | 478 | 1,253 | 1,300 | 818 | 797 | 436 | 503 |
| Hispanic or Latino | 8,811 | 9,450 | 2,256a | 2,680 | 6,555 | 6,770 | 4,626 | 4,941 | 1,929 | 1,829 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 25,008a | 26,982 | 4,254 | 4,773 | 20,754 | 22,209 | 16,065b | 17,967 | 4,690 | 4,242 |
| Part-Time | 9,207 | 9,278 | 3,186 | 3,627 | 6,021 | 5,651 | 3,951 | 3,702 | 2,070 | 1,950 |
| Unemployed | 4,316a | 3,689 | 1,196 | 1,169 | 3,119a | 2,519 | 2,302 | 1,921 | 817 | 598 |
| Other1 | 19,920 | 19,337 | 2,899 | 3,013 | 17,021 | 16,324 | 6,832 | 6,570 | 10,188 | 9,754 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 23.0 | 23.1 | 34.5 | 36.2 | 21.3 | 21.1 | 28.5 | 29.4 | 15.0 | 13.9 |
| GENDER | ||||||||||
| Male | 18.1a | 19.7 | 26.2b | 29.8 | 16.8 | 18.0 | 23.0a | 25.4 | 11.2 | 11.3 |
| Female | 27.7 | 26.4 | 42.8 | 42.6 | 25.5 | 24.0 | 33.9 | 33.4 | 18.5a | 16.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 23.6 | 23.5 | 36.2 | 37.3 | 21.8 | 21.5 | 30.3 | 31.1 | 15.2 | 14.1 |
| AIAN | 25.9 | 19.6 | * | 31.3 | 21.8 | 17.2 | * | 24.1 | * | 9.3 |
| Asian | 16.4 | 16.8 | 30.2 | 33.3 | 14.4 | 13.9 | 17.9 | 17.3 | 9.6 | 9.5 |
| Black or African American | 21.6 | 19.7 | 26.6 | 28.0 | 20.7 | 18.2 | 23.9 | 24.3 | 17.4b | 11.9 |
| NHOPI | 16.1 | * | * | * | * | * | * | * | * | * |
| White | 24.3 | 24.6 | 39.1 | 39.9 | 22.4 | 22.6 | 33.0 | 34.5 | 15.1 | 14.4 |
| Two or More Races | 35.4 | 35.2 | 39.3 | 47.6 | 34.4 | 32.1 | 40.1 | 36.6 | 27.2 | 27.0 |
| Hispanic or Latino | 20.4 | 21.4 | 28.8 | 32.4 | 18.6 | 18.8 | 21.8 | 23.0 | 13.7 | 12.6 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 21.9 | 22.8 | 33.5 | 33.9 | 20.4 | 21.3 | 25.0a | 27.1 | 12.6 | 11.2 |
| Part-Time | 30.3 | 28.3 | 39.0 | 41.3 | 27.1a | 23.5 | 38.3a | 33.1 | 17.4 | 15.2 |
| Unemployed | 33.0 | 33.5 | 37.7 | 36.4 | 31.5 | 32.3 | 35.7 | 38.1 | 23.5 | 21.6 |
| Other1 | 20.7 | 20.6 | 30.8a | 34.6 | 19.6 | 19.1 | 32.1 | 32.9 | 15.6 | 14.9 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 58,451 | 59,286 | 11,536b | 12,583 | 46,916 | 46,703 | 29,150 | 30,160 | 17,765 | 16,543 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 9,380 | 9,805 | 1,899 | 2,004 | 7,481 | 7,802 | 4,826 | 4,986 | 2,654 | 2,816 |
| Midwest | 12,407 | 12,964 | 2,588 | 2,623 | 9,820 | 10,341 | 6,310 | 6,436 | 3,510 | 3,905 |
| South | 22,010 | 21,382 | 4,225a | 4,644 | 17,785 | 16,738 | 10,607 | 10,701 | 7,177a | 6,037 |
| West | 14,654 | 15,135 | 2,824b | 3,313 | 11,831 | 11,822 | 7,407 | 8,038 | 4,423 | 3,784 |
| COUNTY TYPE | ||||||||||
| Large Metro | 30,550 | 31,197 | 6,089 | 6,817 | 24,461 | 24,380 | 15,927 | 16,029 | 8,534 | 8,351 |
| Small Metro | 18,786 | 20,311 | 3,843a | 4,400 | 14,943 | 15,911 | 9,186a | 10,338 | 5,757 | 5,572 |
| Nonmetro | 9,115 | 7,778 | 1,603 | 1,366 | 7,512 | 6,413 | 4,037 | 3,793 | 3,475a | 2,620 |
| Urbanized | 3,603 | 3,317 | 819 | 660 | 2,785 | 2,657 | 1,651 | 1,602 | 1,134 | 1,055 |
| Less Urbanized | 4,556 | 3,798 | 670 | 650 | 3,886 | 3,148 | 2,031 | 1,941 | 1,855a | 1,207 |
| Completely Rural | 955 | 663 | * | 55 | 841 | 608 | 355 | 250 | 486 | * |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 11,083 | 10,459 | 2,807 | 2,707 | 8,276 | 7,752 | 4,786 | 4,647 | 3,490 | 3,105 |
| 100-199% | 13,661 | 12,663 | 2,852 | 3,064 | 10,809 | 9,600 | 6,009 | 5,757 | 4,800 | 3,842 |
| 200% or More | 33,663a | 36,161 | 5,832b | 6,810 | 27,831 | 29,351 | 18,355 | 19,756 | 9,476 | 9,596 |
| EDUCATION LEVEL | ||||||||||
| < High School | 5,540 | 5,214 | 1,038 | 1,208 | 4,502 | 4,006 | 2,020 | 1,863 | 2,482 | 2,144 |
| High School Graduate | 14,062 | 14,235 | 3,303 | 3,648 | 10,759 | 10,587 | 5,829 | 6,235 | 4,930 | 4,351 |
| Some College/Associate’s Degree | 21,199 | 20,777 | 5,417 | 5,575 | 15,781 | 15,202 | 9,890 | 9,970 | 5,892 | 5,232 |
| College Graduate | 17,651a | 19,060 | 1,777a | 2,152 | 15,873 | 16,908 | 11,412 | 12,092 | 4,462 | 4,816 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 32,105 | 33,891 | 7,005a | 7,820 | 25,100 | 26,071 | 16,357a | 17,907 | 8,743 | 8,165 |
| Medicaid/CHIP | 15,014 | 15,340 | 2,767 | 3,138 | 12,247 | 12,202 | 7,661 | 7,810 | 4,586 | 4,392 |
| Other3 | 14,083a | 12,398 | 947 | 905 | 13,136a | 11,493 | 3,503 | 2,981 | 9,633 | 8,512 |
| No Coverage | 6,028 | 5,856 | 1,349 | 1,366 | 4,679 | 4,490 | 3,766 | 3,431 | 913 | 1,059 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 23.0 | 23.1 | 34.5 | 36.2 | 21.3 | 21.1 | 28.5 | 29.4 | 15.0 | 13.9 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 20.9 | 21.8 | 33.2 | 33.9 | 19.2 | 20.0 | 27.7 | 28.7 | 12.3 | 13.0 |
| Midwest | 23.6 | 24.6 | 36.4 | 35.9 | 21.6 | 22.7 | 30.7 | 31.4 | 14.1 | 15.6 |
| South | 22.8 | 21.8 | 33.3 | 34.8 | 21.2 | 19.8 | 27.3 | 27.3 | 16.0a | 13.3 |
| West | 24.4 | 25.0 | 35.6a | 40.2 | 22.7 | 22.6 | 29.1 | 31.6 | 16.6 | 14.1 |
| COUNTY TYPE | ||||||||||
| Large Metro | 22.3 | 22.1 | 34.5 | 35.7 | 20.5 | 20.0 | 27.5 | 27.2 | 14.0 | 13.2 |
| Small Metro | 24.2 | 25.0 | 35.1 | 37.6 | 22.4 | 22.8 | 30.2 | 31.9 | 15.8 | 15.0 |
| Nonmetro | 23.2 | 23.0 | 33.1 | 34.3 | 21.8 | 21.5 | 28.9b | 33.6 | 16.9 | 14.1 |
| Urbanized | 24.6 | 23.3 | 40.5 | 37.5 | 22.1 | 21.3 | 31.8 | 32.8 | 15.3 | 13.9 |
| Less Urbanized | 22.2 | 22.3 | 28.5 | 33.0 | 21.4 | 20.9 | 27.6b | 35.1 | 17.2 | 12.7 |
| Completely Rural | 22.9 | 25.7 | * | 22.0 | 22.8 | 26.1 | 25.4 | 28.2 | 21.1 | * |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 29.3 | 28.9 | 33.2 | 33.6 | 28.1 | 27.5 | 30.8 | 30.6 | 25.1 | 24.0 |
| 100-199% | 26.9 | 25.4 | 35.6 | 36.1 | 25.3 | 23.2 | 29.7 | 29.9 | 21.3 | 17.4 |
| 200% or More | 20.4 | 21.2 | 34.6a | 37.3 | 18.8 | 19.3 | 27.6 | 29.0 | 11.6 | 11.4 |
| EDUCATION LEVEL | ||||||||||
| < High School | 19.6 | 21.4 | 28.2a | 33.7 | 18.3 | 19.3 | 20.8 | 23.5 | 16.7 | 16.7 |
| High School Graduate | 20.3 | 20.6 | 31.3 | 31.4 | 18.3 | 18.4 | 24.1 | 26.7 | 14.2 | 12.7 |
| Some College/Associate’s Degree | 27.5 | 26.7 | 38.3 | 40.1 | 25.0 | 23.8 | 33.1 | 33.5 | 17.8 | 15.4 |
| College Graduate | 22.3 | 22.4 | 35.0 | 37.8 | 21.5 | 21.3 | 29.6 | 29.2 | 12.6 | 12.7 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 20.8 | 21.7 | 37.1 | 39.3 | 18.5 | 19.2 | 26.2 | 27.9 | 12.0 | 11.4 |
| Medicaid/CHIP | 31.6 | 31.9 | 31.8 | 33.9 | 31.6 | 31.4 | 35.1 | 35.9 | 27.1 | 25.7 |
| Other3 | 18.7b | 16.2 | 37.2 | 32.2 | 18.1b | 15.5 | 38.4a | 32.5 | 15.1a | 13.1 |
| No Coverage | 24.3 | 25.2 | 28.1 | 29.5 | 23.4 | 24.1 | 26.2 | 26.0 | 16.3 | 19.6 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Age Category | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 14,526 | 15,360 | 5,020a | 6,019 | 9,506 | 9,341 |
| 18-25 | 4,012 | 4,031 | 1,199a | 1,493 | 2,813 | 2,539 |
| 18-20 | 1,565 | 1,405 | 424 | 538 | 1,141a | 867 |
| 21-25 | 2,447 | 2,626 | 775 | 955 | 1,672 | 1,672 |
| 26 or Older | 10,513 | 11,329 | 3,820 | 4,526 | 6,693 | 6,803 |
| 26-49 | 7,448 | 7,809 | 2,918 | 3,290 | 4,530 | 4,519 |
| 26-29 | 1,717 | 1,580 | 561 | 619 | 1,157 | 961 |
| 30-34 | 1,839a | 2,264 | 697a | 964 | 1,142 | 1,300 |
| 35-39 | 1,759 | 1,577 | 712 | 746 | 1,047 | 831 |
| 40-44 | 1,015 | 1,251 | 440 | 568 | 575 | 683 |
| 45-49 | 1,117 | 1,137 | 509 | 393 | 608 | 744 |
| 50 or Older | 3,066 | 3,520 | 902 | 1,236 | 2,164 | 2,284 |
| 50-54 | 955 | 1,068 | 308 | 276 | 647 | 792 |
| 55-59 | 776 | 834 | 282 | 472 | 494 | 361 |
| 60-64 | 619 | 802 | 141 | 349 | 478 | 453 |
| 65 or Older | 715 | 817 | 171 | 139 | 544 | 677 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Age Category | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 5.7 | 6.0 | 4.1a | 4.8 | 7.3 | 7.1 |
| 18-25 | 12.0 | 11.6 | 7.2 | 8.5 | 16.8 | 14.7 |
| 18-20 | 12.0 | 10.9 | 6.3 | 7.8 | 18.1a | 14.3 |
| 21-25 | 12.0 | 12.0 | 7.8 | 9.0 | 16.1 | 14.9 |
| 26 or Older | 4.8 | 5.1 | 3.6 | 4.2 | 5.9 | 6.0 |
| 26-49 | 7.3 | 7.6 | 5.7 | 6.4 | 8.8 | 8.8 |
| 26-29 | 9.8 | 9.3 | 6.5 | 7.2 | 13.2 | 11.4 |
| 30-34 | 8.1 | 9.8 | 6.2 | 8.4 | 10.0 | 11.2 |
| 35-39 | 7.9 | 7.2 | 6.3 | 6.7 | 9.5 | 7.6 |
| 40-44 | 5.0 | 6.0 | 4.5 | 5.4 | 5.5 | 6.6 |
| 45-49 | 5.7 | 5.8 | 5.3 | 4.1 | 6.2 | 7.4 |
| 50 or Older | 2.6 | 3.0 | 1.6 | 2.2 | 3.5 | 3.6 |
| 50-54 | 4.9 | 5.4 | 3.3 | 3.0 | 6.3 | 7.4 |
| 55-59 | 3.6 | 4.2 | 2.6 | 4.6 | 4.8 | 3.7 |
| 60-64 | 2.8 | 3.5 | 1.3 | 3.1 | 4.1 | 4.0 |
| 65 or Older | 1.3 | 1.4 | 0.7 | 0.5 | 1.8 | 2.2 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 14,526 | 15,360 | 4,012 | 4,031 | 10,513 | 11,329 | 7,448 | 7,809 | 3,066 | 3,520 |
| GENDER | ||||||||||
| Male | 5,020a | 6,019 | 1,199a | 1,493 | 3,820 | 4,526 | 2,918 | 3,290 | 902 | 1,236 |
| Female | 9,506 | 9,341 | 2,813 | 2,539 | 6,693 | 6,803 | 4,530 | 4,519 | 2,164 | 2,284 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 12,266 | 13,031 | 3,193 | 3,195 | 9,073 | 9,836 | 6,430 | 6,691 | 2,643 | 3,145 |
| AIAN | 153 | 91 | * | * | 74 | 61 | 29 | 49 | * | 11 |
| Asian | 469 | 626 | 150a | 324 | 318 | 302 | 256 | 191 | * | 111 |
| Black or African American | 1,323 | 1,467 | 384 | 341 | 939 | 1,126 | 681 | 801 | 257 | 325 |
| NHOPI | 57 | 43 | * | * | * | 42 | * | * | * | * |
| White | 9,874 | 10,207 | 2,427 | 2,341 | 7,447 | 7,866 | 5,243 | 5,298 | 2,204 | 2,568 |
| Two or More Races | 389a | 598 | 132 | 159 | 257a | 439 | 182a | 324 | 75 | 115 |
| Hispanic or Latino | 2,260 | 2,330 | 820 | 837 | 1,441 | 1,493 | 1,018 | 1,118 | 422 | 375 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 5,778 | 6,390 | 1,390 | 1,558 | 4,388 | 4,832 | 3,568 | 4,051 | 820 | 781 |
| Part-Time | 2,482 | 2,717 | 1,099 | 1,170 | 1,383 | 1,547 | 1,077 | 1,118 | 306 | 429 |
| Unemployed | 1,223 | 1,149 | 486 | 361 | 737 | 787 | 625 | 663 | 112 | 124 |
| Other1 | 5,043 | 5,105 | 1,036 | 942 | 4,007 | 4,163 | 2,178 | 1,977 | 1,828 | 2,186 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 5.7 | 6.0 | 12.0 | 11.6 | 4.8 | 5.1 | 7.3 | 7.6 | 2.6 | 3.0 |
| GENDER | ||||||||||
| Male | 4.1a | 4.8 | 7.2 | 8.5 | 3.6 | 4.2 | 5.7 | 6.4 | 1.6 | 2.2 |
| Female | 7.3 | 7.1 | 16.8 | 14.7 | 5.9 | 6.0 | 8.8 | 8.8 | 3.5 | 3.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 5.8 | 6.1 | 12.5 | 12.0 | 4.9 | 5.3 | 7.9 | 8.3 | 2.5 | 3.0 |
| AIAN | 9.3 | 7.3 | * | * | 5.6 | 5.9 | 5.0 | 9.0 | * | 2.3 |
| Asian | 3.1 | 4.1 | 7.7a | 14.3 | 2.5 | 2.3 | 3.5 | 2.6 | * | 1.9 |
| Black or African American | 4.3 | 4.7 | 8.5 | 7.3 | 3.6 | 4.3 | 5.1 | 6.0 | 2.0 | 2.5 |
| NHOPI | 5.7 | 3.5 | * | * | * | 3.9 | * | * | * | * |
| White | 6.3 | 6.5 | 13.7 | 12.8 | 5.3 | 5.6 | 9.2 | 9.3 | 2.7 | 3.1 |
| Two or More Races | 8.5 | 11.8 | 14.3 | 15.8 | 7.1 | 10.9 | 8.9a | 14.9 | 4.7 | 6.1 |
| Hispanic or Latino | 5.2 | 5.3 | 10.5 | 10.1 | 4.1 | 4.1 | 4.8 | 5.2 | 3.0 | 2.6 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 5.1 | 5.4 | 10.9 | 11.1 | 4.3 | 4.6 | 5.6 | 6.1 | 2.2 | 2.1 |
| Part-Time | 8.2 | 8.3 | 13.5 | 13.3 | 6.2 | 6.4 | 10.4 | 10.0 | 2.6 | 3.3 |
| Unemployed | 9.3 | 10.4 | 15.3 | 11.3 | 7.4 | 10.1 | 9.7 | 13.2 | 3.2 | 4.5 |
| Other1 | 5.3 | 5.4 | 11.0 | 10.8 | 4.6 | 4.9 | 10.2 | 9.9 | 2.8 | 3.3 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 14,526 | 15,360 | 4,012 | 4,031 | 10,513 | 11,329 | 7,448 | 7,809 | 3,066 | 3,520 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2,153 | 2,323 | 621 | 624 | 1,532 | 1,698 | 1,188 | 1,198 | 344 | 501 |
| Midwest | 3,051 | 3,334 | 828 | 811 | 2,223 | 2,523 | 1,669 | 1,746 | 554 | 777 |
| South | 5,538 | 5,764 | 1,529 | 1,523 | 4,009 | 4,240 | 2,710 | 2,841 | 1,299 | 1,399 |
| West | 3,783 | 3,940 | 1,034 | 1,073 | 2,749 | 2,867 | 1,881 | 2,024 | 868 | 843 |
| COUNTY TYPE | ||||||||||
| Large Metro | 7,066 | 7,675 | 2,073 | 2,147 | 4,994 | 5,528 | 3,657 | 3,865 | 1,336 | 1,663 |
| Small Metro | 5,068 | 5,539 | 1,358 | 1,429 | 3,710 | 4,110 | 2,657 | 2,919 | 1,053 | 1,190 |
| Nonmetro | 2,392 | 2,147 | 582 | 455 | 1,810 | 1,692 | 1,134 | 1,025 | 676 | 667 |
| Urbanized | 999 | 918 | 289 | 239 | 710 | 679 | 517 | 431 | 193 | 248 |
| Less Urbanized | 1,200 | 998 | 235 | 196 | 965 | 801 | 544 | 538 | 421 | 263 |
| Completely Rural | 192 | 231 | 58 | * | 134 | 211 | 72 | 55 | 62 | * |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 3,176 | 3,085 | 948 | 790 | 2,228 | 2,295 | 1,460 | 1,493 | 768 | 801 |
| 100-199% | 3,509 | 3,691 | 1,093 | 1,053 | 2,416 | 2,638 | 1,655 | 1,520 | 761 | 1,118 |
| 200% or More | 7,837 | 8,584 | 1,968 | 2,188 | 5,869 | 6,396 | 4,333 | 4,796 | 1,536 | 1,600 |
| EDUCATION LEVEL | ||||||||||
| < High School | 1,205 | 1,272 | 325 | 394 | 880 | 878 | 448 | 421 | 432 | 457 |
| High School Graduate | 3,446a | 4,110 | 1,241 | 1,313 | 2,205 | 2,796 | 1,328a | 1,712 | 876 | 1,084 |
| Some College/Associate’s Degree | 6,272 | 5,829 | 1,979 | 1,765 | 4,293 | 4,064 | 3,177 | 2,964 | 1,116 | 1,100 |
| College Graduate | 3,603 | 4,150 | 467 | 559 | 3,136 | 3,591 | 2,494 | 2,712 | 642 | 879 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 7,206a | 8,179 | 2,431 | 2,491 | 4,775a | 5,687 | 3,630 | 4,165 | 1,145 | 1,523 |
| Medicaid/CHIP | 4,149a | 4,942 | 959 | 1,035 | 3,191a | 3,908 | 2,248 | 2,515 | 943 | 1,393 |
| Other3 | 3,071 | 2,929 | 315 | 319 | 2,756 | 2,610 | 1,149 | 884 | 1,607 | 1,726 |
| No Coverage | 1,718 | 1,512 | 472 | 427 | 1,246 | 1,084 | 1,048 | 887 | 198 | 197 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 5.7 | 6.0 | 12.0 | 11.6 | 4.8 | 5.1 | 7.3 | 7.6 | 2.6 | 3.0 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 4.8 | 5.2 | 10.8 | 10.6 | 3.9 | 4.3 | 6.8 | 6.9 | 1.6 | 2.3 |
| Midwest | 5.8 | 6.3 | 11.7 | 11.1 | 4.9 | 5.6 | 8.1 | 8.5 | 2.2 | 3.1 |
| South | 5.7 | 5.9 | 12.0 | 11.4 | 4.8 | 5.0 | 7.0 | 7.2 | 2.9 | 3.1 |
| West | 6.3 | 6.5 | 13.0 | 13.0 | 5.3 | 5.5 | 7.4 | 7.9 | 3.3 | 3.1 |
| COUNTY TYPE | ||||||||||
| Large Metro | 5.2 | 5.4 | 11.7 | 11.2 | 4.2 | 4.5 | 6.3 | 6.6 | 2.2 | 2.6 |
| Small Metro | 6.5 | 6.8 | 12.4 | 12.2 | 5.6 | 5.9 | 8.7 | 9.0 | 2.9 | 3.2 |
| Nonmetro | 6.1 | 6.3 | 12.0 | 11.4 | 5.2 | 5.7 | 8.1 | 9.1 | 3.3 | 3.6 |
| Urbanized | 6.8 | 6.5 | 14.3 | 13.6 | 5.6 | 5.4 | 10.0 | 8.8 | 2.6 | 3.3 |
| Less Urbanized | 5.8 | 5.9 | 10.0 | 10.0 | 5.3 | 5.3 | 7.4 | 9.7 | 3.9 | 2.8 |
| Completely Rural | 4.6 | 9.0 | 12.5 | * | 3.6 | 9.1 | 5.1 | 6.2 | 2.7 | * |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 8.4 | 8.5 | 11.2 | 9.8 | 7.6 | 8.2 | 9.4 | 9.8 | 5.5 | 6.2 |
| 100-199% | 6.9 | 7.4 | 13.6 | 12.4 | 5.6 | 6.4 | 8.2 | 7.9 | 3.4 | 5.1 |
| 200% or More | 4.7 | 5.0 | 11.7 | 12.0 | 4.0 | 4.2 | 6.5 | 7.0 | 1.9 | 1.9 |
| EDUCATION LEVEL | ||||||||||
| < High School | 4.3 | 5.2 | 8.8 | 11.0 | 3.6 | 4.2 | 4.6 | 5.3 | 2.9 | 3.6 |
| High School Graduate | 5.0a | 5.9 | 11.8 | 11.3 | 3.7a | 4.9 | 5.5a | 7.3 | 2.5 | 3.2 |
| Some College/Associate’s Degree | 8.1 | 7.5 | 14.0 | 12.7 | 6.8 | 6.4 | 10.6 | 9.9 | 3.4 | 3.2 |
| College Graduate | 4.6 | 4.9 | 9.2 | 9.8 | 4.2 | 4.5 | 6.5 | 6.5 | 1.8 | 2.3 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 4.7a | 5.2 | 12.9 | 12.5 | 3.5a | 4.2 | 5.8 | 6.5 | 1.6 | 2.1 |
| Medicaid/CHIP | 8.7a | 10.3 | 11.0 | 11.2 | 8.2a | 10.1 | 10.3 | 11.6 | 5.6 | 8.1 |
| Other3 | 4.1 | 3.8 | 12.4 | 11.4 | 3.8 | 3.5 | 12.6 | 9.6 | 2.5 | 2.7 |
| No Coverage | 6.9 | 6.5 | 9.8 | 9.2 | 6.2 | 5.8 | 7.3 | 6.7 | 3.5 | 3.7 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness (2021) |
No Mental Illness (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | 58,451 | 59,286 | 14,526 | 15,360 | 43,926 | 43,926 | 195,373 | 196,996 |
| AGE GROUP | ||||||||
| 18-25 | 11,536b | 12,583 | 4,012 | 4,031 | 7,523b | 8,551 | 21,923 | 22,203 |
| 26 or Older | 46,916 | 46,703 | 10,513 | 11,329 | 36,402 | 35,374 | 173,451 | 174,792 |
| 26-49 | 29,150 | 30,160 | 7,448 | 7,809 | 21,702 | 22,351 | 73,163 | 72,408 |
| 50 or Older | 17,765 | 16,543 | 3,066 | 3,520 | 14,700a | 13,023 | 100,287a | 102,384 |
| GENDER | ||||||||
| Male | 22,335b | 24,627 | 5,020a | 6,019 | 17,316 | 18,608 | 101,140 | 100,455 |
| Female | 36,116 | 34,659 | 9,506 | 9,341 | 26,610 | 25,318 | 94,233a | 96,541 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 49,640 | 49,836 | 12,266 | 13,031 | 37,375 | 36,806 | 161,050 | 162,191 |
| AIAN | 425a | 243 | 153 | 91 | 272 | 153 | 1,215 | 1,000 |
| Asian | 2,452 | 2,587 | 469 | 626 | 1,983 | 1,961 | 12,462 | 12,824 |
| Black or African American | 6,609 | 6,095 | 1,323 | 1,467 | 5,286 | 4,628 | 23,995 | 24,834 |
| NHOPI | 163 | * | 57 | 43 | 105 | * | 845 | * |
| White | 38,374 | 38,875 | 9,874 | 10,207 | 28,500 | 28,668 | 119,583 | 119,309 |
| Two or More Races | 1,617 | 1,778 | 389a | 598 | 1,228 | 1,180 | 2,950 | 3,270 |
| Hispanic or Latino | 8,811 | 9,450 | 2,260 | 2,330 | 6,551 | 7,120 | 34,324 | 34,805 |
| EMPLOYMENT STATUS | ||||||||
| Full-Time | 25,008a | 26,982 | 5,778 | 6,390 | 19,231 | 20,593 | 89,294 | 91,395 |
| Part-Time | 9,207 | 9,278 | 2,482 | 2,717 | 6,725 | 6,561 | 21,175a | 23,552 |
| Unemployed | 4,316a | 3,689 | 1,223 | 1,149 | 3,092a | 2,540 | 8,770b | 7,328 |
| Other1 | 19,920 | 19,337 | 5,043 | 5,105 | 14,877 | 14,232 | 76,134 | 74,720 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness (2021) |
No Mental Illness (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | 23.0 | 23.1 | 5.7 | 6.0 | 17.3 | 17.1 | 77.0 | 76.9 |
| AGE GROUP | ||||||||
| 18-25 | 34.5 | 36.2 | 12.0 | 11.6 | 22.5a | 24.6 | 65.5 | 63.8 |
| 26 or Older | 21.3 | 21.1 | 4.8 | 5.1 | 16.5 | 16.0 | 78.7 | 78.9 |
| 26-49 | 28.5 | 29.4 | 7.3 | 7.6 | 21.2 | 21.8 | 71.5 | 70.6 |
| 50 or Older | 15.0 | 13.9 | 2.6 | 3.0 | 12.5a | 11.0 | 85.0 | 86.1 |
| GENDER | ||||||||
| Male | 18.1a | 19.7 | 4.1a | 4.8 | 14.0 | 14.9 | 81.9a | 80.3 |
| Female | 27.7 | 26.4 | 7.3 | 7.1 | 20.4 | 19.3 | 72.3 | 73.6 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | 23.6 | 23.5 | 5.8 | 6.1 | 17.7 | 17.4 | 76.4 | 76.5 |
| AIAN | 25.9 | 19.6 | 9.3 | 7.3 | 16.6 | 12.3 | 74.1 | 80.4 |
| Asian | 16.4 | 16.8 | 3.1 | 4.1 | 13.3 | 12.7 | 83.6 | 83.2 |
| Black or African American | 21.6 | 19.7 | 4.3 | 4.7 | 17.3a | 15.0 | 78.4 | 80.3 |
| NHOPI | 16.1 | * | 5.7 | 3.5 | 10.4 | * | 83.9 | * |
| White | 24.3 | 24.6 | 6.3 | 6.5 | 18.0 | 18.1 | 75.7 | 75.4 |
| Two or More Races | 35.4 | 35.2 | 8.5 | 11.8 | 26.9 | 23.4 | 64.6 | 64.8 |
| Hispanic or Latino | 20.4 | 21.4 | 5.2 | 5.3 | 15.2 | 16.1 | 79.6 | 78.6 |
| EMPLOYMENT STATUS | ||||||||
| Full-Time | 21.9 | 22.8 | 5.1 | 5.4 | 16.8 | 17.4 | 78.1 | 77.2 |
| Part-Time | 30.3 | 28.3 | 8.2 | 8.3 | 22.1 | 20.0 | 69.7 | 71.7 |
| Unemployed | 33.0 | 33.5 | 9.3 | 10.4 | 23.6 | 23.1 | 67.0 | 66.5 |
| Other1 | 20.7 | 20.6 | 5.3 | 5.4 | 15.5 | 15.1 | 79.3 | 79.4 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic Characteristic | Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness (2021) |
No Mental Illness (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | 58,451 | 59,286 | 14,526 | 15,360 | 43,926 | 43,926 | 195,373 | 196,996 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 9,380 | 9,805 | 2,153 | 2,323 | 7,227 | 7,482 | 35,406 | 35,154 |
| Midwest | 12,407 | 12,964 | 3,051 | 3,334 | 9,356 | 9,630 | 40,132 | 39,792 |
| South | 22,010 | 21,382 | 5,538 | 5,764 | 16,471 | 15,619 | 74,426b | 76,604 |
| West | 14,654 | 15,135 | 3,783 | 3,940 | 10,871 | 11,195 | 45,409 | 45,446 |
| COUNTY TYPE | ||||||||
| Large Metro | 30,550 | 31,197 | 7,066 | 7,675 | 23,484 | 23,523 | 106,166 | 109,925 |
| Small Metro | 18,786 | 20,311 | 5,068 | 5,539 | 13,718 | 14,772 | 58,991 | 61,038 |
| Nonmetro | 9,115 | 7,778 | 2,392 | 2,147 | 6,723a | 5,631 | 30,216a | 26,032 |
| Urbanized | 3,603 | 3,317 | 999 | 918 | 2,604 | 2,399 | 11,037 | 10,914 |
| Less Urbanized | 4,556 | 3,798 | 1,200 | 998 | 3,356 | 2,800 | 15,970 | 13,206 |
| Completely Rural | 955 | 663 | 192 | 231 | 763 | 432 | 3,208a | 1,913 |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | 11,083 | 10,459 | 3,176 | 3,085 | 7,907 | 7,374 | 26,781 | 25,746 |
| 100-199% | 13,661 | 12,663 | 3,509 | 3,691 | 10,152 | 8,972 | 37,122 | 37,163 |
| 200% or More | 33,663a | 36,161 | 7,837 | 8,584 | 25,826 | 27,577 | 131,413 | 134,082 |
| EDUCATION LEVEL | ||||||||
| < High School | 5,540 | 5,214 | 1,205 | 1,272 | 4,335 | 3,942 | 22,721b | 19,149 |
| High School Graduate | 14,062 | 14,235 | 3,446a | 4,110 | 10,616 | 10,125 | 55,331 | 54,909 |
| Some College/Associate’s Degree | 21,199 | 20,777 | 6,272 | 5,829 | 14,926 | 14,948 | 55,989 | 56,991 |
| College Graduate | 17,651a | 19,060 | 3,603 | 4,150 | 14,048 | 14,910 | 61,332b | 65,947 |
| HEALTH INSURANCE2 | ||||||||
| Private | 32,105 | 33,891 | 7,206a | 8,179 | 24,899 | 25,713 | 122,340 | 122,020 |
| Medicaid/CHIP | 15,014 | 15,340 | 4,149a | 4,942 | 10,864 | 10,398 | 32,431 | 32,745 |
| Other3 | 14,083a | 12,398 | 3,071 | 2,929 | 11,012a | 9,469 | 61,206 | 64,327 |
| No Coverage | 6,028 | 5,856 | 1,718 | 1,512 | 4,310 | 4,345 | 18,767 | 17,388 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic Characteristic | Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness (2021) |
No Mental Illness (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL | 23.0 | 23.1 | 5.7 | 6.0 | 17.3 | 17.1 | 77.0 | 76.9 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | 20.9 | 21.8 | 4.8 | 5.2 | 16.1 | 16.6 | 79.1 | 78.2 |
| Midwest | 23.6 | 24.6 | 5.8 | 6.3 | 17.8 | 18.3 | 76.4 | 75.4 |
| South | 22.8 | 21.8 | 5.7 | 5.9 | 17.1 | 15.9 | 77.2 | 78.2 |
| West | 24.4 | 25.0 | 6.3 | 6.5 | 18.1 | 18.5 | 75.6 | 75.0 |
| COUNTY TYPE | ||||||||
| Large Metro | 22.3 | 22.1 | 5.2 | 5.4 | 17.2 | 16.7 | 77.7 | 77.9 |
| Small Metro | 24.2 | 25.0 | 6.5 | 6.8 | 17.6 | 18.2 | 75.8 | 75.0 |
| Nonmetro | 23.2 | 23.0 | 6.1 | 6.3 | 17.1 | 16.7 | 76.8 | 77.0 |
| Urbanized | 24.6 | 23.3 | 6.8 | 6.5 | 17.8 | 16.9 | 75.4 | 76.7 |
| Less Urbanized | 22.2 | 22.3 | 5.8 | 5.9 | 16.3 | 16.5 | 77.8 | 77.7 |
| Completely Rural | 22.9 | 25.7 | 4.6 | 9.0 | 18.3 | 16.8 | 77.1 | 74.3 |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | 29.3 | 28.9 | 8.4 | 8.5 | 20.9 | 20.4 | 70.7 | 71.1 |
| 100-199% | 26.9 | 25.4 | 6.9 | 7.4 | 20.0 | 18.0 | 73.1 | 74.6 |
| 200% or More | 20.4 | 21.2 | 4.7 | 5.0 | 15.6 | 16.2 | 79.6 | 78.8 |
| EDUCATION LEVEL | ||||||||
| < High School | 19.6 | 21.4 | 4.3 | 5.2 | 15.3 | 16.2 | 80.4 | 78.6 |
| High School Graduate | 20.3 | 20.6 | 5.0a | 5.9 | 15.3 | 14.6 | 79.7 | 79.4 |
| Some College/Associate’s Degree | 27.5 | 26.7 | 8.1 | 7.5 | 19.3 | 19.2 | 72.5 | 73.3 |
| College Graduate | 22.3 | 22.4 | 4.6 | 4.9 | 17.8 | 17.5 | 77.7 | 77.6 |
| HEALTH INSURANCE2 | ||||||||
| Private | 20.8 | 21.7 | 4.7a | 5.2 | 16.1 | 16.5 | 79.2 | 78.3 |
| Medicaid/CHIP | 31.6 | 31.9 | 8.7a | 10.3 | 22.9 | 21.6 | 68.4 | 68.1 |
| Other3 | 18.7b | 16.2 | 4.1 | 3.8 | 14.6b | 12.3 | 81.3b | 83.8 |
| No Coverage | 24.3 | 25.2 | 6.9 | 6.5 | 17.4 | 18.7 | 75.7 | 74.8 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 83,142 | 84,236 | 15,674b | 16,982 | 67,468 | 67,255 | 40,740 | 41,677 | 26,728 | 25,577 |
| GENDER | ||||||||||
| Male | 38,506a | 40,897 | 7,080b | 7,982 | 31,425 | 32,915 | 19,429a | 20,857 | 11,996 | 12,058 |
| Female | 44,637 | 43,339 | 8,593 | 9,000 | 36,043 | 34,340 | 21,311 | 20,820 | 14,732 | 13,520 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 70,207 | 70,189 | 12,479a | 13,228 | 57,728 | 56,961 | 33,759 | 34,274 | 23,969 | 22,687 |
| AIAN | 740a | 446 | * | * | 540 | 345 | * | 219 | * | * |
| Asian | 3,202 | 3,469 | 741 | 886 | 2,462 | 2,582 | 1,665 | 1,718 | 796 | 865 |
| Black or African American | 9,888 | 9,676 | 1,773 | 1,925 | 8,115 | 7,752 | 4,984 | 5,017 | 3,131 | 2,735 |
| NHOPI | * | * | * | * | * | * | * | * | * | * |
| White | 53,862 | 53,805 | 9,208 | 9,675 | 44,654 | 44,129 | 25,486 | 26,067 | 19,169 | 18,063 |
| Two or More Races | 2,242 | 2,343 | 490 | 592 | 1,752 | 1,751 | 1,156 | 1,082 | 596 | 669 |
| Hispanic or Latino | 12,936 | 14,047 | 3,195b | 3,753 | 9,741 | 10,293 | 6,981 | 7,403 | 2,759 | 2,891 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 37,418b | 40,847 | 6,210a | 6,980 | 31,208a | 33,867 | 23,653a | 26,058 | 7,555 | 7,809 |
| Part-Time | 11,974 | 12,567 | 4,009a | 4,635 | 7,965 | 7,932 | 4,898 | 4,807 | 3,067 | 3,125 |
| Unemployed | 6,101b | 4,999 | 1,586 | 1,594 | 4,515b | 3,405 | 3,365b | 2,484 | 1,150 | 920 |
| Other1 | 27,650 | 25,823 | 3,869 | 3,773 | 23,781 | 22,050 | 8,825 | 8,327 | 14,955 | 13,723 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 32.8 | 32.9 | 46.8 | 48.8 | 30.6 | 30.4 | 39.8 | 40.6 | 22.6 | 21.5 |
| GENDER | ||||||||||
| Male | 31.2 | 32.7 | 42.3a | 45.6 | 29.4 | 30.6 | 38.2a | 40.7 | 21.4 | 21.4 |
| Female | 34.2 | 33.0 | 51.4 | 52.0 | 31.7 | 30.1 | 41.4 | 40.6 | 23.7 | 21.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 33.3 | 33.1 | 48.7 | 49.9 | 31.2 | 30.7 | 41.7 | 42.3 | 23.0 | 21.7 |
| AIAN | 45.1 | 35.9 | * | * | 41.3 | 33.4 | * | 39.8 | * | * |
| Asian | 21.5 | 22.5 | 37.9 | 39.1 | 19.0 | 19.6 | 22.5 | 23.0 | 14.3 | 15.2 |
| Black or African American | 32.3 | 31.3 | 39.1 | 41.3 | 31.1 | 29.5 | 37.3 | 37.4 | 24.6 | 21.3 |
| NHOPI | * | * | * | * | * | * | * | * | * | * |
| White | 34.1 | 34.0 | 52.0 | 53.0 | 31.8 | 31.5 | 44.5 | 45.8 | 23.1 | 21.8 |
| Two or More Races | 49.1 | 46.4 | 52.9 | 59.0 | 48.1 | 43.3 | 56.8 | 49.7 | 37.2 | 35.9 |
| Hispanic or Latino | 30.0 | 31.7 | 40.8a | 45.4 | 27.6 | 28.6 | 32.8 | 34.4 | 19.6 | 19.9 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 32.7a | 34.5 | 48.8 | 49.6 | 30.7a | 32.5 | 36.8a | 39.3 | 20.2 | 20.6 |
| Part-Time | 39.4 | 38.3 | 49.1 | 52.7 | 35.8 | 33.0 | 47.5 | 43.0 | 25.8 | 24.3 |
| Unemployed | 46.6 | 45.4 | 50.0 | 49.7 | 45.5 | 43.6 | 52.2 | 49.3 | 33.1 | 33.3 |
| Other1 | 28.8 | 27.5 | 41.1 | 43.3 | 27.4 | 25.8 | 41.4 | 41.7 | 22.9 | 21.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 19,692b | 21,543 | 4,626b | 5,270 | 15,066 | 16,274 | 10,616a | 11,669 | 4,450 | 4,605 |
| GENDER | ||||||||||
| Male | 8,869b | 10,408 | 1,966 | 2,278 | 6,903a | 8,129 | 4,984a | 5,920 | 1,919 | 2,209 |
| Female | 10,824 | 11,136 | 2,660 | 2,991 | 8,164 | 8,144 | 5,632 | 5,749 | 2,532 | 2,396 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 16,563a | 17,927 | 3,751 | 4,083 | 12,811 | 13,844 | 8,795a | 9,665 | 4,016 | 4,179 |
| AIAN | 164 | 121 | * | 43 | 73 | 78 | 66 | 63 | * | 14 |
| Asian | 546 | 593 | 143 | 164 | 403 | 428 | 374 | 322 | 29 | 106 |
| Black or African American | 2,250 | 2,430 | 525 | 498 | 1,726 | 1,932 | 1,137 | 1,405 | 589 | 527 |
| NHOPI | 95 | * | * | * | * | * | * | * | * | * |
| White | 12,765a | 14,068 | 2,832 | 3,186 | 9,933 | 10,882 | 6,753 | 7,559 | 3,180 | 3,323 |
| Two or More Races | 742 | 630 | 148 | 187 | 594 | 443 | 392 | 284 | * | 159 |
| Hispanic or Latino | 3,130 | 3,617 | 875b | 1,187 | 2,255 | 2,430 | 1,821 | 2,004 | 434 | 425 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 8,400b | 9,960 | 1,762b | 2,279 | 6,637a | 7,681 | 5,382b | 6,551 | 1,255 | 1,129 |
| Part-Time | 3,452 | 3,455 | 1,324 | 1,395 | 2,128 | 2,060 | 1,523 | 1,472 | 605 | 588 |
| Unemployed | 1,779 | 1,760 | 586 | 483 | 1,193 | 1,276 | 965 | 1,059 | 228 | 218 |
| Other1 | 6,062 | 6,369 | 953 | 1,112 | 5,108 | 5,257 | 2,746 | 2,587 | 2,362 | 2,670 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 7.8a | 8.4 | 13.8 | 15.1 | 6.8 | 7.3 | 10.4a | 11.4 | 3.8 | 3.9 |
| GENDER | ||||||||||
| Male | 7.2b | 8.3 | 11.8 | 13.0 | 6.5a | 7.6 | 9.8a | 11.5 | 3.4 | 3.9 |
| Female | 8.3 | 8.5 | 15.9 | 17.3 | 7.2 | 7.2 | 10.9 | 11.2 | 4.1 | 3.8 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 7.9 | 8.5 | 14.6 | 15.4 | 6.9 | 7.5 | 10.9a | 11.9 | 3.9 | 4.0 |
| AIAN | 10.0 | 9.7 | * | 20.5 | 5.6 | 7.5 | 11.3 | 11.5 | * | 3.0 |
| Asian | 3.7 | 3.8 | 7.3 | 7.3 | 3.1 | 3.3 | 5.1 | 4.3 | 0.5 | 1.9 |
| Black or African American | 7.4 | 7.9 | 11.6 | 10.7 | 6.6 | 7.4 | 8.5 | 10.5 | 4.6 | 4.1 |
| NHOPI | 9.4 | * | * | * | * | * | * | * | * | * |
| White | 8.1a | 8.9 | 16.0 | 17.5 | 7.1 | 7.8 | 11.8a | 13.3 | 3.8 | 4.0 |
| Two or More Races | 16.3 | 12.5 | 16.0 | 18.7 | 16.3 | 11.0 | 19.3 | 13.0 | * | 8.5 |
| Hispanic or Latino | 7.3 | 8.2 | 11.2a | 14.4 | 6.4 | 6.7 | 8.6 | 9.3 | 3.1 | 2.9 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 7.3b | 8.4 | 13.9a | 16.2 | 6.5 | 7.4 | 8.4b | 9.9 | 3.4 | 3.0 |
| Part-Time | 11.4 | 10.5 | 16.2 | 15.9 | 9.6 | 8.6 | 14.8 | 13.2 | 5.1 | 4.6 |
| Unemployed | 13.6 | 16.0 | 18.5 | 15.1 | 12.0a | 16.3 | 15.0a | 21.0 | 6.6 | 7.9 |
| Other1 | 6.3 | 6.8 | 10.1a | 12.8 | 5.9 | 6.2 | 12.9 | 12.9 | 3.6 | 4.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 19,692b | 21,543 | 4,626b | 5,270 | 15,066 | 16,274 | 10,616a | 11,669 | 4,450 | 4,605 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2,902 | 3,388 | 734 | 853 | 2,167 | 2,536 | 1,524 | 1,799 | 644 | 736 |
| Midwest | 4,254a | 4,866 | 1,070 | 1,142 | 3,185a | 3,724 | 2,262 | 2,441 | 923 | 1,284 |
| South | 7,140 | 7,516 | 1,580 | 1,782 | 5,560 | 5,734 | 3,814 | 4,159 | 1,745 | 1,576 |
| West | 5,397 | 5,773 | 1,242a | 1,494 | 4,155 | 4,279 | 3,016 | 3,270 | 1,138 | 1,009 |
| COUNTY TYPE | ||||||||||
| Large Metro | 10,728 | 11,394 | 2,389 | 2,794 | 8,339 | 8,600 | 6,116 | 6,174 | 2,222 | 2,425 |
| Small Metro | 5,918b | 7,506 | 1,595 | 1,920 | 4,323b | 5,586 | 3,074b | 3,966 | 1,249 | 1,621 |
| Nonmetro | 3,046 | 2,643 | 642 | 555 | 2,404 | 2,088 | 1,426 | 1,530 | 979a | 558 |
| Urbanized | 1,227 | 1,196 | 317 | 266 | 910 | 930 | 599 | 678 | 310 | 252 |
| Less Urbanized | 1,459 | 1,225 | 269 | 279 | 1,190 | 946 | 672 | 740 | 518a | 207 |
| Completely Rural | 360 | 222 | 55b | 10 | 305 | 212 | 154 | * | 150 | * |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 3,942 | 4,189 | 1,159 | 1,129 | 2,783 | 3,059 | 1,873 | 2,025 | 910 | 1,035 |
| 100-199% | 4,856 | 4,934 | 1,156 | 1,389 | 3,700 | 3,545 | 2,306 | 2,346 | 1,394 | 1,198 |
| 200% or More | 10,888b | 12,421 | 2,306a | 2,751 | 8,583a | 9,670 | 6,437a | 7,298 | 2,146 | 2,372 |
| EDUCATION LEVEL | ||||||||||
| < High School | 1,937 | 1,783 | 384 | 456 | 1,553 | 1,327 | 850 | 896 | 703 | 431 |
| High School Graduate | 4,752a | 5,519 | 1,371 | 1,498 | 3,380 | 4,021 | 2,298 | 2,706 | 1,083 | 1,315 |
| Some College/Associate’s Degree | 8,060 | 8,187 | 2,172 | 2,399 | 5,887 | 5,788 | 4,114 | 4,267 | 1,773 | 1,521 |
| College Graduate | 4,944b | 6,055 | 699a | 917 | 4,246a | 5,139 | 3,354 | 3,801 | 892a | 1,338 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 9,467b | 11,347 | 2,716a | 3,223 | 6,750b | 8,124 | 4,775b | 6,060 | 1,975 | 2,065 |
| Medicaid/CHIP | 6,147 | 6,449 | 1,110a | 1,390 | 5,037 | 5,059 | 3,550 | 3,552 | 1,487 | 1,507 |
| Other3 | 3,988 | 3,944 | 455 | 374 | 3,533 | 3,570 | 1,492 | 1,281 | 2,041 | 2,289 |
| No Coverage | 2,316 | 2,404 | 544 | 540 | 1,772 | 1,864 | 1,594 | 1,572 | 178 | 292 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 7.8a | 8.4 | 13.8 | 15.1 | 6.8 | 7.3 | 10.4a | 11.4 | 3.8 | 3.9 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 6.5 | 7.5 | 12.8 | 14.4 | 5.5 | 6.5 | 8.8 | 10.4 | 3.0 | 3.4 |
| Midwest | 8.1a | 9.2 | 15.1 | 15.6 | 7.0a | 8.2 | 11.0 | 11.9 | 3.7 | 5.1 |
| South | 7.4 | 7.7 | 12.4 | 13.4 | 6.6 | 6.8 | 9.8 | 10.6 | 3.9 | 3.5 |
| West | 9.0 | 9.5 | 15.7 | 18.1 | 8.0 | 8.2 | 11.8 | 12.8 | 4.3 | 3.8 |
| COUNTY TYPE | ||||||||||
| Large Metro | 7.8 | 8.1 | 13.5 | 14.6 | 7.0 | 7.0 | 10.6 | 10.5 | 3.6 | 3.8 |
| Small Metro | 7.6b | 9.2 | 14.5 | 16.4 | 6.5b | 8.0 | 10.1b | 12.2 | 3.4 | 4.4 |
| Nonmetro | 7.7 | 7.8 | 13.3 | 13.9 | 7.0 | 7.0 | 10.2b | 13.5 | 4.8 | 3.0 |
| Urbanized | 8.4 | 8.4 | 15.7 | 15.1 | 7.2 | 7.5 | 11.5 | 13.9 | 4.2 | 3.3 |
| Less Urbanized | 7.1 | 7.2 | 11.4 | 14.2 | 6.5 | 6.3 | 9.1a | 13.4 | 4.8a | 2.2 |
| Completely Rural | 8.7 | 8.6 | 11.9a | 4.1 | 8.2 | 9.1 | 11.0 | * | 6.5 | * |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 10.4 | 11.6 | 13.7 | 14.0 | 9.5 | 10.9 | 12.1 | 13.3 | 6.6 | 8.0 |
| 100-199% | 9.6 | 9.9 | 14.4 | 16.4 | 8.7 | 8.6 | 11.4 | 12.2 | 6.2 | 5.4 |
| 200% or More | 6.6a | 7.3 | 13.7 | 15.1 | 5.8 | 6.4 | 9.7 | 10.7 | 2.6 | 2.8 |
| EDUCATION LEVEL | ||||||||||
| < High School | 6.9 | 7.3 | 10.4 | 12.7 | 6.3 | 6.4 | 8.8 | 11.3 | 4.7 | 3.4 |
| High School Graduate | 6.8a | 8.0 | 13.0 | 12.9 | 5.7a | 7.0 | 9.5a | 11.6 | 3.1 | 3.8 |
| Some College/Associate’s Degree | 10.4 | 10.5 | 15.4 | 17.3 | 9.3 | 9.1 | 13.8 | 14.3 | 5.3 | 4.5 |
| College Graduate | 6.3a | 7.1 | 13.8 | 16.1 | 5.7 | 6.5 | 8.7 | 9.2 | 2.5 | 3.5 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 6.1b | 7.3 | 14.4 | 16.2 | 5.0b | 6.0 | 7.6b | 9.4 | 2.7 | 2.9 |
| Medicaid/CHIP | 13.0 | 13.4 | 12.8 | 15.0 | 13.0 | 13.0 | 16.3 | 16.3 | 8.8 | 8.8 |
| Other3 | 5.3 | 5.1 | 17.9 | 13.3 | 4.9 | 4.8 | 16.4 | 14.0 | 3.2 | 3.5 |
| No Coverage | 9.3 | 10.3 | 11.3 | 11.7 | 8.9 | 10.0 | 11.1 | 11.9 | 3.2 | 5.4 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 52,353 | 54,444 | 10,877a | 11,622 | 41,476 | 42,822 | 26,205 | 27,168 | 15,271 | 15,655 |
| GENDER | ||||||||||
| Male | 27,447a | 29,366 | 5,244a | 5,785 | 22,203 | 23,581 | 14,169 | 15,186 | 8,034 | 8,395 |
| Female | 24,906 | 25,078 | 5,633 | 5,837 | 19,273 | 19,242 | 12,036 | 11,982 | 7,237 | 7,260 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 44,022 | 45,188 | 8,668 | 9,026 | 35,355 | 36,163 | 21,587 | 22,198 | 13,768 | 13,964 |
| AIAN | 572a | 350 | * | * | 383 | 268 | 217 | 166 | * | * |
| Asian | 1,673 | 1,924 | 407 | 564 | 1,266 | 1,361 | 915 | 873 | 351 | 487 |
| Black or African American | 6,174 | 6,633 | 1,264 | 1,299 | 4,910 | 5,333 | 3,305 | 3,485 | 1,605 | 1,848 |
| NHOPI | * | * | * | * | * | * | * | * | * | * |
| White | 33,808 | 34,470 | 6,406 | 6,674 | 27,402 | 27,795 | 16,205 | 16,797 | 11,197 | 10,998 |
| Two or More Races | 1,571 | 1,521 | 352 | 365 | 1,219 | 1,156 | 825 | 757 | * | 399 |
| Hispanic or Latino | 8,331 | 9,256 | 2,209a | 2,596 | 6,121 | 6,660 | 4,618 | 4,970 | 1,503 | 1,690 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 24,182b | 27,254 | 4,417b | 5,141 | 19,765b | 22,113 | 15,134a | 16,918 | 4,631 | 5,195 |
| Part-Time | 7,414 | 8,107 | 2,744 | 3,024 | 4,670 | 5,083 | 2,915 | 3,121 | 1,755 | 1,962 |
| Unemployed | 4,101 | 3,564 | 1,161 | 1,115 | 2,939 | 2,449 | 2,327a | 1,823 | 613 | 627 |
| Other1 | 16,656 | 15,520 | 2,554 | 2,343 | 14,102 | 13,177 | 5,830 | 5,306 | 8,273 | 7,871 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 20.6 | 21.2 | 32.5 | 33.4 | 18.8 | 19.3 | 25.6 | 26.5 | 12.9 | 13.2 |
| GENDER | ||||||||||
| Male | 22.2 | 23.5 | 31.4 | 33.1 | 20.8 | 21.9 | 27.9 | 29.6 | 14.4 | 14.9 |
| Female | 19.1 | 19.1 | 33.7 | 33.7 | 17.0 | 16.9 | 23.4 | 23.4 | 11.7 | 11.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 20.9 | 21.3 | 33.8 | 34.0 | 19.1 | 19.5 | 26.6 | 27.4 | 13.2 | 13.4 |
| AIAN | 34.9 | 28.2 | * | * | 29.3 | 26.0 | 37.2 | 30.2 | * | * |
| Asian | 11.2 | 12.5 | 20.8 | 24.9 | 9.8 | 10.4 | 12.4 | 11.7 | 6.3 | 8.6 |
| Black or African American | 20.2 | 21.4 | 27.9 | 27.9 | 18.8 | 20.3 | 24.8 | 26.0 | 12.6 | 14.4 |
| NHOPI | * | * | * | * | * | * | * | * | * | * |
| White | 21.4 | 21.8 | 36.2 | 36.6 | 19.5 | 19.9 | 28.3 | 29.5 | 13.5 | 13.2 |
| Two or More Races | 34.4 | 30.1 | 38.0 | 36.4 | 33.5 | 28.6 | 40.5 | 34.8 | * | 21.4 |
| Hispanic or Latino | 19.3 | 20.9 | 28.2 | 31.4 | 17.3 | 18.5 | 21.7 | 23.1 | 10.7 | 11.7 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 21.2b | 23.0 | 34.7 | 36.5 | 19.5a | 21.2 | 23.6a | 25.5 | 12.4 | 13.7 |
| Part-Time | 24.4 | 24.7 | 33.6 | 34.4 | 21.0 | 21.1 | 28.2 | 27.9 | 14.8 | 15.3 |
| Unemployed | 31.3 | 32.3 | 36.6 | 34.7 | 29.6 | 31.4 | 36.1 | 36.2 | 17.7 | 22.6 |
| Other1 | 17.3 | 16.5 | 27.1 | 26.9 | 16.3 | 15.4 | 27.4 | 26.5 | 12.7 | 12.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 6,556a | 7,410 | 1,900 | 2,078 | 4,656 | 5,332 | 3,449 | 3,827 | 1,208 | 1,504 |
| GENDER | ||||||||||
| Male | 2,612a | 3,331 | 626 | 759 | 1,986a | 2,572 | 1,495 | 1,835 | 491 | 737 |
| Female | 3,944 | 4,079 | 1,273 | 1,320 | 2,671 | 2,759 | 1,954 | 1,992 | 716 | 767 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 5,372 | 6,122 | 1,475 | 1,577 | 3,897 | 4,545 | 2,873 | 3,213 | 1,024 | 1,332 |
| AIAN | 60 | 64 | * | * | 18 | 38 | 17 | 33 | * | 5 |
| Asian | 91 | 176 | 36 | 57 | 55 | 120 | 55 | 67 | * | * |
| Black or African American | 678 | 846 | 211 | 156 | 467 | 690 | 311 | 480 | 156 | 209 |
| NHOPI | 38 | 30 | * | * | * | * | * | * | * | * |
| White | 4,318 | 4,734 | 1,130 | 1,243 | 3,189 | 3,492 | 2,366 | 2,470 | 823 | 1,021 |
| Two or More Races | 185 | 272 | 55 | 95 | 131 | 177 | 87 | 137 | 44 | 40 |
| Hispanic or Latino | 1,184 | 1,288 | 425 | 501 | 759 | 786 | 576 | 614 | 184 | 172 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 2,405a | 2,961 | 691a | 903 | 1,714 | 2,058 | 1,404a | 1,775 | 310 | 283 |
| Part-Time | 1,286 | 1,354 | 502 | 549 | 784 | 806 | 632 | 575 | 152 | 230 |
| Unemployed | 686 | 655 | 301a | 155 | 385 | 500 | 326 | 462 | 60 | 38 |
| Other1 | 2,179 | 2,440 | 406 | 472 | 1,773 | 1,969 | 1,087 | 1,015 | 685 | 954 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 2.6 | 2.9 | 5.7 | 6.0 | 2.1 | 2.4 | 3.4 | 3.7 | 1.0 | 1.3 |
| GENDER | ||||||||||
| Male | 2.1a | 2.7 | 3.7 | 4.3 | 1.9a | 2.4 | 2.9 | 3.6 | 0.9 | 1.3 |
| Female | 3.0 | 3.1 | 7.6 | 7.6 | 2.4 | 2.4 | 3.8 | 3.9 | 1.2 | 1.2 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 2.5 | 2.9 | 5.8 | 5.9 | 2.1 | 2.5 | 3.5 | 4.0 | 1.0 | 1.3 |
| AIAN | 3.7 | 5.2 | * | * | 1.4 | 3.7 | 3.0 | 5.9 | * | 1.0 |
| Asian | 0.6 | 1.1 | 1.9 | 2.5 | 0.4 | 0.9 | 0.7 | 0.9 | * | * |
| Black or African American | 2.2 | 2.7 | 4.7 | 3.3 | 1.8 | 2.6 | 2.3 | 3.6 | 1.2 | 1.6 |
| NHOPI | 3.8 | 2.5 | * | * | * | * | * | * | * | * |
| White | 2.7 | 3.0 | 6.4 | 6.8 | 2.3 | 2.5 | 4.1 | 4.3 | 1.0 | 1.2 |
| Two or More Races | 4.1 | 5.4 | 5.9 | 9.5 | 3.6 | 4.4 | 4.3 | 6.3 | 2.7 | 2.2 |
| Hispanic or Latino | 2.7 | 2.9 | 5.4 | 6.1 | 2.2 | 2.2 | 2.7 | 2.9 | 1.3 | 1.2 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 2.1 | 2.5 | 5.4 | 6.4 | 1.7 | 2.0 | 2.2 | 2.7 | 0.8 | 0.7 |
| Part-Time | 4.2 | 4.1 | 6.1 | 6.2 | 3.5 | 3.4 | 6.1 | 5.1 | 1.3 | 1.8 |
| Unemployed | 5.2 | 5.9 | 9.5a | 4.8 | 3.9a | 6.4 | 5.1a | 9.2 | 1.7 | 1.4 |
| Other1 | 2.3 | 2.6 | 4.3 | 5.4 | 2.0 | 2.3 | 5.1 | 5.1 | 1.0 | 1.5 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 6,556a | 7,410 | 1,900 | 2,078 | 4,656 | 5,332 | 3,449 | 3,827 | 1,208 | 1,504 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 921 | 1,131 | 302 | 316 | 619 | 815 | 506 | 561 | 113 | 254 |
| Midwest | 1,341 | 1,685 | 417 | 423 | 924a | 1,262 | 735 | 818 | 189a | 444 |
| South | 2,423 | 2,628 | 664 | 737 | 1,759 | 1,891 | 1,193 | 1,429 | 566 | 462 |
| West | 1,870 | 1,966 | 517 | 603 | 1,354 | 1,363 | 1,014 | 1,019 | 339 | 344 |
| COUNTY TYPE | ||||||||||
| Large Metro | 3,142 | 3,759 | 946 | 1,064 | 2,196 | 2,695 | 1,721 | 1,903 | 475 | 792 |
| Small Metro | 2,308 | 2,749 | 682 | 820 | 1,626 | 1,929 | 1,265 | 1,477 | 361 | 452 |
| Nonmetro | 1,106 | 902 | 271 | 195 | 835 | 707 | 463 | 447 | 372 | 260 |
| Urbanized | 435 | 476 | 125 | 97 | 310 | 379 | 218 | 250 | 92 | 129 |
| Less Urbanized | 565 | 353 | 109 | 97 | 457 | 256 | 208 | 182 | 249 | 74 |
| Completely Rural | 106 | 73 | 37 | * | 68 | 73 | 37 | 15 | * | * |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 1,571 | 1,654 | 502 | 410 | 1,069 | 1,244 | 733 | 862 | 335 | 381 |
| 100-199% | 1,651 | 1,779 | 519 | 566 | 1,132 | 1,212 | 773 | 733 | 359 | 479 |
| 200% or More | 3,334a | 3,978 | 878 | 1,102 | 2,456 | 2,876 | 1,943 | 2,232 | 513 | 644 |
| EDUCATION LEVEL | ||||||||||
| < High School | 589 | 600 | 125 | 199 | 464 | 401 | 232 | 271 | 232 | 130 |
| High School Graduate | 1,630a | 2,088 | 615 | 660 | 1,016a | 1,428 | 693 | 881 | 323 | 547 |
| Some College/Associate’s Degree | 2,884 | 3,083 | 932 | 926 | 1,952 | 2,156 | 1,548 | 1,642 | 403 | 514 |
| College Graduate | 1,453 | 1,640 | 227 | 294 | 1,225 | 1,346 | 976 | 1,033 | 249 | 313 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 2,637b | 3,604 | 1,030 | 1,229 | 1,607b | 2,375 | 1,222b | 1,824 | 385 | 550 |
| Medicaid/CHIP | 2,201 | 2,579 | 491 | 582 | 1,711 | 1,997 | 1,270 | 1,316 | 440 | 680 |
| Other3 | 1,440 | 1,325 | 165 | 162 | 1,275 | 1,163 | 657 | 456 | 618 | 707 |
| No Coverage | 951 | 772 | 270 | 217 | 681 | 555 | 566 | 486 | 115 | 69 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 2.6 | 2.9 | 5.7 | 6.0 | 2.1 | 2.4 | 3.4 | 3.7 | 1.0 | 1.3 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 2.1 | 2.5 | 5.3 | 5.3 | 1.6 | 2.1 | 2.9 | 3.2 | 0.5 | 1.2 |
| Midwest | 2.6 | 3.2 | 5.9 | 5.8 | 2.0a | 2.8 | 3.6 | 4.0 | 0.8a | 1.8 |
| South | 2.5 | 2.7 | 5.2 | 5.5 | 2.1 | 2.2 | 3.1 | 3.6 | 1.3 | 1.0 |
| West | 3.1 | 3.2 | 6.5 | 7.3 | 2.6 | 2.6 | 4.0 | 4.0 | 1.3 | 1.3 |
| COUNTY TYPE | ||||||||||
| Large Metro | 2.3 | 2.7 | 5.4 | 5.6 | 1.8 | 2.2 | 3.0 | 3.2 | 0.8 | 1.3 |
| Small Metro | 3.0 | 3.4 | 6.2 | 7.0 | 2.4 | 2.8 | 4.2 | 4.6 | 1.0 | 1.2 |
| Nonmetro | 2.8 | 2.7 | 5.6 | 4.9 | 2.4 | 2.4 | 3.3 | 4.0 | 1.8 | 1.4 |
| Urbanized | 3.0 | 3.3 | 6.2 | 5.5 | 2.5 | 3.0 | 4.2 | 5.1 | 1.2 | 1.7 |
| Less Urbanized | 2.8 | 2.1 | 4.6 | 4.9 | 2.5 | 1.7 | 2.8 | 3.3 | 2.3 | 0.8 |
| Completely Rural | 2.5 | 2.8 | 8.0 | * | 1.9 | 3.1 | 2.6 | 1.7 | * | * |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 4.1 | 4.6 | 5.9 | 5.1 | 3.6 | 4.4 | 4.7 | 5.7 | 2.4 | 2.9 |
| 100-199% | 3.3 | 3.6 | 6.5 | 6.7 | 2.6 | 2.9 | 3.8 | 3.8 | 1.6 | 2.2 |
| 200% or More | 2.0 | 2.3 | 5.2 | 6.0 | 1.7 | 1.9 | 2.9 | 3.3 | 0.6 | 0.8 |
| EDUCATION LEVEL | ||||||||||
| < High School | 2.1 | 2.5 | 3.4a | 5.5 | 1.9 | 1.9 | 2.4 | 3.4 | 1.6 | 1.0 |
| High School Graduate | 2.3a | 3.0 | 5.8 | 5.7 | 1.7a | 2.5 | 2.9 | 3.8 | 0.9 | 1.6 |
| Some College/Associate’s Degree | 3.7 | 4.0 | 6.6 | 6.7 | 3.1 | 3.4 | 5.2 | 5.5 | 1.2 | 1.5 |
| College Graduate | 1.8 | 1.9 | 4.5 | 5.2 | 1.7 | 1.7 | 2.5 | 2.5 | 0.7 | 0.8 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 1.7b | 2.3 | 5.4 | 6.2 | 1.2b | 1.7 | 2.0b | 2.8 | 0.5 | 0.8 |
| Medicaid/CHIP | 4.6 | 5.4 | 5.6 | 6.3 | 4.4 | 5.1 | 5.8 | 6.1 | 2.6 | 4.0 |
| Other3 | 1.9 | 1.7 | 6.5 | 5.8 | 1.8 | 1.6 | 7.2 | 5.0 | 1.0 | 1.1 |
| No Coverage | 3.8 | 3.3 | 5.6 | 4.7 | 3.4 | 3.0 | 3.9 | 3.7 | 2.0 | 1.3 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 13,136 | 14,134 | 2,726a | 3,191 | 10,410 | 10,942 | 7,167 | 7,842 | 3,243 | 3,100 |
| GENDER | ||||||||||
| Male | 6,257 | 7,077 | 1,340 | 1,520 | 4,917 | 5,557 | 3,490 | 4,085 | 1,427 | 1,472 |
| Female | 6,880 | 7,057 | 1,386a | 1,672 | 5,493 | 5,385 | 3,678 | 3,757 | 1,815 | 1,628 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 11,191 | 11,805 | 2,276 | 2,506 | 8,914 | 9,299 | 5,922 | 6,452 | 2,992 | 2,847 |
| AIAN | 104 | 57 | * | 17 | 54 | 40 | 49 | 31 | * | 9 |
| Asian | 454 | 417 | 107 | 108 | 348 | 309 | 319 | 255 | 29 | 54 |
| Black or African American | 1,572 | 1,584 | 314 | 342 | 1,259 | 1,242 | 826 | 924 | 433 | 318 |
| NHOPI | 57 | * | * | * | * | * | * | 6 | * | * |
| White | 8,446 | 9,333 | 1,702 | 1,943 | 6,744 | 7,390 | 4,387a | 5,088 | 2,357 | 2,302 |
| Two or More Races | 557 | 358 | 93 | 92 | 463 | 266 | 305a | 148 | * | * |
| Hispanic or Latino | 1,946 | 2,329 | 450b | 686 | 1,496 | 1,643 | 1,245 | 1,390 | 250 | 253 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 5,995a | 6,999 | 1,072a | 1,376 | 4,923 | 5,623 | 3,978a | 4,776 | 945 | 846 |
| Part-Time | 2,166 | 2,100 | 822 | 846 | 1,343 | 1,255 | 891 | 896 | 453 | 358 |
| Unemployed | 1,093 | 1,105 | 285 | 329 | 807 | 777 | 639 | 597 | 168 | 180 |
| Other1 | 3,883 | 3,929 | 547 | 641 | 3,336 | 3,288 | 1,658 | 1,572 | 1,677 | 1,716 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 5.2 | 5.5 | 8.1 | 9.2 | 4.7 | 4.9 | 7.0 | 7.6 | 2.7 | 2.6 |
| GENDER | ||||||||||
| Male | 5.1 | 5.7 | 8.0 | 8.7 | 4.6 | 5.2 | 6.9 | 8.0 | 2.6 | 2.6 |
| Female | 5.3 | 5.4 | 8.3 | 9.7 | 4.8 | 4.7 | 7.1 | 7.3 | 2.9 | 2.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 5.3 | 5.6 | 8.9 | 9.4 | 4.8 | 5.0 | 7.3 | 8.0 | 2.9 | 2.7 |
| AIAN | 6.4 | 4.6 | * | 7.9 | 4.2 | 3.9 | 8.3 | 5.6 | * | 1.9 |
| Asian | 3.0 | 2.7 | 5.5 | 4.8 | 2.7 | 2.3 | 4.3 | 3.4 | 0.5 | 0.9 |
| Black or African American | 5.1 | 5.1 | 6.9 | 7.3 | 4.8 | 4.7 | 6.2 | 6.9 | 3.4 | 2.5 |
| NHOPI | 5.6 | * | * | * | * | * | * | 1.1 | * | * |
| White | 5.3 | 5.9 | 9.6 | 10.6 | 4.8 | 5.3 | 7.7a | 8.9 | 2.8 | 2.8 |
| Two or More Races | 12.2a | 7.1 | 10.1 | 9.2 | 12.7a | 6.6 | 15.0a | 6.8 | * | * |
| Hispanic or Latino | 4.5 | 5.3 | 5.8a | 8.3 | 4.2 | 4.6 | 5.9 | 6.5 | 1.8 | 1.7 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 5.2 | 5.9 | 8.4 | 9.8 | 4.8 | 5.4 | 6.2a | 7.2 | 2.5 | 2.2 |
| Part-Time | 7.1 | 6.4 | 10.1 | 9.6 | 6.0 | 5.2 | 8.6 | 8.0 | 3.8 | 2.8 |
| Unemployed | 8.4 | 10.0 | 9.0 | 10.2 | 8.1 | 9.9 | 9.9 | 11.8 | 4.8 | 6.5 |
| Other1 | 4.0 | 4.2 | 5.8 | 7.4 | 3.8 | 3.9 | 7.8 | 7.9 | 2.6 | 2.6 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 13,136 | 14,134 | 2,726a | 3,191 | 10,410 | 10,942 | 7,167 | 7,842 | 3,243 | 3,100 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1,980 | 2,258 | 432 | 537 | 1,548 | 1,721 | 1,017 | 1,238 | 531 | 482 |
| Midwest | 2,913 | 3,181 | 653 | 719 | 2,260 | 2,462 | 1,527 | 1,622 | 733 | 840 |
| South | 4,716 | 4,888 | 916 | 1,044 | 3,800 | 3,843 | 2,621 | 2,730 | 1,179 | 1,114 |
| West | 3,526 | 3,807 | 725 | 891 | 2,801 | 2,916 | 2,002 | 2,251 | 799 | 665 |
| COUNTY TYPE | ||||||||||
| Large Metro | 7,586 | 7,635 | 1,443 | 1,730 | 6,143 | 5,904 | 4,395 | 4,271 | 1,748 | 1,634 |
| Small Metro | 3,610b | 4,757 | 913 | 1,100 | 2,697b | 3,657 | 1,809b | 2,489 | 888 | 1,168 |
| Nonmetro | 1,940 | 1,741 | 370 | 361 | 1,570 | 1,381 | 963 | 1,083 | 607a | 298 |
| Urbanized | 792 | 719 | 192 | 168 | 600 | 551 | 381 | 428 | 219 | 123 |
| Less Urbanized | 894 | 873 | 160 | 182 | 733 | 691 | 464 | 558 | 269 | 133 |
| Completely Rural | 255 | 150 | 18 | 10 | 236 | 139 | 118 | * | 119 | * |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 2,371 | 2,535 | 657 | 720 | 1,714 | 1,816 | 1,139 | 1,162 | 575 | 654 |
| 100-199% | 3,205 | 3,155 | 637a | 823 | 2,569 | 2,332 | 1,534 | 1,613 | 1,035 | 719 |
| 200% or More | 7,554 | 8,443 | 1,428 | 1,649 | 6,127 | 6,794 | 4,494 | 5,067 | 1,633 | 1,727 |
| EDUCATION LEVEL | ||||||||||
| < High School | 1,348 | 1,183 | 259 | 257 | 1,089 | 925 | 619 | 624 | 470 | 301 |
| High School Graduate | 3,121 | 3,431 | 756 | 839 | 2,365 | 2,593 | 1,605 | 1,825 | 760 | 768 |
| Some College/Associate’s Degree | 5,176 | 5,104 | 1,240 | 1,473 | 3,936 | 3,632 | 2,566 | 2,624 | 1,370 | 1,007 |
| College Graduate | 3,492b | 4,416 | 471 | 623 | 3,020b | 3,793 | 2,378 | 2,768 | 643a | 1,025 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 6,830a | 7,743 | 1,687 | 1,993 | 5,143 | 5,750 | 3,553a | 4,236 | 1,590 | 1,514 |
| Medicaid/CHIP | 3,946 | 3,870 | 620a | 808 | 3,326 | 3,062 | 2,279 | 2,235 | 1,047 | 827 |
| Other3 | 2,548 | 2,619 | 290 | 212 | 2,258 | 2,407 | 836 | 825 | 1,423 | 1,583 |
| No Coverage | 1,365 | 1,632 | 274 | 323 | 1,091 | 1,309 | 1,028 | 1,086 | 63a | 223 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 5.2 | 5.5 | 8.1 | 9.2 | 4.7 | 4.9 | 7.0 | 7.6 | 2.7 | 2.6 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 4.4 | 5.0 | 7.5 | 9.1 | 4.0 | 4.4 | 5.8 | 7.1 | 2.5 | 2.2 |
| Midwest | 5.5 | 6.0 | 9.2 | 9.8 | 5.0 | 5.4 | 7.4 | 7.9 | 2.9 | 3.4 |
| South | 4.9 | 5.0 | 7.2 | 7.8 | 4.5 | 4.5 | 6.7 | 7.0 | 2.6 | 2.5 |
| West | 5.9 | 6.3 | 9.1 | 10.8 | 5.4 | 5.6 | 7.9 | 8.8 | 3.0 | 2.5 |
| COUNTY TYPE | ||||||||||
| Large Metro | 5.5 | 5.4 | 8.2 | 9.1 | 5.2 | 4.8 | 7.6 | 7.3 | 2.9 | 2.6 |
| Small Metro | 4.6b | 5.8 | 8.3 | 9.4 | 4.0b | 5.2 | 5.9b | 7.7 | 2.4 | 3.1 |
| Nonmetro | 4.9 | 5.2 | 7.7 | 9.1 | 4.6 | 4.6 | 6.9a | 9.6 | 3.0 | 1.6 |
| Urbanized | 5.4 | 5.1 | 9.5 | 9.6 | 4.8 | 4.4 | 7.3 | 8.8 | 2.9 | 1.6 |
| Less Urbanized | 4.4 | 5.1 | 6.8 | 9.2 | 4.0 | 4.6 | 6.3b | 10.1 | 2.5 | 1.4 |
| Completely Rural | 6.1 | 5.8 | 3.9 | 4.1 | 6.4 | 6.0 | 8.4 | * | 5.2 | * |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 6.3 | 7.0 | 7.8 | 8.9 | 5.8 | 6.4 | 7.3 | 7.6 | 4.1 | 5.0 |
| 100-199% | 6.3 | 6.3 | 7.9 | 9.7 | 6.0 | 5.6 | 7.6 | 8.4 | 4.6 | 3.3 |
| 200% or More | 4.6 | 5.0 | 8.5 | 9.0 | 4.1 | 4.5 | 6.8 | 7.4 | 2.0 | 2.1 |
| EDUCATION LEVEL | ||||||||||
| < High School | 4.8 | 4.9 | 7.0 | 7.2 | 4.4 | 4.5 | 6.4 | 7.9 | 3.2 | 2.3 |
| High School Graduate | 4.5 | 5.0 | 7.2 | 7.2 | 4.0 | 4.5 | 6.6 | 7.8 | 2.2 | 2.2 |
| Some College/Associate’s Degree | 6.7 | 6.6 | 8.8a | 10.6 | 6.2 | 5.7 | 8.6 | 8.8 | 4.1 | 3.0 |
| College Graduate | 4.4a | 5.2 | 9.3 | 10.9 | 4.1 | 4.8 | 6.2 | 6.7 | 1.8 | 2.7 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 4.4a | 5.0 | 8.9 | 10.0 | 3.8 | 4.2 | 5.7 | 6.6 | 2.2 | 2.1 |
| Medicaid/CHIP | 8.3 | 8.0 | 7.1 | 8.7 | 8.6 | 7.9 | 10.4 | 10.3 | 6.2 | 4.8 |
| Other3 | 3.4 | 3.4 | 11.4 | 7.6 | 3.1 | 3.3 | 9.2 | 9.0 | 2.2 | 2.4 |
| No Coverage | 5.5a | 7.0 | 5.7 | 7.0 | 5.5 | 7.0 | 7.1 | 8.2 | 1.1a | 4.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Severity Level | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 253,825 | 256,282 | 58,451 | 59,286 | 14,526 | 15,360 | 43,926 | 43,926 | 195,373 | 196,996 |
| Substance Use Disorder2 | 44,383 | 46,494 | 19,692a | 21,543 | 6,556a | 7,410 | 13,136 | 14,134 | 24,691 | 24,950 |
| Mild SUD | 25,210 | 25,616 | 9,081 | 9,553 | 2,742 | 2,833 | 6,339 | 6,719 | 16,128 | 16,064 |
| Moderate SUD | 10,054 | 10,478 | 4,713 | 5,199 | 1,398 | 1,769 | 3,315 | 3,430 | 5,341 | 5,279 |
| Severe SUD | 9,119a | 10,400 | 5,898a | 6,792 | 2,416 | 2,808 | 3,482 | 3,984 | 3,221 | 3,608 |
| No SUD | 209,442 | 209,788 | 38,759 | 37,743 | 7,970 | 7,951 | 30,789 | 29,792 | 170,683 | 172,045 |
| Drug Use Disorder2 | 22,571b | 25,417 | 12,333b | 14,504 | 4,610b | 5,587 | 7,723a | 8,916 | 10,237 | 10,913 |
| Mild SUD | 12,696a | 14,124 | 5,827b | 6,940 | 2,042 | 2,373 | 3,785a | 4,567 | 6,869 | 7,184 |
| Moderate SUD | 5,357 | 5,938 | 3,283 | 3,531 | 1,087 | 1,358 | 2,196 | 2,174 | 2,073 | 2,407 |
| Severe SUD | 4,518a | 5,354 | 3,223b | 4,033 | 1,481 | 1,857 | 1,743 | 2,176 | 1,295 | 1,322 |
| No SUD | 231,254 | 230,865 | 46,118 | 44,782 | 9,915 | 9,773 | 36,202 | 35,009 | 185,136 | 186,082 |
| Marijuana Use Disorder | 15,313b | 17,669 | 8,065b | 9,837 | 2,878b | 3,767 | 5,187a | 6,070 | 7,248 | 7,832 |
| Mild SUD | 9,041 | 9,892 | 4,219 | 4,802 | 1,377a | 1,772 | 2,842 | 3,030 | 4,822 | 5,090 |
| Moderate SUD | 3,905b | 4,859 | 2,298a | 2,897 | 805 | 1,073 | 1,493 | 1,824 | 1,606 | 1,963 |
| Severe SUD | 2,367a | 2,918 | 1,547b | 2,138 | 696 | 922 | 851a | 1,217 | 820 | 779 |
| No SUD | 238,512 | 238,613 | 50,386 | 49,449 | 11,647 | 11,593 | 38,739 | 37,856 | 188,125 | 189,164 |
| Opioid Use Disorder2 | 5,308 | 5,852 | 3,150 | 3,527 | 1,113 | 1,329 | 2,036 | 2,198 | 2,159 | 2,325 |
| Mild SUD | 3,226 | 3,677 | 1,603 | 1,949 | 534 | 661 | 1,069 | 1,288 | 1,623 | 1,728 |
| Moderate SUD | 991 | 790 | 631 | 519 | 244 | 221 | 387 | 299 | 360 | 271 |
| Severe SUD | 1,091 | 1,384 | 916 | 1,058 | 335 | 448 | 580 | 610 | 175 | 326 |
| No SUD | 248,517b | 250,430 | 55,302 | 55,759 | 13,413 | 14,031 | 41,889 | 41,728 | 193,215 | 194,671 |
| Alcohol Use Disorder | 28,769 | 28,788 | 11,693 | 12,145 | 3,799 | 3,824 | 7,894 | 8,322 | 17,076 | 16,643 |
| Mild SUD | 16,983 | 16,946 | 5,746 | 5,973 | 1,738 | 1,764 | 4,008 | 4,209 | 11,237 | 10,974 |
| Moderate SUD | 6,192 | 5,784 | 2,481 | 2,552 | 743 | 691 | 1,738 | 1,860 | 3,710 | 3,232 |
| Severe SUD | 5,594 | 6,058 | 3,465 | 3,621 | 1,318 | 1,368 | 2,147 | 2,253 | 2,129 | 2,437 |
| No SUD | 225,056b | 227,493 | 46,759 | 47,141 | 10,727 | 11,537 | 36,032 | 35,604 | 178,297 | 180,353 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Severity Level | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| Substance Use Disorder2 | 17.5 | 18.1 | 33.7b | 36.3 | 45.1 | 48.2 | 29.9a | 32.2 | 12.6 | 12.7 |
| Mild SUD | 9.9 | 10.0 | 15.5 | 16.1 | 18.9 | 18.4 | 14.4 | 15.3 | 8.3 | 8.2 |
| Moderate SUD | 4.0 | 4.1 | 8.1 | 8.8 | 9.6 | 11.5 | 7.5 | 7.8 | 2.7 | 2.7 |
| Severe SUD | 3.6a | 4.1 | 10.1a | 11.5 | 16.6 | 18.3 | 7.9 | 9.1 | 1.6 | 1.8 |
| No SUD | 82.5 | 81.9 | 66.3b | 63.7 | 54.9 | 51.8 | 70.1a | 67.8 | 87.4 | 87.3 |
| Drug Use Disorder2 | 8.9b | 9.9 | 21.1b | 24.5 | 31.7a | 36.4 | 17.6b | 20.3 | 5.2 | 5.5 |
| Mild SUD | 5.0 | 5.5 | 10.0b | 11.7 | 14.1 | 15.4 | 8.6a | 10.4 | 3.5 | 3.6 |
| Moderate SUD | 2.1 | 2.3 | 5.6 | 6.0 | 7.5 | 8.8 | 5.0 | 4.9 | 1.1 | 1.2 |
| Severe SUD | 1.8a | 2.1 | 5.5a | 6.8 | 10.2 | 12.1 | 4.0 | 5.0 | 0.7 | 0.7 |
| No SUD | 91.1b | 90.1 | 78.9b | 75.5 | 68.3a | 63.6 | 82.4b | 79.7 | 94.8 | 94.5 |
| Marijuana Use Disorder | 6.0b | 6.9 | 13.8b | 16.6 | 19.8b | 24.5 | 11.8a | 13.8 | 3.7 | 4.0 |
| Mild SUD | 3.6 | 3.9 | 7.2 | 8.1 | 9.5 | 11.5 | 6.5 | 6.9 | 2.5 | 2.6 |
| Moderate SUD | 1.5b | 1.9 | 3.9a | 4.9 | 5.5 | 7.0 | 3.4 | 4.2 | 0.8 | 1.0 |
| Severe SUD | 0.9a | 1.1 | 2.6b | 3.6 | 4.8 | 6.0 | 1.9a | 2.8 | 0.4 | 0.4 |
| No SUD | 94.0b | 93.1 | 86.2b | 83.4 | 80.2b | 75.5 | 88.2a | 86.2 | 96.3 | 96.0 |
| Opioid Use Disorder2 | 2.1 | 2.3 | 5.4 | 5.9 | 7.7 | 8.7 | 4.6 | 5.0 | 1.1 | 1.2 |
| Mild SUD | 1.3 | 1.4 | 2.7 | 3.3 | 3.7 | 4.3 | 2.4 | 2.9 | 0.8 | 0.9 |
| Moderate SUD | 0.4 | 0.3 | 1.1 | 0.9 | 1.7 | 1.4 | 0.9 | 0.7 | 0.2 | 0.1 |
| Severe SUD | 0.4 | 0.5 | 1.6 | 1.8 | 2.3 | 2.9 | 1.3 | 1.4 | 0.1 | 0.2 |
| No SUD | 97.9 | 97.7 | 94.6 | 94.1 | 92.3 | 91.3 | 95.4 | 95.0 | 98.9 | 98.8 |
| Alcohol Use Disorder | 11.3 | 11.2 | 20.0 | 20.5 | 26.2 | 24.9 | 18.0 | 18.9 | 8.7 | 8.4 |
| Mild SUD | 6.7 | 6.6 | 9.8 | 10.1 | 12.0 | 11.5 | 9.1 | 9.6 | 5.8 | 5.6 |
| Moderate SUD | 2.4 | 2.3 | 4.2 | 4.3 | 5.1 | 4.5 | 4.0 | 4.2 | 1.9 | 1.6 |
| Severe SUD | 2.2 | 2.4 | 5.9 | 6.1 | 9.1 | 8.9 | 4.9 | 5.1 | 1.1 | 1.2 |
| No SUD | 88.7 | 88.8 | 80.0 | 79.5 | 73.8 | 75.1 | 82.0 | 81.1 | 91.3 | 91.6 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Any Mental Illness Among Adults 18+1 (2021) |
Any Mental Illness Among Adults 18+1 (2022) |
Any Mental Illness Among Adults on Probation (2021) |
Any Mental Illness Among Adults on Probation (2022) |
Any Mental Illness Among Adults Not on Probation (2021) |
Any Mental Illness Among Adults Not on Probation (2022) |
Serious Mental Illness Among Adults 18+1 (2021) |
Serious Mental Illness Among Adults 18+1 (2022) |
Serious Mental Illness Among Adults on Probation (2021) |
Serious Mental Illness Among Adults on Probation (2022) |
Serious Mental Illness Among Adults Not on Probation (2021) |
Serious Mental Illness Among Adults Not on Probation (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL 18 OR OLDER | 58,451 | 59,286 | 1,227 | 1,271 | 56,328 | 57,218 | 14,526 | 15,360 | 426 | 603 | 14,017 | 14,634 |
| AGE GROUP | ||||||||||||
| 18-49 | 40,686a | 42,743 | 984 | 1,030 | 39,111 | 41,134 | 11,460 | 11,841 | 345 | 428 | 11,042 | 11,329 |
| 18-25 | 11,536b | 12,583 | 197 | 158 | 11,237 | 12,275 | 4,012 | 4,031 | 67 | 59 | 3,936 | 3,949 |
| 26-34 | 13,419 | 14,107 | 364 | 363 | 12,814 | 13,544 | 3,556 | 3,844 | 93 | 136 | 3,417 | 3,670 |
| 35-49 | 15,731 | 16,054 | 423 | 509 | 15,060 | 15,315 | 3,892 | 3,965 | * | 233 | 3,689 | 3,710 |
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 22,335b | 24,627 | 702 | 736 | 21,151a | 23,465 | 5,020a | 6,019 | 179 | 357 | 4,814a | 5,594 |
| Male 18-49 | 16,044b | 18,255 | 582 | 580 | 15,181b | 17,390 | 4,118a | 4,783 | 177 | 234 | 3,914 | 4,499 |
| Female 18 or Older | 36,116 | 34,659 | * | 535 | 35,177 | 33,753 | 9,506 | 9,341 | * | 246 | 9,203 | 9,040 |
| Female 18-49 | 24,642 | 24,488 | 402 | 450 | 23,930 | 23,744 | 7,342 | 7,058 | 167 | 193 | 7,128 | 6,830 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 The 18+ column includes respondents with unknown past year probation status. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
| Demographic Characteristic | Any Mental Illness Among Adults 18+1 (2021) |
Any Mental Illness Among Adults 18+1 (2022) |
Any Mental Illness Among Adults on Probation (2021) |
Any Mental Illness Among Adults on Probation (2022) |
Any Mental Illness Among Adults Not on Probation (2021) |
Any Mental Illness Among Adults Not on Probation (2022) |
Serious Mental Illness Among Adults 18+1 (2021) |
Serious Mental Illness Among Adults 18+1 (2022) |
Serious Mental Illness Among Adults on Probation (2021) |
Serious Mental Illness Among Adults on Probation (2022) |
Serious Mental Illness Among Adults Not on Probation (2021) |
Serious Mental Illness Among Adults Not on Probation (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL 18 OR OLDER | 23.0 | 23.1 | 39.5 | 41.7 | 22.8 | 22.8 | 5.7 | 6.0 | 13.7 | 19.8 | 5.7 | 5.8 |
| AGE GROUP | ||||||||||||
| 18-49 | 30.0 | 31.1 | 43.5 | 45.2 | 29.7 | 30.8 | 8.4 | 8.6 | 15.2 | 18.8 | 8.4 | 8.5 |
| 18-25 | 34.5 | 36.2 | 41.3 | 40.9 | 34.4 | 36.0 | 12.0 | 11.6 | 14.0 | 15.3 | 12.1 | 11.6 |
| 26-34 | 33.4 | 35.1 | 41.6 | 42.4 | 33.1 | 34.9 | 8.9 | 9.6 | 10.7 | 15.9 | 8.8 | 9.5 |
| 35-49 | 25.3 | 25.7 | 46.4 | 49.1 | 24.9 | 25.3 | 6.3 | 6.4 | * | 22.5 | 6.1 | 6.1 |
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 18.1a | 19.7 | 33.3 | 34.6 | 17.7a | 19.3 | 4.1a | 4.8 | 8.5 | 16.8 | 4.0 | 4.6 |
| Male 18-49 | 23.8b | 26.5 | 37.7 | 38.1 | 23.4b | 26.2 | 6.1 | 7.0 | 11.5 | 15.4 | 6.0 | 6.8 |
| Female 18 or Older | 27.7 | 26.4 | * | 58.4 | 27.5 | 26.2 | 7.3 | 7.1 | * | 26.9 | 7.2 | 7.0 |
| Female 18-49 | 36.1 | 35.7 | 55.8 | 59.4 | 35.8 | 35.4 | 10.8 | 10.3 | 23.2 | 25.5 | 10.7 | 10.2 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 The 18+ column includes respondents with unknown past year probation status. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
| Demographic Characteristic | Any Mental Illness Among Adults 18+1 (2021) |
Any Mental Illness Among Adults 18+1 (2022) |
Any Mental Illness Among Adults on Parole/ Supervised Release (2021) |
Any Mental Illness Among Adults on Parole/ Supervised Release (2022) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release (2021) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release (2022) |
Serious Mental Illness Among Adults 18+1 (2021) |
Serious Mental Illness Among Adults 18+1 (2022) |
Serious Mental Illness Among Adults on Parole/ Supervised Release (2021) |
Serious Mental Illness Among Adults on Parole/ Supervised Release (2022) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release (2021) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL 18 OR OLDER | 58,451 | 59,286 | 539 | 663 | 57,122 | 57,831 | 14,526 | 15,360 | * | 208 | 14,242 | 15,035 |
| AGE GROUP | ||||||||||||
| 18-49 | 40,686a | 42,743 | 370 | 461 | 39,754 | 41,708 | 11,460 | 11,841 | * | 160 | 11,244 | 11,604 |
| 18-25 | 11,536b | 12,583 | * | * | 11,389 | 12,391 | 4,012 | 4,031 | * | * | 3,968 | 3,984 |
| 26-34 | 13,419 | 14,107 | * | * | 13,038 | 13,781 | 3,556 | 3,844 | * | * | 3,497 | 3,787 |
| 35-49 | 15,731 | 16,054 | * | * | 15,327 | 15,536 | 3,892 | 3,965 | * | * | 3,779 | 3,832 |
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 22,335b | 24,627 | 317 | 423 | 21,629a | 23,805 | 5,020a | 6,019 | * | 102 | 4,919a | 5,854 |
| Male 18-49 | 16,044b | 18,255 | * | 265 | 15,543b | 17,731 | 4,118a | 4,783 | * | 77 | 4,019a | 4,662 |
| Female 18 or Older | 36,116 | 34,659 | * | * | 35,493 | 34,027 | 9,506 | 9,341 | * | * | 9,323 | 9,181 |
| Female 18-49 | 24,642 | 24,488 | * | * | 24,211 | 23,977 | 7,342 | 7,058 | * | * | 7,225 | 6,941 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 The 18+ column includes respondents with unknown past year parole/supervised release status. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
| Demographic Characteristic | Any Mental Illness Among Adults 18+1 (2021) |
Any Mental Illness Among Adults 18+1 (2022) |
Any Mental Illness Among Adults on Parole/ Supervised Release (2021) |
Any Mental Illness Among Adults on Parole/ Supervised Release (2022) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release (2021) |
Any Mental Illness Among Adults Not on Parole/ Supervised Release (2022) |
Serious Mental Illness Among Adults 18+1 (2021) |
Serious Mental Illness Among Adults 18+1 (2022) |
Serious Mental Illness Among Adults on Parole/ Supervised Release (2021) |
Serious Mental Illness Among Adults on Parole/ Supervised Release (2022) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release (2021) |
Serious Mental Illness Among Adults Not on Parole/ Supervised Release (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL 18 OR OLDER | 23.0 | 23.1 | 39.0 | 43.1 | 22.9 | 22.9 | 5.7 | 6.0 | * | 13.5 | 5.7 | 6.0 |
| AGE GROUP | ||||||||||||
| 18-49 | 30.0 | 31.1 | 40.4 | 41.4 | 29.9 | 31.0 | 8.4 | 8.6 | * | 14.3 | 8.5 | 8.6 |
| 18-25 | 34.5 | 36.2 | * | * | 34.5 | 36.1 | 12.0 | 11.6 | * | * | 12.0 | 11.6 |
| 26-34 | 33.4 | 35.1 | * | * | 33.3 | 35.0 | 8.9 | 9.6 | * | * | 8.9 | 9.6 |
| 35-49 | 25.3 | 25.7 | * | * | 25.2 | 25.5 | 6.3 | 6.4 | * | * | 6.2 | 6.3 |
| GENDER/AGE GROUP | ||||||||||||
| Male 18 or Older | 18.1a | 19.7 | 32.7 | 35.1 | 17.9a | 19.4 | 4.1a | 4.8 | * | 8.5 | 4.1a | 4.8 |
| Male 18-49 | 23.8b | 26.5 | * | 32.1 | 23.6b | 26.4 | 6.1 | 7.0 | * | 9.3 | 6.1 | 6.9 |
| Female 18 or Older | 27.7 | 26.4 | * | * | 27.6 | 26.3 | 7.3 | 7.1 | * | * | 7.3 | 7.1 |
| Female 18-49 | 36.1 | 35.7 | * | * | 36.0 | 35.5 | 10.8 | 10.3 | * | * | 10.7 | 10.3 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 The 18+ column includes respondents with unknown past year parole/supervised release status. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
| Type/Location of Treatment or Other Services | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| MENTAL HEALTH TREATMENT OR OTHER SERVICES |
-- | 58,089 | -- | 9,652 | -- | 48,437 | -- | 26,077 | -- | 22,360 |
| MENTAL HEALTH TREATMENT | -- | 55,836 | -- | 9,283 | -- | 46,553 | -- | 25,142 | -- | 21,411 |
| Inpatient | -- | 3,384 | -- | 732 | -- | 2,652 | -- | 1,370 | -- | 1,283 |
| Hospital | -- | 2,369 | -- | 547 | -- | 1,822 | -- | 917 | -- | 905 |
| Residential Mental Health Treatment Center | -- | 1,352 | -- | 361 | -- | 990 | -- | 599 | -- | 391 |
| Residential Drug or Alcohol Rehab or Treatment Center |
-- | 973 | -- | 125 | -- | 848 | -- | 494 | -- | 353 |
| Some Other Place as an Inpatient | -- | 708 | -- | 92 | -- | 616 | -- | 321 | -- | 295 |
| Outpatient | -- | 35,067 | -- | 6,188 | -- | 28,879 | -- | 16,442 | -- | 12,437 |
| Mental Health Treatment Center | -- | 7,294 | -- | 1,267 | -- | 6,027 | -- | 3,226 | -- | 2,800 |
| Drug or Alcohol Rehab or Treatment Center | -- | 1,485 | -- | 115 | -- | 1,369 | -- | 831 | -- | 538 |
| Office of a Therapist, Psychologist, Psychiatrist, or Mental Health Professional |
-- | 23,042 | -- | 4,613 | -- | 18,428 | -- | 11,700 | -- | 6,729 |
| General Medical Clinic or Doctor’s Office | -- | 18,329 | -- | 2,599 | -- | 15,730 | -- | 7,993 | -- | 7,737 |
| Hospital | -- | 3,058 | -- | 348 | -- | 2,710 | -- | 1,062 | -- | 1,648 |
| School’s Health or Counseling Center | -- | 1,678 | -- | 1,162 | -- | 516 | -- | 367 | -- | 149 |
| Some Other Place as an Outpatient | -- | 967 | -- | 135 | -- | 832 | -- | 324 | -- | 508 |
| Outpatient, Other Than General Medical Clinic or Doctor’s Office |
-- | 27,371 | -- | 5,391 | -- | 21,980 | -- | 13,242 | -- | 8,737 |
| Prescription Medication | -- | 38,865 | -- | 6,085 | -- | 32,780 | -- | 17,605 | -- | 15,174 |
| Telehealth Treatment1 | -- | 31,013 | -- | 5,981 | -- | 25,032 | -- | 15,798 | -- | 9,234 |
| Prison, Jail, or Juvenile Detention Center | -- | 2,228 | -- | 285 | -- | 1,943 | -- | 969 | -- | 974 |
| OTHER SERVICES | ||||||||||
| Support Services | ||||||||||
| Support Group | -- | 8,534 | -- | 1,513 | -- | 7,021 | -- | 3,838 | -- | 3,183 |
| Peer Support Specialist or Recovery Coach | -- | 3,655 | -- | 667 | -- | 2,989 | -- | 1,587 | -- | 1,401 |
| Emergency Room/Department | -- | 2,820 | -- | 783 | -- | 2,037 | -- | 1,167 | -- | 870 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment or other services; thus, these response categories are not mutually exclusive. 1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Type/Location of Treatment or Other Services | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| MENTAL HEALTH TREATMENT OR OTHER SERVICES |
-- | 22.7 | -- | 27.7 | -- | 21.9 | -- | 25.4 | -- | 18.8 |
| MENTAL HEALTH TREATMENT | -- | 21.8 | -- | 26.7 | -- | 21.0 | -- | 24.5 | -- | 18.0 |
| Inpatient | -- | 1.3 | -- | 2.1 | -- | 1.2 | -- | 1.3 | -- | 1.1 |
| Hospital | -- | 0.9 | -- | 1.6 | -- | 0.8 | -- | 0.9 | -- | 0.8 |
| Residential Mental Health Treatment Center | -- | 0.5 | -- | 1.0 | -- | 0.4 | -- | 0.6 | -- | 0.3 |
| Residential Drug or Alcohol Rehab or Treatment Center |
-- | 0.4 | -- | 0.4 | -- | 0.4 | -- | 0.5 | -- | 0.3 |
| Some Other Place as an Inpatient | -- | 0.3 | -- | 0.3 | -- | 0.3 | -- | 0.3 | -- | 0.2 |
| Outpatient | -- | 13.7 | -- | 17.8 | -- | 13.0 | -- | 16.0 | -- | 10.5 |
| Mental Health Treatment Center | -- | 2.8 | -- | 3.6 | -- | 2.7 | -- | 3.1 | -- | 2.4 |
| Drug or Alcohol Rehab or Treatment Center | -- | 0.6 | -- | 0.3 | -- | 0.6 | -- | 0.8 | -- | 0.5 |
| Office of a Therapist, Psychologist, Psychiatrist, or Mental Health Professional |
-- | 9.0 | -- | 13.3 | -- | 8.3 | -- | 11.4 | -- | 5.7 |
| General Medical Clinic or Doctor’s Office | -- | 7.2 | -- | 7.5 | -- | 7.1 | -- | 7.8 | -- | 6.5 |
| Hospital | -- | 1.2 | -- | 1.0 | -- | 1.2 | -- | 1.0 | -- | 1.4 |
| School’s Health or Counseling Center | -- | 0.7 | -- | 3.3 | -- | 0.2 | -- | 0.4 | -- | 0.1 |
| Some Other Place as an Outpatient | -- | 0.4 | -- | 0.4 | -- | 0.4 | -- | 0.3 | -- | 0.4 |
| Outpatient, Other Than General Medical Clinic or Doctor’s Office |
-- | 10.7 | -- | 15.5 | -- | 9.9 | -- | 12.9 | -- | 7.3 |
| Prescription Medication | -- | 15.2 | -- | 17.5 | -- | 14.8 | -- | 17.2 | -- | 12.8 |
| Telehealth Treatment1 | -- | 12.1 | -- | 17.2 | -- | 11.3 | -- | 15.4 | -- | 7.8 |
| Prison, Jail, or Juvenile Detention Center | -- | 0.9 | -- | 0.8 | -- | 0.9 | -- | 0.9 | -- | 0.8 |
| OTHER SERVICES | ||||||||||
| Support Services | ||||||||||
| Support Group | -- | 3.3 | -- | 4.3 | -- | 3.2 | -- | 3.7 | -- | 2.7 |
| Peer Support Specialist or Recovery Coach | -- | 1.4 | -- | 1.9 | -- | 1.3 | -- | 1.5 | -- | 1.2 |
| Emergency Room/Department | -- | 1.1 | -- | 2.3 | -- | 0.9 | -- | 1.1 | -- | 0.7 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple types/locations for receiving mental health treatment or other services; thus, these response categories are not mutually exclusive. 1 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 55,836 | -- | 29,970 | -- | 10,241 | -- | 19,729 | -- | 25,865 |
| AGE GROUP | ||||||||||
| 18-25 | -- | 9,283 | -- | 6,176 | -- | 2,474 | -- | 3,702 | -- | 3,106 |
| 26 or Older | -- | 46,553 | -- | 23,794 | -- | 7,767 | -- | 16,027 | -- | 22,759 |
| 26-49 | -- | 25,142 | -- | 15,071 | -- | 5,267 | -- | 9,804 | -- | 10,071 |
| 50 or Older | -- | 21,411 | -- | 8,723 | -- | 2,500 | -- | 6,223 | -- | 12,688 |
| GENDER | ||||||||||
| Male | -- | 20,399 | -- | 10,239 | -- | 3,568 | -- | 6,671 | -- | 10,161 |
| Female | -- | 35,437 | -- | 19,732 | -- | 6,673 | -- | 13,059 | -- | 15,705 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | -- | 49,384 | -- | 26,233 | -- | 8,880 | -- | 17,352 | -- | 23,151 |
| AIAN | -- | 145 | -- | * | -- | * | -- | * | -- | 55 |
| Asian | -- | 1,890 | -- | 935 | -- | * | -- | 599 | -- | 955 |
| Black or African American | -- | 4,729 | -- | 2,310 | -- | 767 | -- | 1,543 | -- | 2,419 |
| NHOPI | -- | * | -- | * | -- | * | -- | * | -- | * |
| White | -- | 40,937 | -- | 21,805 | -- | 7,285 | -- | 14,520 | -- | 19,132 |
| Two or More Races | -- | 1,443 | -- | 995 | -- | 442 | -- | 553 | -- | 448 |
| Hispanic or Latino | -- | 6,452 | -- | 3,738 | -- | 1,361 | -- | 2,377 | -- | 2,714 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | -- | 24,545 | -- | 13,077 | -- | 4,195 | -- | 8,882 | -- | 11,467 |
| Part-Time | -- | 8,593 | -- | 5,126 | -- | 1,811 | -- | 3,316 | -- | 3,467 |
| Unemployed | -- | 2,403 | -- | 1,535 | -- | 602 | -- | 932 | -- | 868 |
| Other2 | -- | 20,295 | -- | 10,232 | -- | 3,633 | -- | 6,599 | -- | 10,063 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 21.8 | -- | 50.6 | -- | 66.7 | -- | 44.9 | -- | 13.1 |
| AGE GROUP | ||||||||||
| 18-25 | -- | 26.7 | -- | 49.1 | -- | 61.4 | -- | 43.3 | -- | 14.0 |
| 26 or Older | -- | 21.0 | -- | 50.9 | -- | 68.6 | -- | 45.3 | -- | 13.0 |
| 26-49 | -- | 24.5 | -- | 50.0 | -- | 67.4 | -- | 43.9 | -- | 13.9 |
| 50 or Older | -- | 18.0 | -- | 52.7 | -- | 71.0 | -- | 47.8 | -- | 12.4 |
| GENDER | ||||||||||
| Male | -- | 16.3 | -- | 41.6 | -- | 59.3 | -- | 35.8 | -- | 10.1 |
| Female | -- | 27.0 | -- | 56.9 | -- | 71.4 | -- | 51.6 | -- | 16.3 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | -- | 23.3 | -- | 52.6 | -- | 68.1 | -- | 47.1 | -- | 14.3 |
| AIAN | -- | 11.6 | -- | * | -- | * | -- | * | -- | 5.5 |
| Asian | -- | 12.3 | -- | 36.1 | -- | * | -- | 30.5 | -- | 7.4 |
| Black or African American | -- | 15.3 | -- | 37.9 | -- | 52.3 | -- | 33.3 | -- | 9.7 |
| NHOPI | -- | * | -- | * | -- | * | -- | * | -- | * |
| White | -- | 25.9 | -- | 56.1 | -- | 71.4 | -- | 50.6 | -- | 16.0 |
| Two or More Races | -- | 28.6 | -- | 56.0 | -- | 73.9 | -- | 46.9 | -- | 13.7 |
| Hispanic or Latino | -- | 14.6 | -- | 39.6 | -- | 58.4 | -- | 33.4 | -- | 7.8 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | -- | 20.7 | -- | 48.5 | -- | 65.7 | -- | 43.1 | -- | 12.5 |
| Part-Time | -- | 26.2 | -- | 55.3 | -- | 66.6 | -- | 50.5 | -- | 14.7 |
| Unemployed | -- | 21.8 | -- | 41.6 | -- | 52.4 | -- | 36.7 | -- | 11.9 |
| Other2 | -- | 21.6 | -- | 52.9 | -- | 71.2 | -- | 46.4 | -- | 13.5 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 55,836 | -- | 29,970 | -- | 10,241 | -- | 19,729 | -- | 25,865 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | -- | 10,113 | -- | 5,210 | -- | 1,582 | -- | 3,627 | -- | 4,903 |
| Midwest | -- | 13,543 | -- | 7,230 | -- | 2,421 | -- | 4,809 | -- | 6,313 |
| South | -- | 19,362 | -- | 10,301 | -- | 3,718 | -- | 6,583 | -- | 9,061 |
| West | -- | 12,819 | -- | 7,230 | -- | 2,520 | -- | 4,710 | -- | 5,589 |
| COUNTY TYPE | ||||||||||
| Large Metro | -- | 29,294 | -- | 15,387 | -- | 5,020 | -- | 10,368 | -- | 13,907 |
| Small Metro | -- | 18,856 | -- | 10,366 | -- | 3,713 | -- | 6,654 | -- | 8,490 |
| Nonmetro | -- | 7,685 | -- | 4,217 | -- | 1,509 | -- | 2,708 | -- | 3,468 |
| Urbanized | -- | 3,303 | -- | 1,829 | -- | 597 | -- | 1,232 | -- | 1,474 |
| Less Urbanized | -- | 3,821 | -- | 2,036 | -- | 699 | -- | 1,337 | -- | 1,785 |
| Completely Rural | -- | 561 | -- | * | -- | * | -- | * | -- | 210 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | -- | 8,653 | -- | 5,156 | -- | 2,164 | -- | 2,992 | -- | 3,497 |
| 100-199% | -- | 10,636 | -- | 6,005 | -- | 2,267 | -- | 3,738 | -- | 4,631 |
| 200% or More | -- | 36,545 | -- | 18,808 | -- | 5,810 | -- | 12,998 | -- | 17,737 |
| EDUCATION LEVEL | ||||||||||
| < High School | -- | 3,776 | -- | 2,089 | -- | 784 | -- | 1,305 | -- | 1,687 |
| High School Graduate | -- | 12,082 | -- | 6,458 | -- | 2,535 | -- | 3,924 | -- | 5,624 |
| Some College/Associate's Degree | -- | 18,611 | -- | 10,482 | -- | 3,848 | -- | 6,635 | -- | 8,129 |
| College Graduate | -- | 21,366 | -- | 10,941 | -- | 3,075 | -- | 7,866 | -- | 10,425 |
| HEALTH INSURANCE3 | ||||||||||
| Private | -- | 34,845 | -- | 18,121 | -- | 5,735 | -- | 12,386 | -- | 16,724 |
| Medicaid/CHIP | -- | 13,734 | -- | 8,445 | -- | 3,493 | -- | 4,952 | -- | 5,289 |
| Other4 | -- | 15,186 | -- | 6,627 | -- | 2,197 | -- | 4,430 | -- | 8,559 |
| No Coverage | -- | 2,791 | -- | 1,721 | -- | 621 | -- | 1,100 | -- | 1,071 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 21.8 | -- | 50.6 | -- | 66.7 | -- | 44.9 | -- | 13.1 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | -- | 22.5 | -- | 53.1 | -- | 68.1 | -- | 48.5 | -- | 13.9 |
| Midwest | -- | 25.7 | -- | 55.8 | -- | 72.6 | -- | 49.9 | -- | 15.9 |
| South | -- | 19.8 | -- | 48.2 | -- | 64.5 | -- | 42.2 | -- | 11.8 |
| West | -- | 21.2 | -- | 47.8 | -- | 64.0 | -- | 42.1 | -- | 12.3 |
| COUNTY TYPE | ||||||||||
| Large Metro | -- | 20.8 | -- | 49.3 | -- | 65.4 | -- | 44.1 | -- | 12.7 |
| Small Metro | -- | 23.2 | -- | 51.0 | -- | 67.0 | -- | 45.0 | -- | 13.9 |
| Nonmetro | -- | 22.7 | -- | 54.2 | -- | 70.3 | -- | 48.1 | -- | 13.3 |
| Urbanized | -- | 23.2 | -- | 55.1 | -- | 65.1 | -- | 51.3 | -- | 13.5 |
| Less Urbanized | -- | 22.5 | -- | 53.6 | -- | 70.0 | -- | 47.8 | -- | 13.5 |
| Completely Rural | -- | 21.8 | -- | * | -- | * | -- | * | -- | 11.0 |
| POVERTY LEVEL2 | ||||||||||
| Less Than 100% | -- | 23.9 | -- | 49.3 | -- | 70.2 | -- | 40.6 | -- | 13.6 |
| 100-199% | -- | 21.3 | -- | 47.4 | -- | 61.4 | -- | 41.7 | -- | 12.5 |
| 200% or More | -- | 21.5 | -- | 52.0 | -- | 67.7 | -- | 47.1 | -- | 13.2 |
| EDUCATION LEVEL | ||||||||||
| < High School | -- | 15.5 | -- | 40.1 | -- | 61.7 | -- | 33.1 | -- | 8.8 |
| High School Graduate | -- | 17.5 | -- | 45.4 | -- | 61.7 | -- | 38.8 | -- | 10.2 |
| Some College/Associate's Degree | -- | 23.9 | -- | 50.5 | -- | 66.0 | -- | 44.4 | -- | 14.3 |
| College Graduate | -- | 25.1 | -- | 57.4 | -- | 74.1 | -- | 52.8 | -- | 15.8 |
| HEALTH INSURANCE3 | ||||||||||
| Private | -- | 22.3 | -- | 53.5 | -- | 70.1 | -- | 48.2 | -- | 13.7 |
| Medicaid/CHIP | -- | 28.6 | -- | 55.1 | -- | 70.7 | -- | 47.6 | -- | 16.2 |
| Other4 | -- | 19.8 | -- | 53.4 | -- | 75.0 | -- | 46.8 | -- | 13.3 |
| No Coverage | -- | 12.0 | -- | 29.4 | -- | 41.1 | -- | 25.3 | -- | 6.2 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 3 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 4 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 3,384 | -- | 2,155 | -- | 1,127 | -- | 1,029 | -- | 1,229 |
| AGE GROUP | ||||||||||
| 18-25 | -- | 732 | -- | 519 | -- | 300 | -- | 218 | -- | 213 |
| 26 or Older | -- | 2,652 | -- | 1,637 | -- | 826 | -- | 810 | -- | 1,016 |
| 26-49 | -- | 1,370 | -- | 981 | -- | 495 | -- | 486 | -- | 389 |
| 50 or Older | -- | 1,283 | -- | 656 | -- | 331 | -- | 325 | -- | 627 |
| GENDER | ||||||||||
| Male | -- | 1,960 | -- | 1,200 | -- | 588 | -- | 612 | -- | 759 |
| Female | -- | 1,424 | -- | 955 | -- | 538 | -- | 417 | -- | 470 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | -- | 2,813 | -- | 1,816 | -- | 954 | -- | 862 | -- | 997 |
| AIAN | -- | 12 | -- | * | -- | * | -- | * | -- | 2 |
| Asian | -- | 98 | -- | 60 | -- | * | -- | 28 | -- | 38 |
| Black or African American | -- | 729 | -- | 349 | -- | 152 | -- | 197 | -- | 380 |
| NHOPI | -- | * | -- | * | -- | * | -- | * | -- | * |
| White | -- | 1,871 | -- | 1,352 | -- | 739 | -- | 613 | -- | 519 |
| Two or More Races | -- | 65 | -- | 38 | -- | 23 | -- | 16 | -- | 27 |
| Hispanic or Latino | -- | 571 | -- | 340 | -- | 172 | -- | 167 | -- | 232 |
| HEALTH INSURANCE2 | ||||||||||
| Private | -- | 1,218 | -- | 756 | -- | 471 | -- | 285 | -- | 462 |
| Medicaid/CHIP | -- | 1,706 | -- | 1,110 | -- | 547 | -- | 563 | -- | 596 |
| Other3 | -- | 1,160 | -- | 643 | -- | 300 | -- | 344 | -- | 516 |
| No Coverage | -- | 304 | -- | 174 | -- | 61 | -- | 113 | -- | 130 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | -- | 939 | -- | 593 | -- | 317 | -- | 275 | -- | 347 |
| Part-Time | -- | 520 | -- | 441 | -- | 209 | -- | 231 | -- | 79 |
| Unemployed | -- | 388 | -- | 217 | -- | 111 | -- | 106 | -- | 171 |
| Other4 | -- | 1,537 | -- | 904 | -- | 488 | -- | 416 | -- | 632 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 1.3 | -- | 3.6 | -- | 7.3 | -- | 2.3 | -- | 0.6 |
| AGE GROUP | ||||||||||
| 18-25 | -- | 2.1 | -- | 4.1 | -- | 7.5 | -- | 2.6 | -- | 1.0 |
| 26 or Older | -- | 1.2 | -- | 3.5 | -- | 7.3 | -- | 2.3 | -- | 0.6 |
| 26-49 | -- | 1.3 | -- | 3.3 | -- | 6.3 | -- | 2.2 | -- | 0.5 |
| 50 or Older | -- | 1.1 | -- | 4.0 | -- | 9.4 | -- | 2.5 | -- | 0.6 |
| GENDER | ||||||||||
| Male | -- | 1.6 | -- | 4.9 | -- | 9.8 | -- | 3.3 | -- | 0.8 |
| Female | -- | 1.1 | -- | 2.8 | -- | 5.8 | -- | 1.6 | -- | 0.5 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | -- | 1.3 | -- | 3.6 | -- | 7.3 | -- | 2.3 | -- | 0.6 |
| AIAN | -- | 1.0 | -- | * | -- | * | -- | * | -- | 0.2 |
| Asian | -- | 0.6 | -- | 2.3 | -- | * | -- | 1.4 | -- | 0.3 |
| Black or African American | -- | 2.4 | -- | 5.7 | -- | 10.4 | -- | 4.3 | -- | 1.5 |
| NHOPI | -- | * | -- | * | -- | * | -- | * | -- | * |
| White | -- | 1.2 | -- | 3.5 | -- | 7.2 | -- | 2.1 | -- | 0.4 |
| Two or More Races | -- | 1.3 | -- | 2.2 | -- | 3.8 | -- | 1.3 | -- | 0.8 |
| Hispanic or Latino | -- | 1.3 | -- | 3.6 | -- | 7.4 | -- | 2.3 | -- | 0.7 |
| HEALTH INSURANCE2 | ||||||||||
| Private | -- | 0.8 | -- | 2.2 | -- | 5.8 | -- | 1.1 | -- | 0.4 |
| Medicaid/CHIP | -- | 3.5 | -- | 7.2 | -- | 11.1 | -- | 5.4 | -- | 1.8 |
| Other3 | -- | 1.5 | -- | 5.2 | -- | 10.2 | -- | 3.6 | -- | 0.8 |
| No Coverage | -- | 1.3 | -- | 3.0 | -- | 4.0 | -- | 2.6 | -- | 0.7 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | -- | 0.8 | -- | 2.2 | -- | 5.0 | -- | 1.3 | -- | 0.4 |
| Part-Time | -- | 1.6 | -- | 4.8 | -- | 7.7 | -- | 3.5 | -- | 0.3 |
| Unemployed | -- | 3.5 | -- | 5.9 | -- | 9.7 | -- | 4.2 | -- | 2.3 |
| Other4 | -- | 1.6 | -- | 4.7 | -- | 9.6 | -- | 2.9 | -- | 0.8 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 35,067 | -- | 20,996 | -- | 7,839 | -- | 13,156 | -- | 14,072 |
| AGE GROUP | ||||||||||
| 18-25 | -- | 6,188 | -- | 4,407 | -- | 1,831 | -- | 2,576 | -- | 1,781 |
| 26 or Older | -- | 28,879 | -- | 16,588 | -- | 6,008 | -- | 10,580 | -- | 12,291 |
| 26-49 | -- | 16,442 | -- | 10,918 | -- | 4,099 | -- | 6,819 | -- | 5,524 |
| 50 or Older | -- | 12,437 | -- | 5,670 | -- | 1,909 | -- | 3,761 | -- | 6,767 |
| GENDER | ||||||||||
| Male | -- | 12,667 | -- | 6,995 | -- | 2,683 | -- | 4,312 | -- | 5,672 |
| Female | -- | 22,400 | -- | 14,000 | -- | 5,156 | -- | 8,844 | -- | 8,400 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | -- | 30,717 | -- | 18,336 | -- | 6,785 | -- | 11,551 | -- | 12,381 |
| AIAN | -- | 78 | -- | 55 | -- | * | -- | * | -- | 23 |
| Asian | -- | 1,262 | -- | 686 | -- | * | -- | 413 | -- | 576 |
| Black or African American | -- | 2,992 | -- | 1,475 | -- | 493 | -- | 982 | -- | 1,517 |
| NHOPI | -- | * | -- | * | -- | * | -- | * | -- | * |
| White | -- | 25,269 | -- | 15,355 | -- | 5,629 | -- | 9,727 | -- | 9,914 |
| Two or More Races | -- | 1,001 | -- | 715 | -- | * | -- | 353 | -- | 287 |
| Hispanic or Latino | -- | 4,350 | -- | 2,659 | -- | 1,054 | -- | 1,605 | -- | 1,691 |
| HEALTH INSURANCE2 | ||||||||||
| Private | -- | 21,343 | -- | 12,742 | -- | 4,411 | -- | 8,331 | -- | 8,602 |
| Medicaid/CHIP | -- | 9,164 | -- | 5,878 | -- | 2,689 | -- | 3,189 | -- | 3,286 |
| Other3 | -- | 9,141 | -- | 4,485 | -- | 1,607 | -- | 2,878 | -- | 4,656 |
| No Coverage | -- | 1,731 | -- | 1,136 | -- | 474 | -- | 662 | -- | 595 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | -- | 15,159 | -- | 8,937 | -- | 3,178 | -- | 5,759 | -- | 6,223 |
| Part-Time | -- | 5,904 | -- | 3,837 | -- | 1,463 | -- | 2,374 | -- | 2,066 |
| Unemployed | -- | 1,532 | -- | 1,000 | -- | 465 | -- | 535 | -- | 532 |
| Other4 | -- | 12,472 | -- | 7,221 | -- | 2,733 | -- | 4,488 | -- | 5,251 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 13.7 | -- | 35.4 | -- | 51.0 | -- | 30.0 | -- | 7.1 |
| AGE GROUP | ||||||||||
| 18-25 | -- | 17.8 | -- | 35.0 | -- | 45.4 | -- | 30.1 | -- | 8.0 |
| 26 or Older | -- | 13.0 | -- | 35.5 | -- | 53.0 | -- | 29.9 | -- | 7.0 |
| 26-49 | -- | 16.0 | -- | 36.2 | -- | 52.5 | -- | 30.5 | -- | 7.6 |
| 50 or Older | -- | 10.5 | -- | 34.3 | -- | 54.2 | -- | 28.9 | -- | 6.6 |
| GENDER | ||||||||||
| Male | -- | 10.1 | -- | 28.4 | -- | 44.6 | -- | 23.2 | -- | 5.6 |
| Female | -- | 17.1 | -- | 40.4 | -- | 55.2 | -- | 34.9 | -- | 8.7 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | -- | 14.5 | -- | 36.8 | -- | 52.1 | -- | 31.4 | -- | 7.6 |
| AIAN | -- | 6.3 | -- | 22.8 | -- | * | -- | * | -- | 2.3 |
| Asian | -- | 8.2 | -- | 26.5 | -- | * | -- | 21.0 | -- | 4.5 |
| Black or African American | -- | 9.7 | -- | 24.2 | -- | 33.6 | -- | 21.2 | -- | 6.1 |
| NHOPI | -- | * | -- | * | -- | * | -- | * | -- | * |
| White | -- | 16.0 | -- | 39.5 | -- | 55.1 | -- | 33.9 | -- | 8.3 |
| Two or More Races | -- | 19.8 | -- | 40.2 | -- | * | -- | 30.0 | -- | 8.8 |
| Hispanic or Latino | -- | 9.8 | -- | 28.1 | -- | 45.3 | -- | 22.5 | -- | 4.9 |
| HEALTH INSURANCE2 | ||||||||||
| Private | -- | 13.7 | -- | 37.6 | -- | 53.9 | -- | 32.4 | -- | 7.0 |
| Medicaid/CHIP | -- | 19.1 | -- | 38.3 | -- | 54.4 | -- | 30.7 | -- | 10.0 |
| Other3 | -- | 11.9 | -- | 36.2 | -- | 54.9 | -- | 30.4 | -- | 7.2 |
| No Coverage | -- | 7.4 | -- | 19.4 | -- | 31.3 | -- | 15.2 | -- | 3.4 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | -- | 12.8 | -- | 33.1 | -- | 49.7 | -- | 28.0 | -- | 6.8 |
| Part-Time | -- | 18.0 | -- | 41.4 | -- | 53.9 | -- | 36.2 | -- | 8.8 |
| Unemployed | -- | 13.9 | -- | 27.1 | -- | 40.5 | -- | 21.1 | -- | 7.3 |
| Other4 | -- | 13.3 | -- | 37.3 | -- | 53.5 | -- | 31.5 | -- | 7.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 38,865 | -- | 22,817 | -- | 8,266 | -- | 14,551 | -- | 16,048 |
| AGE GROUP | ||||||||||
| 18-25 | -- | 6,085 | -- | 4,278 | -- | 1,856 | -- | 2,422 | -- | 1,808 |
| 26 or Older | -- | 32,780 | -- | 18,539 | -- | 6,410 | -- | 12,129 | -- | 14,240 |
| 26-49 | -- | 17,605 | -- | 11,345 | -- | 4,297 | -- | 7,048 | -- | 6,260 |
| 50 or Older | -- | 15,174 | -- | 7,194 | -- | 2,113 | -- | 5,081 | -- | 7,980 |
| GENDER | ||||||||||
| Male | -- | 13,374 | -- | 7,591 | -- | 2,794 | -- | 4,797 | -- | 5,784 |
| Female | -- | 25,491 | -- | 15,226 | -- | 5,472 | -- | 9,754 | -- | 10,264 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | -- | 35,161 | -- | 20,347 | -- | 7,264 | -- | 13,083 | -- | 14,814 |
| AIAN | -- | 101 | -- | 64 | -- | * | -- | * | -- | 37 |
| Asian | -- | 921 | -- | 557 | -- | * | -- | 344 | -- | 364 |
| Black or African American | -- | 2,376 | -- | 1,479 | -- | 607 | -- | 872 | -- | 897 |
| NHOPI | -- | * | -- | * | -- | * | -- | * | -- | * |
| White | -- | 30,822 | -- | 17,578 | -- | 6,099 | -- | 11,479 | -- | 13,244 |
| Two or More Races | -- | 832 | -- | 619 | -- | * | -- | 319 | -- | 213 |
| Hispanic or Latino | -- | 3,704 | -- | 2,470 | -- | 1,002 | -- | 1,468 | -- | 1,234 |
| HEALTH INSURANCE2 | ||||||||||
| Private | -- | 24,314 | -- | 13,592 | -- | 4,609 | -- | 8,983 | -- | 10,722 |
| Medicaid/CHIP | -- | 9,826 | -- | 6,645 | -- | 2,952 | -- | 3,693 | -- | 3,181 |
| Other3 | -- | 10,561 | -- | 5,338 | -- | 1,777 | -- | 3,561 | -- | 5,223 |
| No Coverage | -- | 1,817 | -- | 1,301 | -- | 498 | -- | 803 | -- | 516 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | -- | 16,853 | -- | 9,779 | -- | 3,385 | -- | 6,394 | -- | 7,074 |
| Part-Time | -- | 5,960 | -- | 3,813 | -- | 1,413 | -- | 2,400 | -- | 2,147 |
| Unemployed | -- | 1,653 | -- | 1,178 | -- | 464 | -- | 714 | -- | 475 |
| Other4 | -- | 14,398 | -- | 8,046 | -- | 3,004 | -- | 5,042 | -- | 6,352 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 15.2 | -- | 38.5 | -- | 53.8 | -- | 33.1 | -- | 8.1 |
| AGE GROUP | ||||||||||
| 18-25 | -- | 17.5 | -- | 34.0 | -- | 46.0 | -- | 28.3 | -- | 8.1 |
| 26 or Older | -- | 14.8 | -- | 39.7 | -- | 56.6 | -- | 34.3 | -- | 8.1 |
| 26-49 | -- | 17.2 | -- | 37.6 | -- | 55.0 | -- | 31.5 | -- | 8.6 |
| 50 or Older | -- | 12.8 | -- | 43.5 | -- | 60.0 | -- | 39.0 | -- | 7.8 |
| GENDER | ||||||||||
| Male | -- | 10.7 | -- | 30.8 | -- | 46.4 | -- | 25.8 | -- | 5.8 |
| Female | -- | 19.4 | -- | 43.9 | -- | 58.6 | -- | 38.5 | -- | 10.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | -- | 16.6 | -- | 40.8 | -- | 55.7 | -- | 35.5 | -- | 9.1 |
| AIAN | -- | 8.2 | -- | 26.4 | -- | * | -- | * | -- | 3.7 |
| Asian | -- | 6.0 | -- | 21.5 | -- | * | -- | 17.5 | -- | 2.8 |
| Black or African American | -- | 7.7 | -- | 24.3 | -- | 41.4 | -- | 18.8 | -- | 3.6 |
| NHOPI | -- | * | -- | * | -- | * | -- | * | -- | * |
| White | -- | 19.5 | -- | 45.2 | -- | 59.7 | -- | 40.0 | -- | 11.1 |
| Two or More Races | -- | 16.5 | -- | 34.8 | -- | * | -- | 27.0 | -- | 6.5 |
| Hispanic or Latino | -- | 8.4 | -- | 26.1 | -- | 43.0 | -- | 20.6 | -- | 3.5 |
| HEALTH INSURANCE2 | ||||||||||
| Private | -- | 15.6 | -- | 40.1 | -- | 56.3 | -- | 34.9 | -- | 8.8 |
| Medicaid/CHIP | -- | 20.4 | -- | 43.3 | -- | 59.7 | -- | 35.5 | -- | 9.7 |
| Other3 | -- | 13.8 | -- | 43.1 | -- | 60.7 | -- | 37.6 | -- | 8.1 |
| No Coverage | -- | 7.8 | -- | 22.2 | -- | 32.9 | -- | 18.5 | -- | 3.0 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | -- | 14.2 | -- | 36.2 | -- | 53.0 | -- | 31.0 | -- | 7.7 |
| Part-Time | -- | 18.2 | -- | 41.1 | -- | 52.0 | -- | 36.6 | -- | 9.1 |
| Unemployed | -- | 15.0 | -- | 31.9 | -- | 40.4 | -- | 28.1 | -- | 6.5 |
| Other4 | -- | 15.3 | -- | 41.6 | -- | 58.8 | -- | 35.4 | -- | 8.5 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic/Socioeconomic Characteristic |
Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 31,013 | -- | 19,628 | -- | 7,527 | -- | 12,101 | -- | 11,385 |
| AGE GROUP | ||||||||||
| 18-25 | -- | 5,981 | -- | 4,283 | -- | 1,891 | -- | 2,392 | -- | 1,698 |
| 26 or Older | -- | 25,032 | -- | 15,345 | -- | 5,636 | -- | 9,709 | -- | 9,687 |
| 26-49 | -- | 15,798 | -- | 10,260 | -- | 3,915 | -- | 6,345 | -- | 5,538 |
| 50 or Older | -- | 9,234 | -- | 5,085 | -- | 1,721 | -- | 3,364 | -- | 4,149 |
| GENDER | ||||||||||
| Male | -- | 10,812 | -- | 6,607 | -- | 2,566 | -- | 4,041 | -- | 4,205 |
| Female | -- | 20,201 | -- | 13,021 | -- | 4,962 | -- | 8,060 | -- | 7,179 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | -- | 26,833 | -- | 16,869 | -- | 6,451 | -- | 10,418 | -- | 9,964 |
| AIAN | -- | 82 | -- | 50 | -- | * | -- | 18 | -- | 32 |
| Asian | -- | 1,239 | -- | 738 | -- | * | -- | 440 | -- | 501 |
| Black or African American | -- | 2,342 | -- | 1,491 | -- | 547 | -- | 944 | -- | 851 |
| NHOPI | -- | * | -- | * | -- | * | -- | * | -- | * |
| White | -- | 22,174 | -- | 13,825 | -- | 5,187 | -- | 8,638 | -- | 8,348 |
| Two or More Races | -- | 902 | -- | 714 | -- | * | -- | 332 | -- | 188 |
| Hispanic or Latino | -- | 4,180 | -- | 2,760 | -- | 1,076 | -- | 1,683 | -- | 1,421 |
| HEALTH INSURANCE2 | ||||||||||
| Private | -- | 19,835 | -- | 12,074 | -- | 4,284 | -- | 7,790 | -- | 7,761 |
| Medicaid/CHIP | -- | 7,925 | -- | 5,515 | -- | 2,458 | -- | 3,057 | -- | 2,410 |
| Other3 | -- | 6,692 | -- | 3,900 | -- | 1,543 | -- | 2,358 | -- | 2,791 |
| No Coverage | -- | 1,370 | -- | 967 | -- | 443 | -- | 524 | -- | 403 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | -- | 14,661 | -- | 8,850 | -- | 3,143 | -- | 5,706 | -- | 5,811 |
| Part-Time | -- | 5,098 | -- | 3,375 | -- | 1,459 | -- | 1,916 | -- | 1,723 |
| Unemployed | -- | 1,448 | -- | 1,016 | -- | 465 | -- | 551 | -- | 432 |
| Other4 | -- | 9,806 | -- | 6,388 | -- | 2,460 | -- | 3,928 | -- | 3,418 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic/Socioeconomic Characteristic |
Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness (2021) |
Any Mental Illness (2022) |
Serious Mental Illness (2021) |
Serious Mental Illness (2022) |
Any Mental Illness Excluding Serious Mental Illness (2021) |
Any Mental Illness Excluding Serious Mental Illness (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | -- | 12.1 | -- | 33.1 | -- | 49.0 | -- | 27.5 | -- | 5.8 |
| AGE GROUP | ||||||||||
| 18-25 | -- | 17.2 | -- | 34.0 | -- | 46.9 | -- | 28.0 | -- | 7.6 |
| 26 or Older | -- | 11.3 | -- | 32.9 | -- | 49.8 | -- | 27.4 | -- | 5.5 |
| 26-49 | -- | 15.4 | -- | 34.0 | -- | 50.1 | -- | 28.4 | -- | 7.6 |
| 50 or Older | -- | 7.8 | -- | 30.7 | -- | 48.9 | -- | 25.8 | -- | 4.1 |
| GENDER | ||||||||||
| Male | -- | 8.6 | -- | 26.8 | -- | 42.6 | -- | 21.7 | -- | 4.2 |
| Female | -- | 15.4 | -- | 37.6 | -- | 53.1 | -- | 31.8 | -- | 7.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | -- | 12.7 | -- | 33.8 | -- | 49.5 | -- | 28.3 | -- | 6.1 |
| AIAN | -- | 6.6 | -- | 20.6 | -- | * | -- | 11.9 | -- | 3.2 |
| Asian | -- | 8.0 | -- | 28.5 | -- | * | -- | 22.4 | -- | 3.9 |
| Black or African American | -- | 7.6 | -- | 24.5 | -- | 37.3 | -- | 20.4 | -- | 3.4 |
| NHOPI | -- | * | -- | * | -- | * | -- | * | -- | * |
| White | -- | 14.0 | -- | 35.6 | -- | 50.8 | -- | 30.1 | -- | 7.0 |
| Two or More Races | -- | 17.9 | -- | 40.1 | -- | * | -- | 28.2 | -- | 5.8 |
| Hispanic or Latino | -- | 9.4 | -- | 29.2 | -- | 46.2 | -- | 23.6 | -- | 4.1 |
| HEALTH INSURANCE2 | ||||||||||
| Private | -- | 12.7 | -- | 35.6 | -- | 52.4 | -- | 30.3 | -- | 6.4 |
| Medicaid/CHIP | -- | 16.5 | -- | 36.0 | -- | 49.7 | -- | 29.4 | -- | 7.4 |
| Other3 | -- | 8.7 | -- | 31.5 | -- | 52.7 | -- | 24.9 | -- | 4.3 |
| No Coverage | -- | 5.9 | -- | 16.5 | -- | 29.3 | -- | 12.1 | -- | 2.3 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | -- | 12.4 | -- | 32.8 | -- | 49.2 | -- | 27.7 | -- | 6.4 |
| Part-Time | -- | 15.5 | -- | 36.4 | -- | 53.7 | -- | 29.2 | -- | 7.3 |
| Unemployed | -- | 13.1 | -- | 27.5 | -- | 40.5 | -- | 21.7 | -- | 5.9 |
| Other4 | -- | 10.4 | -- | 33.0 | -- | 48.2 | -- | 27.6 | -- | 4.6 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents with no mental illness may still have received mental health treatment for a past disorder that is in partial or full remission or treatment for a disorder that was not included in the definition of mental illness or for other reasons. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Co-Occurring Substance Use Disorder and Level of Mental Illness/Age Group |
Received Substance Use Treatment (SU Tx) OR Mental Health (MH) Treatment (2021) |
Received Substance Use Treatment (SU Tx) OR Mental Health (MH) Treatment (2022) |
Received SU Tx BUT NOT MH Treatment (2021) |
Received SU Tx BUT NOT MH Treatment (2022) |
Received MH Treatment BUT NOT SU Tx (2021) |
Received MH Treatment BUT NOT SU Tx (2022) |
Received SU Tx AND MH Treatment (2021) |
Received SU Tx AND MH Treatment (2022) |
Received NEITHER SU Tx NOR MH Treatment (2021) |
Received NEITHER SU Tx NOR MH Treatment (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| Substance Use Disorder and Any Mental Illness |
-- | 12,725 | -- | 910 | -- | 8,157 | -- | 3,657 | -- | 8,818 |
| 18-25 | -- | 3,076 | -- | 154 | -- | 2,212 | -- | 710 | -- | 2,193 |
| 26 or Older | -- | 9,649 | -- | 757 | -- | 5,945 | -- | 2,947 | -- | 6,625 |
| 26-49 | -- | 6,616 | -- | 569 | -- | 4,143 | -- | 1,904 | -- | 5,053 |
| 50 or Older | -- | 3,033 | -- | 188 | -- | 1,802 | -- | 1,043 | -- | 1,572 |
| Substance Use Disorder and Serious Mental Illness |
-- | 5,273 | -- | 173 | -- | 3,329 | -- | 1,771 | -- | 2,137 |
| 18-25 | -- | 1,393 | -- | 22 | -- | 1,066 | -- | 304 | -- | 686 |
| 26 or Older | -- | 3,880 | -- | 150 | -- | 2,263 | -- | 1,467 | -- | 1,451 |
| 26-49 | -- | 2,609 | -- | 96 | -- | 1,577 | -- | 936 | -- | 1,218 |
| 50 or Older | -- | 1,271 | -- | 54 | -- | * | -- | * | -- | 233 |
| Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness |
-- | 7,452 | -- | 738 | -- | 4,828 | -- | 1,887 | -- | 6,682 |
| 18-25 | -- | 1,684 | -- | 131 | -- | 1,146 | -- | 406 | -- | 1,508 |
| 26 or Older | -- | 5,768 | -- | 606 | -- | 3,682 | -- | 1,480 | -- | 5,174 |
| 26-49 | -- | 4,007 | -- | 473 | -- | 2,566 | -- | 968 | -- | 3,835 |
| 50 or Older | -- | 1,762 | -- | 134 | -- | 1,116 | -- | 512 | -- | 1,339 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment. NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Co-Occurring Substance Use Disorder and Level of Mental Illness/Age Group |
Received Substance Use Treatment (SU Tx) OR Mental Health (MH) Treatment (2021) |
Received Substance Use Treatment (SU Tx) OR Mental Health (MH) Treatment (2022) |
Received SU Tx BUT NOT MH Treatment (2021) |
Received SU Tx BUT NOT MH Treatment (2022) |
Received MH Treatment BUT NOT SU Tx (2021) |
Received MH Treatment BUT NOT SU Tx (2022) |
Received SU Tx AND MH Treatment (2021) |
Received SU Tx AND MH Treatment (2022) |
Received NEITHER SU Tx NOR MH Treatment (2021) |
Received NEITHER SU Tx NOR MH Treatment (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| Substance Use Disorder and Any Mental Illness |
-- | 59.1 | -- | 4.2 | -- | 37.9 | -- | 17.0 | -- | 40.9 |
| 18-25 | -- | 58.4 | -- | 2.9 | -- | 42.0 | -- | 13.5 | -- | 41.6 |
| 26 or Older | -- | 59.3 | -- | 4.6 | -- | 36.5 | -- | 18.1 | -- | 40.7 |
| 26-49 | -- | 56.7 | -- | 4.9 | -- | 35.5 | -- | 16.3 | -- | 43.3 |
| 50 or Older | -- | 65.9 | -- | 4.1 | -- | 39.1 | -- | 22.7 | -- | 34.1 |
| Substance Use Disorder and Serious Mental Illness |
-- | 71.2 | -- | 2.3 | -- | 44.9 | -- | 23.9 | -- | 28.8 |
| 18-25 | -- | 67.0 | -- | 1.1 | -- | 51.3 | -- | 14.6 | -- | 33.0 |
| 26 or Older | -- | 72.8 | -- | 2.8 | -- | 42.4 | -- | 27.5 | -- | 27.2 |
| 26-49 | -- | 68.2 | -- | 2.5 | -- | 41.2 | -- | 24.4 | -- | 31.8 |
| 50 or Older | -- | 84.5 | -- | 3.6 | -- | * | -- | * | -- | 15.5 |
| Substance Use Disorder and Any Mental Illness Excluding Serious Mental Illness |
-- | 52.7 | -- | 5.2 | -- | 34.2 | -- | 13.3 | -- | 47.3 |
| 18-25 | -- | 52.8 | -- | 4.1 | -- | 35.9 | -- | 12.7 | -- | 47.2 |
| 26 or Older | -- | 52.7 | -- | 5.5 | -- | 33.6 | -- | 13.5 | -- | 47.3 |
| 26-49 | -- | 51.1 | -- | 6.0 | -- | 32.7 | -- | 12.3 | -- | 48.9 |
| 50 or Older | -- | 56.8 | -- | 4.3 | -- | 36.0 | -- | 16.5 | -- | 43.2 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used alcohol or drugs in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment. NOTE: Because of the proportion of respondents in the “substance unspecified” category for treatment, the estimates in this table have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. The estimates in this table include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. NOTE: Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Among People Aged 18 or Older Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 12,082 | -- | 1,876 | -- | 10,190 | -- | 184,591 |
| AGE GROUP | ||||||||
| 18-25 | -- | 4,026 | -- | 606 | -- | 3,409 | -- | 21,072 |
| 26 or Older | -- | 8,057 | -- | 1,270 | -- | 6,781 | -- | 163,519 |
| 26-49 | -- | 6,268 | -- | 1,017 | -- | 5,246 | -- | 69,585 |
| 50 or Older | -- | 1,789 | -- | 253 | -- | 1,536 | -- | 93,934 |
| GENDER | ||||||||
| Male | -- | 5,380 | -- | 773 | -- | 4,597 | -- | 97,111 |
| Female | -- | 6,702 | -- | 1,103 | -- | 5,593 | -- | 87,480 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 10,083 | -- | 1,548 | -- | 8,523 | -- | 149,687 |
| AIAN | -- | 65 | -- | 5 | -- | 50 | -- | 1,013 |
| Asian | -- | 884 | -- | 130 | -- | 754 | -- | 12,400 |
| Black or African American | -- | 1,211 | -- | 251 | -- | 959 | -- | 24,404 |
| NHOPI | -- | * | -- | 10 | -- | * | -- | * |
| White | -- | 7,609 | -- | 1,115 | -- | 6,493 | -- | 107,702 |
| Two or More Races | -- | 288 | -- | 37 | -- | 252 | -- | 3,232 |
| Hispanic or Latino | -- | 2,000 | -- | 328 | -- | 1,667 | -- | 34,904 |
| EMPLOYMENT STATUS | ||||||||
| Full-Time | -- | 6,551 | -- | 1,007 | -- | 5,543 | -- | 85,788 |
| Part-Time | -- | 2,394 | -- | 342 | -- | 2,038 | -- | 21,442 |
| Unemployed | -- | 695 | -- | 85 | -- | 610 | -- | 7,765 |
| Other1 | -- | 2,442 | -- | 442 | -- | 1,999 | -- | 69,597 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Among People Aged 18 or Older Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 6.1 | -- | 1.0 | -- | 5.2 | -- | 93.9 |
| AGE GROUP | ||||||||
| 18-25 | -- | 16.0 | -- | 2.4 | -- | 13.6 | -- | 84.0 |
| 26 or Older | -- | 4.7 | -- | 0.7 | -- | 4.0 | -- | 95.3 |
| 26-49 | -- | 8.3 | -- | 1.3 | -- | 6.9 | -- | 91.7 |
| 50 or Older | -- | 1.9 | -- | 0.3 | -- | 1.6 | -- | 98.1 |
| GENDER | ||||||||
| Male | -- | 5.2 | -- | 0.8 | -- | 4.5 | -- | 94.8 |
| Female | -- | 7.1 | -- | 1.2 | -- | 5.9 | -- | 92.9 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 6.3 | -- | 1.0 | -- | 5.3 | -- | 93.7 |
| AIAN | -- | 6.0 | -- | 0.5 | -- | 4.7 | -- | 94.0 |
| Asian | -- | 6.7 | -- | 1.0 | -- | 5.7 | -- | 93.3 |
| Black or African American | -- | 4.7 | -- | 1.0 | -- | 3.7 | -- | 95.3 |
| NHOPI | -- | * | -- | 1.0 | -- | * | -- | * |
| White | -- | 6.6 | -- | 1.0 | -- | 5.6 | -- | 93.4 |
| Two or More Races | -- | 8.2 | -- | 1.0 | -- | 7.1 | -- | 91.8 |
| Hispanic or Latino | -- | 5.4 | -- | 0.9 | -- | 4.5 | -- | 94.6 |
| EMPLOYMENT STATUS | ||||||||
| Full-Time | -- | 7.1 | -- | 1.1 | -- | 6.0 | -- | 92.9 |
| Part-Time | -- | 10.0 | -- | 1.4 | -- | 8.6 | -- | 90.0 |
| Unemployed | -- | 8.2 | -- | 1.0 | -- | 7.2 | -- | 91.8 |
| Other1 | -- | 3.4 | -- | 0.6 | -- | 2.8 | -- | 96.6 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic Characteristic | Among People Aged 18 or Older Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 12,082 | -- | 1,876 | -- | 10,190 | -- | 184,591 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 2,127 | -- | 435 | -- | 1,691 | -- | 32,018 |
| Midwest | -- | 2,393 | -- | 302 | -- | 2,091 | -- | 36,214 |
| South | -- | 4,020 | -- | 607 | -- | 3,401 | -- | 73,138 |
| West | -- | 3,543 | -- | 531 | -- | 3,007 | -- | 43,221 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 7,143 | -- | 1,146 | -- | 5,991 | -- | 102,862 |
| Small Metro | -- | 3,857 | -- | 572 | -- | 3,275 | -- | 57,219 |
| Nonmetro | -- | 1,082 | -- | 158 | -- | 924 | -- | 24,510 |
| Urbanized | -- | 587 | -- | 69 | -- | 518 | -- | 10,116 |
| Less Urbanized | -- | 448 | -- | 82 | -- | 366 | -- | 12,466 |
| Completely Rural | -- | 47 | -- | 7 | -- | 40 | -- | 1,928 |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | -- | 1,371 | -- | 232 | -- | 1,134 | -- | 25,491 |
| 100-199% | -- | 2,099 | -- | 317 | -- | 1,781 | -- | 36,144 |
| 200% or More | -- | 8,610 | -- | 1,324 | -- | 7,275 | -- | 122,953 |
| EDUCATION LEVEL | ||||||||
| < High School | -- | 450 | -- | 99 | -- | 350 | -- | 19,511 |
| High School Graduate | -- | 2,391 | -- | 354 | -- | 2,027 | -- | 53,310 |
| Some College/Associate’s Degree | -- | 4,224 | -- | 607 | -- | 3,612 | -- | 53,965 |
| College Graduate | -- | 5,018 | -- | 816 | -- | 4,201 | -- | 57,805 |
| HEALTH INSURANCE2 | ||||||||
| Private | -- | 7,990 | -- | 1,148 | -- | 6,830 | -- | 111,206 |
| Medicaid/CHIP | -- | 2,136 | -- | 457 | -- | 1,679 | -- | 31,326 |
| Other3 | -- | 1,400 | -- | 231 | -- | 1,166 | -- | 58,792 |
| No Coverage | -- | 1,308 | -- | 220 | -- | 1,088 | -- | 18,707 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic Characteristic | Among People Aged 18 or Older Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 6.1 | -- | 1.0 | -- | 5.2 | -- | 93.9 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 6.2 | -- | 1.3 | -- | 5.0 | -- | 93.8 |
| Midwest | -- | 6.2 | -- | 0.8 | -- | 5.4 | -- | 93.8 |
| South | -- | 5.2 | -- | 0.8 | -- | 4.4 | -- | 94.8 |
| West | -- | 7.6 | -- | 1.1 | -- | 6.4 | -- | 92.4 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 6.5 | -- | 1.0 | -- | 5.4 | -- | 93.5 |
| Small Metro | -- | 6.3 | -- | 0.9 | -- | 5.4 | -- | 93.7 |
| Nonmetro | -- | 4.2 | -- | 0.6 | -- | 3.6 | -- | 95.8 |
| Urbanized | -- | 5.5 | -- | 0.6 | -- | 4.8 | -- | 94.5 |
| Less Urbanized | -- | 3.5 | -- | 0.6 | -- | 2.8 | -- | 96.5 |
| Completely Rural | -- | 2.4 | -- | 0.3 | -- | 2.0 | -- | 97.6 |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | -- | 5.1 | -- | 0.9 | -- | 4.2 | -- | 94.9 |
| 100-199% | -- | 5.5 | -- | 0.8 | -- | 4.7 | -- | 94.5 |
| 200% or More | -- | 6.5 | -- | 1.0 | -- | 5.5 | -- | 93.5 |
| EDUCATION LEVEL | ||||||||
| < High School | -- | 2.3 | -- | 0.5 | -- | 1.8 | -- | 97.7 |
| High School Graduate | -- | 4.3 | -- | 0.6 | -- | 3.6 | -- | 95.7 |
| Some College/Associate’s Degree | -- | 7.3 | -- | 1.0 | -- | 6.2 | -- | 92.7 |
| College Graduate | -- | 8.0 | -- | 1.3 | -- | 6.7 | -- | 92.0 |
| HEALTH INSURANCE2 | ||||||||
| Private | -- | 6.7 | -- | 1.0 | -- | 5.7 | -- | 93.3 |
| Medicaid/CHIP | -- | 6.4 | -- | 1.4 | -- | 5.0 | -- | 93.6 |
| Other3 | -- | 2.3 | -- | 0.4 | -- | 1.9 | -- | 97.7 |
| No Coverage | -- | 6.5 | -- | 1.1 | -- | 5.4 | -- | 93.5 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Among People Aged 18 or Older with Past Year Any Mental Illness Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 7,585 | -- | 1,181 | -- | 6,398 | -- | 20,943 |
| AGE GROUP | ||||||||
| 18-25 | -- | 2,672 | -- | 469 | -- | 2,203 | -- | 3,591 |
| 26 or Older | -- | 4,913 | -- | 713 | -- | 4,196 | -- | 17,353 |
| 26-49 | -- | 4,170 | -- | 610 | -- | 3,556 | -- | 10,457 |
| 50 or Older | -- | 743 | -- | 103 | -- | 640 | -- | 6,895 |
| GENDER | ||||||||
| Male | -- | 3,447 | -- | 428 | -- | 3,019 | -- | 10,504 |
| Female | -- | 4,138 | -- | 753 | -- | 3,380 | -- | 10,440 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 6,243 | -- | 967 | -- | 5,275 | -- | 16,780 |
| AIAN | -- | * | -- | * | -- | * | -- | * |
| Asian | -- | 486 | -- | 60 | -- | 426 | -- | 1,146 |
| Black or African American | -- | 715 | -- | 163 | -- | 551 | -- | 2,971 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 4,777 | -- | 707 | -- | 4,069 | -- | 11,875 |
| Two or More Races | -- | 199 | -- | 22 | -- | 177 | -- | 551 |
| Hispanic or Latino | -- | 1,342 | -- | 214 | -- | 1,123 | -- | 4,164 |
| EMPLOYMENT STATUS | ||||||||
| Full-Time | -- | 3,938 | -- | 646 | -- | 3,293 | -- | 9,574 |
| Part-Time | -- | 1,534 | -- | 178 | -- | 1,352 | -- | 2,545 |
| Unemployed | -- | 504 | -- | 47 | -- | 457 | -- | 1,609 |
| Other1 | -- | 1,608 | -- | 310 | -- | 1,297 | -- | 7,215 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Among People Aged 18 or Older with Past Year Any Mental Illness Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 26.6 | -- | 4.1 | -- | 22.4 | -- | 73.4 |
| AGE GROUP | ||||||||
| 18-25 | -- | 42.7 | -- | 7.5 | -- | 35.2 | -- | 57.3 |
| 26 or Older | -- | 22.1 | -- | 3.2 | -- | 18.8 | -- | 77.9 |
| 26-49 | -- | 28.5 | -- | 4.2 | -- | 24.3 | -- | 71.5 |
| 50 or Older | -- | 9.7 | -- | 1.3 | -- | 8.4 | -- | 90.3 |
| GENDER | ||||||||
| Male | -- | 24.7 | -- | 3.1 | -- | 21.6 | -- | 75.3 |
| Female | -- | 28.4 | -- | 5.2 | -- | 23.2 | -- | 71.6 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 27.1 | -- | 4.2 | -- | 22.9 | -- | 72.9 |
| AIAN | -- | * | -- | * | -- | * | -- | * |
| Asian | -- | 29.8 | -- | 3.7 | -- | 26.1 | -- | 70.2 |
| Black or African American | -- | 19.4 | -- | 4.4 | -- | 15.0 | -- | 80.6 |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 28.7 | -- | 4.2 | -- | 24.4 | -- | 71.3 |
| Two or More Races | -- | 26.5 | -- | 2.9 | -- | 23.6 | -- | 73.5 |
| Hispanic or Latino | -- | 24.4 | -- | 3.9 | -- | 20.4 | -- | 75.6 |
| EMPLOYMENT STATUS | ||||||||
| Full-Time | -- | 29.1 | -- | 4.8 | -- | 24.4 | -- | 70.9 |
| Part-Time | -- | 37.6 | -- | 4.4 | -- | 33.2 | -- | 62.4 |
| Unemployed | -- | 23.9 | -- | 2.2 | -- | 21.6 | -- | 76.1 |
| Other1 | -- | 18.2 | -- | 3.5 | -- | 14.7 | -- | 81.8 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic Characteristic | Among People Aged 18 or Older with Past Year Any Mental Illness Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 7,585 | -- | 1,181 | -- | 6,398 | -- | 20,943 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 1,266 | -- | 312 | -- | 954 | -- | 3,228 |
| Midwest | -- | 1,419 | -- | 198 | -- | 1,221 | -- | 4,168 |
| South | -- | 2,621 | -- | 414 | -- | 2,206 | -- | 8,104 |
| West | -- | 2,279 | -- | 257 | -- | 2,017 | -- | 5,444 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 4,158 | -- | 678 | -- | 3,476 | -- | 11,308 |
| Small Metro | -- | 2,606 | -- | 388 | -- | 2,217 | -- | 7,080 |
| Nonmetro | -- | 821 | -- | 116 | -- | 705 | -- | 2,556 |
| Urbanized | -- | 450 | -- | 46 | -- | 405 | -- | 974 |
| Less Urbanized | -- | 343 | -- | 65 | -- | 278 | -- | 1,322 |
| Completely Rural | -- | * | -- | * | -- | * | -- | * |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | -- | 993 | -- | 167 | -- | 822 | -- | 4,111 |
| 100-199% | -- | 1,538 | -- | 245 | -- | 1,292 | -- | 4,945 |
| 200% or More | -- | 5,054 | -- | 769 | -- | 4,284 | -- | 11,886 |
| EDUCATION LEVEL | ||||||||
| < High School | -- | 346 | -- | 84 | -- | 261 | -- | 2,638 |
| High School Graduate | -- | 1,749 | -- | 269 | -- | 1,480 | -- | 5,756 |
| Some College/Associate’s Degree | -- | 2,868 | -- | 413 | -- | 2,451 | -- | 7,207 |
| College Graduate | -- | 2,622 | -- | 415 | -- | 2,207 | -- | 5,341 |
| HEALTH INSURANCE2 | ||||||||
| Private | -- | 4,649 | -- | 696 | -- | 3,953 | -- | 10,753 |
| Medicaid/CHIP | -- | 1,523 | -- | 298 | -- | 1,225 | -- | 5,108 |
| Other3 | -- | 809 | -- | 171 | -- | 633 | -- | 4,839 |
| No Coverage | -- | 985 | -- | 105 | -- | 880 | -- | 3,033 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic Characteristic | Among People Aged 18 or Older with Past Year Any Mental Illness Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 26.6 | -- | 4.1 | -- | 22.4 | -- | 73.4 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | 28.2 | -- | 6.9 | -- | 21.2 | -- | 71.8 |
| Midwest | -- | 25.4 | -- | 3.5 | -- | 21.9 | -- | 74.6 |
| South | -- | 24.4 | -- | 3.8 | -- | 20.6 | -- | 75.6 |
| West | -- | 29.5 | -- | 3.3 | -- | 26.1 | -- | 70.5 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 26.9 | -- | 4.4 | -- | 22.5 | -- | 73.1 |
| Small Metro | -- | 26.9 | -- | 4.0 | -- | 22.9 | -- | 73.1 |
| Nonmetro | -- | 24.3 | -- | 3.4 | -- | 20.9 | -- | 75.7 |
| Urbanized | -- | 31.6 | -- | 3.2 | -- | 28.4 | -- | 68.4 |
| Less Urbanized | -- | 20.6 | -- | 3.9 | -- | 16.7 | -- | 79.4 |
| Completely Rural | -- | * | -- | * | -- | * | -- | * |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | -- | 19.5 | -- | 3.3 | -- | 16.1 | -- | 80.5 |
| 100-199% | -- | 23.7 | -- | 3.8 | -- | 19.9 | -- | 76.3 |
| 200% or More | -- | 29.8 | -- | 4.5 | -- | 25.3 | -- | 70.2 |
| EDUCATION LEVEL | ||||||||
| < High School | -- | 11.6 | -- | 2.8 | -- | 8.7 | -- | 88.4 |
| High School Graduate | -- | 23.3 | -- | 3.6 | -- | 19.7 | -- | 76.7 |
| Some College/Associate’s Degree | -- | 28.5 | -- | 4.1 | -- | 24.3 | -- | 71.5 |
| College Graduate | -- | 32.9 | -- | 5.2 | -- | 27.7 | -- | 67.1 |
| HEALTH INSURANCE2 | ||||||||
| Private | -- | 30.2 | -- | 4.5 | -- | 25.7 | -- | 69.8 |
| Medicaid/CHIP | -- | 23.0 | -- | 4.5 | -- | 18.5 | -- | 77.0 |
| Other3 | -- | 14.3 | -- | 3.0 | -- | 11.2 | -- | 85.7 |
| No Coverage | -- | 24.5 | -- | 2.6 | -- | 21.9 | -- | 75.5 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Among People Aged 18 or Older with Past Year Serious Mental Illness Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 2,520 | -- | 408 | -- | 2,112 | -- | 2,549 |
| AGE GROUP | ||||||||
| 18-25 | -- | 987 | -- | 180 | -- | 806 | -- | 548 |
| 26 or Older | -- | 1,534 | -- | 228 | -- | 1,306 | -- | 2,001 |
| 26-49 | -- | 1,312 | -- | 184 | -- | 1,127 | -- | 1,203 |
| 50 or Older | -- | * | -- | * | -- | * | -- | * |
| GENDER | ||||||||
| Male | -- | 1,141 | -- | 137 | -- | 1,005 | -- | 1,277 |
| Female | -- | 1,379 | -- | 272 | -- | 1,108 | -- | 1,272 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 2,095 | -- | 325 | -- | 1,770 | -- | 2,022 |
| AIAN | -- | * | -- | * | -- | * | -- | * |
| Asian | -- | * | -- | * | -- | * | -- | * |
| Black or African American | -- | * | -- | * | -- | * | -- | * |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 1,496 | -- | 200 | -- | 1,296 | -- | 1,403 |
| Two or More Races | -- | * | -- | * | -- | * | -- | * |
| Hispanic or Latino | -- | 426 | -- | 83 | -- | 342 | -- | 527 |
| EMPLOYMENT STATUS | ||||||||
| Full-Time | -- | 1,120 | -- | 209 | -- | 911 | -- | 1,048 |
| Part-Time | -- | 572 | -- | 56 | -- | 516 | -- | 332 |
| Unemployed | -- | * | -- | 29 | -- | * | -- | * |
| Other1 | -- | 541 | -- | 114 | -- | 426 | -- | 917 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic Characteristic | Among People Aged 18 or Older with Past Year Serious Mental Illness Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 49.7 | -- | 8.0 | -- | 41.7 | -- | 50.3 |
| AGE GROUP | ||||||||
| 18-25 | -- | 64.3 | -- | 11.7 | -- | 52.5 | -- | 35.7 |
| 26 or Older | -- | 43.4 | -- | 6.4 | -- | 36.9 | -- | 56.6 |
| 26-49 | -- | 52.2 | -- | 7.3 | -- | 44.8 | -- | 47.8 |
| 50 or Older | -- | * | -- | * | -- | * | -- | * |
| GENDER | ||||||||
| Male | -- | 47.2 | -- | 5.6 | -- | 41.5 | -- | 52.8 |
| Female | -- | 52.0 | -- | 10.2 | -- | 41.8 | -- | 48.0 |
| HISPANIC ORIGIN AND RACE | ||||||||
| Not Hispanic or Latino | -- | 50.9 | -- | 7.9 | -- | 43.0 | -- | 49.1 |
| AIAN | -- | * | -- | * | -- | * | -- | * |
| Asian | -- | * | -- | * | -- | * | -- | * |
| Black or African American | -- | * | -- | * | -- | * | -- | * |
| NHOPI | -- | * | -- | * | -- | * | -- | * |
| White | -- | 51.6 | -- | 6.9 | -- | 44.7 | -- | 48.4 |
| Two or More Races | -- | * | -- | * | -- | * | -- | * |
| Hispanic or Latino | -- | 44.7 | -- | 8.7 | -- | 35.9 | -- | 55.3 |
| EMPLOYMENT STATUS | ||||||||
| Full-Time | -- | 51.7 | -- | 9.6 | -- | 42.0 | -- | 48.3 |
| Part-Time | -- | 63.3 | -- | 6.2 | -- | 57.1 | -- | 36.7 |
| Unemployed | -- | * | -- | 5.3 | -- | * | -- | * |
| Other1 | -- | 37.1 | -- | 7.8 | -- | 29.2 | -- | 62.9 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic Characteristic | Among People Aged 18 or Older with Past Year Serious Mental Illness Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 2,520 | -- | 408 | -- | 2,112 | -- | 2,549 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | * | -- | * | -- | * | -- | * |
| Midwest | -- | 439 | -- | 81 | -- | 358 | -- | 467 |
| South | -- | 940 | -- | 168 | -- | 772 | -- | 1,081 |
| West | -- | 753 | -- | 54 | -- | 700 | -- | 662 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 1,286 | -- | 207 | -- | 1,079 | -- | 1,337 |
| Small Metro | -- | 882 | -- | 152 | -- | 729 | -- | 938 |
| Nonmetro | -- | * | -- | 49 | -- | * | -- | * |
| Urbanized | -- | * | -- | * | -- | * | -- | * |
| Less Urbanized | -- | * | -- | * | -- | * | -- | * |
| Completely Rural | -- | * | -- | * | -- | * | -- | * |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | -- | 442 | -- | 79 | -- | 363 | -- | 463 |
| 100-199% | -- | 594 | -- | 81 | -- | 513 | -- | 818 |
| 200% or More | -- | 1,484 | -- | 248 | -- | 1,236 | -- | 1,268 |
| EDUCATION LEVEL | ||||||||
| < High School | -- | * | -- | 25 | -- | * | -- | * |
| High School Graduate | -- | 779 | -- | 104 | -- | 675 | -- | 765 |
| Some College/Associate’s Degree | -- | 1,039 | -- | 170 | -- | 870 | -- | 929 |
| College Graduate | -- | 553 | -- | 110 | -- | 443 | -- | 517 |
| HEALTH INSURANCE2 | ||||||||
| Private | -- | 1,196 | -- | 209 | -- | 987 | -- | 1,233 |
| Medicaid/CHIP | -- | 718 | -- | 150 | -- | 568 | -- | 705 |
| Other3 | -- | * | -- | 59 | -- | * | -- | * |
| No Coverage | -- | 448 | -- | 42 | -- | 406 | -- | 433 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Geographic/Socioeconomic Characteristic | Among People Aged 18 or Older with Past Year Serious Mental Illness Who Did Not Receive Mental Health Treatment in Past Year | |||||||
|---|---|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2021) |
Did Not Seek Treatment and Did Not Think Should Get Treatment (2022) |
|
| TOTAL | -- | 49.7 | -- | 8.0 | -- | 41.7 | -- | 50.3 |
| GEOGRAPHIC REGION | ||||||||
| Northeast | -- | * | -- | * | -- | * | -- | * |
| Midwest | -- | 48.4 | -- | 8.9 | -- | 39.5 | -- | 51.6 |
| South | -- | 46.5 | -- | 8.3 | -- | 38.2 | -- | 53.5 |
| West | -- | 53.2 | -- | 3.8 | -- | 49.4 | -- | 46.8 |
| COUNTY TYPE | ||||||||
| Large Metro | -- | 49.0 | -- | 7.9 | -- | 41.1 | -- | 51.0 |
| Small Metro | -- | 48.5 | -- | 8.4 | -- | 40.1 | -- | 51.5 |
| Nonmetro | -- | * | -- | 7.8 | -- | * | -- | * |
| Urbanized | -- | * | -- | * | -- | * | -- | * |
| Less Urbanized | -- | * | -- | * | -- | * | -- | * |
| Completely Rural | -- | * | -- | * | -- | * | -- | * |
| POVERTY LEVEL1 | ||||||||
| Less Than 100% | -- | 48.8 | -- | 8.8 | -- | 40.1 | -- | 51.2 |
| 100-199% | -- | 42.1 | -- | 5.7 | -- | 36.3 | -- | 57.9 |
| 200% or More | -- | 53.9 | -- | 9.0 | -- | 44.9 | -- | 46.1 |
| EDUCATION LEVEL | ||||||||
| < High School | -- | * | -- | 5.1 | -- | * | -- | * |
| High School Graduate | -- | 50.5 | -- | 6.7 | -- | 43.7 | -- | 49.5 |
| Some College/Associate’s Degree | -- | 52.8 | -- | 8.6 | -- | 44.2 | -- | 47.2 |
| College Graduate | -- | 51.7 | -- | 10.3 | -- | 41.4 | -- | 48.3 |
| HEALTH INSURANCE2 | ||||||||
| Private | -- | 49.2 | -- | 8.6 | -- | 40.6 | -- | 50.8 |
| Medicaid/CHIP | -- | 50.4 | -- | 10.5 | -- | 39.9 | -- | 49.6 |
| Other3 | -- | * | -- | 8.1 | -- | * | -- | * |
| No Coverage | -- | 50.9 | -- | 4.8 | -- | 46.1 | -- | 49.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Reason Did Not Receive Mental Health Treatment | Among People Aged 18 or Older Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year |
|||||
|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
|
| Thought It Would Cost Too Much | -- | 6,178 | -- | 867 | -- | 5,305 |
| Did Not Have Health Insurance Coverage for Mental Health Treatment | -- | 3,369 | -- | 554 | -- | 2,814 |
| Health Insurance Would Not Pay Enough of Costs for Treatment | -- | 3,890 | -- | 603 | -- | 3,287 |
| Did Not Know How or Where to Get Treatment | -- | 5,475 | -- | 723 | -- | 4,749 |
| Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to |
-- | 4,798 | -- | 872 | -- | 3,926 |
| No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to |
-- | 1,955 | -- | 577 | -- | 1,378 |
| Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them |
-- | 2,862 | -- | 426 | -- | 2,436 |
| Did Not Have Enough Time for Treatment | -- | 5,288 | -- | 489 | -- | 4,798 |
| Worried That Information Would Not Be Kept Private | -- | 2,317 | -- | 251 | -- | 2,065 |
| Worried about What People Would Think or Say if They Got Treatment | -- | 3,152 | -- | 262 | -- | 2,889 |
| Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children |
-- | 1,256 | -- | 181 | -- | 1,075 |
| Not Ready to Start Treatment | -- | 5,820 | -- | 488 | -- | 5,331 |
| Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own |
-- | 8,316 | -- | 937 | -- | 7,373 |
| Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment |
-- | 1,554 | -- | 161 | -- | 1,388 |
| Afraid of Being Committed to Hospital or Forced into Treatment against Their Will |
-- | 1,978 | -- | 315 | -- | 1,658 |
| Thought They Would Be Told They Needed to Take Medication | -- | 3,488 | -- | 440 | -- | 3,043 |
| Did Not Think Treatment Would Help Them | -- | 3,437 | -- | 479 | -- | 2,953 |
| Thought No One Would Care if They Got Better | -- | 1,628 | -- | 176 | -- | 1,448 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Reason Did Not Receive Mental Health Treatment | Among People Aged 18 or Older Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year |
|||||
|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
|
| Thought It Would Cost Too Much | -- | 51.4 | -- | 46.4 | -- | 52.4 |
| Did Not Have Health Insurance Coverage for Mental Health Treatment | -- | 29.4 | -- | 30.1 | -- | 29.3 |
| Health Insurance Would Not Pay Enough of Costs for Treatment | -- | 34.9 | -- | 32.8 | -- | 35.4 |
| Did Not Know How or Where to Get Treatment | -- | 45.5 | -- | 38.6 | -- | 46.7 |
| Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to |
-- | 40.7 | -- | 46.6 | -- | 39.7 |
| No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to |
-- | 17.0 | -- | 31.5 | -- | 14.3 |
| Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them |
-- | 24.1 | -- | 23.0 | -- | 24.3 |
| Did Not Have Enough Time for Treatment | -- | 44.2 | -- | 26.2 | -- | 47.6 |
| Worried That Information Would Not Be Kept Private | -- | 19.4 | -- | 13.4 | -- | 20.5 |
| Worried about What People Would Think or Say if They Got Treatment | -- | 26.2 | -- | 14.1 | -- | 28.4 |
| Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children |
-- | 10.5 | -- | 9.7 | -- | 10.6 |
| Not Ready to Start Treatment | -- | 49.1 | -- | 26.4 | -- | 53.3 |
| Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own |
-- | 69.6 | -- | 50.1 | -- | 73.2 |
| Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment |
-- | 13.0 | -- | 8.7 | -- | 13.7 |
| Afraid of Being Committed to Hospital or Forced into Treatment against Their Will |
-- | 16.5 | -- | 16.9 | -- | 16.4 |
| Thought They Would Be Told They Needed to Take Medication | -- | 29.2 | -- | 23.5 | -- | 30.2 |
| Did Not Think Treatment Would Help Them | -- | 29.1 | -- | 25.9 | -- | 29.7 |
| Thought No One Would Care if They Got Better | -- | 13.6 | -- | 9.5 | -- | 14.3 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Reason Did Not Receive Mental Health Treatment | Among People Aged 18 or Older with Past Year Any Mental Illness Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year |
|||||
|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
|
| Thought It Would Cost Too Much | -- | 4,447 | -- | 663 | -- | 3,779 |
| Did Not Have Health Insurance Coverage for Mental Health Treatment | -- | 2,568 | -- | 435 | -- | 2,132 |
| Health Insurance Would Not Pay Enough of Costs for Treatment | -- | 2,867 | -- | 453 | -- | 2,414 |
| Did Not Know How or Where to Get Treatment | -- | 3,863 | -- | 548 | -- | 3,315 |
| Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to |
-- | 3,477 | -- | 664 | -- | 2,813 |
| No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to |
-- | 1,448 | -- | 437 | -- | 1,011 |
| Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them |
-- | 2,181 | -- | 320 | -- | 1,861 |
| Did Not Have Enough Time for Treatment | -- | 3,677 | -- | 418 | -- | 3,259 |
| Worried That Information Would Not Be Kept Private | -- | 1,914 | -- | 226 | -- | 1,687 |
| Worried about What People Would Think or Say if They Got Treatment | -- | 2,216 | -- | 241 | -- | 1,974 |
| Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children |
-- | 1,110 | -- | 172 | -- | 937 |
| Not Ready to Start Treatment | -- | 3,853 | -- | 381 | -- | 3,473 |
| Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own |
-- | 5,590 | -- | 720 | -- | 4,865 |
| Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment |
-- | 1,192 | -- | 151 | -- | 1,036 |
| Afraid of Being Committed to Hospital or Forced into Treatment against Their Will |
-- | 1,760 | -- | 313 | -- | 1,442 |
| Thought They Would Be Told They Needed to Take Medication | -- | 2,815 | -- | 403 | -- | 2,407 |
| Did Not Think Treatment Would Help Them | -- | 2,494 | -- | 332 | -- | 2,158 |
| Thought No One Would Care if They Got Better | -- | 1,481 | -- | 175 | -- | 1,301 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Reason Did Not Receive Mental Health Treatment | Among People Aged 18 or Older with Past Year Any Mental Illness Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year |
|||||
|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
|
| Thought It Would Cost Too Much | -- | 58.9 | -- | 56.2 | -- | 59.4 |
| Did Not Have Health Insurance Coverage for Mental Health Treatment | -- | 35.7 | -- | 37.3 | -- | 35.4 |
| Health Insurance Would Not Pay Enough of Costs for Treatment | -- | 40.8 | -- | 39.0 | -- | 41.2 |
| Did Not Know How or Where to Get Treatment | -- | 51.1 | -- | 46.5 | -- | 52.0 |
| Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to |
-- | 46.8 | -- | 56.4 | -- | 45.0 |
| No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to |
-- | 20.1 | -- | 37.7 | -- | 16.7 |
| Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them |
-- | 29.2 | -- | 27.4 | -- | 29.6 |
| Did Not Have Enough Time for Treatment | -- | 48.9 | -- | 35.4 | -- | 51.5 |
| Worried That Information Would Not Be Kept Private | -- | 25.5 | -- | 19.2 | -- | 26.7 |
| Worried about What People Would Think or Say if They Got Treatment | -- | 29.3 | -- | 20.7 | -- | 30.9 |
| Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children |
-- | 14.7 | -- | 14.6 | -- | 14.7 |
| Not Ready to Start Treatment | -- | 51.6 | -- | 32.3 | -- | 55.2 |
| Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own |
-- | 74.2 | -- | 61.0 | -- | 76.7 |
| Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment |
-- | 15.9 | -- | 13.0 | -- | 16.3 |
| Afraid of Being Committed to Hospital or Forced into Treatment against Their Will |
-- | 23.4 | -- | 26.5 | -- | 22.7 |
| Thought They Would Be Told They Needed to Take Medication | -- | 37.4 | -- | 34.1 | -- | 37.9 |
| Did Not Think Treatment Would Help Them | -- | 33.5 | -- | 28.7 | -- | 34.4 |
| Thought No One Would Care if They Got Better | -- | 19.7 | -- | 15.1 | -- | 20.5 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded. NOTE: Any Mental Illness (AMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Reason Did Not Receive Mental Health Treatment | Among People Aged 18 or Older with Past Year Serious Mental Illness Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year |
|||||
|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
|
| Thought It Would Cost Too Much | -- | 1,660 | -- | * | -- | 1,422 |
| Did Not Have Health Insurance Coverage for Mental Health Treatment | -- | 1,119 | -- | * | -- | 931 |
| Health Insurance Would Not Pay Enough of Costs for Treatment | -- | 1,054 | -- | * | -- | 916 |
| Did Not Know How or Where to Get Treatment | -- | 1,426 | -- | * | -- | 1,211 |
| Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to |
-- | 1,249 | -- | * | -- | 1,004 |
| No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to |
-- | 535 | -- | * | -- | 364 |
| Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them |
-- | 879 | -- | * | -- | 767 |
| Did Not Have Enough Time for Treatment | -- | 1,262 | -- | * | -- | 1,090 |
| Worried That Information Would Not Be Kept Private | -- | 921 | -- | * | -- | 800 |
| Worried about What People Would Think or Say if They Got Treatment | -- | 853 | -- | * | -- | 739 |
| Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children |
-- | 554 | -- | * | -- | 470 |
| Not Ready to Start Treatment | -- | 1,221 | -- | * | -- | 1,038 |
| Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own |
-- | 2,063 | -- | * | -- | 1,770 |
| Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment |
-- | 546 | -- | * | -- | 490 |
| Afraid of Being Committed to Hospital or Forced into Treatment against Their Will |
-- | 911 | -- | * | -- | 725 |
| Thought They Would Be Told They Needed to Take Medication | -- | 1,173 | -- | * | -- | 975 |
| Did Not Think Treatment Would Help Them | -- | 939 | -- | * | -- | 799 |
| Thought No One Would Care if They Got Better | -- | 785 | -- | * | -- | 716 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Reason Did Not Receive Mental Health Treatment | Among People Aged 18 or Older with Past Year Serious Mental Illness Who Did Not Receive Mental Health Treatment and Sought or Thought Should Get Mental Health Treatment in Past Year |
|||||
|---|---|---|---|---|---|---|
| Sought or Thought Should Get Treatment (2021) |
Sought or Thought Should Get Treatment (2022) |
Sought Treatment (2021) |
Sought Treatment (2022) |
Thought Should Get Treatment but Did Not Seek Treatment (2021) |
Thought Should Get Treatment but Did Not Seek Treatment (2022) |
|
| Thought It Would Cost Too Much | -- | 66.3 | -- | * | -- | 67.8 |
| Did Not Have Health Insurance Coverage for Mental Health Treatment | -- | 46.1 | -- | * | -- | 46.0 |
| Health Insurance Would Not Pay Enough of Costs for Treatment | -- | 43.5 | -- | * | -- | 45.3 |
| Did Not Know How or Where to Get Treatment | -- | 56.7 | -- | * | -- | 57.5 |
| Could Not Find Treatment Program or Healthcare Professional They Wanted to Go to |
-- | 50.4 | -- | * | -- | 48.5 |
| No Openings in Treatment Program or with Healthcare Professional They Wanted to Go to |
-- | 21.9 | -- | * | -- | 17.7 |
| Had Problems with Things Like Transportation, Childcare, or Getting Appointments at Times That Worked for Them |
-- | 35.1 | -- | * | -- | 36.5 |
| Did Not Have Enough Time for Treatment | -- | 50.3 | -- | * | -- | 51.8 |
| Worried That Information Would Not Be Kept Private | -- | 36.7 | -- | * | -- | 38.0 |
| Worried about What People Would Think or Say if They Got Treatment | -- | 34.1 | -- | * | -- | 35.1 |
| Thought That if People Knew They Were in Treatment, Bad Things Would Happen, Like Losing Their Job, Home, or Children |
-- | 22.0 | -- | * | -- | 22.3 |
| Not Ready to Start Treatment | -- | 48.7 | -- | * | -- | 49.4 |
| Thought They Should Have Been Able to Handle Their Mental Health, Emotions, or Behavior on Their Own |
-- | 82.0 | -- | * | -- | 83.9 |
| Thought Their Family, Friends, or Religious Group Would Not Like It if They Got Treatment |
-- | 21.8 | -- | * | -- | 23.3 |
| Afraid of Being Committed to Hospital or Forced into Treatment against Their Will |
-- | 36.5 | -- | * | -- | 34.7 |
| Thought They Would Be Told They Needed to Take Medication | -- | 46.8 | -- | * | -- | 46.5 |
| Did Not Think Treatment Would Help Them | -- | 37.9 | -- | * | -- | 38.3 |
| Thought No One Would Care if They Got Better | -- | 31.4 | -- | * | -- | 34.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. NOTE: Respondents could indicate multiple reasons for not receiving mental health treatment; thus, these response categories are not mutually exclusive. Respondents with unknown reason for not receiving treatment data were excluded. NOTE: Serious Mental Illness (SMI) aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of SMI are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. NOTE: Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Age Category | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 21,553 | 22,475 | 7,844 | 8,780 | 13,709 | 13,695 |
| 18-25 | 6,442 | 6,990 | 2,139b | 2,633 | 4,303 | 4,357 |
| 18-20 | 2,601 | 2,627 | 816 | 1,026 | 1,784 | 1,601 |
| 21-25 | 3,842 | 4,363 | 1,323a | 1,608 | 2,519 | 2,755 |
| 26 or Older | 15,111 | 15,485 | 5,705 | 6,147 | 9,406 | 9,338 |
| 26-49 | 9,810 | 9,975 | 3,928 | 4,227 | 5,881 | 5,748 |
| 26-29 | 2,306 | 2,170 | 865 | 918 | 1,441 | 1,252 |
| 30-34 | 2,324 | 2,698 | 910a | 1,220 | 1,415 | 1,479 |
| 35-39 | 2,012 | 1,961 | 873 | 891 | 1,139 | 1,070 |
| 40-44 | 1,507 | 1,584 | 575 | 660 | 932 | 924 |
| 45-49 | 1,660 | 1,562 | 705 | 538 | 955 | 1,024 |
| 50 or Older | 5,301 | 5,510 | 1,777 | 1,919 | 3,525 | 3,590 |
| 50-54 | 1,438 | 1,348 | 506 | 361 | 931 | 987 |
| 55-59 | 1,120 | 1,427 | 353a | 758 | 767 | 669 |
| 60-64 | 1,167 | 1,206 | 386 | 523 | 781 | 683 |
| 65 or Older | 1,577 | 1,528 | 532a | 277 | 1,045 | 1,251 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Age Category | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 8.5 | 8.8 | 6.4 | 7.0 | 10.5 | 10.4 |
| 18-25 | 19.3 | 20.1 | 12.8a | 15.1 | 25.7 | 25.2 |
| 18-20 | 19.9 | 20.3 | 12.1 | 14.9 | 28.2 | 26.4 |
| 21-25 | 18.8 | 20.0 | 13.3 | 15.1 | 24.2 | 24.5 |
| 26 or Older | 6.9 | 7.0 | 5.3 | 5.7 | 8.3 | 8.2 |
| 26-49 | 9.6 | 9.7 | 7.7 | 8.2 | 11.4 | 11.2 |
| 26-29 | 13.2 | 12.7 | 10.0 | 10.7 | 16.4 | 14.9 |
| 30-34 | 10.2 | 11.6 | 8.0a | 10.6 | 12.4 | 12.7 |
| 35-39 | 9.0 | 8.9 | 7.7 | 8.0 | 10.4 | 9.8 |
| 40-44 | 7.4 | 7.6 | 5.8 | 6.3 | 8.8 | 8.9 |
| 45-49 | 8.5 | 8.0 | 7.3 | 5.7 | 9.8 | 10.2 |
| 50 or Older | 4.5 | 4.6 | 3.2 | 3.4 | 5.7 | 5.7 |
| 50-54 | 7.3 | 6.8 | 5.4 | 4.0 | 9.1 | 9.2 |
| 55-59 | 5.3 | 7.1 | 3.2b | 7.3 | 7.4 | 6.9 |
| 60-64 | 5.2 | 5.3 | 3.6 | 4.6 | 6.7 | 6.0 |
| 65 or Older | 2.9 | 2.7 | 2.1a | 1.1 | 3.5 | 4.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Age Category | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 14,889 | 15,873 | 5,170b | 6,246 | 9,719 | 9,627 |
| 18-25 | 4,603a | 5,109 | 1,417b | 1,910 | 3,186 | 3,199 |
| 18-20 | 1,864 | 1,934 | 513a | 741 | 1,351 | 1,192 |
| 21-25 | 2,739 | 3,175 | 903a | 1,169 | 1,835 | 2,007 |
| 26 or Older | 10,286 | 10,764 | 3,753 | 4,336 | 6,532 | 6,428 |
| 26-49 | 6,792 | 7,068 | 2,668 | 2,972 | 4,124 | 4,096 |
| 26-29 | 1,643 | 1,658 | 614 | 722 | 1,029 | 936 |
| 30-34 | 1,624 | 1,864 | 629 | 820 | 995 | 1,045 |
| 35-39 | 1,396 | 1,462 | 589 | 697 | 806 | 765 |
| 40-44 | 1,034 | 1,062 | 352 | 458 | 682 | 604 |
| 45-49 | 1,095 | 1,022 | 483 | 276 | 612 | 746 |
| 50 or Older | 3,494 | 3,695 | 1,086 | 1,364 | 2,408 | 2,331 |
| 50-54 | 1,065 | 894 | 462 | 256 | 603 | 639 |
| 55-59 | 854 | 986 | 274a | 585 | 580 | 402 |
| 60-64 | 818 | 838 | 194 | 367 | 624 | 471 |
| 65 or Older | 757 | 977 | 156 | 156 | 601 | 820 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Age Category | Total (2021) |
Total (2022) |
Male (2021) |
Male (2022) |
Female (2021) |
Female (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 5.9 | 6.2 | 4.2a | 5.0 | 7.5 | 7.3 |
| 18-25 | 13.8 | 14.7 | 8.5b | 10.9 | 19.0 | 18.5 |
| 18-20 | 14.3 | 15.0 | 7.6a | 10.8 | 21.4 | 19.7 |
| 21-25 | 13.4 | 14.5 | 9.1 | 11.0 | 17.6 | 17.9 |
| 26 or Older | 4.7 | 4.9 | 3.5 | 4.0 | 5.7 | 5.6 |
| 26-49 | 6.6 | 6.9 | 5.3 | 5.8 | 8.0 | 8.0 |
| 26-29 | 9.4 | 9.7 | 7.1 | 8.4 | 11.7 | 11.1 |
| 30-34 | 7.2 | 8.0 | 5.6 | 7.1 | 8.7 | 9.0 |
| 35-39 | 6.3 | 6.6 | 5.2 | 6.2 | 7.3 | 7.0 |
| 40-44 | 5.1 | 5.1 | 3.6 | 4.4 | 6.5 | 5.8 |
| 45-49 | 5.6 | 5.2 | 5.0 | 2.9 | 6.2 | 7.5 |
| 50 or Older | 3.0 | 3.1 | 1.9 | 2.4 | 3.9 | 3.7 |
| 50-54 | 5.4 | 4.5 | 4.9 | 2.8 | 5.9 | 6.0 |
| 55-59 | 4.0 | 4.9 | 2.5a | 5.6 | 5.6 | 4.2 |
| 60-64 | 3.7 | 3.7 | 1.8 | 3.2 | 5.4 | 4.2 |
| 65 or Older | 1.4 | 1.7 | 0.6 | 0.6 | 2.0 | 2.7 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Gender/Age Group | Received Treatment for Depression in Past Year among People with MDE (2021) |
Received Treatment for Depression in Past Year among People with MDE (2022) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment (2021) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment (2022) |
|---|---|---|---|---|
| TOTAL | 12,932 | 14,088 | 9,423a | 10,493 |
| 18-25 | 3,192a | 3,766 | 2,483a | 2,982 |
| 26 or Older | 9,740 | 10,322 | 6,940 | 7,511 |
| 26-49 | 6,121 | 6,542 | 4,449 | 4,853 |
| 50 or Older | 3,619 | 3,780 | 2,491 | 2,658 |
| MALE | 4,184 | 4,725 | 2,828b | 3,619 |
| 18-25 | 755b | 1,202 | 576b | 950 |
| 26 or Older | 3,429 | 3,523 | 2,252 | 2,669 |
| 26-49 | 2,280 | 2,377 | 1,576 | 1,807 |
| 50 or Older | 1,149 | 1,146 | * | * |
| FEMALE | 8,748 | 9,363 | 6,595 | 6,874 |
| 18-25 | 2,437 | 2,564 | 1,907 | 2,032 |
| 26 or Older | 6,311 | 6,799 | 4,688 | 4,842 |
| 26-49 | 3,841 | 4,165 | 2,873 | 3,046 |
| 50 or Older | 2,470 | 2,634 | 1,816 | 1,796 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year treatment for depression data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Gender/Age Group | Received Treatment for Depression in Past Year among People with MDE (2021) |
Received Treatment for Depression in Past Year among People with MDE (2022) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment (2021) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment (2022) |
|---|---|---|---|---|
| TOTAL | 60.8 | 63.7 | 64.4 | 67.1 |
| 18-25 | 50.3 | 54.8 | 55.1 | 59.4 |
| 26 or Older | 65.3 | 67.8 | 68.5 | 70.7 |
| 26-49 | 63.1 | 66.5 | 66.1 | 69.1 |
| 50 or Older | 69.5 | 70.1 | 73.3 | 74.1 |
| MALE | 53.5 | 55.6 | 55.1 | 59.4 |
| 18-25 | 35.6b | 46.2 | 41.4 | 50.3 |
| 26 or Older | 60.2 | 59.8 | 60.2 | 63.6 |
| 26-49 | 58.5 | 57.8 | 59.3 | 61.5 |
| 50 or Older | 63.9 | 64.3 | * | * |
| FEMALE | 65.1 | 68.8 | 69.4 | 72.0 |
| 18-25 | 57.7 | 60.0 | 61.3 | 64.8 |
| 26 or Older | 68.5 | 72.9 | 73.3 | 75.4 |
| 26-49 | 66.2a | 72.8 | 70.5 | 74.5 |
| 50 or Older | 72.4 | 73.0 | 78.2 | 77.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year treatment for depression data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Demographic Characteristic | Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
|---|---|---|---|---|
| TOTAL | 21,553 | 22,475 | 14,889 | 15,873 |
| GENDER | ||||
| Male | 7,844 | 8,780 | 5,170b | 6,246 |
| Female | 13,709 | 13,695 | 9,719 | 9,627 |
| HISPANIC ORIGIN AND RACE | ||||
| Not Hispanic or Latino | 18,074 | 18,573 | 12,484 | 13,151 |
| AIAN | 177 | 94 | 126 | 65 |
| Asian | 746 | 963 | 515 | 781 |
| Black or African American | 2,121 | 2,038 | 1,439 | 1,507 |
| NHOPI | 44 | * | 41 | 34 |
| White | 14,342 | 14,574 | 9,924 | 10,090 |
| Two or More Races | 644 | 825 | 440a | 674 |
| Hispanic or Latino | 3,479 | 3,902 | 2,404 | 2,722 |
| EMPLOYMENT STATUS | ||||
| Full-Time | 9,000 | 9,608 | 6,065 | 6,415 |
| Part-Time | 3,739 | 3,967 | 2,474 | 2,772 |
| Unemployed | 1,687 | 1,574 | 1,194 | 1,147 |
| Other1 | 7,128 | 7,326 | 5,155 | 5,538 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Demographic Characteristic | Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
|---|---|---|---|---|
| TOTAL | 8.5 | 8.8 | 5.9 | 6.2 |
| GENDER | ||||
| Male | 6.4 | 7.0 | 4.2a | 5.0 |
| Female | 10.5 | 10.4 | 7.5 | 7.3 |
| HISPANIC ORIGIN AND RACE | ||||
| Not Hispanic or Latino | 8.6 | 8.8 | 5.9 | 6.2 |
| AIAN | 10.8 | 7.6 | 7.7 | 5.2 |
| Asian | 5.0 | 6.3 | 3.5 | 5.1 |
| Black or African American | 6.9 | 6.6 | 4.7 | 4.9 |
| NHOPI | 4.3 | * | 4.1 | 2.8 |
| White | 9.1 | 9.2 | 6.3 | 6.4 |
| Two or More Races | 14.1 | 16.4 | 9.6 | 13.4 |
| Hispanic or Latino | 8.1 | 8.8 | 5.6 | 6.2 |
| EMPLOYMENT STATUS | ||||
| Full-Time | 7.9 | 8.1 | 5.3 | 5.4 |
| Part-Time | 12.3 | 12.1 | 8.1 | 8.4 |
| Unemployed | 12.9 | 14.3 | 9.1 | 10.4 |
| Other1 | 7.4 | 7.8 | 5.4 | 5.9 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Demographic Characteristic | Received Treatment for Depression in Past Year among People with MDE (2021) |
Received Treatment for Depression in Past Year among People with MDE (2022) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment (2021) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment (2022) |
|---|---|---|---|---|
| TOTAL | 12,932 | 14,088 | 9,423a | 10,493 |
| GENDER | ||||
| Male | 4,184 | 4,725 | 2,828b | 3,619 |
| Female | 8,748 | 9,363 | 6,595 | 6,874 |
| HISPANIC ORIGIN AND RACE | ||||
| Not Hispanic or Latino | 10,975 | 12,098 | 8,076 | 9,018 |
| AIAN | * | * | * | * |
| Asian | * | * | * | * |
| Black or African American | 1,030 | 1,118 | 702 | 876 |
| NHOPI | * | * | * | * |
| White | 9,131 | 9,824 | 6,760 | 7,259 |
| Two or More Races | 374 | 529 | * | * |
| Hispanic or Latino | 1,957 | 1,990 | 1,347 | 1,475 |
| EMPLOYMENT STATUS | ||||
| Full-Time | 5,170 | 5,686 | 3,638 | 3,930 |
| Part-Time | 2,156 | 2,413 | 1,521 | 1,831 |
| Unemployed | 963 | 865 | 772 | 670 |
| Other1 | 4,643 | 5,124 | 3,492 | 4,061 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year treatment for depression data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Demographic Characteristic | Received Treatment for Depression in Past Year among People with MDE (2021) |
Received Treatment for Depression in Past Year among People with MDE (2022) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment (2021) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment (2022) |
|---|---|---|---|---|
| TOTAL | 60.8 | 63.7 | 64.4 | 67.1 |
| GENDER | ||||
| Male | 53.5 | 55.6 | 55.1 | 59.4 |
| Female | 65.1 | 68.8 | 69.4 | 72.0 |
| HISPANIC ORIGIN AND RACE | ||||
| Not Hispanic or Latino | 61.3b | 66.1 | 65.4 | 69.5 |
| AIAN | * | * | * | * |
| Asian | * | * | * | * |
| Black or African American | 49.6 | 56.1 | 50.9 | 59.3 |
| NHOPI | * | * | * | * |
| White | 64.0a | 68.4 | 68.4 | 72.8 |
| Two or More Races | 58.6 | 66.2 | * | * |
| Hispanic or Latino | 58.3 | 52.2 | 59.0 | 55.5 |
| EMPLOYMENT STATUS | ||||
| Full-Time | 57.8 | 60.1 | 60.1 | 61.9 |
| Part-Time | 58.4 | 62.3 | 63.7 | 67.4 |
| Unemployed | 57.5 | 55.5 | 62.5 | 58.8 |
| Other1 | 66.8 | 71.0 | 70.4 | 74.7 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year treatment for depression data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Geographic/Socioeconomic/Health Characteristic | Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
|---|---|---|---|---|
| TOTAL | 21,553 | 22,475 | 14,889 | 15,873 |
| GEOGRAPHIC REGION | ||||
| Northeast | 3,281 | 3,495 | 2,268 | 2,465 |
| Midwest | 4,579 | 4,879 | 3,105 | 3,390 |
| South | 7,991 | 8,393 | 5,549 | 6,044 |
| West | 5,702 | 5,708 | 3,966 | 3,974 |
| COUNTY TYPE | ||||
| Large Metro | 11,027 | 11,568 | 7,663 | 8,293 |
| Small Metro | 7,413 | 7,882 | 4,951 | 5,457 |
| Nonmetro | 3,113 | 3,024 | 2,275 | 2,122 |
| POVERTY LEVEL1 | ||||
| Less Than 100% | 4,373 | 4,059 | 3,281 | 2,984 |
| 100-199% | 4,951 | 5,509 | 3,502 | 4,067 |
| 200% or More | 12,215 | 12,906 | 8,093 | 8,821 |
| EDUCATION LEVEL | ||||
| < High School | 1,715 | 1,742 | 1,186 | 1,217 |
| High School Graduate | 4,835 | 5,507 | 3,275a | 4,123 |
| Some College/Associate’s Degree | 8,848 | 8,666 | 6,572 | 6,347 |
| College Graduate | 6,155 | 6,560 | 3,856 | 4,186 |
| HEALTH INSURANCE2 | ||||
| Private | 11,750 | 12,551 | 7,837 | 8,394 |
| Medicaid/CHIP | 5,584 | 6,432 | 4,164a | 4,973 |
| Other3 | 4,534 | 4,399 | 3,166 | 3,185 |
| No Coverage | 2,297 | 2,196 | 1,413 | 1,563 |
| OVERALL HEALTH4 | ||||
| Excellent | 1,926 | 2,101 | 1,163 | 1,381 |
| Very Good | 5,915 | 5,805 | 3,796 | 3,858 |
| Good | 7,684 | 8,294 | 5,253 | 5,829 |
| Fair/Poor | 5,935 | 6,270 | 4,583 | 4,801 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Geographic/Socioeconomic/Health Characteristic | Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
|---|---|---|---|---|
| TOTAL | 8.5 | 8.8 | 5.9 | 6.2 |
| GEOGRAPHIC REGION | ||||
| Northeast | 7.3 | 7.8 | 5.1 | 5.5 |
| Midwest | 8.7 | 9.2 | 5.9 | 6.4 |
| South | 8.3 | 8.6 | 5.8 | 6.2 |
| West | 9.5 | 9.4 | 6.6 | 6.6 |
| COUNTY TYPE | ||||
| Large Metro | 8.1 | 8.2 | 5.6 | 5.9 |
| Small Metro | 9.5 | 9.7 | 6.4 | 6.7 |
| Nonmetro | 7.9 | 8.9 | 5.8 | 6.3 |
| POVERTY LEVEL1 | ||||
| Less Than 100% | 11.6 | 11.2 | 8.7 | 8.2 |
| 100-199% | 9.7 | 11.1 | 6.9 | 8.2 |
| 200% or More | 7.4 | 7.6 | 4.9 | 5.2 |
| EDUCATION LEVEL | ||||
| < High School | 6.1 | 7.1 | 4.2 | 5.0 |
| High School Graduate | 7.0 | 8.0 | 4.7a | 6.0 |
| Some College/Associate’s Degree | 11.5 | 11.1 | 8.5 | 8.2 |
| College Graduate | 7.8 | 7.7 | 4.9 | 4.9 |
| HEALTH INSURANCE2 | ||||
| Private | 7.6 | 8.0 | 5.1 | 5.4 |
| Medicaid/CHIP | 11.8 | 13.4 | 8.8a | 10.3 |
| Other3 | 6.0 | 5.7 | 4.2 | 4.2 |
| No Coverage | 9.3 | 9.4 | 5.7 | 6.7 |
| OVERALL HEALTH4 | ||||
| Excellent | 4.1 | 4.8 | 2.5 | 3.1 |
| Very Good | 6.8 | 6.3 | 4.4 | 4.2 |
| Good | 9.5 | 10.1 | 6.5 | 7.1 |
| Fair/Poor | 15.2 | 16.1 | 11.8 | 12.4 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Geographic/Socioeconomic/Health Characteristic | Received Treatment for Depression in Past Year among People with MDE (2021) |
Received Treatment for Depression in Past Year among People with MDE (2022) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment (2021) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment (2022) |
|---|---|---|---|---|
| TOTAL | 12,932 | 14,088 | 9,423a | 10,493 |
| GEOGRAPHIC REGION | ||||
| Northeast | 1,951 | 2,372 | 1,451 | 1,779 |
| Midwest | 3,051 | 3,285 | 2,198 | 2,364 |
| South | 4,648 | 5,088 | 3,470 | 3,939 |
| West | 3,281 | 3,343 | 2,303 | 2,410 |
| COUNTY TYPE | ||||
| Large Metro | 6,519 | 6,992 | 4,627 | 5,194 |
| Small Metro | 4,435 | 5,088 | 3,222a | 3,837 |
| Nonmetro | 1,978 | 2,008 | 1,574 | 1,462 |
| POVERTY LEVEL1 | ||||
| Less Than 100% | 2,646 | 2,586 | 2,120 | 2,043 |
| 100-199% | 2,897 | 3,240 | 2,317 | 2,516 |
| 200% or More | 7,384 | 8,261 | 4,983a | 5,933 |
| EDUCATION LEVEL | ||||
| < High School | 967 | 945 | * | * |
| High School Graduate | 2,480b | 3,255 | 1,906b | 2,639 |
| Some College/Associate’s Degree | 5,413 | 5,354 | 4,249 | 4,132 |
| College Graduate | 4,073 | 4,534 | 2,617 | 3,002 |
| HEALTH INSURANCE2 | ||||
| Private | 7,540 | 8,240 | 5,097a | 5,844 |
| Medicaid/CHIP | 3,624 | 4,267 | 2,903 | 3,418 |
| Other3 | 3,049 | 3,199 | 2,184 | 2,488 |
| No Coverage | 845 | 800 | 604 | 580 |
| OVERALL HEALTH4 | ||||
| Excellent | 878 | 1,033 | 539 | 669 |
| Very Good | 3,351 | 3,444 | 2,281 | 2,375 |
| Good | 4,556 | 5,165 | 3,207a | 3,877 |
| Fair/Poor | 4,084 | 4,446 | 3,332 | 3,572 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year treatment for depression data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Geographic/Socioeconomic/Health Characteristic | Received Treatment for Depression in Past Year among People with MDE (2021) |
Received Treatment for Depression in Past Year among People with MDE (2022) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment (2021) |
Received Treatment for Depression in Past Year among People with MDE with Severe Impairment (2022) |
|---|---|---|---|---|
| TOTAL | 60.8 | 63.7 | 64.4 | 67.1 |
| GEOGRAPHIC REGION | ||||
| Northeast | 59.9a | 69.2 | 63.8 | 73.6 |
| Midwest | 66.0 | 68.5 | 70.3 | 71.2 |
| South | 59.6 | 61.7 | 64.6 | 65.9 |
| West | 58.7 | 59.3 | 59.5 | 61.5 |
| COUNTY TYPE | ||||
| Large Metro | 60.7 | 61.8 | 62.2 | 64.1 |
| Small Metro | 60.1 | 65.0 | 65.5 | 70.2 |
| Nonmetro | 63.1 | 67.7 | 68.9 | 70.6 |
| POVERTY LEVEL1 | ||||
| Less Than 100% | 61.7 | 65.5 | 66.3 | 70.6 |
| 100-199% | 59.4 | 59.9 | 67.2 | 63.0 |
| 200% or More | 61.1 | 64.8 | 62.4 | 67.8 |
| EDUCATION LEVEL | ||||
| < High School | 56.2 | 55.9 | * | * |
| High School Graduate | 53.2a | 60.4 | 60.4 | 64.5 |
| Some College/Associate’s Degree | 62.0 | 62.6 | 66.1 | 66.3 |
| College Graduate | 66.3 | 70.1 | 67.2 | 72.7 |
| HEALTH INSURANCE2 | ||||
| Private | 64.2 | 66.6 | 64.9a | 70.4 |
| Medicaid/CHIP | 66.2 | 67.7 | 71.9 | 70.3 |
| Other3 | 68.1 | 73.2 | 71.6 | 79.3 |
| No Coverage | 38.2 | 37.3 | 43.7 | 37.5 |
| OVERALL HEALTH4 | ||||
| Excellent | 46.6 | 51.1 | 48.2 | 51.1 |
| Very Good | 56.7 | 59.9 | 60.3 | 62.8 |
| Good | 59.8 | 63.4 | 61.7 | 66.7 |
| Fair/Poor | 70.6 | 71.9 | 74.4 | 75.4 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Respondents with unknown past year treatment for depression data were excluded. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Respondents with unknown health data were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Type of Professional1 | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 11,805 | 12,806 | 2,987a | 3,463 | 8,818 | 9,343 | 5,680 | 6,037 | 3,138 | 3,306 |
| HEALTH PROFESSIONAL | 11,421 | 12,471 | 2,931a | 3,413 | 8,490 | 9,058 | 5,434 | 5,860 | 3,056 | 3,198 |
| General Practitioner or Family Doctor | 5,983b | 7,175 | 1,293 | 1,568 | 4,690a | 5,608 | 2,850a | 3,406 | 1,840 | 2,202 |
| Other Medical Doctor2 | 1,037 | 1,219 | 267 | 192 | 770 | 1,027 | 536 | 512 | 234a | 515 |
| Psychologist | 3,966 | 4,418 | 1,156 | 1,429 | 2,811 | 2,989 | 1,832 | 2,032 | 978 | 957 |
| Psychiatrist or Psychotherapist | 4,569 | 5,237 | 1,260 | 1,538 | 3,309 | 3,699 | 2,133 | 2,449 | 1,176 | 1,250 |
| Social Worker | 1,377 | 1,774 | 249b | 414 | 1,128 | 1,360 | 830 | 814 | 299 | 546 |
| Counselor | 4,168 | 4,217 | 1,328 | 1,277 | 2,839 | 2,940 | 2,013 | 2,010 | 827 | 930 |
| Other Mental Health Professional3 | 1,262b | 1,933 | 323b | 504 | 939a | 1,429 | 671 | 871 | 268a | 557 |
| Nurse, Occupational Therapist, or Other Health Professional | 1,072 | 1,384 | 280 | 384 | 792 | 1,000 | 533 | 567 | 259 | 433 |
| ALTERNATIVE SERVICE PROFESSIONAL | 1,745 | 1,793 | 219 | 315 | 1,526 | 1,477 | 926 | 888 | 600 | 589 |
| Religious or Spiritual Advisor | 1,265 | 1,252 | 170 | 243 | 1,096 | 1,010 | 647 | 560 | 448 | 450 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 631 | 690 | 57a | 119 | 574 | 572 | 377 | 359 | 197 | 213 |
| OTHER PROFESSIONAL4 | 135 | 245 | 36 | 25 | 99 | 220 | 91 | 126 | 8 | 94 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded from the estimates for each specific type of professional but were included in the Total row. 2 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 3 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 4 Respondents with unknown or invalid responses to the other-specify question on other types of professionals seen for depression were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Type of Professional1 | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| HEALTH PROFESSIONAL | 97.0 | 98.0 | 99.2 | 99.0 | 96.3 | 97.6 | 95.7 | 97.6 | 97.4 | 97.5 |
| General Practitioner or Family Doctor | 50.8a | 56.4 | 43.8 | 45.5 | 53.2a | 60.4 | 50.2a | 56.7 | 58.6 | 67.1 |
| Other Medical Doctor2 | 8.8 | 9.6 | 9.0a | 5.6 | 8.7 | 11.1 | 9.4 | 8.5 | 7.5a | 15.7 |
| Psychologist | 33.7 | 34.7 | 39.1 | 41.5 | 31.9 | 32.2 | 32.3 | 33.8 | 31.2 | 29.2 |
| Psychiatrist or Psychotherapist | 38.8 | 41.1 | 42.6 | 44.6 | 37.5 | 39.8 | 37.6 | 40.8 | 37.5 | 38.1 |
| Social Worker | 11.7 | 13.9 | 8.4a | 12.0 | 12.8 | 14.6 | 14.6 | 13.6 | 9.5 | 16.6 |
| Counselor | 35.4 | 33.1 | 45.0b | 37.1 | 32.2 | 31.7 | 35.4 | 33.5 | 26.3 | 28.3 |
| Other Mental Health Professional3 | 10.7b | 15.2 | 10.9 | 14.6 | 10.6a | 15.4 | 11.8 | 14.5 | 8.5a | 17.0 |
| Nurse, Occupational Therapist, or Other Health Professional | 9.1 | 10.9 | 9.5 | 11.1 | 9.0 | 10.8 | 9.4 | 9.5 | 8.2 | 13.2 |
| ALTERNATIVE SERVICE PROFESSIONAL | 14.8 | 14.1 | 7.4 | 9.2 | 17.3 | 15.9 | 16.3 | 14.8 | 19.1 | 17.9 |
| Religious or Spiritual Advisor | 10.7 | 9.8 | 5.7 | 7.0 | 12.4 | 10.9 | 11.4 | 9.3 | 14.3 | 13.7 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 5.4 | 5.4 | 1.9 | 3.4 | 6.5 | 6.2 | 6.6 | 6.0 | 6.3 | 6.5 |
| OTHER PROFESSIONAL4 | 1.2 | 2.0 | 1.2 | 0.7 | 1.2 | 2.4 | 1.6 | 2.1 | 0.3 | 2.9 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded from the estimates for each specific type of professional but were included in the Total row. 2 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 3 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 4 Respondents with unknown or invalid responses to the other-specify question on other types of professionals seen for depression were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Type of Professional1 | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 8,569 | 9,519 | 2,320a | 2,750 | 6,249 | 6,769 | 4,110 | 4,460 | 2,140 | 2,309 |
| HEALTH PROFESSIONAL | 8,348 | 9,310 | 2,282a | 2,710 | 6,066 | 6,600 | 3,948 | 4,325 | 2,118 | * |
| General Practitioner or Family Doctor | 4,405b | 5,546 | 1,013 | 1,263 | 3,392a | 4,283 | 2,117a | 2,625 | 1,274 | 1,658 |
| Other Medical Doctor2 | 759 | 897 | 198 | 170 | 561 | 727 | 403 | 398 | 158 | 329 |
| Psychologist | 3,131 | 3,538 | 938 | 1,189 | 2,193 | 2,349 | 1,417 | 1,604 | 776 | 745 |
| Psychiatrist or Psychotherapist | 3,876 | 4,185 | 1,053 | 1,280 | 2,823 | 2,905 | 1,764 | 1,926 | 1,060 | 979 |
| Social Worker | 1,160 | 1,461 | 200b | 343 | 960 | 1,118 | 701 | 683 | 259 | 435 |
| Counselor | 3,241 | 3,184 | 1,013 | 985 | 2,227 | 2,199 | 1,622 | 1,557 | 605 | 642 |
| Other Mental Health Professional3 | 1,088a | 1,543 | 280a | 440 | 808 | 1,102 | 562 | 676 | 246 | 427 |
| Nurse, Occupational Therapist, or Other Health Professional | 905 | 1,126 | 228 | 308 | 678 | 818 | 453 | 457 | 224 | 360 |
| ALTERNATIVE SERVICE PROFESSIONAL | 1,293 | 1,417 | 182 | 241 | 1,111 | 1,176 | 764 | 721 | 347 | 456 |
| Religious or Spiritual Advisor | 924 | 954 | 142 | 179 | 782 | 776 | 510 | 430 | 273 | 345 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 470 | 569 | 47a | 107 | 423 | 462 | 310 | 312 | 112 | 150 |
| OTHER PROFESSIONAL4 | 106 | 188 | 34 | 22 | 71 | 166 | 69 | 105 | 2 | 61 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded from the estimates for each specific type of professional but were included in the Total row. 2 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 3 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 4 Respondents with unknown or invalid responses to the other-specify question on other types of professionals seen for depression were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Type of Professional1 | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| HEALTH PROFESSIONAL | 97.7 | 98.4 | 99.4 | 99.1 | 97.1 | 98.0 | 96.1 | 97.8 | 99.0 | * |
| General Practitioner or Family Doctor | 51.6b | 58.6 | 44.1 | 46.2 | 54.3b | 63.6 | 51.5a | 59.3 | 59.6 | 71.9 |
| Other Medical Doctor2 | 8.9 | 9.5 | 8.6 | 6.2 | 9.0 | 10.8 | 9.8 | 9.0 | 7.4 | 14.3 |
| Psychologist | 36.6 | 37.4 | 40.8 | 43.5 | 35.1 | 34.9 | 34.5 | 36.3 | 36.3 | 32.3 |
| Psychiatrist or Psychotherapist | 45.4 | 44.2 | 45.9 | 46.8 | 45.2 | 43.2 | 42.9 | 43.5 | 49.5 | 42.4 |
| Social Worker | 13.6 | 15.4 | 8.7 | 12.6 | 15.4 | 16.6 | 17.1 | 15.4 | 12.1 | 18.8 |
| Counselor | 37.9 | 33.6 | 44.1a | 36.0 | 35.6 | 32.7 | 39.5 | 35.2 | 28.3 | 27.8 |
| Other Mental Health Professional3 | 12.7 | 16.3 | 12.2 | 16.1 | 12.9 | 16.4 | 13.7 | 15.3 | 11.5 | 18.5 |
| Nurse, Occupational Therapist, or Other Health Professional | 10.6 | 11.9 | 9.9 | 11.3 | 10.8 | 12.1 | 11.0 | 10.3 | 10.5 | 15.6 |
| ALTERNATIVE SERVICE PROFESSIONAL | 15.1 | 15.0 | 7.9 | 8.8 | 17.8 | 17.5 | 18.6 | 16.3 | 16.2 | 19.8 |
| Religious or Spiritual Advisor | 10.8 | 10.1 | 6.2 | 6.5 | 12.5 | 11.5 | 12.4 | 9.7 | 12.7 | 15.0 |
| Herbalist, Chiropractor, Acupuncturist, or Massage Therapist | 5.5 | 6.0 | 2.1 | 3.9 | 6.8 | 6.9 | 7.5 | 7.0 | 5.3 | 6.5 |
| OTHER PROFESSIONAL4 | 1.3 | 2.0 | 1.5 | 0.8 | 1.2 | 2.5 | 1.7 | 2.4 | 0.1 | 2.7 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of professionals; thus, these response categories are not mutually exclusive. Respondents with unknown type of professional data were excluded from the estimates for each specific type of professional but were included in the Total row. 2 Other Medical Doctor includes cardiologists, gynecologists, urologists, and other medical doctors that are not general practitioners or family doctors. 3 Other Mental Health Professional includes mental health nurses and other therapists where type is not specified. 4 Respondents with unknown or invalid responses to the other-specify question on other types of professionals seen for depression were excluded. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 253,825 | 256,282 | 58,451 | 59,286 | 14,526 | 15,360 | 43,926 | 43,926 | 195,373 | 196,996 |
| DRUGS OR ALCOHOL2 | 44,383 | 46,494 | 19,692a | 21,543 | 6,556a | 7,410 | 13,136 | 14,134 | 24,691 | 24,950 |
| DRUGS2 | 22,571b | 25,417 | 12,333b | 14,504 | 4,610b | 5,587 | 7,723a | 8,916 | 10,237 | 10,913 |
| Marijuana | 15,313b | 17,669 | 8,065b | 9,837 | 2,878b | 3,767 | 5,187a | 6,070 | 7,248 | 7,832 |
| Cocaine | 1,431 | 1,429 | 965 | 918 | 347 | 386 | 618 | 532 | 467 | 511 |
| Heroin | 989 | 898 | * | * | * | 247 | * | 360 | * | * |
| Hallucinogens | 456 | 514 | * | 437 | * | * | * | * | * | 77 |
| Inhalants | * | * | * | * | * | * | * | * | * | * |
| Methamphetamine | 1,604 | 1,818 | 1,098 | 1,151 | 452 | 511 | 646 | 640 | 507 | 667 |
| Prescription Psychotherapeutics2 | 6,860 | 7,687 | 4,256 | 4,864 | 1,744 | 2,022 | 2,512 | 2,842 | 2,604 | 2,822 |
| Pain Relievers2 | 4,745 | 5,312 | 2,804 | 3,192 | 1,077 | 1,197 | 1,727 | 1,996 | 1,941 | 2,119 |
| Stimulants2 | 1,266 | 1,569 | 932 | 1,192 | 401 | 538 | 531 | 654 | 334 | 377 |
| Tranquilizers or Sedatives2 | 2,110 | 2,221 | 1,604 | 1,600 | 846 | 768 | 758 | 832 | 506 | 621 |
| Tranquilizers2 | 1,607 | 1,730 | 1,275 | 1,216 | 712 | 590 | 563 | 626 | 333 | 515 |
| Sedatives2 | 879 | 769 | * | 610 | * | * | * | * | * | 160 |
| Opioids2 | 5,308 | 5,852 | 3,150 | 3,527 | 1,113 | 1,329 | 2,036 | 2,198 | 2,159 | 2,325 |
| Central Nervous System Stimulants2 | 3,932 | 4,247 | 2,670 | 2,873 | 1,070 | 1,225 | 1,599 | 1,648 | 1,262 | 1,374 |
| ALCOHOL | 28,769 | 28,788 | 11,693 | 12,145 | 3,799 | 3,824 | 7,894 | 8,322 | 17,076 | 16,643 |
| BOTH DRUGS AND ALCOHOL2 | 6,956 | 7,712 | 4,334a | 5,106 | 1,853 | 2,001 | 2,480a | 3,105 | 2,623 | 2,606 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)2 | 15,615b | 17,706 | 8,000b | 9,398 | 2,757b | 3,586 | 5,243 | 5,812 | 7,615 | 8,307 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)2 | 21,812 | 21,077 | 7,359 | 7,040 | 1,946 | 1,823 | 5,413 | 5,217 | 14,453 | 14,037 |
| NO SUBSTANCE USE DISORDER2 | 209,442 | 209,788 | 38,759 | 37,743 | 7,970 | 7,951 | 30,789 | 29,792 | 170,683 | 172,045 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 23.0 | 23.1 | 5.7 | 6.0 | 17.3 | 17.1 | 77.0 | 76.9 |
| DRUGS OR ALCOHOL2 | 100.0 | 100.0 | 44.4 | 46.3 | 14.8 | 15.9 | 29.6 | 30.4 | 55.6 | 53.7 |
| DRUGS2 | 100.0 | 100.0 | 54.6 | 57.1 | 20.4 | 22.0 | 34.2 | 35.1 | 45.4 | 42.9 |
| Marijuana | 100.0 | 100.0 | 52.7 | 55.7 | 18.8 | 21.3 | 33.9 | 34.4 | 47.3 | 44.3 |
| Cocaine | 100.0 | 100.0 | 67.4 | 64.2 | 24.2 | 27.0 | 43.2 | 37.3 | 32.6 | 35.8 |
| Heroin | 100.0 | 100.0 | * | * | * | 27.5 | * | 40.1 | * | * |
| Hallucinogens | 100.0 | 100.0 | * | 85.0 | * | * | * | * | * | 15.0 |
| Inhalants | * | * | * | * | * | * | * | * | * | * |
| Methamphetamine | 100.0 | 100.0 | 68.4 | 63.3 | 28.2 | 28.1 | 40.2 | 35.2 | 31.6 | 36.7 |
| Prescription Psychotherapeutics2 | 100.0 | 100.0 | 62.0 | 63.3 | 25.4 | 26.3 | 36.6 | 37.0 | 38.0 | 36.7 |
| Pain Relievers2 | 100.0 | 100.0 | 59.1 | 60.1 | 22.7 | 22.5 | 36.4 | 37.6 | 40.9 | 39.9 |
| Stimulants2 | 100.0 | 100.0 | 73.6 | 76.0 | 31.7 | 34.3 | 42.0 | 41.7 | 26.4 | 24.0 |
| Tranquilizers or Sedatives2 | 100.0 | 100.0 | 76.0 | 72.0 | 40.1 | 34.6 | 35.9 | 37.5 | 24.0 | 28.0 |
| Tranquilizers2 | 100.0 | 100.0 | 79.3 | 70.3 | 44.3 | 34.1 | 35.0 | 36.2 | 20.7 | 29.7 |
| Sedatives2 | 100.0 | 100.0 | * | 79.3 | * | * | * | * | * | 20.7 |
| Opioids2 | 100.0 | 100.0 | 59.3 | 60.3 | 21.0 | 22.7 | 38.4 | 37.6 | 40.7 | 39.7 |
| Central Nervous System Stimulants2 | 100.0 | 100.0 | 67.9 | 67.6 | 27.2 | 28.8 | 40.7 | 38.8 | 32.1 | 32.4 |
| ALCOHOL | 100.0 | 100.0 | 40.6 | 42.2 | 13.2 | 13.3 | 27.4 | 28.9 | 59.4 | 57.8 |
| BOTH DRUGS AND ALCOHOL2 | 100.0 | 100.0 | 62.3 | 66.2 | 26.6 | 25.9 | 35.7 | 40.3 | 37.7 | 33.8 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)2 | 100.0 | 100.0 | 51.2 | 53.1 | 17.7 | 20.3 | 33.6 | 32.8 | 48.8 | 46.9 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)2 | 100.0 | 100.0 | 33.7 | 33.4 | 8.9 | 8.6 | 24.8 | 24.8 | 66.3 | 66.6 |
| NO SUBSTANCE USE DISORDER2 | 100.0 | 100.0 | 18.5 | 18.0 | 3.8 | 3.8 | 14.7 | 14.2 | 81.5 | 82.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status | Aged 18+ (2021) |
Aged 18+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 253,825 | 256,282 | 21,553 | 22,475 | 14,889 | 15,873 | 232,272a | 233,807 |
| DRUGS OR ALCOHOL1 | 44,383 | 46,494 | 8,187a | 9,337 | 6,426 | 7,175 | 36,196 | 37,156 |
| DRUGS1 | 22,571b | 25,417 | 5,499b | 6,713 | 4,368b | 5,385 | 17,072a | 18,704 |
| Marijuana | 15,313b | 17,669 | 3,572b | 4,641 | 2,717b | 3,681 | 11,741a | 13,028 |
| Cocaine | 1,431 | 1,429 | 427 | 396 | 383 | 295 | 1,004 | 1,033 |
| Heroin | 989 | 898 | * | 216 | * | 186 | * | 682 |
| Hallucinogens | 456 | 514 | * | * | * | * | * | * |
| Inhalants | * | * | * | * | * | * | * | * |
| Methamphetamine | 1,604 | 1,818 | 453 | 485 | 367 | 427 | 1,151 | 1,333 |
| Prescription Psychotherapeutics1 | 6,860 | 7,687 | 2,017 | 2,146 | 1,723 | 1,805 | 4,843 | 5,541 |
| Pain Relievers1 | 4,745 | 5,312 | 1,305 | 1,263 | 1,112 | 1,088 | 3,439 | 4,049 |
| Stimulants1 | 1,266 | 1,569 | 532 | 539 | 448 | 471 | 734a | 1,030 |
| Tranquilizers or Sedatives1 | 2,110 | 2,221 | 865 | 772 | 810 | 573 | 1,245 | 1,449 |
| Tranquilizers1 | 1,607 | 1,730 | 704 | 569 | 661 | 455 | 903 | 1,161 |
| Sedatives1 | 879 | 769 | * | * | * | 192 | * | * |
| Opioids1 | 5,308 | 5,852 | 1,350 | 1,403 | 1,149 | 1,205 | 3,958 | 4,448 |
| Central Nervous System Stimulants1 | 3,932 | 4,247 | 1,197 | 1,283 | 1,004 | 1,070 | 2,735 | 2,964 |
| ALCOHOL | 28,769 | 28,788 | 4,831 | 5,087 | 3,746 | 3,760 | 23,938 | 23,701 |
| BOTH DRUGS AND ALCOHOL1 | 6,956 | 7,712 | 2,143 | 2,463 | 1,688 | 1,970 | 4,813 | 5,249 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 15,615b | 17,706 | 3,356b | 4,250 | 2,680b | 3,415 | 12,258 | 13,455 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 21,812 | 21,077 | 2,688 | 2,624 | 2,058 | 1,790 | 19,125 | 18,452 |
| NO SUBSTANCE USE DISORDER1 | 209,442 | 209,788 | 13,366 | 13,137 | 8,463 | 8,698 | 196,075 | 196,651 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance Use Disorder Status | Aged 18+ (2021) |
Aged 18+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 8.5 | 8.8 | 5.9 | 6.2 | 91.5 | 91.2 |
| DRUGS OR ALCOHOL1 | 100.0 | 100.0 | 18.4 | 20.1 | 14.5 | 15.4 | 81.6 | 79.9 |
| DRUGS1 | 100.0 | 100.0 | 24.4 | 26.4 | 19.4 | 21.2 | 75.6 | 73.6 |
| Marijuana | 100.0 | 100.0 | 23.3 | 26.3 | 17.7a | 20.8 | 76.7 | 73.7 |
| Cocaine | 100.0 | 100.0 | 29.8 | 27.7 | 26.8 | 20.6 | 70.2 | 72.3 |
| Heroin | 100.0 | 100.0 | * | 24.1 | * | 20.7 | * | 75.9 |
| Hallucinogens | 100.0 | 100.0 | * | * | * | * | * | * |
| Inhalants | * | * | * | * | * | * | * | * |
| Methamphetamine | 100.0 | 100.0 | 28.2 | 26.7 | 22.9 | 23.5 | 71.8 | 73.3 |
| Prescription Psychotherapeutics1 | 100.0 | 100.0 | 29.4 | 27.9 | 25.1 | 23.5 | 70.6 | 72.1 |
| Pain Relievers1 | 100.0 | 100.0 | 27.5 | 23.8 | 23.4 | 20.5 | 72.5 | 76.2 |
| Stimulants1 | 100.0 | 100.0 | 42.0 | 34.4 | 35.4 | 30.0 | 58.0 | 65.6 |
| Tranquilizers or Sedatives1 | 100.0 | 100.0 | 41.0 | 34.8 | 38.4a | 25.8 | 59.0 | 65.2 |
| Tranquilizers1 | 100.0 | 100.0 | 43.8 | 32.9 | 41.1a | 26.3 | 56.2 | 67.1 |
| Sedatives1 | 100.0 | 100.0 | * | * | * | 24.9 | * | * |
| Opioids1 | 100.0 | 100.0 | 25.4 | 24.0 | 21.6 | 20.6 | 74.6 | 76.0 |
| Central Nervous System Stimulants1 | 100.0 | 100.0 | 30.4 | 30.2 | 25.5 | 25.2 | 69.6 | 69.8 |
| ALCOHOL | 100.0 | 100.0 | 16.8 | 17.7 | 13.0 | 13.1 | 83.2 | 82.3 |
| BOTH DRUGS AND ALCOHOL1 | 100.0 | 100.0 | 30.8 | 31.9 | 24.3 | 25.5 | 69.2 | 68.1 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 100.0 | 100.0 | 21.5 | 24.0 | 17.2 | 19.3 | 78.5 | 76.0 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 100.0 | 100.0 | 12.3 | 12.5 | 9.4 | 8.5 | 87.7 | 87.5 |
| NO SUBSTANCE USE DISORDER1 | 100.0 | 100.0 | 6.4 | 6.3 | 4.0 | 4.1 | 93.6 | 93.7 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS2 | 58,192b | 66,650 | 23,404b | 26,052 | 7,267 | 8,129 | 16,136a | 17,923 | 34,789b | 40,598 |
| Marijuana | 50,337b | 58,955 | 19,923b | 23,028 | 6,027b | 7,227 | 13,896b | 15,801 | 30,414b | 35,927 |
| Cocaine | 4,725 | 5,235 | 2,581 | 2,604 | 705 | 925 | 1,876 | 1,680 | 2,145 | 2,630 |
| Crack | 1,000 | 917 | 613 | 543 | 159 | 287 | 454 | 256 | 387 | 374 |
| Heroin | 1,088 | 1,046 | 801 | 685 | 212 | 272 | 589 | 414 | 287 | 361 |
| Hallucinogens | 7,195a | 8,151 | 3,810 | 4,165 | 1,400 | 1,492 | 2,410 | 2,674 | 3,385 | 3,986 |
| LSD | 2,307 | 2,154 | 1,267 | 1,147 | 465 | 472 | 802 | 676 | 1,040 | 1,006 |
| PCP | 175 | 190 | 65 | 148 | 30 | 55 | 36 | 93 | 110 | 42 |
| Ecstasy | 2,132 | 2,046 | 1,223 | 1,045 | 375 | 281 | 848 | 764 | 909 | 1,000 |
| Inhalants | 1,475 | 1,700 | 806 | 998 | 295 | 320 | 511 | 678 | 669 | 702 |
| Methamphetamine | 2,605 | 2,687 | 1,456 | 1,575 | 518 | 589 | 939 | 985 | 1,148 | 1,113 |
| Misuse of Prescription Psychotherapeutics | 13,621 | 13,564 | 7,166 | 6,815 | 2,426 | 2,344 | 4,740 | 4,471 | 6,455 | 6,748 |
| Pain Relievers | 8,335 | 8,051 | 4,250 | 3,918 | 1,411 | 1,307 | 2,839 | 2,611 | 4,085 | 4,133 |
| Stimulants | 3,608 | 4,072 | 1,913 | 2,301 | 680 | 767 | 1,233 | 1,534 | 1,695 | 1,771 |
| Tranquilizers or Sedatives | 4,565 | 4,711 | 2,786 | 2,789 | 1,065 | 1,119 | 1,721 | 1,670 | 1,779 | 1,922 |
| Tranquilizers | 4,063 | 4,038 | 2,572 | 2,320 | 959 | 910 | 1,613 | 1,411 | 1,492 | 1,718 |
| Sedatives | 834 | 931 | 487 | 660 | 254 | 304 | 233 | 356 | 347 | 272 |
| Benzodiazepines | 3,729 | 3,569 | 2,343 | 2,071 | 857 | 782 | 1,486 | 1,289 | 1,386 | 1,497 |
| Opioids2 | 8,871 | 8,513 | 4,598 | 4,163 | 1,494 | 1,403 | 3,104 | 2,760 | 4,272 | 4,350 |
| Central Nervous System Stimulants | 9,042 | 9,916 | 4,764 | 5,158 | 1,537 | 1,804 | 3,227 | 3,354 | 4,278 | 4,758 |
| Illicit Drugs Other Than Marijuana2,3 | 21,944 | 23,348 | 11,154 | 11,291 | 3,839 | 3,971 | 7,314 | 7,321 | 10,791a | 12,057 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 74,431 | -- | 23,767 | -- | 7,230 | -- | 16,537 | -- | 50,664 |
| Tobacco Products | 66,867b | 62,311 | 20,278 | 19,023 | 5,599 | 5,657 | 14,679 | 13,366 | 46,588a | 43,288 |
| Cigarettes | 52,666a | 49,253 | 17,353 | 16,065 | 4,864 | 4,901 | 12,489a | 11,164 | 35,314 | 33,188 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 9,860b | 8,102 | 2,297 | 2,211 | 682 | 636 | 1,614 | 1,576 | 7,563b | 5,891 |
| Cigars | 18,381 | 18,762 | 5,900 | 5,771 | 1,734 | 1,649 | 4,166 | 4,121 | 12,481 | 12,992 |
| Pipe Tobacco4 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 31,542 | -- | 12,628 | -- | 4,130 | -- | 8,498 | -- | 18,914 |
| ALCOHOL | 169,487 | 172,675 | 41,752 | 43,102 | 10,999 | 11,420 | 30,753 | 31,681 | 127,735 | 129,573 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 8,642 | -- | 4,245 | -- | 1,405 | -- | 2,840 | -- | 4,397 |
| Illegally Made Fentanyl | -- | 666 | -- | 455 | -- | 166 | -- | 290 | -- | 210 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS2 | 22.9b | 26.0 | 40.0b | 43.9 | 50.0 | 52.9 | 36.7b | 40.8 | 17.8b | 20.6 |
| Marijuana | 19.8b | 23.0 | 34.1b | 38.8 | 41.5a | 47.1 | 31.6b | 36.0 | 15.6b | 18.2 |
| Cocaine | 1.9 | 2.0 | 4.4 | 4.4 | 4.9 | 6.0 | 4.3 | 3.8 | 1.1 | 1.3 |
| Crack | 0.4 | 0.4 | 1.0 | 0.9 | 1.1 | 1.9 | 1.0 | 0.6 | 0.2 | 0.2 |
| Heroin | 0.4 | 0.4 | 1.4 | 1.2 | 1.5 | 1.8 | 1.3 | 0.9 | 0.1 | 0.2 |
| Hallucinogens | 2.8 | 3.2 | 6.5 | 7.0 | 9.6 | 9.7 | 5.5 | 6.1 | 1.7 | 2.0 |
| LSD | 0.9 | 0.8 | 2.2 | 1.9 | 3.2 | 3.1 | 1.8 | 1.5 | 0.5 | 0.5 |
| PCP | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.4 | 0.1 | 0.2 | 0.1 | 0.0 |
| Ecstasy | 0.8 | 0.8 | 2.1 | 1.8 | 2.6 | 1.8 | 1.9 | 1.7 | 0.5 | 0.5 |
| Inhalants | 0.6 | 0.7 | 1.4 | 1.7 | 2.0 | 2.1 | 1.2 | 1.5 | 0.3 | 0.4 |
| Methamphetamine | 1.0 | 1.0 | 2.5 | 2.7 | 3.6 | 3.8 | 2.1 | 2.2 | 0.6 | 0.6 |
| Misuse of Prescription Psychotherapeutics | 5.4 | 5.3 | 12.3 | 11.5 | 16.7 | 15.3 | 10.8 | 10.2 | 3.3 | 3.4 |
| Pain Relievers | 3.3 | 3.1 | 7.3 | 6.6 | 9.7 | 8.5 | 6.5 | 5.9 | 2.1 | 2.1 |
| Stimulants | 1.4 | 1.6 | 3.3 | 3.9 | 4.7 | 5.0 | 2.8 | 3.5 | 0.9 | 0.9 |
| Tranquilizers or Sedatives | 1.8 | 1.8 | 4.8 | 4.7 | 7.3 | 7.3 | 3.9 | 3.8 | 0.9 | 1.0 |
| Tranquilizers | 1.6 | 1.6 | 4.4 | 3.9 | 6.6 | 5.9 | 3.7 | 3.2 | 0.8 | 0.9 |
| Sedatives | 0.3 | 0.4 | 0.8 | 1.1 | 1.7 | 2.0 | 0.5 | 0.8 | 0.2 | 0.1 |
| Benzodiazepines | 1.5 | 1.4 | 4.0 | 3.5 | 5.9 | 5.1 | 3.4 | 2.9 | 0.7 | 0.8 |
| Opioids2 | 3.5 | 3.3 | 7.9 | 7.0 | 10.3 | 9.1 | 7.1 | 6.3 | 2.2 | 2.2 |
| Central Nervous System Stimulants | 3.6 | 3.9 | 8.2 | 8.7 | 10.6 | 11.7 | 7.3 | 7.6 | 2.2 | 2.4 |
| Illicit Drugs Other Than Marijuana2,3 | 8.6 | 9.1 | 19.1 | 19.0 | 26.4 | 25.9 | 16.7 | 16.7 | 5.5a | 6.1 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 29.0 | -- | 40.1 | -- | 47.1 | -- | 37.6 | -- | 25.7 |
| Tobacco Products | 26.3b | 24.3 | 34.7a | 32.1 | 38.5 | 36.8 | 33.4a | 30.4 | 23.8b | 22.0 |
| Cigarettes | 20.7b | 19.2 | 29.7a | 27.1 | 33.5 | 31.9 | 28.4a | 25.4 | 18.1a | 16.8 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 3.9b | 3.2 | 3.9 | 3.7 | 4.7 | 4.1 | 3.7 | 3.6 | 3.9b | 3.0 |
| Cigars | 7.2 | 7.3 | 10.1 | 9.7 | 11.9 | 10.7 | 9.5 | 9.4 | 6.4 | 6.6 |
| Pipe Tobacco4 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 12.3 | -- | 21.3 | -- | 26.9 | -- | 19.3 | -- | 9.6 |
| ALCOHOL | 66.8 | 67.4 | 71.4 | 72.7 | 75.7 | 74.3 | 70.0 | 72.1 | 65.4 | 65.8 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 3.4 | -- | 7.2 | -- | 9.1 | -- | 6.5 | -- | 2.2 |
| Illegally Made Fentanyl | -- | 0.3 | -- | 0.8 | -- | 1.1 | -- | 0.7 | -- | 0.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance | Aged 18+ (2021) |
Aged 18+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 58,192b | 66,650 | 9,612b | 11,073 | 7,065b | 8,287 | 48,580b | 55,578 |
| Marijuana | 50,337b | 58,955 | 7,957b | 9,925 | 5,820b | 7,386 | 42,380b | 49,030 |
| Cocaine | 4,725 | 5,235 | 924 | 1,071 | 763 | 822 | 3,802 | 4,163 |
| Crack | 1,000 | 917 | 145 | 285 | 127 | 210 | 854 | 632 |
| Heroin | 1,088 | 1,046 | 233 | 245 | 223 | 212 | 855 | 802 |
| Hallucinogens | 7,195a | 8,151 | 1,854 | 1,990 | 1,427 | 1,536 | 5,341 | 6,161 |
| LSD | 2,307 | 2,154 | 667 | 532 | 503 | 404 | 1,639 | 1,622 |
| PCP | 175 | 190 | 38 | 55 | 20 | 55 | 137 | 135 |
| Ecstasy | 2,132 | 2,046 | 494 | 408 | 369 | 325 | 1,638 | 1,638 |
| Inhalants | 1,475 | 1,700 | 389 | 485 | 329 | 392 | 1,087 | 1,215 |
| Methamphetamine | 2,605 | 2,687 | 531 | 658 | 427 | 575 | 2,074 | 2,029 |
| Misuse of Prescription Psychotherapeutics | 13,621 | 13,564 | 3,219 | 2,878 | 2,405 | 2,270 | 10,402 | 10,685 |
| Pain Relievers | 8,335 | 8,051 | 1,773 | 1,630 | 1,359 | 1,340 | 6,563 | 6,421 |
| Stimulants | 3,608 | 4,072 | 958 | 885 | 763 | 673 | 2,650a | 3,187 |
| Tranquilizers or Sedatives | 4,565 | 4,711 | 1,287 | 1,246 | 979 | 993 | 3,278 | 3,466 |
| Tranquilizers | 4,063 | 4,038 | 1,167 | 991 | 874 | 824 | 2,896 | 3,047 |
| Sedatives | 834 | 931 | 274 | 343 | 250 | 252 | 561 | 589 |
| Benzodiazepines | 3,729 | 3,569 | 1,063 | 894 | 784 | 735 | 2,666 | 2,675 |
| Opioids1 | 8,871 | 8,513 | 1,806 | 1,733 | 1,386 | 1,428 | 7,064 | 6,780 |
| Central Nervous System Stimulants | 9,042 | 9,916 | 1,905 | 2,057 | 1,550 | 1,603 | 7,136 | 7,859 |
| Illicit Drugs Other Than Marijuana1,2 | 21,944 | 23,348 | 4,887 | 5,021 | 3,658 | 3,877 | 17,057 | 18,327 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 74,431 | -- | 9,755 | -- | 7,142 | -- | 64,676 |
| Tobacco Products | 66,867b | 62,311 | 7,288 | 7,417 | 5,403 | 5,397 | 59,578a | 54,894 |
| Cigarettes | 52,666a | 49,253 | 6,262 | 6,309 | 4,643 | 4,638 | 46,404a | 42,944 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 9,860b | 8,102 | 840 | 700 | 648 | 494 | 9,020b | 7,402 |
| Cigars | 18,381 | 18,762 | 2,344 | 2,358 | 1,756 | 1,768 | 16,037 | 16,404 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 31,542 | -- | 5,757 | -- | 4,321 | -- | 25,785 |
| ALCOHOL | 169,487 | 172,675 | 16,314 | 16,868 | 11,299 | 11,896 | 153,173 | 155,807 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 8,642 | -- | 1,736 | -- | 1,429 | -- | 6,906 |
| Illegally Made Fentanyl | -- | 666 | -- | 178 | -- | 165 | -- | 488 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance | Aged 18+ (2021) |
Aged 18+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 22.9b | 26.0 | 44.6b | 49.3 | 47.5a | 52.2 | 20.9b | 23.8 |
| Marijuana | 19.8b | 23.0 | 36.9b | 44.2 | 39.1b | 46.5 | 18.2b | 21.0 |
| Cocaine | 1.9 | 2.0 | 4.3 | 4.8 | 5.1 | 5.2 | 1.6 | 1.8 |
| Crack | 0.4 | 0.4 | 0.7 | 1.3 | 0.9 | 1.3 | 0.4 | 0.3 |
| Heroin | 0.4 | 0.4 | 1.1 | 1.1 | 1.5 | 1.3 | 0.4 | 0.3 |
| Hallucinogens | 2.8 | 3.2 | 8.6 | 8.9 | 9.6 | 9.7 | 2.3 | 2.6 |
| LSD | 0.9 | 0.8 | 3.1 | 2.4 | 3.4 | 2.5 | 0.7 | 0.7 |
| PCP | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.3 | 0.1 | 0.1 |
| Ecstasy | 0.8 | 0.8 | 2.3 | 1.8 | 2.5 | 2.0 | 0.7 | 0.7 |
| Inhalants | 0.6 | 0.7 | 1.8 | 2.2 | 2.2 | 2.5 | 0.5 | 0.5 |
| Methamphetamine | 1.0 | 1.0 | 2.5 | 2.9 | 2.9 | 3.6 | 0.9 | 0.9 |
| Misuse of Prescription Psychotherapeutics | 5.4 | 5.3 | 14.9 | 12.8 | 16.2 | 14.3 | 4.5 | 4.6 |
| Pain Relievers | 3.3 | 3.1 | 8.2 | 7.3 | 9.1 | 8.4 | 2.8 | 2.7 |
| Stimulants | 1.4 | 1.6 | 4.4 | 3.9 | 5.1 | 4.2 | 1.1 | 1.4 |
| Tranquilizers or Sedatives | 1.8 | 1.8 | 6.0 | 5.5 | 6.6 | 6.3 | 1.4 | 1.5 |
| Tranquilizers | 1.6 | 1.6 | 5.4 | 4.4 | 5.9 | 5.2 | 1.2 | 1.3 |
| Sedatives | 0.3 | 0.4 | 1.3 | 1.5 | 1.7 | 1.6 | 0.2 | 0.3 |
| Benzodiazepines | 1.5 | 1.4 | 4.9 | 4.0 | 5.3 | 4.6 | 1.1 | 1.1 |
| Opioids1 | 3.5 | 3.3 | 8.4 | 7.7 | 9.3 | 9.0 | 3.0 | 2.9 |
| Central Nervous System Stimulants | 3.6 | 3.9 | 8.8 | 9.2 | 10.4 | 10.1 | 3.1 | 3.4 |
| Illicit Drugs Other Than Marijuana1,2 | 8.6 | 9.1 | 22.7 | 22.3 | 24.6 | 24.4 | 7.3 | 7.8 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 29.0 | -- | 43.4 | -- | 45.0 | -- | 27.7 |
| Tobacco Products | 26.3b | 24.3 | 33.8 | 33.0 | 36.3 | 34.0 | 25.7b | 23.5 |
| Cigarettes | 20.7b | 19.2 | 29.1 | 28.1 | 31.2 | 29.2 | 20.0b | 18.4 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 3.9b | 3.2 | 3.9 | 3.1 | 4.4 | 3.1 | 3.9b | 3.2 |
| Cigars | 7.2 | 7.3 | 10.9 | 10.5 | 11.8 | 11.1 | 6.9 | 7.0 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 12.3 | -- | 25.6 | -- | 27.2 | -- | 11.0 |
| ALCOHOL | 66.8 | 67.4 | 75.7 | 75.1 | 75.9 | 74.9 | 65.9 | 66.6 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 3.4 | -- | 7.7 | -- | 9.0 | -- | 3.0 |
| Illegally Made Fentanyl | -- | 0.3 | -- | 0.8 | -- | 1.0 | -- | 0.2 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance | Aged 18-25 (2021) |
Aged 18-25 (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS2 | 13,036b | 14,221 | 6,053b | 7,008 | 2,300 | 2,553 | 3,753a | 4,455 | 6,983 | 7,213 |
| Marijuana | 12,133b | 13,299 | 5,589b | 6,537 | 2,091 | 2,395 | 3,498a | 4,142 | 6,544 | 6,762 |
| Cocaine | 1,225 | 1,295 | 598 | 713 | 170a | 274 | 428 | 439 | 627 | 582 |
| Crack | 75 | 39 | 27 | 30 | 15 | 7 | 12 | 23 | 48 | 10 |
| Heroin | 71 | 55 | 57 | 39 | 28 | 17 | 30 | 22 | 13 | 16 |
| Hallucinogens | 2,462 | 2,676 | 1,410 | 1,542 | 563 | 633 | 847 | 909 | 1,051 | 1,134 |
| LSD | 1,077 | 894 | 619 | 556 | 224 | 251 | 395 | 305 | 458 | 339 |
| PCP | 54 | 13 | 36 | 9 | 26 | 3 | 10 | 6 | 19 | 4 |
| Ecstasy | 709 | 639 | 377 | 336 | 143 | 110 | 234 | 226 | 332 | 303 |
| Inhalants | 507 | 647 | 333 | 389 | 155 | 157 | 178 | 232 | 174 | 258 |
| Methamphetamine | 183 | 161 | 112 | 111 | 44 | 41 | 68 | 70 | 71 | 50 |
| Misuse of Prescription Psychotherapeutics | 2,638 | 2,542 | 1,516 | 1,494 | 620 | 642 | 896 | 853 | 1,122 | 1,047 |
| Pain Relievers | 1,050 | 1,099 | 599 | 683 | 237 | 319 | 362 | 364 | 451 | 416 |
| Stimulants | 1,359 | 1,278 | 720 | 743 | 275 | 300 | 444 | 442 | 639 | 535 |
| Tranquilizers or Sedatives | 916 | 842 | 625 | 560 | 307 | 242 | 318 | 318 | 291 | 283 |
| Tranquilizers | 855 | 779 | 577 | 515 | 269 | 226 | 308 | 289 | 277 | 264 |
| Sedatives | 144 | 93 | 126 | 74 | 90b | 23 | 36 | 50 | 18 | 19 |
| Benzodiazepines | 825 | 747 | 550 | 491 | 269 | 210 | 281 | 281 | 274 | 256 |
| Opioids2 | 1,070 | 1,120 | 615 | 694 | 249 | 323 | 366 | 372 | 455 | 425 |
| Central Nervous System Stimulants | 2,230 | 2,272 | 1,137 | 1,289 | 381 | 509 | 756 | 781 | 1,093 | 982 |
| Illicit Drugs Other Than Marijuana2,3 | 4,807 | 5,092 | 2,649 | 2,947 | 1,074 | 1,236 | 1,575 | 1,710 | 2,158 | 2,146 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 14,041 | -- | 6,151 | -- | 2,153 | -- | 3,997 | -- | 7,891 |
| Tobacco Products | 8,980 | 8,610 | 3,822 | 3,787 | 1,383 | 1,329 | 2,439 | 2,458 | 5,158 | 4,824 |
| Cigarettes | 6,407 | 6,341 | 2,950 | 2,978 | 1,093 | 1,116 | 1,857 | 1,862 | 3,457 | 3,364 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 1,639 | 1,475 | 584 | 537 | 180 | 193 | 405 | 344 | 1,054 | 938 |
| Cigars | 3,981 | 3,929 | 1,715 | 1,730 | 580 | 518 | 1,135 | 1,212 | 2,266 | 2,199 |
| Pipe Tobacco4 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 11,608 | -- | 5,185 | -- | 1,884 | -- | 3,301 | -- | 6,423 |
| ALCOHOL | 22,790a | 23,608 | 8,814a | 9,740 | 3,222 | 3,282 | 5,592b | 6,458 | 13,976 | 13,867 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 1,145 | -- | 709 | -- | 323 | -- | 386 | -- | 436 |
| Illegally Made Fentanyl | -- | 48 | -- | 32 | -- | 6 | -- | 26 | -- | 17 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance | Aged 18-25 (2021) |
Aged 18-25 (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS2 | 39.0 | 40.9 | 52.5 | 55.7 | 57.3a | 63.3 | 49.9 | 52.1 | 31.9 | 32.5 |
| Marijuana | 36.3 | 38.2 | 48.5a | 52.0 | 52.1a | 59.4 | 46.5 | 48.4 | 29.8 | 30.5 |
| Cocaine | 3.7 | 3.7 | 5.2 | 5.7 | 4.2a | 6.8 | 5.7 | 5.1 | 2.9 | 2.6 |
| Crack | 0.2 | 0.1 | 0.2 | 0.2 | 0.4 | 0.2 | 0.2 | 0.3 | 0.2 | 0.0 |
| Heroin | 0.2 | 0.2 | 0.5 | 0.3 | 0.7 | 0.4 | 0.4 | 0.3 | 0.1 | 0.1 |
| Hallucinogens | 7.4 | 7.7 | 12.2 | 12.3 | 14.0 | 15.7 | 11.3 | 10.6 | 4.8 | 5.1 |
| LSD | 3.2 | 2.6 | 5.4 | 4.4 | 5.6 | 6.2 | 5.2a | 3.6 | 2.1 | 1.5 |
| PCP | 0.2 | 0.0 | 0.3 | 0.1 | 0.6 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 |
| Ecstasy | 2.1 | 1.8 | 3.3 | 2.7 | 3.6 | 2.7 | 3.1 | 2.6 | 1.5 | 1.4 |
| Inhalants | 1.5 | 1.9 | 2.9 | 3.1 | 3.9 | 3.9 | 2.4 | 2.7 | 0.8 | 1.2 |
| Methamphetamine | 0.5 | 0.5 | 1.0 | 0.9 | 1.1 | 1.0 | 0.9 | 0.8 | 0.3 | 0.2 |
| Misuse of Prescription Psychotherapeutics | 7.9 | 7.3 | 13.1 | 11.9 | 15.4 | 15.9 | 11.9 | 10.0 | 5.1 | 4.7 |
| Pain Relievers | 3.1 | 3.2 | 5.2 | 5.4 | 5.9 | 7.9 | 4.8 | 4.3 | 2.1 | 1.9 |
| Stimulants | 4.1 | 3.7 | 6.2 | 5.9 | 6.9 | 7.4 | 5.9 | 5.2 | 2.9 | 2.4 |
| Tranquilizers or Sedatives | 2.7 | 2.4 | 5.4 | 4.4 | 7.6 | 6.0 | 4.2 | 3.7 | 1.3 | 1.3 |
| Tranquilizers | 2.6 | 2.2 | 5.0 | 4.1 | 6.7 | 5.6 | 4.1 | 3.4 | 1.3 | 1.2 |
| Sedatives | 0.4 | 0.3 | 1.1 | 0.6 | 2.2b | 0.6 | 0.5 | 0.6 | 0.1 | 0.1 |
| Benzodiazepines | 2.5 | 2.1 | 4.8 | 3.9 | 6.7 | 5.2 | 3.7 | 3.3 | 1.3 | 1.2 |
| Opioids2 | 3.2 | 3.2 | 5.3 | 5.5 | 6.2 | 8.0 | 4.9 | 4.3 | 2.1 | 1.9 |
| Central Nervous System Stimulants | 6.7 | 6.5 | 9.9 | 10.2 | 9.5 | 12.6 | 10.1 | 9.1 | 5.0 | 4.4 |
| Illicit Drugs Other Than Marijuana2,3 | 14.4 | 14.6 | 23.0 | 23.4 | 26.8 | 30.7 | 20.9 | 20.0 | 9.8 | 9.7 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 40.4 | -- | 48.9 | -- | 53.4 | -- | 46.7 | -- | 35.5 |
| Tobacco Products | 26.8a | 24.8 | 33.1 | 30.1 | 34.5 | 33.0 | 32.4 | 28.7 | 23.5 | 21.7 |
| Cigarettes | 19.1 | 18.2 | 25.6 | 23.7 | 27.2 | 27.7 | 24.7 | 21.8 | 15.8 | 15.1 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 4.9 | 4.2 | 5.1 | 4.3 | 4.5 | 4.8 | 5.4 | 4.0 | 4.8 | 4.2 |
| Cigars | 11.9 | 11.3 | 14.9 | 13.8 | 14.5 | 12.9 | 15.1 | 14.2 | 10.3 | 9.9 |
| Pipe Tobacco4 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 33.4 | -- | 41.2 | -- | 46.7 | -- | 38.6 | -- | 28.9 |
| ALCOHOL | 68.1 | 67.9 | 76.4 | 77.4 | 80.3 | 81.4 | 74.3 | 75.5 | 63.8 | 62.5 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 3.3 | -- | 5.6 | -- | 8.0 | -- | 4.5 | -- | 2.0 |
| Illegally Made Fentanyl | -- | 0.1 | -- | 0.3 | -- | 0.1 | -- | 0.3 | -- | 0.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance | Aged 18-25 (2021) |
Aged 18-25 (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 13,036b | 14,221 | 3,414a | 4,017 | 2,389b | 3,048 | 9,622 | 10,204 |
| Marijuana | 12,133b | 13,299 | 3,145a | 3,747 | 2,182b | 2,841 | 8,988 | 9,552 |
| Cocaine | 1,225 | 1,295 | 262 | 386 | 208 | 296 | 963 | 910 |
| Crack | 75 | 39 | 12 | 7 | 3 | 5 | 62 | 33 |
| Heroin | 71 | 55 | 34 | 23 | 33 | 21 | 37 | 32 |
| Hallucinogens | 2,462 | 2,676 | 798 | 922 | 566a | 759 | 1,664 | 1,754 |
| LSD | 1,077 | 894 | 361 | 307 | 254 | 253 | 716 | 587 |
| PCP | 54 | 13 | 31 | 2 | 16 | 2 | 23 | 10 |
| Ecstasy | 709 | 639 | 211 | 196 | 147 | 164 | 498 | 443 |
| Inhalants | 507 | 647 | 205 | 273 | 153 | 224 | 302 | 375 |
| Methamphetamine | 183 | 161 | 53 | 48 | 38 | 48 | 130 | 113 |
| Misuse of Prescription Psychotherapeutics | 2,638 | 2,542 | 882 | 925 | 636 | 713 | 1,756 | 1,617 |
| Pain Relievers | 1,050 | 1,099 | 328 | 401 | 235 | 309 | 722 | 698 |
| Stimulants | 1,359 | 1,278 | 386 | 452 | 292 | 359 | 973 | 825 |
| Tranquilizers or Sedatives | 916 | 842 | 395 | 347 | 285 | 266 | 521 | 496 |
| Tranquilizers | 855 | 779 | 353 | 320 | 256 | 242 | 501 | 459 |
| Sedatives | 144 | 93 | 93a | 34 | 75 | 33 | 51 | 58 |
| Benzodiazepines | 825 | 747 | 342 | 313 | 244 | 239 | 483 | 434 |
| Opioids1 | 1,070 | 1,120 | 336 | 411 | 243 | 317 | 734 | 709 |
| Central Nervous System Stimulants | 2,230 | 2,272 | 546 | 721 | 419 | 572 | 1,684 | 1,551 |
| Illicit Drugs Other Than Marijuana1,2 | 4,807 | 5,092 | 1,486 | 1,777 | 1,030b | 1,421 | 3,321 | 3,316 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 14,041 | -- | 3,402 | -- | 2,557 | -- | 10,639 |
| Tobacco Products | 8,980 | 8,610 | 2,012 | 2,001 | 1,456 | 1,548 | 6,968 | 6,609 |
| Cigarettes | 6,407 | 6,341 | 1,584 | 1,576 | 1,145 | 1,249 | 4,824 | 4,765 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 1,639 | 1,475 | 268 | 271 | 176 | 194 | 1,370 | 1,204 |
| Cigars | 3,981 | 3,929 | 886 | 883 | 660 | 697 | 3,096 | 3,047 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 11,608 | -- | 2,943 | -- | 2,216 | -- | 8,665 |
| ALCOHOL | 22,790a | 23,608 | 4,967 | 5,543 | 3,544 | 4,008 | 17,824 | 18,064 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 1,145 | -- | 412 | -- | 317 | -- | 733 |
| Illegally Made Fentanyl | -- | 48 | -- | 8 | -- | 7 | -- | 41 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance | Aged 18-25 (2021) |
Aged 18-25 (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 39.0 | 40.9 | 53.0 | 57.5 | 51.9b | 59.6 | 35.6 | 36.7 |
| Marijuana | 36.3 | 38.2 | 48.8a | 53.6 | 47.4b | 55.6 | 33.3 | 34.4 |
| Cocaine | 3.7 | 3.7 | 4.1 | 5.5 | 4.5 | 5.8 | 3.6 | 3.3 |
| Crack | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 |
| Heroin | 0.2 | 0.2 | 0.5 | 0.3 | 0.7 | 0.4 | 0.1 | 0.1 |
| Hallucinogens | 7.4 | 7.7 | 12.4 | 13.2 | 12.3 | 14.9 | 6.2 | 6.3 |
| LSD | 3.2 | 2.6 | 5.6 | 4.4 | 5.5 | 5.0 | 2.7 | 2.1 |
| PCP | 0.2 | 0.0 | 0.5 | 0.0 | 0.3 | 0.0 | 0.1 | 0.0 |
| Ecstasy | 2.1 | 1.8 | 3.3 | 2.8 | 3.2 | 3.2 | 1.8 | 1.6 |
| Inhalants | 1.5 | 1.9 | 3.2 | 3.9 | 3.3 | 4.4 | 1.1 | 1.3 |
| Methamphetamine | 0.5 | 0.5 | 0.8 | 0.7 | 0.8 | 0.9 | 0.5 | 0.4 |
| Misuse of Prescription Psychotherapeutics | 7.9 | 7.3 | 13.7 | 13.2 | 13.8 | 14.0 | 6.5 | 5.8 |
| Pain Relievers | 3.1 | 3.2 | 5.1 | 5.7 | 5.1 | 6.0 | 2.7 | 2.5 |
| Stimulants | 4.1 | 3.7 | 6.0 | 6.5 | 6.4 | 7.0 | 3.6 | 3.0 |
| Tranquilizers or Sedatives | 2.7 | 2.4 | 6.1 | 5.0 | 6.2 | 5.2 | 1.9 | 1.8 |
| Tranquilizers | 2.6 | 2.2 | 5.5 | 4.6 | 5.6 | 4.7 | 1.9 | 1.7 |
| Sedatives | 0.4 | 0.3 | 1.5a | 0.5 | 1.6a | 0.6 | 0.2 | 0.2 |
| Benzodiazepines | 2.5 | 2.1 | 5.3 | 4.5 | 5.3 | 4.7 | 1.8 | 1.6 |
| Opioids1 | 3.2 | 3.2 | 5.2 | 5.9 | 5.3 | 6.2 | 2.7 | 2.6 |
| Central Nervous System Stimulants | 6.7 | 6.5 | 8.5 | 10.3 | 9.1 | 11.2 | 6.2 | 5.6 |
| Illicit Drugs Other Than Marijuana1,2 | 14.4 | 14.6 | 23.1 | 25.4 | 22.4a | 27.8 | 12.3 | 11.9 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 40.4 | -- | 48.7 | -- | 50.0 | -- | 38.3 |
| Tobacco Products | 26.8a | 24.8 | 31.2 | 28.6 | 31.6 | 30.3 | 25.8a | 23.8 |
| Cigarettes | 19.1 | 18.2 | 24.6 | 22.6 | 24.9 | 24.4 | 17.9 | 17.1 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 4.9 | 4.2 | 4.2 | 3.9 | 3.8 | 3.8 | 5.1 | 4.3 |
| Cigars | 11.9 | 11.3 | 13.7 | 12.6 | 14.3 | 13.6 | 11.5 | 11.0 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 33.4 | -- | 42.1 | -- | 43.4 | -- | 31.2 |
| ALCOHOL | 68.1 | 67.9 | 77.1 | 79.3 | 77.0 | 78.5 | 66.0 | 65.0 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 3.3 | -- | 5.9 | -- | 6.2 | -- | 2.6 |
| Illegally Made Fentanyl | -- | 0.1 | -- | 0.1 | -- | 0.1 | -- | 0.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance | Aged 26+ (2021) |
Aged 26+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS2 | 45,156b | 52,429 | 17,351a | 19,044 | 4,967 | 5,576 | 12,384 | 13,468 | 27,805b | 33,386 |
| Marijuana | 38,204b | 45,656 | 14,334b | 16,490 | 3,935a | 4,832 | 10,398a | 11,658 | 23,870b | 29,165 |
| Cocaine | 3,500 | 3,939 | 1,983 | 1,891 | 535 | 651 | 1,448 | 1,241 | 1,517a | 2,048 |
| Crack | 925 | 877 | 585 | 513 | 144 | 280 | 442 | 233 | 339 | 365 |
| Heroin | 1,018 | 991 | 744 | 647 | 185 | 255 | 559 | 392 | 274 | 345 |
| Hallucinogens | 4,733 | 5,475 | 2,399 | 2,624 | 837 | 859 | 1,563 | 1,765 | 2,334 | 2,852 |
| LSD | 1,230 | 1,259 | 648 | 592 | 241 | 221 | 407 | 371 | 582 | 668 |
| PCP | 121 | 177 | 30 | 139 | 4 | 53 | 26 | 87 | 92 | 37 |
| Ecstasy | 1,423 | 1,407 | 846 | 709 | 233 | 171 | 613 | 539 | 577 | 698 |
| Inhalants | 968 | 1,053 | 474 | 609 | 140 | 163 | 334 | 446 | 494 | 444 |
| Methamphetamine | 2,422 | 2,526 | 1,345 | 1,463 | 474 | 548 | 870 | 915 | 1,078 | 1,062 |
| Misuse of Prescription Psychotherapeutics | 10,983 | 11,022 | 5,650 | 5,321 | 1,806 | 1,703 | 3,844 | 3,619 | 5,333 | 5,701 |
| Pain Relievers | 7,286 | 6,953 | 3,651 | 3,235 | 1,174 | 988 | 2,477 | 2,247 | 3,634 | 3,718 |
| Stimulants | 2,249a | 2,794 | 1,193a | 1,559 | 405 | 467 | 788a | 1,092 | 1,056 | 1,236 |
| Tranquilizers or Sedatives | 3,649 | 3,869 | 2,161 | 2,230 | 758 | 878 | 1,403 | 1,352 | 1,488 | 1,639 |
| Tranquilizers | 3,209 | 3,259 | 1,994 | 1,805 | 690 | 683 | 1,304 | 1,122 | 1,214 | 1,453 |
| Sedatives | 690 | 839 | 361a | 586 | 164 | 281 | 197 | 305 | 329 | 252 |
| Benzodiazepines | 2,904 | 2,822 | 1,793 | 1,581 | 587 | 572 | 1,205 | 1,008 | 1,111 | 1,241 |
| Opioids2 | 7,801 | 7,393 | 3,983 | 3,469 | 1,245 | 1,080 | 2,738 | 2,388 | 3,818 | 3,924 |
| Central Nervous System Stimulants | 6,812 | 7,644 | 3,627 | 3,869 | 1,156 | 1,295 | 2,471 | 2,574 | 3,185 | 3,775 |
| Illicit Drugs Other Than Marijuana2,3 | 17,137 | 18,256 | 8,504 | 8,345 | 2,765 | 2,734 | 5,739 | 5,611 | 8,633a | 9,911 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 60,390 | -- | 17,616 | -- | 5,077 | -- | 12,540 | -- | 42,773 |
| Tobacco Products | 57,887b | 53,701 | 16,456 | 15,237 | 4,216 | 4,328 | 12,240a | 10,909 | 41,431 | 38,465 |
| Cigarettes | 46,259a | 42,912 | 14,403 | 13,087 | 3,771 | 3,785 | 10,632a | 9,302 | 31,856 | 29,825 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 8,221b | 6,627 | 1,712 | 1,674 | 502 | 442 | 1,210 | 1,232 | 6,509b | 4,953 |
| Cigars | 14,399 | 14,833 | 4,185 | 4,040 | 1,154 | 1,131 | 3,031 | 2,909 | 10,214 | 10,793 |
| Pipe Tobacco4 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 19,934 | -- | 7,443 | -- | 2,246 | -- | 5,197 | -- | 12,491 |
| ALCOHOL | 146,696 | 149,067 | 32,937 | 33,361 | 7,776 | 8,138 | 25,161 | 25,223 | 113,759 | 115,706 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 7,497 | -- | 3,536 | -- | 1,083 | -- | 2,454 | -- | 3,961 |
| Illegally Made Fentanyl | -- | 617 | -- | 424 | -- | 160 | -- | 264 | -- | 193 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance | Aged 26+ (2021) |
Aged 26+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS2 | 20.5b | 23.7 | 37.0b | 40.8 | 47.2 | 49.2 | 34.0b | 38.1 | 16.0b | 19.1 |
| Marijuana | 17.3b | 20.6 | 30.6b | 35.3 | 37.4 | 42.7 | 28.6b | 33.0 | 13.8b | 16.7 |
| Cocaine | 1.6 | 1.8 | 4.2 | 4.0 | 5.1 | 5.7 | 4.0 | 3.5 | 0.9a | 1.2 |
| Crack | 0.4 | 0.4 | 1.2 | 1.1 | 1.4 | 2.5 | 1.2 | 0.7 | 0.2 | 0.2 |
| Heroin | 0.5 | 0.4 | 1.6 | 1.4 | 1.8 | 2.3 | 1.5 | 1.1 | 0.2 | 0.2 |
| Hallucinogens | 2.1 | 2.5 | 5.1 | 5.6 | 8.0 | 7.6 | 4.3 | 5.0 | 1.3 | 1.6 |
| LSD | 0.6 | 0.6 | 1.4 | 1.3 | 2.3 | 2.0 | 1.1 | 1.0 | 0.3 | 0.4 |
| PCP | 0.1 | 0.1 | 0.1 | 0.3 | 0.0 | 0.5 | 0.1 | 0.2 | 0.1 | 0.0 |
| Ecstasy | 0.6 | 0.6 | 1.8 | 1.5 | 2.2 | 1.5 | 1.7 | 1.5 | 0.3 | 0.4 |
| Inhalants | 0.4 | 0.5 | 1.0 | 1.3 | 1.3 | 1.4 | 0.9 | 1.3 | 0.3 | 0.3 |
| Methamphetamine | 1.1 | 1.1 | 2.9 | 3.1 | 4.5 | 4.8 | 2.4 | 2.6 | 0.6 | 0.6 |
| Misuse of Prescription Psychotherapeutics | 5.0 | 5.0 | 12.0 | 11.4 | 17.2 | 15.0 | 10.6 | 10.2 | 3.1 | 3.3 |
| Pain Relievers | 3.3 | 3.1 | 7.8 | 6.9 | 11.2 | 8.7 | 6.8 | 6.4 | 2.1 | 2.1 |
| Stimulants | 1.0a | 1.3 | 2.5a | 3.3 | 3.9 | 4.1 | 2.2a | 3.1 | 0.6 | 0.7 |
| Tranquilizers or Sedatives | 1.7 | 1.7 | 4.6 | 4.8 | 7.2 | 7.7 | 3.9 | 3.8 | 0.9 | 0.9 |
| Tranquilizers | 1.5 | 1.5 | 4.3 | 3.9 | 6.6 | 6.0 | 3.6 | 3.2 | 0.7 | 0.8 |
| Sedatives | 0.3 | 0.4 | 0.8a | 1.3 | 1.6 | 2.5 | 0.5 | 0.9 | 0.2 | 0.1 |
| Benzodiazepines | 1.3 | 1.3 | 3.8 | 3.4 | 5.6 | 5.1 | 3.3 | 2.9 | 0.6 | 0.7 |
| Opioids2 | 3.5 | 3.3 | 8.5 | 7.4 | 11.8 | 9.5 | 7.5 | 6.8 | 2.2 | 2.2 |
| Central Nervous System Stimulants | 3.1 | 3.5 | 7.7 | 8.3 | 11.0 | 11.4 | 6.8 | 7.3 | 1.8 | 2.2 |
| Illicit Drugs Other Than Marijuana2,3 | 7.8 | 8.2 | 18.1 | 17.9 | 26.3 | 24.1 | 15.8 | 15.9 | 5.0a | 5.7 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 27.3 | -- | 37.7 | -- | 44.8 | -- | 35.4 | -- | 24.5 |
| Tobacco Products | 26.3b | 24.2 | 35.1 | 32.6 | 40.1 | 38.2 | 33.6 | 30.8 | 23.9a | 22.0 |
| Cigarettes | 21.0b | 19.4 | 30.7a | 28.0 | 35.9 | 33.4 | 29.2a | 26.3 | 18.4a | 17.1 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 3.7b | 3.0 | 3.6 | 3.6 | 4.8 | 3.9 | 3.3 | 3.5 | 3.8b | 2.8 |
| Cigars | 6.5 | 6.7 | 8.9 | 8.7 | 11.0 | 10.0 | 8.3 | 8.2 | 5.9 | 6.2 |
| Pipe Tobacco4 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 9.0 | -- | 15.9 | -- | 19.8 | -- | 14.7 | -- | 7.1 |
| ALCOHOL | 66.6 | 67.3 | 70.2 | 71.4 | 74.0 | 71.8 | 69.1 | 71.3 | 65.6 | 66.2 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 3.4 | -- | 7.6 | -- | 9.6 | -- | 6.9 | -- | 2.3 |
| Illegally Made Fentanyl | -- | 0.3 | -- | 0.9 | -- | 1.4 | -- | 0.7 | -- | 0.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance | Aged 26+ (2021) |
Aged 26+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 45,156b | 52,429 | 6,198 | 7,056 | 4,676 | 5,240 | 38,959b | 45,373 |
| Marijuana | 38,204b | 45,656 | 4,812b | 6,178 | 3,638a | 4,545 | 33,392b | 39,477 |
| Cocaine | 3,500 | 3,939 | 661 | 686 | 556 | 526 | 2,839 | 3,253 |
| Crack | 925 | 877 | 133 | 278 | 124 | 205 | 792 | 599 |
| Heroin | 1,018 | 991 | 200 | 222 | 190 | 192 | 818 | 769 |
| Hallucinogens | 4,733 | 5,475 | 1,056 | 1,068 | 861 | 777 | 3,678 | 4,407 |
| LSD | 1,230 | 1,259 | 307 | 225 | 249 | 151 | 923 | 1,034 |
| PCP | 121 | 177 | 7 | 53 | 4 | 53 | 114 | 124 |
| Ecstasy | 1,423 | 1,407 | 283 | 212 | 222 | 161 | 1,140 | 1,195 |
| Inhalants | 968 | 1,053 | 184 | 212 | 176 | 167 | 784 | 841 |
| Methamphetamine | 2,422 | 2,526 | 478 | 610 | 389 | 527 | 1,944 | 1,916 |
| Misuse of Prescription Psychotherapeutics | 10,983 | 11,022 | 2,336 | 1,953 | 1,769 | 1,557 | 8,647 | 9,069 |
| Pain Relievers | 7,286 | 6,953 | 1,445 | 1,229 | 1,123 | 1,031 | 5,841 | 5,723 |
| Stimulants | 2,249a | 2,794 | 572 | 432 | 470 | 314 | 1,677b | 2,362 |
| Tranquilizers or Sedatives | 3,649 | 3,869 | 892 | 899 | 694 | 727 | 2,757 | 2,970 |
| Tranquilizers | 3,209 | 3,259 | 814 | 670 | 618 | 583 | 2,395 | 2,588 |
| Sedatives | 690 | 839 | 180 | 308 | 174 | 219 | 510 | 530 |
| Benzodiazepines | 2,904 | 2,822 | 721 | 581 | 540 | 496 | 2,183 | 2,241 |
| Opioids1 | 7,801 | 7,393 | 1,471 | 1,322 | 1,143 | 1,111 | 6,330 | 6,071 |
| Central Nervous System Stimulants | 6,812 | 7,644 | 1,359 | 1,336 | 1,131 | 1,031 | 5,453 | 6,308 |
| Illicit Drugs Other Than Marijuana1,2 | 17,137 | 18,256 | 3,401 | 3,244 | 2,627 | 2,456 | 13,736 | 15,012 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 60,390 | -- | 6,353 | -- | 4,585 | -- | 54,037 |
| Tobacco Products | 57,887b | 53,701 | 5,277 | 5,416 | 3,947 | 3,850 | 52,610a | 48,285 |
| Cigarettes | 46,259a | 42,912 | 4,678 | 4,733 | 3,499 | 3,389 | 41,580a | 38,179 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 8,221b | 6,627 | 572 | 429 | 472 | 300 | 7,650b | 6,198 |
| Cigars | 14,399 | 14,833 | 1,458 | 1,476 | 1,095 | 1,071 | 12,941 | 13,357 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 19,934 | -- | 2,813 | -- | 2,105 | -- | 17,121 |
| ALCOHOL | 146,696 | 149,067 | 11,347 | 11,324 | 7,755 | 7,888 | 135,349 | 137,743 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 7,497 | -- | 1,324 | -- | 1,112 | -- | 6,173 |
| Illegally Made Fentanyl | -- | 617 | -- | 170 | -- | 158 | -- | 447 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance | Aged 26+ (2021) |
Aged 26+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 20.5b | 23.7 | 41.0a | 45.6 | 45.5 | 48.7 | 19.0b | 22.0 |
| Marijuana | 17.3b | 20.6 | 31.8b | 39.9 | 35.4a | 42.2 | 16.3b | 19.2 |
| Cocaine | 1.6 | 1.8 | 4.4 | 4.4 | 5.4 | 4.9 | 1.4 | 1.6 |
| Crack | 0.4 | 0.4 | 0.9 | 1.8 | 1.2 | 1.9 | 0.4 | 0.3 |
| Heroin | 0.5 | 0.4 | 1.3 | 1.4 | 1.8 | 1.8 | 0.4 | 0.4 |
| Hallucinogens | 2.1 | 2.5 | 7.0 | 6.9 | 8.4 | 7.2 | 1.8 | 2.1 |
| LSD | 0.6 | 0.6 | 2.0 | 1.5 | 2.4 | 1.4 | 0.4 | 0.5 |
| PCP | 0.1 | 0.1 | 0.0 | 0.3 | 0.0 | 0.5 | 0.1 | 0.1 |
| Ecstasy | 0.6 | 0.6 | 1.9 | 1.4 | 2.2 | 1.5 | 0.6 | 0.6 |
| Inhalants | 0.4 | 0.5 | 1.2 | 1.4 | 1.7 | 1.6 | 0.4 | 0.4 |
| Methamphetamine | 1.1 | 1.1 | 3.2 | 3.9 | 3.8 | 4.9 | 0.9 | 0.9 |
| Misuse of Prescription Psychotherapeutics | 5.0 | 5.0 | 15.5 | 12.6 | 17.2 | 14.5 | 4.2 | 4.4 |
| Pain Relievers | 3.3 | 3.1 | 9.6 | 7.9 | 10.9 | 9.6 | 2.8 | 2.8 |
| Stimulants | 1.0a | 1.3 | 3.8 | 2.8 | 4.6 | 2.9 | 0.8b | 1.1 |
| Tranquilizers or Sedatives | 1.7 | 1.7 | 5.9 | 5.8 | 6.8 | 6.8 | 1.3 | 1.4 |
| Tranquilizers | 1.5 | 1.5 | 5.4 | 4.3 | 6.0 | 5.4 | 1.2 | 1.3 |
| Sedatives | 0.3 | 0.4 | 1.2 | 2.0 | 1.7 | 2.0 | 0.2 | 0.3 |
| Benzodiazepines | 1.3 | 1.3 | 4.8 | 3.8 | 5.3 | 4.6 | 1.1 | 1.1 |
| Opioids1 | 3.5 | 3.3 | 9.7 | 8.5 | 11.1 | 10.3 | 3.1 | 2.9 |
| Central Nervous System Stimulants | 3.1 | 3.5 | 9.0 | 8.6 | 11.0 | 9.6 | 2.7 | 3.1 |
| Illicit Drugs Other Than Marijuana1,2 | 7.8 | 8.2 | 22.5 | 21.0 | 25.5 | 22.8 | 6.7 | 7.3 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 27.3 | -- | 41.0 | -- | 42.6 | -- | 26.2 |
| Tobacco Products | 26.3b | 24.2 | 34.9 | 35.0 | 38.4 | 35.8 | 25.6b | 23.4 |
| Cigarettes | 21.0b | 19.4 | 31.0 | 30.6 | 34.0 | 31.5 | 20.3b | 18.5 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 3.7b | 3.0 | 3.8 | 2.8 | 4.6a | 2.8 | 3.7b | 3.0 |
| Cigars | 6.5 | 6.7 | 9.7 | 9.5 | 10.6 | 10.0 | 6.3 | 6.5 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 9.0 | -- | 18.2 | -- | 19.6 | -- | 8.3 |
| ALCOHOL | 66.6 | 67.3 | 75.1 | 73.1 | 75.4 | 73.3 | 65.9 | 66.9 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 3.4 | -- | 8.6 | -- | 10.3 | -- | 3.0 |
| Illegally Made Fentanyl | -- | 0.3 | -- | 1.1 | -- | 1.5 | -- | 0.2 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance | Aged 26-49 (2021) |
Aged 26-49 (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS2 | 29,188b | 32,809 | 12,743a | 14,370 | 3,823 | 4,301 | 8,920a | 10,069 | 16,445b | 18,439 |
| Marijuana | 25,373b | 29,525 | 11,030b | 12,905 | 3,224a | 3,859 | 7,806a | 9,046 | 14,343b | 16,620 |
| Cocaine | 2,500 | 2,824 | 1,443 | 1,501 | 391 | 436 | 1,053 | 1,065 | 1,057 | 1,323 |
| Crack | 415 | 426 | 291 | 300 | 72 | 136 | 219 | 164 | 124 | 126 |
| Heroin | 616 | 723 | 459 | 515 | 93a | 197 | 366 | 318 | 157 | 208 |
| Hallucinogens | 4,160 | 4,599 | 2,213 | 2,336 | 790 | 758 | 1,424 | 1,578 | 1,946 | 2,263 |
| LSD | 1,112 | 1,123 | 608 | 535 | 241 | 221 | 367 | 314 | 504 | 588 |
| PCP | 50 | 59 | 30 | 42 | 4 | 8 | 26 | 34 | 21 | 17 |
| Ecstasy | 1,353 | 1,275 | 786 | 614 | 233 | 151 | 553 | 463 | 567 | 661 |
| Inhalants | 801 | 857 | 436 | 528 | 134 | 163 | 302 | 364 | 365 | 329 |
| Methamphetamine | 1,472 | 1,652 | 986 | 1,021 | 360 | 407 | 626 | 614 | 486 | 631 |
| Misuse of Prescription Psychotherapeutics | 6,944 | 6,848 | 3,811 | 3,745 | 1,311 | 1,266 | 2,500 | 2,479 | 3,132 | 3,103 |
| Pain Relievers | 4,194 | 4,074 | 2,258 | 2,238 | 849 | 723 | 1,410 | 1,515 | 1,936 | 1,837 |
| Stimulants | 1,958 | 2,365 | 1,098 | 1,317 | 382 | 420 | 716 | 896 | 860 | 1,049 |
| Tranquilizers or Sedatives | 2,385 | 2,277 | 1,555 | 1,417 | 531 | 578 | 1,025 | 839 | 829 | 860 |
| Tranquilizers | 2,220 | 2,028 | 1,487 | 1,232 | 509 | 482 | 977 | 749 | 733 | 796 |
| Sedatives | 394 | 369 | 248 | 262 | 113 | 137 | 135 | 125 | 146 | 106 |
| Benzodiazepines | 2,070 | 1,845 | 1,398 | 1,149 | 464 | 428 | 935 | 721 | 672 | 696 |
| Opioids2 | 4,471 | 4,364 | 2,450 | 2,429 | 868 | 805 | 1,582 | 1,624 | 2,021 | 1,935 |
| Central Nervous System Stimulants | 4,846 | 5,476 | 2,757 | 2,966 | 918 | 976 | 1,839 | 1,991 | 2,089 | 2,509 |
| Illicit Drugs Other Than Marijuana2,3 | 11,457 | 11,977 | 6,109 | 6,164 | 2,090 | 2,110 | 4,018 | 4,054 | 5,348 | 5,813 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 36,281 | -- | 12,602 | -- | 3,632 | -- | 8,970 | -- | 23,679 |
| Tobacco Products | 32,237 | 31,014 | 10,974 | 10,778 | 3,026 | 3,095 | 7,948 | 7,683 | 21,264 | 20,236 |
| Cigarettes | 25,514 | 24,496 | 9,288 | 9,118 | 2,625 | 2,685 | 6,663 | 6,432 | 16,226 | 15,379 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 5,158b | 4,102 | 1,407 | 1,210 | 371 | 376 | 1,036 | 834 | 3,752b | 2,892 |
| Cigars | 9,391 | 9,911 | 3,274 | 3,302 | 946 | 931 | 2,328 | 2,371 | 6,118 | 6,609 |
| Pipe Tobacco4 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 15,846 | -- | 6,231 | -- | 1,906 | -- | 4,324 | -- | 9,615 |
| ALCOHOL | 74,908 | 75,737 | 22,512 | 23,854 | 5,847 | 6,273 | 16,664 | 17,581 | 52,396 | 51,882 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 4,462 | -- | 2,497 | -- | 807 | -- | 1,690 | -- | 1,965 |
| Illegally Made Fentanyl | -- | 461 | -- | 349 | -- | 120 | -- | 229 | -- | 112 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance | Aged 26-49 (2021) |
Aged 26-49 (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS2 | 28.5b | 32.0 | 43.7b | 47.6 | 51.3 | 55.1 | 41.1a | 45.0 | 22.5b | 25.5 |
| Marijuana | 24.8b | 28.8 | 37.8b | 42.8 | 43.3a | 49.4 | 36.0b | 40.5 | 19.6b | 23.0 |
| Cocaine | 2.4 | 2.8 | 5.0 | 5.0 | 5.2 | 5.6 | 4.8 | 4.8 | 1.4 | 1.8 |
| Crack | 0.4 | 0.4 | 1.0 | 1.0 | 1.0 | 1.7 | 1.0 | 0.7 | 0.2 | 0.2 |
| Heroin | 0.6 | 0.7 | 1.6 | 1.7 | 1.3a | 2.5 | 1.7 | 1.4 | 0.2 | 0.3 |
| Hallucinogens | 4.1 | 4.5 | 7.6 | 7.7 | 10.6 | 9.7 | 6.6 | 7.1 | 2.7 | 3.1 |
| LSD | 1.1 | 1.1 | 2.1 | 1.8 | 3.2 | 2.8 | 1.7 | 1.4 | 0.7 | 0.8 |
| PCP | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.0 | 0.0 |
| Ecstasy | 1.3 | 1.2 | 2.7 | 2.0 | 3.1 | 1.9 | 2.5 | 2.1 | 0.8 | 0.9 |
| Inhalants | 0.8 | 0.8 | 1.5 | 1.8 | 1.8 | 2.1 | 1.4 | 1.6 | 0.5 | 0.5 |
| Methamphetamine | 1.4 | 1.6 | 3.4 | 3.4 | 4.8 | 5.2 | 2.9 | 2.7 | 0.7 | 0.9 |
| Misuse of Prescription Psychotherapeutics | 6.8 | 6.7 | 13.1 | 12.4 | 17.6 | 16.2 | 11.5 | 11.1 | 4.3 | 4.3 |
| Pain Relievers | 4.1 | 4.0 | 7.7 | 7.4 | 11.4 | 9.3 | 6.5 | 6.8 | 2.6 | 2.5 |
| Stimulants | 1.9 | 2.3 | 3.8 | 4.4 | 5.1 | 5.4 | 3.3 | 4.0 | 1.2 | 1.4 |
| Tranquilizers or Sedatives | 2.3 | 2.2 | 5.3 | 4.7 | 7.1 | 7.4 | 4.7 | 3.8 | 1.1 | 1.2 |
| Tranquilizers | 2.2 | 2.0 | 5.1 | 4.1 | 6.8 | 6.2 | 4.5 | 3.4 | 1.0 | 1.1 |
| Sedatives | 0.4 | 0.4 | 0.9 | 0.9 | 1.5 | 1.8 | 0.6 | 0.6 | 0.2 | 0.1 |
| Benzodiazepines | 2.0 | 1.8 | 4.8 | 3.8 | 6.2 | 5.5 | 4.3 | 3.2 | 0.9 | 1.0 |
| Opioids2 | 4.4 | 4.3 | 8.4 | 8.1 | 11.6 | 10.3 | 7.3 | 7.3 | 2.8 | 2.7 |
| Central Nervous System Stimulants | 4.7 | 5.3 | 9.5 | 9.8 | 12.3 | 12.5 | 8.5 | 8.9 | 2.9 | 3.5 |
| Illicit Drugs Other Than Marijuana2,3 | 11.2 | 11.7 | 21.0 | 20.4 | 28.1 | 27.0 | 18.5 | 18.1 | 7.3 | 8.0 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 35.4 | -- | 41.8 | -- | 46.5 | -- | 40.1 | -- | 32.7 |
| Tobacco Products | 31.5 | 30.2 | 37.6 | 35.7 | 40.6 | 39.6 | 36.6 | 34.4 | 29.1 | 27.9 |
| Cigarettes | 24.9 | 23.9 | 31.9 | 30.2 | 35.2 | 34.4 | 30.7 | 28.8 | 22.2 | 21.2 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 5.0b | 4.0 | 4.8 | 4.0 | 5.0 | 4.8 | 4.8 | 3.7 | 5.1b | 4.0 |
| Cigars | 9.2 | 9.7 | 11.2 | 10.9 | 12.7 | 11.9 | 10.7 | 10.6 | 8.4 | 9.1 |
| Pipe Tobacco4 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 15.4 | -- | 20.7 | -- | 24.4 | -- | 19.3 | -- | 13.3 |
| ALCOHOL | 73.2 | 73.8 | 77.2 | 79.1 | 78.5 | 80.3 | 76.8 | 78.7 | 71.6 | 71.7 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 4.4 | -- | 8.3 | -- | 10.3 | -- | 7.6 | -- | 2.7 |
| Illegally Made Fentanyl | -- | 0.4 | -- | 1.2 | -- | 1.5 | -- | 1.0 | -- | 0.2 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance | Aged 26-49 (2021) |
Aged 26-49 (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 29,188b | 32,809 | 4,639 | 5,002 | 3,503 | 3,699 | 24,550b | 27,808 |
| Marijuana | 25,373b | 29,525 | 3,868a | 4,550 | 2,885 | 3,339 | 21,505b | 24,975 |
| Cocaine | 2,500 | 2,824 | 486 | 496 | 380 | 386 | 2,015 | 2,328 |
| Crack | 415 | 426 | 93 | 139 | 84 | 115 | 321 | 287 |
| Heroin | 616 | 723 | 136 | 180 | 127 | 154 | 480 | 543 |
| Hallucinogens | 4,160 | 4,599 | 1,048 | 936 | 855 | 689 | 3,111 | 3,663 |
| LSD | 1,112 | 1,123 | 303 | 225 | 245 | 151 | 809 | 898 |
| PCP | 50 | 59 | 7 | 8 | 4 | 8 | 43 | 51 |
| Ecstasy | 1,353 | 1,275 | 282 | 212 | 222 | 161 | 1,071 | 1,063 |
| Inhalants | 801 | 857 | 172 | 211 | 165 | 167 | 629 | 646 |
| Methamphetamine | 1,472 | 1,652 | 395 | 379 | 325 | 330 | 1,077 | 1,273 |
| Misuse of Prescription Psychotherapeutics | 6,944 | 6,848 | 1,627a | 1,242 | 1,269 | 986 | 5,316 | 5,606 |
| Pain Relievers | 4,194 | 4,074 | 939 | 746 | 811 | 610 | 3,255 | 3,329 |
| Stimulants | 1,958 | 2,365 | 547 | 390 | 445 | 306 | 1,412b | 1,976 |
| Tranquilizers or Sedatives | 2,385 | 2,277 | 655 | 551 | 490 | 457 | 1,730 | 1,726 |
| Tranquilizers | 2,220 | 2,028 | 633 | 450 | 469 | 377 | 1,587 | 1,578 |
| Sedatives | 394 | 369 | 116 | 130 | 110 | 106 | 278 | 239 |
| Benzodiazepines | 2,070 | 1,845 | 598 | 395 | 449 | 325 | 1,472 | 1,450 |
| Opioids1 | 4,471 | 4,364 | 964 | 827 | 830 | 679 | 3,507 | 3,536 |
| Central Nervous System Stimulants | 4,846 | 5,476 | 1,118 | 956 | 909 | 746 | 3,728a | 4,520 |
| Illicit Drugs Other Than Marijuana1,2 | 11,457 | 11,977 | 2,570 | 2,305 | 2,014 | 1,738 | 8,887 | 9,672 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 36,281 | -- | 4,312 | -- | 3,196 | -- | 31,968 |
| Tobacco Products | 32,237 | 31,014 | 3,763 | 3,692 | 2,766 | 2,725 | 28,475 | 27,322 |
| Cigarettes | 25,514 | 24,496 | 3,247 | 3,146 | 2,391 | 2,346 | 22,267 | 21,350 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 5,158b | 4,102 | 390 | 329 | 315 | 257 | 4,768b | 3,773 |
| Cigars | 9,391 | 9,911 | 1,227 | 1,123 | 900 | 823 | 8,165 | 8,788 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 15,846 | -- | 2,207 | -- | 1,643 | -- | 13,639 |
| ALCOHOL | 74,908 | 75,737 | 7,905 | 7,945 | 5,399 | 5,651 | 67,003 | 67,791 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 4,462 | -- | 830 | -- | 680 | -- | 3,632 |
| Illegally Made Fentanyl | -- | 461 | -- | 130 | -- | 119 | -- | 331 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance | Aged 26-49 (2021) |
Aged 26-49 (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 28.5b | 32.0 | 47.3 | 50.1 | 51.6 | 52.3 | 26.5b | 30.0 |
| Marijuana | 24.8b | 28.8 | 39.4b | 45.6 | 42.5 | 47.2 | 23.2b | 27.0 |
| Cocaine | 2.4 | 2.8 | 4.9 | 5.0 | 5.6 | 5.5 | 2.2 | 2.5 |
| Crack | 0.4 | 0.4 | 0.9 | 1.4 | 1.2 | 1.6 | 0.3 | 0.3 |
| Heroin | 0.6 | 0.7 | 1.4 | 1.8 | 1.9 | 2.2 | 0.5 | 0.6 |
| Hallucinogens | 4.1 | 4.5 | 10.7 | 9.4 | 12.6 | 9.8 | 3.4 | 4.0 |
| LSD | 1.1 | 1.1 | 3.1 | 2.3 | 3.6 | 2.1 | 0.9 | 1.0 |
| PCP | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 |
| Ecstasy | 1.3 | 1.2 | 2.9 | 2.1 | 3.3 | 2.3 | 1.2 | 1.1 |
| Inhalants | 0.8 | 0.8 | 1.8 | 2.1 | 2.4 | 2.4 | 0.7 | 0.7 |
| Methamphetamine | 1.4 | 1.6 | 4.0 | 3.8 | 4.8 | 4.7 | 1.2 | 1.4 |
| Misuse of Prescription Psychotherapeutics | 6.8 | 6.7 | 16.6a | 12.5 | 18.7a | 14.0 | 5.7 | 6.1 |
| Pain Relievers | 4.1 | 4.0 | 9.6 | 7.5 | 11.9 | 8.6 | 3.5 | 3.6 |
| Stimulants | 1.9 | 2.3 | 5.6 | 3.9 | 6.6 | 4.3 | 1.5b | 2.1 |
| Tranquilizers or Sedatives | 2.3 | 2.2 | 6.7 | 5.5 | 7.2 | 6.5 | 1.9 | 1.9 |
| Tranquilizers | 2.2 | 2.0 | 6.5 | 4.5 | 6.9 | 5.3 | 1.7 | 1.7 |
| Sedatives | 0.4 | 0.4 | 1.2 | 1.3 | 1.6 | 1.5 | 0.3 | 0.3 |
| Benzodiazepines | 2.0 | 1.8 | 6.1a | 4.0 | 6.6 | 4.6 | 1.6 | 1.6 |
| Opioids1 | 4.4 | 4.3 | 9.8 | 8.3 | 12.2 | 9.6 | 3.8 | 3.8 |
| Central Nervous System Stimulants | 4.7 | 5.3 | 11.4 | 9.6 | 13.4 | 10.5 | 4.0a | 4.9 |
| Illicit Drugs Other Than Marijuana1,2 | 11.2 | 11.7 | 26.2 | 23.1 | 29.6 | 24.6 | 9.6 | 10.4 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 35.4 | -- | 43.2 | -- | 45.2 | -- | 34.5 |
| Tobacco Products | 31.5 | 30.2 | 38.4 | 37.0 | 40.7 | 38.6 | 30.8 | 29.5 |
| Cigarettes | 24.9 | 23.9 | 33.1 | 31.5 | 35.2 | 33.2 | 24.1 | 23.1 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 5.0b | 4.0 | 4.0 | 3.3 | 4.6 | 3.6 | 5.2b | 4.1 |
| Cigars | 9.2 | 9.7 | 12.5 | 11.3 | 13.3 | 11.6 | 8.8 | 9.5 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 15.4 | -- | 22.1 | -- | 23.3 | -- | 14.7 |
| ALCOHOL | 73.2 | 73.8 | 80.6 | 79.7 | 79.5 | 79.9 | 72.4 | 73.2 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 4.4 | -- | 8.3 | -- | 9.6 | -- | 3.9 |
| Illegally Made Fentanyl | -- | 0.4 | -- | 1.3 | -- | 1.7 | -- | 0.4 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance | Aged 50+ (2021) |
Aged 50+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS2 | 15,968b | 19,620 | 4,608 | 4,674 | 1,144 | 1,275 | 3,464 | 3,399 | 11,360b | 14,946 |
| Marijuana | 12,831b | 16,130 | 3,304 | 3,586 | 711 | 974 | 2,593 | 2,612 | 9,527b | 12,545 |
| Cocaine | 1,000 | 1,115 | 540 | 390 | 144 | 214 | 395 | 176 | 460 | 725 |
| Crack | 510 | 451 | 295 | 213 | 72 | 144 | 223 | 69 | 215 | 238 |
| Heroin | 401 | 269 | 285 | 132 | * | 58 | 193 | 74 | 116 | 137 |
| Hallucinogens | 574 | 876 | 186 | 287 | * | 100 | 139 | 187 | 388 | 589 |
| LSD | 119 | 136 | 40 | 56 | * | * | 40 | 56 | 78 | 80 |
| PCP | 71 | 118 | * | 97 | * | * | * | 53 | 71 | 21 |
| Ecstasy | 70 | 132 | 60 | 95 | * | * | 60 | 75 | 10 | 37 |
| Inhalants | 167 | 196 | 38 | 81 | 7 | * | 32 | 81 | 129 | 115 |
| Methamphetamine | 950 | 874 | 358 | 443 | 114 | 141 | 244 | 301 | 592 | 431 |
| Misuse of Prescription Psychotherapeutics | 4,039 | 4,174 | 1,838 | 1,576 | 495 | 436 | 1,344 | 1,140 | 2,201 | 2,598 |
| Pain Relievers | 3,091 | 2,878 | 1,393 | 998 | 325 | 265 | 1,068 | 733 | 1,698 | 1,881 |
| Stimulants | 290 | 429 | 95 | 242 | 22 | 47 | 72 | 195 | 196 | 187 |
| Tranquilizers or Sedatives | 1,264 | 1,591 | 606 | 812 | 227 | 300 | 379 | 513 | 658 | 779 |
| Tranquilizers | 988 | 1,231 | 508 | 573 | 181 | 201 | 327 | 373 | 481 | 658 |
| Sedatives | 296 | 470 | 113a | 324 | 51 | 143 | 61 | 181 | 183 | 146 |
| Benzodiazepines | 834 | 976 | 394 | 432 | 124 | 144 | 271 | 287 | 439 | 545 |
| Opioids2 | 3,330 | 3,029 | 1,533 | 1,039 | 377 | 276 | 1,156 | 764 | 1,796 | 1,990 |
| Central Nervous System Stimulants | 1,966 | 2,168 | 870 | 902 | 237 | 319 | 632 | 583 | 1,096 | 1,266 |
| Illicit Drugs Other Than Marijuana2,3 | 5,680 | 6,279 | 2,395 | 2,181 | 675 | 624 | 1,721 | 1,557 | 3,285 | 4,098 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 24,109 | -- | 5,015 | -- | 1,445 | -- | 3,570 | -- | 19,094 |
| Tobacco Products | 25,650b | 22,687 | 5,482 | 4,459 | 1,190 | 1,233 | 4,292a | 3,226 | 20,167 | 18,228 |
| Cigarettes | 20,745a | 18,416 | 5,115a | 3,970 | 1,146 | 1,100 | 3,969a | 2,870 | 15,630 | 14,446 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 3,063 | 2,525 | 305 | 464 | 132 | 66 | 174 | 397 | 2,758 | 2,061 |
| Cigars | 5,008 | 4,922 | 911 | 738 | 208 | 200 | 704 | 538 | 4,097 | 4,184 |
| Pipe Tobacco4 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 4,088 | -- | 1,213 | -- | 340 | -- | 873 | -- | 2,875 |
| ALCOHOL | 71,789 | 73,330 | 10,425 | 9,507 | 1,929 | 1,865 | 8,496 | 7,641 | 61,363 | 63,823 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 3,035 | -- | 1,040 | -- | 276 | -- | 764 | -- | 1,996 |
| Illegally Made Fentanyl | -- | 156 | -- | 75 | -- | 40 | -- | 35 | -- | 82 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance | Aged 50+ (2021) |
Aged 50+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS2 | 13.5b | 16.5 | 25.9 | 28.3 | 37.3 | 36.2 | 23.6 | 26.1 | 11.3b | 14.6 |
| Marijuana | 10.9b | 13.6 | 18.6 | 21.7 | 23.2 | 27.7 | 17.6 | 20.1 | 9.5b | 12.3 |
| Cocaine | 0.8 | 0.9 | 3.0 | 2.4 | 4.7 | 6.1 | 2.7 | 1.4 | 0.5 | 0.7 |
| Crack | 0.4 | 0.4 | 1.7 | 1.3 | 2.3 | 4.1 | 1.5 | 0.5 | 0.2 | 0.2 |
| Heroin | 0.3 | 0.2 | 1.6 | 0.8 | * | 1.7 | 1.3 | 0.6 | 0.1 | 0.1 |
| Hallucinogens | 0.5 | 0.7 | 1.0 | 1.7 | * | 2.9 | 0.9 | 1.4 | 0.4 | 0.6 |
| LSD | 0.1 | 0.1 | 0.2 | 0.3 | * | * | 0.3 | 0.4 | 0.1 | 0.1 |
| PCP | 0.1 | 0.1 | * | 0.6 | * | * | * | 0.4 | 0.1 | 0.0 |
| Ecstasy | 0.1 | 0.1 | 0.3 | 0.6 | * | * | 0.4 | 0.6 | 0.0 | 0.0 |
| Inhalants | 0.1 | 0.2 | 0.2 | 0.5 | 0.2 | * | 0.2 | 0.6 | 0.1 | 0.1 |
| Methamphetamine | 0.8 | 0.7 | 2.0 | 2.7 | 3.7 | 4.0 | 1.7 | 2.3 | 0.6 | 0.4 |
| Misuse of Prescription Psychotherapeutics | 3.4 | 3.5 | 10.3 | 9.5 | 16.1 | 12.4 | 9.1 | 8.8 | 2.2 | 2.5 |
| Pain Relievers | 2.6 | 2.4 | 7.8 | 6.0 | 10.6 | 7.5 | 7.3 | 5.6 | 1.7 | 1.8 |
| Stimulants | 0.2 | 0.4 | 0.5a | 1.5 | 0.7 | 1.3 | 0.5 | 1.5 | 0.2 | 0.2 |
| Tranquilizers or Sedatives | 1.1 | 1.3 | 3.4 | 4.9 | 7.4 | 8.5 | 2.6 | 3.9 | 0.7 | 0.8 |
| Tranquilizers | 0.8 | 1.0 | 2.9 | 3.5 | 5.9 | 5.7 | 2.2 | 2.9 | 0.5 | 0.6 |
| Sedatives | 0.3 | 0.4 | 0.6a | 2.0 | 1.7 | 4.1 | 0.4 | 1.4 | 0.2 | 0.1 |
| Benzodiazepines | 0.7 | 0.8 | 2.2 | 2.6 | 4.0 | 4.1 | 1.8 | 2.2 | 0.4 | 0.5 |
| Opioids2 | 2.8 | 2.5 | 8.6 | 6.3 | 12.3 | 7.8 | 7.9 | 5.9 | 1.8 | 1.9 |
| Central Nervous System Stimulants | 1.7 | 1.8 | 4.9 | 5.5 | 7.7 | 9.1 | 4.3 | 4.5 | 1.1 | 1.2 |
| Illicit Drugs Other Than Marijuana2,3 | 4.8 | 5.3 | 13.5 | 13.2 | 22.0 | 17.7 | 11.7 | 12.0 | 3.3 | 4.0 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 20.3 | -- | 30.3 | -- | 41.0 | -- | 27.4 | -- | 18.6 |
| Tobacco Products | 21.7b | 19.1 | 30.9 | 27.0 | 38.8 | 35.0 | 29.2 | 24.8 | 20.1a | 17.8 |
| Cigarettes | 17.6a | 15.5 | 28.8a | 24.0 | 37.4 | 31.2 | 27.0 | 22.0 | 15.6 | 14.1 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 2.6 | 2.1 | 1.7 | 2.8 | 4.3 | 1.9 | 1.2a | 3.1 | 2.8 | 2.0 |
| Cigars | 4.2 | 4.1 | 5.1 | 4.5 | 6.8 | 5.7 | 4.8 | 4.1 | 4.1 | 4.1 |
| Pipe Tobacco4 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 3.4 | -- | 7.3 | -- | 9.7 | -- | 6.7 | -- | 2.8 |
| ALCOHOL | 60.8 | 61.7 | 58.7 | 57.5 | 62.9 | 53.0 | 57.8 | 58.7 | 61.2 | 62.3 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 2.6 | -- | 6.3 | -- | 7.8 | -- | 5.9 | -- | 1.9 |
| Illegally Made Fentanyl | -- | 0.1 | -- | 0.5 | -- | 1.1 | -- | 0.3 | -- | 0.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 3 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 4 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance | Aged 50+ (2021) |
Aged 50+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 15,968b | 19,620 | 1,559 | 2,054 | 1,173 | 1,541 | 14,409b | 17,566 |
| Marijuana | 12,831b | 16,130 | 944a | 1,628 | 753 | 1,206 | 11,887b | 14,502 |
| Cocaine | 1,000 | 1,115 | 176 | 190 | 176 | 140 | 824 | 925 |
| Crack | 510 | 451 | * | 139 | * | 89 | 470 | 312 |
| Heroin | 401 | 269 | * | 42 | * | 38 | 338 | 226 |
| Hallucinogens | 574 | 876 | 7a | 133 | 6 | 87 | 567 | 744 |
| LSD | 119 | 136 | 4 | * | 4 | * | 114 | 136 |
| PCP | 71 | 118 | * | * | * | * | 71 | 73 |
| Ecstasy | 70 | 132 | 1 | * | * | * | 69 | 132 |
| Inhalants | 167 | 196 | 12 | 2 | 11 | * | 155 | 194 |
| Methamphetamine | 950 | 874 | 83 | 231 | 64 | 197 | 867 | 644 |
| Misuse of Prescription Psychotherapeutics | 4,039 | 4,174 | 709 | 711 | 500 | 571 | 3,330 | 3,463 |
| Pain Relievers | 3,091 | 2,878 | 506 | 484 | 312 | 421 | 2,586 | 2,395 |
| Stimulants | 290 | 429 | 25 | 42 | 25 | 9 | 265 | 387 |
| Tranquilizers or Sedatives | 1,264 | 1,591 | 237 | 348 | 204 | 270 | 1,028 | 1,243 |
| Tranquilizers | 988 | 1,231 | 181 | 221 | 148 | 206 | 808 | 1,010 |
| Sedatives | 296 | 470 | 64 | 178 | 64 | 113 | 232 | 292 |
| Benzodiazepines | 834 | 976 | 123 | 186 | 91 | 172 | 711 | 790 |
| Opioids1 | 3,330 | 3,029 | 507 | 495 | 313 | 432 | 2,823 | 2,535 |
| Central Nervous System Stimulants | 1,966 | 2,168 | 240 | 380 | 222 | 286 | 1,725 | 1,788 |
| Illicit Drugs Other Than Marijuana1,2 | 5,680 | 6,279 | 831 | 939 | 613 | 718 | 4,849 | 5,340 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 24,109 | -- | 2,041 | -- | 1,390 | -- | 22,068 |
| Tobacco Products | 25,650b | 22,687 | 1,514 | 1,724 | 1,181 | 1,125 | 24,135b | 20,963 |
| Cigarettes | 20,745a | 18,416 | 1,432 | 1,587 | 1,107 | 1,044 | 19,313a | 16,829 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 3,063 | 2,525 | 182 | 100 | 158 | 44 | 2,882 | 2,425 |
| Cigars | 5,008 | 4,922 | 232 | 353 | 195 | 249 | 4,776 | 4,569 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 4,088 | -- | 607 | -- | 462 | -- | 3,481 |
| ALCOHOL | 71,789 | 73,330 | 3,442 | 3,379 | 2,356 | 2,237 | 68,347 | 69,951 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 3,035 | -- | 495 | -- | 432 | -- | 2,541 |
| Illegally Made Fentanyl | -- | 156 | -- | 40 | -- | 40 | -- | 116 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance | Aged 50+ (2021) |
Aged 50+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 13.5b | 16.5 | 29.4 | 37.3 | 33.6 | 41.7 | 12.8b | 15.5 |
| Marijuana | 10.9b | 13.6 | 17.8b | 29.5 | 21.6a | 32.6 | 10.5b | 12.8 |
| Cocaine | 0.8 | 0.9 | 3.3 | 3.4 | 5.0 | 3.8 | 0.7 | 0.8 |
| Crack | 0.4 | 0.4 | * | 2.5 | * | 2.4 | 0.4 | 0.3 |
| Heroin | 0.3 | 0.2 | * | 0.8 | * | 1.0 | 0.3 | 0.2 |
| Hallucinogens | 0.5 | 0.7 | 0.1a | 2.4 | 0.2 | 2.4 | 0.5 | 0.7 |
| LSD | 0.1 | 0.1 | 0.1 | * | 0.1 | * | 0.1 | 0.1 |
| PCP | 0.1 | 0.1 | * | * | * | * | 0.1 | 0.1 |
| Ecstasy | 0.1 | 0.1 | 0.0 | * | * | * | 0.1 | 0.1 |
| Inhalants | 0.1 | 0.2 | 0.2 | 0.0 | 0.3 | * | 0.1 | 0.2 |
| Methamphetamine | 0.8 | 0.7 | 1.6 | 4.2 | 1.8 | 5.3 | 0.8 | 0.6 |
| Misuse of Prescription Psychotherapeutics | 3.4 | 3.5 | 13.4 | 12.9 | 14.3 | 15.4 | 3.0 | 3.1 |
| Pain Relievers | 2.6 | 2.4 | 9.5 | 8.8 | 8.9 | 11.4 | 2.3 | 2.1 |
| Stimulants | 0.2 | 0.4 | 0.5 | 0.8 | 0.7 | 0.2 | 0.2 | 0.3 |
| Tranquilizers or Sedatives | 1.1 | 1.3 | 4.5 | 6.3 | 5.9 | 7.3 | 0.9 | 1.1 |
| Tranquilizers | 0.8 | 1.0 | 3.4 | 4.0 | 4.2 | 5.6 | 0.7 | 0.9 |
| Sedatives | 0.3 | 0.4 | 1.2 | 3.2 | 1.8 | 3.1 | 0.2 | 0.3 |
| Benzodiazepines | 0.7 | 0.8 | 2.3 | 3.4 | 2.6 | 4.6 | 0.6 | 0.7 |
| Opioids1 | 2.8 | 2.5 | 9.6 | 9.0 | 9.0 | 11.7 | 2.5 | 2.2 |
| Central Nervous System Stimulants | 1.7 | 1.8 | 4.5 | 6.9 | 6.3 | 7.7 | 1.5 | 1.6 |
| Illicit Drugs Other Than Marijuana1,2 | 4.8 | 5.3 | 15.7 | 17.0 | 17.6 | 19.4 | 4.3 | 4.7 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING |
-- | 20.3 | -- | 37.0 | -- | 37.6 | -- | 19.5 |
| Tobacco Products | 21.7b | 19.1 | 28.6 | 31.3 | 33.8 | 30.4 | 21.4b | 18.5 |
| Cigarettes | 17.6a | 15.5 | 27.0 | 28.8 | 31.7 | 28.2 | 17.1b | 14.8 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 2.6 | 2.1 | 3.4 | 1.8 | 4.5 | 1.2 | 2.6 | 2.1 |
| Cigars | 4.2 | 4.1 | 4.4 | 6.4 | 5.6 | 6.7 | 4.2 | 4.0 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 3.4 | -- | 11.0 | -- | 12.5 | -- | 3.1 |
| ALCOHOL | 60.8 | 61.7 | 64.9 | 61.3 | 67.4 | 60.5 | 60.6 | 61.7 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL |
-- | 2.6 | -- | 9.0 | -- | 11.7 | -- | 2.2 |
| Illegally Made Fentanyl | -- | 0.1 | -- | 0.7 | -- | 1.1 | -- | 0.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance Use Disorder Status | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 253,825 | 256,282 | 58,451 | 59,286 | 14,526 | 15,360 | 43,926 | 43,926 | 195,373 | 196,996 |
| DRUGS OR ALCOHOL2 | 44,383 | 46,494 | 19,692a | 21,543 | 6,556a | 7,410 | 13,136 | 14,134 | 24,691 | 24,950 |
| DRUGS2 | 22,571b | 25,417 | 12,333b | 14,504 | 4,610b | 5,587 | 7,723a | 8,916 | 10,237 | 10,913 |
| Marijuana | 15,313b | 17,669 | 8,065b | 9,837 | 2,878b | 3,767 | 5,187a | 6,070 | 7,248 | 7,832 |
| Cocaine | 1,431 | 1,429 | 965 | 918 | 347 | 386 | 618 | 532 | 467 | 511 |
| Heroin | 989 | 898 | 750 | 607 | 148 | 247 | 602 | 360 | 239 | 291 |
| Hallucinogens | 456 | 514 | 362 | 437 | 170 | 150 | 193 | 286 | 94 | 77 |
| Inhalants | 259 | 262 | 194 | 212 | 62 | 42 | 132 | 170 | 65 | 50 |
| Methamphetamine | 1,604 | 1,818 | 1,098 | 1,151 | 452 | 511 | 646 | 640 | 507 | 667 |
| Prescription Psychotherapeutics2 | 6,860 | 7,687 | 4,256 | 4,864 | 1,744 | 2,022 | 2,512 | 2,842 | 2,604 | 2,822 |
| Pain Relievers2 | 4,745 | 5,312 | 2,804 | 3,192 | 1,077 | 1,197 | 1,727 | 1,996 | 1,941 | 2,119 |
| Stimulants2 | 1,266 | 1,569 | 932 | 1,192 | 401 | 538 | 531 | 654 | 334 | 377 |
| Tranquilizers or Sedatives2 | 2,110 | 2,221 | 1,604 | 1,600 | 846 | 768 | 758 | 832 | 506 | 621 |
| Tranquilizers2 | 1,607 | 1,730 | 1,275 | 1,216 | 712 | 590 | 563 | 626 | 333 | 515 |
| Sedatives2 | 879 | 769 | 625 | 610 | 305 | 317 | 320 | 293 | 254 | 160 |
| Opioids2 | 5,308 | 5,852 | 3,150 | 3,527 | 1,113 | 1,329 | 2,036 | 2,198 | 2,159 | 2,325 |
| Central Nervous System Stimulants2 | 3,932 | 4,247 | 2,670 | 2,873 | 1,070 | 1,225 | 1,599 | 1,648 | 1,262 | 1,374 |
| ALCOHOL | 28,769 | 28,788 | 11,693 | 12,145 | 3,799 | 3,824 | 7,894 | 8,322 | 17,076 | 16,643 |
| BOTH DRUGS AND ALCOHOL2 | 6,956 | 7,712 | 4,334a | 5,106 | 1,853 | 2,001 | 2,480a | 3,105 | 2,623 | 2,606 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)2 | 15,615b | 17,706 | 8,000b | 9,398 | 2,757b | 3,586 | 5,243 | 5,812 | 7,615 | 8,307 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)2 | 21,812 | 21,077 | 7,359 | 7,040 | 1,946 | 1,823 | 5,413 | 5,217 | 14,453 | 14,037 |
| NO SUBSTANCE USE DISORDER2 | 209,442 | 209,788 | 38,759 | 37,743 | 7,970 | 7,951 | 30,789 | 29,792 | 170,683 | 172,045 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status | Aged 18+ (2021) |
Aged 18+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| DRUGS OR ALCOHOL2 | 17.5 | 18.1 | 33.7b | 36.3 | 45.1 | 48.2 | 29.9a | 32.2 | 12.6 | 12.7 |
| DRUGS2 | 8.9b | 9.9 | 21.1b | 24.5 | 31.7a | 36.4 | 17.6b | 20.3 | 5.2 | 5.5 |
| Marijuana | 6.0b | 6.9 | 13.8b | 16.6 | 19.8b | 24.5 | 11.8a | 13.8 | 3.7 | 4.0 |
| Cocaine | 0.6 | 0.6 | 1.7 | 1.5 | 2.4 | 2.5 | 1.4 | 1.2 | 0.2 | 0.3 |
| Heroin | 0.4 | 0.4 | 1.3 | 1.0 | 1.0 | 1.6 | 1.4 | 0.8 | 0.1 | 0.1 |
| Hallucinogens | 0.2 | 0.2 | 0.6 | 0.7 | 1.2 | 1.0 | 0.4 | 0.7 | 0.0 | 0.0 |
| Inhalants | 0.1 | 0.1 | 0.3 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.0 | 0.0 |
| Methamphetamine | 0.6 | 0.7 | 1.9 | 1.9 | 3.1 | 3.3 | 1.5 | 1.5 | 0.3 | 0.3 |
| Prescription Psychotherapeutics2 | 2.7 | 3.0 | 7.3 | 8.2 | 12.0 | 13.2 | 5.7 | 6.5 | 1.3 | 1.4 |
| Pain Relievers2 | 1.9 | 2.1 | 4.8 | 5.4 | 7.4 | 7.8 | 3.9 | 4.5 | 1.0 | 1.1 |
| Stimulants2 | 0.5 | 0.6 | 1.6 | 2.0 | 2.8 | 3.5 | 1.2 | 1.5 | 0.2 | 0.2 |
| Tranquilizers or Sedatives2 | 0.8 | 0.9 | 2.7 | 2.7 | 5.8 | 5.0 | 1.7 | 1.9 | 0.3 | 0.3 |
| Tranquilizers2 | 0.6 | 0.7 | 2.2 | 2.1 | 4.9 | 3.8 | 1.3 | 1.4 | 0.2 | 0.3 |
| Sedatives2 | 0.3 | 0.3 | 1.1 | 1.0 | 2.1 | 2.1 | 0.7 | 0.7 | 0.1 | 0.1 |
| Opioids2 | 2.1 | 2.3 | 5.4 | 5.9 | 7.7 | 8.7 | 4.6 | 5.0 | 1.1 | 1.2 |
| Central Nervous System Stimulants2 | 1.5 | 1.7 | 4.6 | 4.8 | 7.4 | 8.0 | 3.6 | 3.8 | 0.6 | 0.7 |
| ALCOHOL | 11.3 | 11.2 | 20.0 | 20.5 | 26.2 | 24.9 | 18.0 | 18.9 | 8.7 | 8.4 |
| BOTH DRUGS AND ALCOHOL2 | 2.7 | 3.0 | 7.4a | 8.6 | 12.8 | 13.0 | 5.6a | 7.1 | 1.3 | 1.3 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)2 | 6.2b | 6.9 | 13.7b | 15.9 | 19.0a | 23.3 | 11.9 | 13.2 | 3.9 | 4.2 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)2 | 8.6 | 8.2 | 12.6 | 11.9 | 13.4 | 11.9 | 12.3 | 11.9 | 7.4 | 7.1 |
| NO SUBSTANCE USE DISORDER2 | 82.5 | 81.9 | 66.3b | 63.7 | 54.9 | 51.8 | 70.1a | 67.8 | 87.4 | 87.3 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status | Aged 18+ (2021) |
Aged 18+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 253,825 | 256,282 | 21,553 | 22,475 | 14,889 | 15,873 | 232,272 | 233,807 |
| DRUGS OR ALCOHOL1 | 44,383 | 46,494 | 8,187a | 9,337 | 6,426 | 7,175 | 36,196 | 37,156 |
| DRUGS1 | 22,571b | 25,417 | 5,499b | 6,713 | 4,368b | 5,385 | 17,072a | 18,704 |
| Marijuana | 15,313b | 17,669 | 3,572b | 4,641 | 2,717b | 3,681 | 11,741a | 13,028 |
| Cocaine | 1,431 | 1,429 | 427 | 396 | 383 | 295 | 1,004 | 1,033 |
| Heroin | 989 | 898 | 226 | 216 | 206 | 186 | 763 | 682 |
| Hallucinogens | 456 | 514 | 184 | 162 | 155 | 146 | 273 | 352 |
| Inhalants | 259 | 262 | 86 | 90 | 68 | 77 | 172 | 172 |
| Methamphetamine | 1,604 | 1,818 | 453 | 485 | 367 | 427 | 1,151 | 1,333 |
| Prescription Psychotherapeutics1 | 6,860 | 7,687 | 2,017 | 2,146 | 1,723 | 1,805 | 4,843 | 5,541 |
| Pain Relievers1 | 4,745 | 5,312 | 1,305 | 1,263 | 1,112 | 1,088 | 3,439 | 4,049 |
| Stimulants1 | 1,266 | 1,569 | 532 | 539 | 448 | 471 | 734a | 1,030 |
| Tranquilizers or Sedatives1 | 2,110 | 2,221 | 865 | 772 | 810 | 573 | 1,245 | 1,449 |
| Tranquilizers1 | 1,607 | 1,730 | 704 | 569 | 661 | 455 | 903 | 1,161 |
| Sedatives1 | 879 | 769 | 355 | 312 | 343 | 192 | 524 | 457 |
| Opioids1 | 5,308 | 5,852 | 1,350 | 1,403 | 1,149 | 1,205 | 3,958 | 4,448 |
| Central Nervous System Stimulants1 | 3,932 | 4,247 | 1,197 | 1,283 | 1,004 | 1,070 | 2,735 | 2,964 |
| ALCOHOL | 28,769 | 28,788 | 4,831 | 5,087 | 3,746 | 3,760 | 23,938 | 23,701 |
| BOTH DRUGS AND ALCOHOL1 | 6,956 | 7,712 | 2,143 | 2,463 | 1,688 | 1,970 | 4,813 | 5,249 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 15,615b | 17,706 | 3,356b | 4,250 | 2,680b | 3,415 | 12,258 | 13,455 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 21,812 | 21,077 | 2,688 | 2,624 | 2,058 | 1,790 | 19,125 | 18,452 |
| NO SUBSTANCE USE DISORDER1 | 209,442 | 209,788 | 13,366 | 13,137 | 8,463 | 8,698 | 196,075 | 196,651 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance Use Disorder Status | Aged 18+ (2021) |
Aged 18+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| DRUGS OR ALCOHOL1 | 17.5 | 18.1 | 38.0 | 41.5 | 43.2 | 45.2 | 15.6 | 15.9 |
| DRUGS1 | 8.9b | 9.9 | 25.5b | 29.9 | 29.3a | 33.9 | 7.3a | 8.0 |
| Marijuana | 6.0b | 6.9 | 16.6b | 20.6 | 18.3b | 23.2 | 5.1a | 5.6 |
| Cocaine | 0.6 | 0.6 | 2.0 | 1.8 | 2.6 | 1.9 | 0.4 | 0.4 |
| Heroin | 0.4 | 0.4 | 1.0 | 1.0 | 1.4 | 1.2 | 0.3 | 0.3 |
| Hallucinogens | 0.2 | 0.2 | 0.9 | 0.7 | 1.0 | 0.9 | 0.1 | 0.2 |
| Inhalants | 0.1 | 0.1 | 0.4 | 0.4 | 0.5 | 0.5 | 0.1 | 0.1 |
| Methamphetamine | 0.6 | 0.7 | 2.1 | 2.2 | 2.5 | 2.7 | 0.5 | 0.6 |
| Prescription Psychotherapeutics1 | 2.7 | 3.0 | 9.4 | 9.5 | 11.6 | 11.4 | 2.1 | 2.4 |
| Pain Relievers1 | 1.9 | 2.1 | 6.1 | 5.6 | 7.5 | 6.9 | 1.5 | 1.7 |
| Stimulants1 | 0.5 | 0.6 | 2.5 | 2.4 | 3.0 | 3.0 | 0.3a | 0.4 |
| Tranquilizers or Sedatives1 | 0.8 | 0.9 | 4.0 | 3.4 | 5.4a | 3.6 | 0.5 | 0.6 |
| Tranquilizers1 | 0.6 | 0.7 | 3.3 | 2.5 | 4.4 | 2.9 | 0.4 | 0.5 |
| Sedatives1 | 0.3 | 0.3 | 1.6 | 1.4 | 2.3 | 1.2 | 0.2 | 0.2 |
| Opioids1 | 2.1 | 2.3 | 6.3 | 6.2 | 7.7 | 7.6 | 1.7 | 1.9 |
| Central Nervous System Stimulants1 | 1.5 | 1.7 | 5.6 | 5.7 | 6.7 | 6.7 | 1.2 | 1.3 |
| ALCOHOL | 11.3 | 11.2 | 22.4 | 22.6 | 25.2 | 23.7 | 10.3 | 10.1 |
| BOTH DRUGS AND ALCOHOL1 | 2.7 | 3.0 | 9.9 | 11.0 | 11.3 | 12.4 | 2.1 | 2.2 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 6.2b | 6.9 | 15.6a | 18.9 | 18.0a | 21.5 | 5.3 | 5.8 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 8.6 | 8.2 | 12.5 | 11.7 | 13.8 | 11.3 | 8.2 | 7.9 |
| NO SUBSTANCE USE DISORDER1 | 82.5 | 81.9 | 62.0 | 58.5 | 56.8 | 54.8 | 84.4 | 84.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance Use Disorder Status | Aged 18-25 (2021) |
Aged 18-25 (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 33,458 | 34,786 | 11,536 | 12,583 | 4,012 | 4,031 | 7,523b | 8,551 | 21,923 | 22,203 |
| DRUGS OR ALCOHOL2 | 8,764b | 9,669 | 4,626a | 5,270 | 1,900 | 2,078 | 2,726a | 3,191 | 4,138 | 4,399 |
| DRUGS2 | 5,569b | 6,482 | 3,197b | 3,862 | 1,359 | 1,599 | 1,838a | 2,262 | 2,371 | 2,621 |
| Marijuana | 4,918b | 5,740 | 2,770b | 3,335 | 1,158 | 1,363 | 1,612a | 1,972 | 2,149 | 2,405 |
| Cocaine | 267 | 268 | 182 | 192 | 82 | 61 | 100 | 131 | 85 | 76 |
| Heroin | 67 | 35 | 57 | 24 | 19 | 12 | 37 | 11 | 10 | 11 |
| Hallucinogens | 202 | 228 | 149 | 186 | 48 | 75 | 101 | 111 | 53 | 42 |
| Inhalants | 90 | 91 | 70 | 57 | 41 | 17 | 30 | 40 | 20 | 34 |
| Methamphetamine | 121 | 84 | 64 | 64 | 37 | 30 | 27 | 34 | 57 | 20 |
| Prescription Psychotherapeutics2 | 910 | 945 | 619 | 752 | 312 | 369 | 307 | 383 | 291 | 193 |
| Pain Relievers2 | 417 | 410 | 291 | 300 | 144 | 140 | 147 | 160 | 126 | 110 |
| Stimulants2 | 390 | 476 | 275 | 396 | 120 | 191 | 155 | 205 | 116 | 80 |
| Tranquilizers or Sedatives2 | 307 | 290 | 223 | 239 | 139 | 139 | 85 | 101 | 84 | 50 |
| Tranquilizers2 | 251 | 236 | 204 | 189 | 129 | 114 | 75 | 75 | 47 | 46 |
| Sedatives2 | 108 | 81 | 62 | 76 | 27 | 45 | 35 | 31 | 46a | 4 |
| Opioids2 | 444 | 424 | 310 | 308 | 152 | 143 | 158 | 165 | 134 | 116 |
| Central Nervous System Stimulants2 | 647 | 755 | 420a | 586 | 187 | 239 | 233 | 346 | 227 | 170 |
| ALCOHOL | 5,181a | 5,689 | 2,711 | 3,051 | 1,131 | 1,187 | 1,581 | 1,864 | 2,470 | 2,638 |
| BOTH DRUGS AND ALCOHOL2 | 1,986b | 2,502 | 1,282b | 1,643 | 590 | 708 | 692a | 935 | 704 | 859 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)2 | 3,583 | 3,980 | 1,915 | 2,218 | 769 | 892 | 1,146 | 1,327 | 1,668 | 1,761 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)2 | 3,195 | 3,186 | 1,429 | 1,408 | 540 | 479 | 888 | 929 | 1,767 | 1,778 |
| NO SUBSTANCE USE DISORDER2 | 24,694 | 25,118 | 6,910 | 7,313 | 2,113 | 1,953 | 4,797a | 5,360 | 17,785 | 17,804 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status | Aged 18-25 (2021) |
Aged 18-25 (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| DRUGS OR ALCOHOL2 | 26.2 | 27.8 | 40.1 | 41.9 | 47.3 | 51.6 | 36.2 | 37.3 | 18.9 | 19.8 |
| DRUGS2 | 16.6b | 18.6 | 27.7a | 30.7 | 33.9a | 39.7 | 24.4 | 26.5 | 10.8 | 11.8 |
| Marijuana | 14.7a | 16.5 | 24.0 | 26.5 | 28.9 | 33.8 | 21.4 | 23.1 | 9.8 | 10.8 |
| Cocaine | 0.8 | 0.8 | 1.6 | 1.5 | 2.0 | 1.5 | 1.3 | 1.5 | 0.4 | 0.3 |
| Heroin | 0.2 | 0.1 | 0.5 | 0.2 | 0.5 | 0.3 | 0.5 | 0.1 | 0.0 | 0.0 |
| Hallucinogens | 0.6 | 0.7 | 1.3 | 1.5 | 1.2 | 1.9 | 1.3 | 1.3 | 0.2 | 0.2 |
| Inhalants | 0.3 | 0.3 | 0.6 | 0.5 | 1.0 | 0.4 | 0.4 | 0.5 | 0.1 | 0.2 |
| Methamphetamine | 0.4 | 0.2 | 0.6 | 0.5 | 0.9 | 0.7 | 0.4 | 0.4 | 0.3 | 0.1 |
| Prescription Psychotherapeutics2 | 2.7 | 2.7 | 5.4 | 6.0 | 7.8 | 9.2 | 4.1 | 4.5 | 1.3 | 0.9 |
| Pain Relievers2 | 1.2 | 1.2 | 2.5 | 2.4 | 3.6 | 3.5 | 2.0 | 1.9 | 0.6 | 0.5 |
| Stimulants2 | 1.2 | 1.4 | 2.4 | 3.1 | 3.0 | 4.7 | 2.1 | 2.4 | 0.5 | 0.4 |
| Tranquilizers or Sedatives2 | 0.9 | 0.8 | 1.9 | 1.9 | 3.5 | 3.4 | 1.1 | 1.2 | 0.4 | 0.2 |
| Tranquilizers2 | 0.7 | 0.7 | 1.8 | 1.5 | 3.2 | 2.8 | 1.0 | 0.9 | 0.2 | 0.2 |
| Sedatives2 | 0.3 | 0.2 | 0.5 | 0.6 | 0.7 | 1.1 | 0.5 | 0.4 | 0.2a | 0.0 |
| Opioids2 | 1.3 | 1.2 | 2.7 | 2.4 | 3.8 | 3.6 | 2.1 | 1.9 | 0.6 | 0.5 |
| Central Nervous System Stimulants2 | 1.9 | 2.2 | 3.6 | 4.7 | 4.7 | 5.9 | 3.1 | 4.1 | 1.0 | 0.8 |
| ALCOHOL | 15.5 | 16.4 | 23.5 | 24.2 | 28.2 | 29.4 | 21.0 | 21.8 | 11.3 | 11.9 |
| BOTH DRUGS AND ALCOHOL2 | 5.9b | 7.2 | 11.1 | 13.1 | 14.7 | 17.6 | 9.2 | 10.9 | 3.2 | 3.9 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)2 | 10.7 | 11.4 | 16.6 | 17.6 | 19.2 | 22.1 | 15.2 | 15.5 | 7.6 | 7.9 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)2 | 9.6 | 9.2 | 12.4 | 11.2 | 13.5 | 11.9 | 11.8 | 10.9 | 8.1 | 8.0 |
| NO SUBSTANCE USE DISORDER2 | 73.8 | 72.2 | 59.9 | 58.1 | 52.7 | 48.4 | 63.8 | 62.7 | 81.1 | 80.2 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status | Aged 18-25 (2021) |
Aged 18-25 (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 33,458 | 34,786 | 6,442 | 6,990 | 4,603 | 5,109 | 27,016 | 27,796 |
| DRUGS OR ALCOHOL1 | 8,764b | 9,669 | 2,517b | 3,082 | 1,906b | 2,458 | 6,247 | 6,586 |
| DRUGS1 | 5,569b | 6,482 | 1,796b | 2,293 | 1,352b | 1,865 | 3,773 | 4,189 |
| Marijuana | 4,918b | 5,740 | 1,566a | 1,967 | 1,141b | 1,588 | 3,353 | 3,773 |
| Cocaine | 267 | 268 | 126 | 77 | 103 | 49 | 141 | 191 |
| Heroin | 67 | 35 | 31 | 12 | 31 | 12 | 36 | 22 |
| Hallucinogens | 202 | 228 | 92 | 79 | 76 | 74 | 110 | 149 |
| Inhalants | 90 | 91 | 43 | 32 | 25 | 32 | 47 | 59 |
| Methamphetamine | 121 | 84 | 44 | 31 | 35 | 31 | 78 | 53 |
| Prescription Psychotherapeutics1 | 910 | 945 | 343 | 437 | 302 | 377 | 567 | 508 |
| Pain Relievers1 | 417 | 410 | 164 | 169 | 142 | 139 | 253 | 242 |
| Stimulants1 | 390 | 476 | 155 | 208 | 131 | 175 | 235 | 267 |
| Tranquilizers or Sedatives1 | 307 | 290 | 137 | 164 | 123 | 155 | 170 | 126 |
| Tranquilizers1 | 251 | 236 | 129 | 135 | 115 | 126 | 122 | 101 |
| Sedatives1 | 108 | 81 | 31 | 51 | 31 | 50 | 77 | 30 |
| Opioids1 | 444 | 424 | 174 | 171 | 152 | 142 | 270 | 253 |
| Central Nervous System Stimulants1 | 647 | 755 | 238 | 287 | 197 | 234 | 408 | 468 |
| ALCOHOL | 5,181a | 5,689 | 1,500a | 1,823 | 1,142 | 1,415 | 3,681 | 3,865 |
| BOTH DRUGS AND ALCOHOL1 | 1,986b | 2,502 | 780a | 1,034 | 588a | 822 | 1,206a | 1,468 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 3,583 | 3,980 | 1,016a | 1,259 | 764a | 1,042 | 2,567 | 2,721 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 3,195 | 3,186 | 720 | 789 | 554 | 593 | 2,475 | 2,397 |
| NO SUBSTANCE USE DISORDER1 | 24,694 | 25,118 | 3,926 | 3,907 | 2,697 | 2,652 | 20,769 | 21,210 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance Use Disorder Status | Aged 18-25 (2021) |
Aged 18-25 (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| DRUGS OR ALCOHOL1 | 26.2 | 27.8 | 39.1a | 44.1 | 41.4a | 48.1 | 23.1 | 23.7 |
| DRUGS1 | 16.6b | 18.6 | 27.9a | 32.8 | 29.4b | 36.5 | 14.0 | 15.1 |
| Marijuana | 14.7a | 16.5 | 24.3 | 28.1 | 24.8a | 31.1 | 12.4 | 13.6 |
| Cocaine | 0.8 | 0.8 | 2.0 | 1.1 | 2.2 | 1.0 | 0.5 | 0.7 |
| Heroin | 0.2 | 0.1 | 0.5 | 0.2 | 0.7 | 0.2 | 0.1 | 0.1 |
| Hallucinogens | 0.6 | 0.7 | 1.4 | 1.1 | 1.7 | 1.4 | 0.4 | 0.5 |
| Inhalants | 0.3 | 0.3 | 0.7 | 0.5 | 0.5 | 0.6 | 0.2 | 0.2 |
| Methamphetamine | 0.4 | 0.2 | 0.7 | 0.4 | 0.8 | 0.6 | 0.3 | 0.2 |
| Prescription Psychotherapeutics1 | 2.7 | 2.7 | 5.3 | 6.3 | 6.6 | 7.4 | 2.1 | 1.8 |
| Pain Relievers1 | 1.2 | 1.2 | 2.5 | 2.4 | 3.1 | 2.7 | 0.9 | 0.9 |
| Stimulants1 | 1.2 | 1.4 | 2.4 | 3.0 | 2.9 | 3.4 | 0.9 | 1.0 |
| Tranquilizers or Sedatives1 | 0.9 | 0.8 | 2.1 | 2.3 | 2.7 | 3.0 | 0.6 | 0.5 |
| Tranquilizers1 | 0.7 | 0.7 | 2.0 | 1.9 | 2.5 | 2.5 | 0.5 | 0.4 |
| Sedatives1 | 0.3 | 0.2 | 0.5 | 0.7 | 0.7 | 1.0 | 0.3 | 0.1 |
| Opioids1 | 1.3 | 1.2 | 2.7 | 2.5 | 3.3 | 2.8 | 1.0 | 0.9 |
| Central Nervous System Stimulants1 | 1.9 | 2.2 | 3.7 | 4.1 | 4.3 | 4.6 | 1.5 | 1.7 |
| ALCOHOL | 15.5 | 16.4 | 23.3 | 26.1 | 24.8 | 27.7 | 13.6 | 13.9 |
| BOTH DRUGS AND ALCOHOL1 | 5.9b | 7.2 | 12.1 | 14.8 | 12.8 | 16.1 | 4.5 | 5.3 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 10.7 | 11.4 | 15.8 | 18.0 | 16.6 | 20.4 | 9.5 | 9.8 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 9.6 | 9.2 | 11.2 | 11.3 | 12.0 | 11.6 | 9.2 | 8.6 |
| NO SUBSTANCE USE DISORDER1 | 73.8 | 72.2 | 60.9a | 55.9 | 58.6a | 51.9 | 76.9 | 76.3 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance Use Disorder Status | Aged 26+ (2021) |
Aged 26+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 220,366 | 221,495 | 46,916 | 46,703 | 10,513 | 11,329 | 36,402 | 35,374 | 173,451 | 174,792 |
| DRUGS OR ALCOHOL2 | 35,619 | 36,825 | 15,066 | 16,274 | 4,656 | 5,332 | 10,410 | 10,942 | 20,553 | 20,551 |
| DRUGS2 | 17,002a | 18,935 | 9,136b | 10,642 | 3,251a | 3,988 | 5,885 | 6,654 | 7,866 | 8,293 |
| Marijuana | 10,395a | 11,928 | 5,295b | 6,502 | 1,721b | 2,404 | 3,575 | 4,098 | 5,100 | 5,426 |
| Cocaine | 1,164 | 1,161 | 782 | 726 | 265 | 325 | 518 | 401 | 382 | 435 |
| Heroin | 921 | 864 | 693 | 583 | 128 | 234 | 565 | 349 | 228 | 281 |
| Hallucinogens | 255 | 286 | 213 | 251 | 121 | 75 | 92 | 176 | 41 | 35 |
| Inhalants | 168 | 171 | 124 | 155 | 22 | 25 | 102 | 130 | 45 | 16 |
| Methamphetamine | 1,483 | 1,734 | 1,034 | 1,087 | 415 | 481 | 618 | 606 | 450 | 647 |
| Prescription Psychotherapeutics2 | 5,950 | 6,742 | 3,637 | 4,112 | 1,432 | 1,653 | 2,205 | 2,460 | 2,313 | 2,629 |
| Pain Relievers2 | 4,328 | 4,902 | 2,513 | 2,892 | 933 | 1,056 | 1,580 | 1,836 | 1,815 | 2,010 |
| Stimulants2 | 876 | 1,093 | 658 | 796 | 281 | 347 | 376 | 449 | 218 | 297 |
| Tranquilizers or Sedatives2 | 1,803 | 1,931 | 1,380 | 1,361 | 707 | 630 | 673 | 731 | 422 | 570 |
| Tranquilizers2 | 1,356 | 1,495 | 1,071 | 1,026 | 583 | 476 | 488 | 551 | 286 | 468 |
| Sedatives2 | 771 | 688 | 563 | 533 | 279 | 271 | 284 | 262 | 208 | 155 |
| Opioids2 | 4,864 | 5,427 | 2,839 | 3,218 | 961 | 1,186 | 1,878 | 2,033 | 2,025 | 2,209 |
| Central Nervous System Stimulants2 | 3,285 | 3,492 | 2,250 | 2,288 | 883 | 986 | 1,367 | 1,302 | 1,035 | 1,204 |
| ALCOHOL | 23,587 | 23,099 | 8,982 | 9,094 | 2,668 | 2,637 | 6,313 | 6,457 | 14,606 | 14,005 |
| BOTH DRUGS AND ALCOHOL2 | 4,970 | 5,209 | 3,051 | 3,462 | 1,263 | 1,293 | 1,788 | 2,169 | 1,919 | 1,747 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)2 | 12,032b | 13,726 | 6,085a | 7,180 | 1,988b | 2,695 | 4,097 | 4,485 | 5,947 | 6,546 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)2 | 18,617 | 17,890 | 5,930 | 5,632 | 1,405 | 1,344 | 4,525 | 4,288 | 12,687 | 12,259 |
| NO SUBSTANCE USE DISORDER2 | 184,747 | 184,670 | 31,849 | 30,429 | 5,857 | 5,997 | 25,992 | 24,432 | 152,898 | 154,241 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status | Aged 26+ (2021) |
Aged 26+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| DRUGS OR ALCOHOL2 | 16.2 | 16.6 | 32.1a | 34.8 | 44.3 | 47.1 | 28.6 | 30.9 | 11.8 | 11.8 |
| DRUGS2 | 7.7a | 8.5 | 19.5b | 22.8 | 30.9 | 35.2 | 16.2a | 18.8 | 4.5 | 4.7 |
| Marijuana | 4.7a | 5.4 | 11.3b | 13.9 | 16.4a | 21.2 | 9.8a | 11.6 | 2.9 | 3.1 |
| Cocaine | 0.5 | 0.5 | 1.7 | 1.6 | 2.5 | 2.9 | 1.4 | 1.1 | 0.2 | 0.2 |
| Heroin | 0.4 | 0.4 | 1.5 | 1.2 | 1.2 | 2.1 | 1.6 | 1.0 | 0.1 | 0.2 |
| Hallucinogens | 0.1 | 0.1 | 0.5 | 0.5 | 1.2 | 0.7 | 0.3 | 0.5 | 0.0 | 0.0 |
| Inhalants | 0.1 | 0.1 | 0.3 | 0.3 | 0.2 | 0.2 | 0.3 | 0.4 | 0.0 | 0.0 |
| Methamphetamine | 0.7 | 0.8 | 2.2 | 2.3 | 3.9 | 4.2 | 1.7 | 1.7 | 0.3 | 0.4 |
| Prescription Psychotherapeutics2 | 2.7 | 3.0 | 7.8 | 8.8 | 13.6 | 14.6 | 6.1 | 7.0 | 1.3 | 1.5 |
| Pain Relievers2 | 2.0 | 2.2 | 5.4 | 6.2 | 8.9 | 9.3 | 4.3 | 5.2 | 1.0 | 1.1 |
| Stimulants2 | 0.4 | 0.5 | 1.4 | 1.7 | 2.7 | 3.1 | 1.0 | 1.3 | 0.1 | 0.2 |
| Tranquilizers or Sedatives2 | 0.8 | 0.9 | 2.9 | 2.9 | 6.7 | 5.6 | 1.8 | 2.1 | 0.2 | 0.3 |
| Tranquilizers2 | 0.6 | 0.7 | 2.3 | 2.2 | 5.5 | 4.2 | 1.3 | 1.6 | 0.2 | 0.3 |
| Sedatives2 | 0.3 | 0.3 | 1.2 | 1.1 | 2.7 | 2.4 | 0.8 | 0.7 | 0.1 | 0.1 |
| Opioids2 | 2.2 | 2.5 | 6.1 | 6.9 | 9.1 | 10.5 | 5.2 | 5.7 | 1.2 | 1.3 |
| Central Nervous System Stimulants2 | 1.5 | 1.6 | 4.8 | 4.9 | 8.4 | 8.7 | 3.8 | 3.7 | 0.6 | 0.7 |
| ALCOHOL | 10.7 | 10.4 | 19.1 | 19.5 | 25.4 | 23.3 | 17.3 | 18.3 | 8.4 | 8.0 |
| BOTH DRUGS AND ALCOHOL2 | 2.3 | 2.4 | 6.5 | 7.4 | 12.0 | 11.4 | 4.9 | 6.1 | 1.1 | 1.0 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)2 | 5.5a | 6.2 | 13.0b | 15.4 | 18.9a | 23.8 | 11.3 | 12.7 | 3.4 | 3.7 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)2 | 8.4 | 8.1 | 12.6 | 12.1 | 13.4 | 11.9 | 12.4 | 12.1 | 7.3 | 7.0 |
| NO SUBSTANCE USE DISORDER2 | 83.8 | 83.4 | 67.9a | 65.2 | 55.7 | 52.9 | 71.4 | 69.1 | 88.2 | 88.2 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status | Aged 26+ (2021) |
Aged 26+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 220,366 | 221,495 | 15,111 | 15,485 | 10,286 | 10,764 | 205,256 | 206,011 |
| DRUGS OR ALCOHOL1 | 35,619 | 36,825 | 5,670 | 6,255 | 4,520 | 4,717 | 29,949 | 30,570 |
| DRUGS1 | 17,002a | 18,935 | 3,703a | 4,420 | 3,016 | 3,520 | 13,299 | 14,515 |
| Marijuana | 10,395a | 11,928 | 2,007a | 2,673 | 1,577a | 2,094 | 8,388 | 9,255 |
| Cocaine | 1,164 | 1,161 | 301 | 319 | 280 | 246 | 863 | 842 |
| Heroin | 921 | 864 | 195 | 204 | 175 | 174 | 726 | 660 |
| Hallucinogens | 255 | 286 | 92 | 83 | 79 | 72 | 163 | 203 |
| Inhalants | 168 | 171 | 43 | 58 | 43 | 45 | 125 | 113 |
| Methamphetamine | 1,483 | 1,734 | 409 | 454 | 333 | 396 | 1,074 | 1,280 |
| Prescription Psychotherapeutics1 | 5,950 | 6,742 | 1,674 | 1,709 | 1,422 | 1,427 | 4,276 | 5,033 |
| Pain Relievers1 | 4,328 | 4,902 | 1,142 | 1,094 | 969 | 949 | 3,186 | 3,807 |
| Stimulants1 | 876 | 1,093 | 377 | 331 | 317 | 296 | 499a | 762 |
| Tranquilizers or Sedatives1 | 1,803 | 1,931 | 728 | 608 | 687a | 418 | 1,075 | 1,323 |
| Tranquilizers1 | 1,356 | 1,495 | 575 | 435 | 546 | 329 | 782 | 1,060 |
| Sedatives1 | 771 | 688 | 324 | 261 | 312 | 142 | 447 | 427 |
| Opioids1 | 4,864 | 5,427 | 1,176 | 1,232 | 997 | 1,064 | 3,688 | 4,195 |
| Central Nervous System Stimulants1 | 3,285 | 3,492 | 958 | 997 | 806 | 836 | 2,327 | 2,496 |
| ALCOHOL | 23,587 | 23,099 | 3,330 | 3,264 | 2,604 | 2,345 | 20,257 | 19,836 |
| BOTH DRUGS AND ALCOHOL1 | 4,970 | 5,209 | 1,363 | 1,429 | 1,101 | 1,148 | 3,607 | 3,781 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 12,032b | 13,726 | 2,340a | 2,991 | 1,916 | 2,373 | 9,692 | 10,734 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 18,617 | 17,890 | 1,967 | 1,835 | 1,504 | 1,197 | 16,650 | 16,055 |
| NO SUBSTANCE USE DISORDER1 | 184,747 | 184,670 | 9,440 | 9,230 | 5,766 | 6,046 | 175,307 | 175,440 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance Use Disorder Status | Aged 26+ (2021) |
Aged 26+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| DRUGS OR ALCOHOL1 | 16.2 | 16.6 | 37.5 | 40.4 | 43.9 | 43.8 | 14.6 | 14.8 |
| DRUGS1 | 7.7a | 8.5 | 24.5a | 28.5 | 29.3 | 32.7 | 6.5 | 7.0 |
| Marijuana | 4.7a | 5.4 | 13.3a | 17.3 | 15.3a | 19.5 | 4.1 | 4.5 |
| Cocaine | 0.5 | 0.5 | 2.0 | 2.1 | 2.7 | 2.3 | 0.4 | 0.4 |
| Heroin | 0.4 | 0.4 | 1.3 | 1.3 | 1.7 | 1.6 | 0.4 | 0.3 |
| Hallucinogens | 0.1 | 0.1 | 0.6 | 0.5 | 0.8 | 0.7 | 0.1 | 0.1 |
| Inhalants | 0.1 | 0.1 | 0.3 | 0.4 | 0.4 | 0.4 | 0.1 | 0.1 |
| Methamphetamine | 0.7 | 0.8 | 2.7 | 2.9 | 3.2 | 3.7 | 0.5 | 0.6 |
| Prescription Psychotherapeutics1 | 2.7 | 3.0 | 11.1 | 11.0 | 13.8 | 13.3 | 2.1 | 2.4 |
| Pain Relievers1 | 2.0 | 2.2 | 7.6 | 7.1 | 9.4 | 8.8 | 1.6 | 1.8 |
| Stimulants1 | 0.4 | 0.5 | 2.5 | 2.1 | 3.1 | 2.8 | 0.2a | 0.4 |
| Tranquilizers or Sedatives1 | 0.8 | 0.9 | 4.8 | 3.9 | 6.7a | 3.9 | 0.5 | 0.6 |
| Tranquilizers1 | 0.6 | 0.7 | 3.8 | 2.8 | 5.3a | 3.1 | 0.4 | 0.5 |
| Sedatives1 | 0.3 | 0.3 | 2.1 | 1.7 | 3.0a | 1.3 | 0.2 | 0.2 |
| Opioids1 | 2.2 | 2.5 | 7.8 | 8.0 | 9.7 | 9.9 | 1.8 | 2.0 |
| Central Nervous System Stimulants1 | 1.5 | 1.6 | 6.3 | 6.4 | 7.8 | 7.8 | 1.1 | 1.2 |
| ALCOHOL | 10.7 | 10.4 | 22.0 | 21.1 | 25.3 | 21.8 | 9.9 | 9.6 |
| BOTH DRUGS AND ALCOHOL1 | 2.3 | 2.4 | 9.0 | 9.2 | 10.7 | 10.7 | 1.8 | 1.8 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 5.5a | 6.2 | 15.5a | 19.3 | 18.6 | 22.0 | 4.7 | 5.2 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 8.4 | 8.1 | 13.0 | 11.8 | 14.6 | 11.1 | 8.1 | 7.8 |
| NO SUBSTANCE USE DISORDER1 | 83.8 | 83.4 | 62.5 | 59.6 | 56.1 | 56.2 | 85.4 | 85.2 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance Use Disorder Status | Aged 26-49 (2021) |
Aged 26-49 (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 102,313 | 102,568 | 29,150 | 30,160 | 7,448 | 7,809 | 21,702 | 22,351 | 73,163 | 72,408 |
| DRUGS OR ALCOHOL2 | 22,206 | 23,186 | 10,616 | 11,669 | 3,449 | 3,827 | 7,167 | 7,842 | 11,590 | 11,517 |
| DRUGS2 | 11,289a | 12,597 | 6,555a | 7,471 | 2,462 | 2,732 | 4,094 | 4,740 | 4,734 | 5,125 |
| Marijuana | 8,191a | 9,269 | 4,429a | 5,307 | 1,555 | 1,880 | 2,874 | 3,427 | 3,762 | 3,963 |
| Cocaine | 710 | 779 | 516 | 516 | 193 | 170 | 323 | 346 | 195 | 263 |
| Heroin | 537 | 668 | 429 | 477 | 89 | 181 | 340 | 296 | 108 | 191 |
| Hallucinogens | 165 | 222 | 136 | 187 | 77 | 63 | 60 | 124 | 29 | 35 |
| Inhalants | 150 | 136 | 106 | 120 | 22 | 25 | 85 | 95 | 44 | 16 |
| Methamphetamine | 1,088 | 1,197 | 820 | 798 | 341 | 345 | 479 | 453 | 269 | 400 |
| Prescription Psychotherapeutics2 | 2,828 | 3,336 | 2,033 | 2,264 | 892 | 974 | 1,141 | 1,290 | 796 | 1,072 |
| Pain Relievers2 | 1,851 | 2,086 | 1,296 | 1,411 | 570 | 557 | 726 | 853 | 554 | 675 |
| Stimulants2 | 718 | 862 | 546 | 587 | 271 | 281 | 275 | 306 | 171 | 275 |
| Tranquilizers or Sedatives2 | 1,002 | 1,046 | 858 | 762 | 413 | 359 | 445 | 403 | 144 | 284 |
| Tranquilizers2 | 835 | 823 | 725 | 562 | 351 | 286 | 374 | 276 | 110 | 261 |
| Sedatives2 | 312 | 383 | 278 | 316 | 118 | 140 | 160 | 176 | 34 | 67 |
| Opioids2 | 2,192 | 2,481 | 1,547 | 1,690 | 598 | 674 | 948 | 1,016 | 646 | 791 |
| Central Nervous System Stimulants2 | 2,281 | 2,454 | 1,660 | 1,650 | 727 | 683 | 933 | 967 | 620 | 804 |
| ALCOHOL | 14,691 | 14,618 | 6,377 | 6,926 | 1,975 | 2,008 | 4,402 | 4,918 | 8,314 | 7,692 |
| BOTH DRUGS AND ALCOHOL2 | 3,774 | 4,029 | 2,316 | 2,728 | 988 | 913 | 1,328a | 1,816 | 1,458 | 1,301 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)2 | 7,515a | 8,568 | 4,239 | 4,743 | 1,474 | 1,819 | 2,765 | 2,924 | 3,276 | 3,825 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)2 | 10,917 | 10,589 | 4,061 | 4,198 | 987 | 1,096 | 3,074 | 3,102 | 6,856 | 6,391 |
| NO SUBSTANCE USE DISORDER2 | 80,107 | 79,382 | 18,534 | 18,491 | 3,999 | 3,982 | 14,535 | 14,509 | 61,573 | 60,891 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status | Aged 26-49 (2021) |
Aged 26-49 (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| DRUGS OR ALCOHOL2 | 21.7 | 22.6 | 36.4 | 38.7 | 46.3 | 49.0 | 33.0 | 35.1 | 15.8 | 15.9 |
| DRUGS2 | 11.0a | 12.3 | 22.5 | 24.8 | 33.1 | 35.0 | 18.9 | 21.2 | 6.5 | 7.1 |
| Marijuana | 8.0a | 9.0 | 15.2a | 17.6 | 20.9 | 24.1 | 13.2 | 15.3 | 5.1 | 5.5 |
| Cocaine | 0.7 | 0.8 | 1.8 | 1.7 | 2.6 | 2.2 | 1.5 | 1.5 | 0.3 | 0.4 |
| Heroin | 0.5 | 0.7 | 1.5 | 1.6 | 1.2 | 2.3 | 1.6 | 1.3 | 0.1 | 0.3 |
| Hallucinogens | 0.2 | 0.2 | 0.5 | 0.6 | 1.0 | 0.8 | 0.3 | 0.6 | 0.0 | 0.0 |
| Inhalants | 0.1 | 0.1 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | 0.4 | 0.1 | 0.0 |
| Methamphetamine | 1.1 | 1.2 | 2.8 | 2.6 | 4.6 | 4.4 | 2.2 | 2.0 | 0.4 | 0.6 |
| Prescription Psychotherapeutics2 | 2.8 | 3.3 | 7.0 | 7.5 | 12.0 | 12.5 | 5.3 | 5.8 | 1.1 | 1.5 |
| Pain Relievers2 | 1.8 | 2.0 | 4.4 | 4.7 | 7.7 | 7.1 | 3.3 | 3.8 | 0.8 | 0.9 |
| Stimulants2 | 0.7 | 0.8 | 1.9 | 1.9 | 3.6 | 3.6 | 1.3 | 1.4 | 0.2 | 0.4 |
| Tranquilizers or Sedatives2 | 1.0 | 1.0 | 2.9 | 2.5 | 5.5 | 4.6 | 2.1 | 1.8 | 0.2 | 0.4 |
| Tranquilizers2 | 0.8 | 0.8 | 2.5 | 1.9 | 4.7 | 3.7 | 1.7 | 1.2 | 0.2a | 0.4 |
| Sedatives2 | 0.3 | 0.4 | 1.0 | 1.0 | 1.6 | 1.8 | 0.7 | 0.8 | 0.0 | 0.1 |
| Opioids2 | 2.1 | 2.4 | 5.3 | 5.6 | 8.0 | 8.6 | 4.4 | 4.5 | 0.9 | 1.1 |
| Central Nervous System Stimulants2 | 2.2 | 2.4 | 5.7 | 5.5 | 9.8 | 8.7 | 4.3 | 4.3 | 0.8 | 1.1 |
| ALCOHOL | 14.4 | 14.3 | 21.9 | 23.0 | 26.5 | 25.7 | 20.3 | 22.0 | 11.4 | 10.6 |
| BOTH DRUGS AND ALCOHOL2 | 3.7 | 3.9 | 7.9 | 9.0 | 13.3 | 11.7 | 6.1a | 8.1 | 2.0 | 1.8 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)2 | 7.3a | 8.4 | 14.5 | 15.7 | 19.8 | 23.3 | 12.7 | 13.1 | 4.5a | 5.3 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)2 | 10.7 | 10.3 | 13.9 | 13.9 | 13.3 | 14.0 | 14.2 | 13.9 | 9.4 | 8.8 |
| NO SUBSTANCE USE DISORDER2 | 78.3 | 77.4 | 63.6 | 61.3 | 53.7 | 51.0 | 67.0 | 64.9 | 84.2 | 84.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status | Aged 26-49 (2021) |
Aged 26-49 (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 102,313 | 102,568 | 9,810 | 9,975 | 6,792 | 7,068 | 92,504 | 92,593 |
| DRUGS OR ALCOHOL1 | 22,206 | 23,186 | 4,158 | 4,260 | 3,283 | 3,200 | 18,048 | 18,926 |
| DRUGS1 | 11,289a | 12,597 | 2,793 | 2,875 | 2,236 | 2,285 | 8,496a | 9,722 |
| Marijuana | 8,191a | 9,269 | 1,744 | 2,024 | 1,362 | 1,554 | 6,447 | 7,245 |
| Cocaine | 710 | 779 | 193 | 184 | 172 | 150 | 517 | 595 |
| Heroin | 537 | 668 | 131 | 167 | 114 | 141 | 405 | 501 |
| Hallucinogens | 165 | 222 | 92 | 71 | 79 | 71 | 73 | 151 |
| Inhalants | 150 | 136 | 40 | 58 | 40 | 45 | 110 | 78 |
| Methamphetamine | 1,088 | 1,197 | 369 | 287 | 309 | 258 | 719 | 911 |
| Prescription Psychotherapeutics1 | 2,828 | 3,336 | 1,079 | 933 | 902 | 804 | 1,750b | 2,403 |
| Pain Relievers1 | 1,851 | 2,086 | 703 | 522 | 604 | 460 | 1,148a | 1,564 |
| Stimulants1 | 718 | 862 | 362 | 277 | 302 | 254 | 356a | 585 |
| Tranquilizers or Sedatives1 | 1,002 | 1,046 | 472 | 322 | 452a | 245 | 530 | 724 |
| Tranquilizers1 | 835 | 823 | 383 | 250 | 370 | 213 | 452 | 572 |
| Sedatives1 | 312 | 383 | 164 | 128 | 157 | 76 | 148 | 255 |
| Opioids1 | 2,192 | 2,481 | 737 | 647 | 630 | 561 | 1,455 | 1,834 |
| Central Nervous System Stimulants1 | 2,281 | 2,454 | 797 | 672 | 662 | 592 | 1,483 | 1,781 |
| ALCOHOL | 14,691 | 14,618 | 2,482 | 2,403 | 1,938 | 1,729 | 12,209 | 12,216 |
| BOTH DRUGS AND ALCOHOL1 | 3,774 | 4,029 | 1,118 | 1,018 | 891 | 813 | 2,657 | 3,011 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 7,515a | 8,568 | 1,676 | 1,857 | 1,345 | 1,472 | 5,839a | 6,711 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 10,917 | 10,589 | 1,365 | 1,385 | 1,047 | 916 | 9,552 | 9,205 |
| NO SUBSTANCE USE DISORDER1 | 80,107 | 79,382 | 5,651 | 5,715 | 3,509 | 3,868 | 74,456 | 73,667 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance Use Disorder Status | Aged 26-49 (2021) |
Aged 26-49 (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| DRUGS OR ALCOHOL1 | 21.7 | 22.6 | 42.4 | 42.7 | 48.3 | 45.3 | 19.5 | 20.4 |
| DRUGS1 | 11.0a | 12.3 | 28.5 | 28.8 | 32.9 | 32.3 | 9.2a | 10.5 |
| Marijuana | 8.0a | 9.0 | 17.8 | 20.3 | 20.0 | 22.0 | 7.0 | 7.8 |
| Cocaine | 0.7 | 0.8 | 2.0 | 1.8 | 2.5 | 2.1 | 0.6 | 0.6 |
| Heroin | 0.5 | 0.7 | 1.3 | 1.7 | 1.7 | 2.0 | 0.4 | 0.5 |
| Hallucinogens | 0.2 | 0.2 | 0.9 | 0.7 | 1.2 | 1.0 | 0.1 | 0.2 |
| Inhalants | 0.1 | 0.1 | 0.4 | 0.6 | 0.6 | 0.6 | 0.1 | 0.1 |
| Methamphetamine | 1.1 | 1.2 | 3.8 | 2.9 | 4.5 | 3.7 | 0.8 | 1.0 |
| Prescription Psychotherapeutics1 | 2.8 | 3.3 | 11.0 | 9.4 | 13.3 | 11.4 | 1.9b | 2.6 |
| Pain Relievers1 | 1.8 | 2.0 | 7.2 | 5.2 | 8.9 | 6.5 | 1.2a | 1.7 |
| Stimulants1 | 0.7 | 0.8 | 3.7 | 2.8 | 4.5 | 3.6 | 0.4a | 0.6 |
| Tranquilizers or Sedatives1 | 1.0 | 1.0 | 4.8 | 3.2 | 6.6b | 3.5 | 0.6 | 0.8 |
| Tranquilizers1 | 0.8 | 0.8 | 3.9 | 2.5 | 5.4 | 3.0 | 0.5 | 0.6 |
| Sedatives1 | 0.3 | 0.4 | 1.7 | 1.3 | 2.3 | 1.1 | 0.2 | 0.3 |
| Opioids1 | 2.1 | 2.4 | 7.5 | 6.5 | 9.3 | 7.9 | 1.6 | 2.0 |
| Central Nervous System Stimulants1 | 2.2 | 2.4 | 8.1 | 6.7 | 9.7 | 8.4 | 1.6 | 1.9 |
| ALCOHOL | 14.4 | 14.3 | 25.3 | 24.1 | 28.5 | 24.5 | 13.2 | 13.2 |
| BOTH DRUGS AND ALCOHOL1 | 3.7 | 3.9 | 11.4 | 10.2 | 13.1 | 11.5 | 2.9 | 3.3 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 7.3a | 8.4 | 17.1 | 18.6 | 19.8 | 20.8 | 6.3a | 7.2 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 10.7 | 10.3 | 13.9 | 13.9 | 15.4 | 13.0 | 10.3 | 9.9 |
| NO SUBSTANCE USE DISORDER1 | 78.3 | 77.4 | 57.6 | 57.3 | 51.7 | 54.7 | 80.5 | 79.6 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance Use Disorder Status | Aged 50+ (2021) |
Aged 50+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 118,053 | 118,927 | 17,765 | 16,543 | 3,066 | 3,520 | 14,700 | 13,023 | 100,287 | 102,384 |
| DRUGS OR ALCOHOL2 | 13,413 | 13,639 | 4,450 | 4,605 | 1,208 | 1,504 | 3,243 | 3,100 | 8,963 | 9,034 |
| DRUGS2 | 5,713 | 6,338 | 2,581 | 3,171 | 789a | 1,256 | 1,791 | 1,914 | 3,132 | 3,167 |
| Marijuana | 2,204 | 2,659 | 866 | 1,196 | 165a | 524 | 700 | 671 | 1,338 | 1,463 |
| Cocaine | 454 | 382 | 267 | 210 | 72 | 155 | 195 | 55 | 187 | 172 |
| Heroin | 385 | 196 | 264 | 106 | * | 53 | 224 | 53 | 121 | 90 |
| Hallucinogens | 89 | 63 | 77 | 63 | * | 12 | 32 | 52 | 13 | * |
| Inhalants | 18 | 35 | 17 | 35 | * | * | 17 | 35 | * | * |
| Methamphetamine | 395 | 536 | 214 | 289 | 75 | 137 | 139 | 153 | 181 | 247 |
| Prescription Psychotherapeutics2 | 3,122 | 3,406 | 1,604 | 1,848 | 540 | 678 | 1,064 | 1,170 | 1,518 | 1,558 |
| Pain Relievers2 | 2,477 | 2,815 | 1,217 | 1,481 | 363 | 499 | 854 | 982 | 1,261 | 1,334 |
| Stimulants2 | 158 | 231 | 111 | 209 | 10 | 66 | 101 | 142 | 47 | 22 |
| Tranquilizers or Sedatives2 | 800 | 885 | 522 | 599 | 294 | 270 | 228 | 328 | 278 | 287 |
| Tranquilizers2 | 521 | 672 | 346 | 464 | 232 | 190 | 114 | 275 | 175 | 207 |
| Sedatives2 | 459 | 305 | 286 | 217 | 161 | 131 | 124 | 86 | 173 | 88 |
| Opioids2 | 2,672 | 2,947 | 1,293 | 1,529 | 363 | 512 | 930 | 1,017 | 1,379 | 1,418 |
| Central Nervous System Stimulants2 | 1,004 | 1,039 | 589 | 638 | 156 | 303 | 434 | 335 | 415 | 401 |
| ALCOHOL | 8,896 | 8,481 | 2,605 | 2,168 | 694 | 628 | 1,911 | 1,539 | 6,292 | 6,313 |
| BOTH DRUGS AND ALCOHOL2 | 1,196 | 1,180 | 735 | 734 | 275 | 380 | 460 | 354 | 461 | 446 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)2 | 4,517 | 5,158 | 1,846 | 2,437 | 514 | 876 | 1,332 | 1,561 | 2,671 | 2,721 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)2 | 7,700 | 7,301 | 1,870 | 1,434 | 418 | 248 | 1,451 | 1,186 | 5,830 | 5,867 |
| NO SUBSTANCE USE DISORDER2 | 104,640 | 105,288 | 13,315 | 11,938 | 1,858 | 2,016 | 11,457a | 9,923 | 91,325 | 93,350 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status | Aged 50+ (2021) |
Aged 50+ (2022) |
Any Mental Illness1 (2021) |
Any Mental Illness1 (2022) |
Serious Mental Illness1 (2021) |
Serious Mental Illness1 (2022) |
Any Mental Illness Excluding Serious Mental Illness1 (2021) |
Any Mental Illness Excluding Serious Mental Illness1 (2022) |
No Mental Illness1 (2021) |
No Mental Illness1 (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| DRUGS OR ALCOHOL2 | 11.4 | 11.5 | 25.1 | 27.8 | 39.4 | 42.7 | 22.1 | 23.8 | 8.9 | 8.8 |
| DRUGS2 | 4.8 | 5.3 | 14.5a | 19.2 | 25.7 | 35.7 | 12.2 | 14.7 | 3.1 | 3.1 |
| Marijuana | 1.9 | 2.2 | 4.9 | 7.2 | 5.4a | 14.9 | 4.8 | 5.2 | 1.3 | 1.4 |
| Cocaine | 0.4 | 0.3 | 1.5 | 1.3 | 2.3 | 4.4 | 1.3 | 0.4 | 0.2 | 0.2 |
| Heroin | 0.3 | 0.2 | 1.5 | 0.6 | * | 1.5 | 1.5 | 0.4 | 0.1 | 0.1 |
| Hallucinogens | 0.1 | 0.1 | 0.4 | 0.4 | * | 0.3 | 0.2 | 0.4 | 0.0 | * |
| Inhalants | 0.0 | 0.0 | 0.1 | 0.2 | * | * | 0.1 | 0.3 | * | * |
| Methamphetamine | 0.3 | 0.5 | 1.2 | 1.7 | 2.4 | 3.9 | 0.9 | 1.2 | 0.2 | 0.2 |
| Prescription Psychotherapeutics2 | 2.6 | 2.9 | 9.0 | 11.2 | 17.6 | 19.3 | 7.2 | 9.0 | 1.5 | 1.5 |
| Pain Relievers2 | 2.1 | 2.4 | 6.8 | 9.0 | 11.8 | 14.2 | 5.8 | 7.5 | 1.3 | 1.3 |
| Stimulants2 | 0.1 | 0.2 | 0.6 | 1.3 | 0.3 | 1.9 | 0.7 | 1.1 | 0.0 | 0.0 |
| Tranquilizers or Sedatives2 | 0.7 | 0.7 | 2.9 | 3.6 | 9.6 | 7.7 | 1.5 | 2.5 | 0.3 | 0.3 |
| Tranquilizers2 | 0.4 | 0.6 | 1.9 | 2.8 | 7.6 | 5.4 | 0.8a | 2.1 | 0.2 | 0.2 |
| Sedatives2 | 0.4 | 0.3 | 1.6 | 1.3 | 5.3 | 3.7 | 0.8 | 0.7 | 0.2 | 0.1 |
| Opioids2 | 2.3 | 2.5 | 7.3 | 9.2 | 11.8 | 14.5 | 6.3 | 7.8 | 1.4 | 1.4 |
| Central Nervous System Stimulants2 | 0.9 | 0.9 | 3.3 | 3.9 | 5.1 | 8.6 | 3.0 | 2.6 | 0.4 | 0.4 |
| ALCOHOL | 7.5 | 7.1 | 14.7 | 13.1 | 22.6 | 17.9 | 13.0 | 11.8 | 6.3 | 6.2 |
| BOTH DRUGS AND ALCOHOL2 | 1.0 | 1.0 | 4.1 | 4.4 | 9.0 | 10.8 | 3.1 | 2.7 | 0.5 | 0.4 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)2 | 3.8 | 4.3 | 10.4a | 14.7 | 16.8 | 24.9 | 9.1 | 12.0 | 2.7 | 2.7 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)2 | 6.5 | 6.1 | 10.5 | 8.7 | 13.6 | 7.0 | 9.9 | 9.1 | 5.8 | 5.7 |
| NO SUBSTANCE USE DISORDER2 | 88.6 | 88.5 | 74.9 | 72.2 | 60.6 | 57.3 | 77.9 | 76.2 | 91.1 | 91.2 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 2 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Substance Use Disorder Status | Aged 50+ (2021) |
Aged 50+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 118,053 | 118,927 | 5,301 | 5,510 | 3,494 | 3,695 | 112,752 | 113,417 |
| DRUGS OR ALCOHOL1 | 13,413 | 13,639 | 1,512 | 1,995 | 1,237 | 1,517 | 11,901 | 11,644 |
| DRUGS1 | 5,713 | 6,338 | 910a | 1,545 | 780 | 1,235 | 4,803 | 4,793 |
| Marijuana | 2,204 | 2,659 | 263a | 650 | 215a | 540 | 1,941 | 2,009 |
| Cocaine | 454 | 382 | 108 | 135 | 108 | 96 | 346 | 247 |
| Heroin | 385 | 196 | * | 37 | * | 33 | 321 | 159 |
| Hallucinogens | 89 | 63 | * | 12 | * | 1 | 89 | 52 |
| Inhalants | 18 | 35 | 3 | * | 3 | * | 14 | 35 |
| Methamphetamine | 395 | 536 | 41 | 167 | 24 | 137 | 354 | 369 |
| Prescription Psychotherapeutics1 | 3,122 | 3,406 | 595 | 776 | 520 | 623 | 2,526 | 2,630 |
| Pain Relievers1 | 2,477 | 2,815 | 438 | 572 | 365 | 489 | 2,039 | 2,244 |
| Stimulants1 | 158 | 231 | 15 | 54 | 15 | 42 | 143 | 177 |
| Tranquilizers or Sedatives1 | 800 | 885 | 255 | 286 | 236 | 173 | 545 | 600 |
| Tranquilizers1 | 521 | 672 | 192 | 184 | 177 | 116 | 329 | 488 |
| Sedatives1 | 459 | 305 | 160 | 133 | 155 | 66 | 299 | 172 |
| Opioids1 | 2,672 | 2,947 | 440 | 585 | 366 | 502 | 2,232 | 2,362 |
| Central Nervous System Stimulants1 | 1,004 | 1,039 | 161 | 324 | 144 | 243 | 843 | 714 |
| ALCOHOL | 8,896 | 8,481 | 848 | 861 | 667 | 616 | 8,048 | 7,620 |
| BOTH DRUGS AND ALCOHOL1 | 1,196 | 1,180 | 245 | 410 | 210 | 335 | 951 | 770 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 4,517 | 5,158 | 664a | 1,134 | 570 | 901 | 3,853 | 4,024 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 7,700 | 7,301 | 602 | 450 | 457 | 281 | 7,098 | 6,851 |
| NO SUBSTANCE USE DISORDER1 | 104,640 | 105,288 | 3,789 | 3,514 | 2,257 | 2,178 | 100,851 | 101,773 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Substance Use Disorder Status | Aged 50+ (2021) |
Aged 50+ (2022) |
Had MDE (2021) |
Had MDE (2022) |
Had MDE with Severe Impairment (2021) |
Had MDE with Severe Impairment (2022) |
No MDE (2021) |
No MDE (2022) |
|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| DRUGS OR ALCOHOL1 | 11.4 | 11.5 | 28.5 | 36.2 | 35.4 | 41.0 | 10.6 | 10.3 |
| DRUGS1 | 4.8 | 5.3 | 17.2b | 28.0 | 22.3a | 33.4 | 4.3 | 4.2 |
| Marijuana | 1.9 | 2.2 | 5.0a | 11.8 | 6.2a | 14.6 | 1.7 | 1.8 |
| Cocaine | 0.4 | 0.3 | 2.0 | 2.5 | 3.1 | 2.6 | 0.3 | 0.2 |
| Heroin | 0.3 | 0.2 | * | 0.7 | * | 0.9 | 0.3 | 0.1 |
| Hallucinogens | 0.1 | 0.1 | * | 0.2 | * | 0.0 | 0.1 | 0.0 |
| Inhalants | 0.0 | 0.0 | 0.1 | * | 0.1 | * | 0.0 | 0.0 |
| Methamphetamine | 0.3 | 0.5 | 0.8 | 3.0 | 0.7 | 3.7 | 0.3 | 0.3 |
| Prescription Psychotherapeutics1 | 2.6 | 2.9 | 11.2 | 14.1 | 14.9 | 16.9 | 2.2 | 2.3 |
| Pain Relievers1 | 2.1 | 2.4 | 8.3 | 10.4 | 10.5 | 13.2 | 1.8 | 2.0 |
| Stimulants1 | 0.1 | 0.2 | 0.3 | 1.0 | 0.4 | 1.1 | 0.1 | 0.2 |
| Tranquilizers or Sedatives1 | 0.7 | 0.7 | 4.8 | 5.2 | 6.8 | 4.7 | 0.5 | 0.5 |
| Tranquilizers1 | 0.4 | 0.6 | 3.6 | 3.3 | 5.1 | 3.1 | 0.3 | 0.4 |
| Sedatives1 | 0.4 | 0.3 | 3.0 | 2.4 | 4.4 | 1.8 | 0.3 | 0.2 |
| Opioids1 | 2.3 | 2.5 | 8.3 | 10.6 | 10.5 | 13.6 | 2.0 | 2.1 |
| Central Nervous System Stimulants1 | 0.9 | 0.9 | 3.0 | 5.9 | 4.1 | 6.6 | 0.7 | 0.6 |
| ALCOHOL | 7.5 | 7.1 | 16.0 | 15.6 | 19.1 | 16.7 | 7.1 | 6.7 |
| BOTH DRUGS AND ALCOHOL1 | 1.0 | 1.0 | 4.6 | 7.4 | 6.0 | 9.1 | 0.8 | 0.7 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 3.8 | 4.3 | 12.5a | 20.6 | 16.3 | 24.4 | 3.4 | 3.5 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 6.5 | 6.1 | 11.4 | 8.2 | 13.1 | 7.6 | 6.3 | 6.0 |
| NO SUBSTANCE USE DISORDER1 | 88.6 | 88.5 | 71.5 | 63.8 | 64.6 | 59.0 | 89.4 | 89.7 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Age Category | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 12,521 | 13,200 | 3,624 | 3,753 | 1,811 | 1,623 |
| 18-25 | 4,497 | 4,746 | 1,737 | 1,714 | 947 | 728 |
| 18-20 | 1,863 | 1,958 | 846 | 788 | 494a | 329 |
| 21-25 | 2,634 | 2,788 | 892 | 926 | 453 | 399 |
| 26 or Older | 8,024 | 8,453 | 1,886 | 2,040 | 864 | 895 |
| 26-49 | 5,629 | 5,629 | 1,482 | 1,372 | 676 | 485 |
| 26-29 | 1,539 | 1,403 | 296 | 383 | 177 | 178 |
| 30-34 | 1,415 | 1,502 | 305 | 416 | 109 | 150 |
| 35-39 | 1,163 | 1,173 | 334 | 219 | 121 | 50 |
| 40-44 | 807 | 933 | 307 | 228 | 125 | 75 |
| 45-49 | 705 | 619 | 240 | 126 | 144a | 32 |
| 50 or Older | 2,395 | 2,824 | 405 | 667 | 188 | 410 |
| 50-54 | 746 | 687 | 77 | 111 | 37 | 101 |
| 55-59 | 425a | 780 | 84a | 269 | 10a | 92 |
| 60-64 | 464 | 703 | 146 | 141 | 25 | 146 |
| 65 or Older | 761 | 654 | 98 | 146 | 116 | 70 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Age Category | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 4.9 | 5.2 | 1.4 | 1.5 | 0.7 | 0.6 |
| 18-25 | 13.4 | 13.6 | 5.2 | 4.9 | 2.8a | 2.1 |
| 18-20 | 14.3 | 15.1 | 6.5 | 6.1 | 3.8a | 2.5 |
| 21-25 | 12.9 | 12.8 | 4.4 | 4.2 | 2.2 | 1.8 |
| 26 or Older | 3.6 | 3.8 | 0.9 | 0.9 | 0.4 | 0.4 |
| 26-49 | 5.5 | 5.5 | 1.4 | 1.3 | 0.7 | 0.5 |
| 26-29 | 8.8 | 8.2 | 1.7 | 2.2 | 1.0 | 1.0 |
| 30-34 | 6.2 | 6.5 | 1.3 | 1.8 | 0.5 | 0.6 |
| 35-39 | 5.2 | 5.3 | 1.5 | 1.0 | 0.5 | 0.2 |
| 40-44 | 4.0 | 4.5 | 1.5 | 1.1 | 0.6 | 0.4 |
| 45-49 | 3.6 | 3.2 | 1.2 | 0.6 | 0.7a | 0.2 |
| 50 or Older | 2.0 | 2.4 | 0.3 | 0.6 | 0.2 | 0.3 |
| 50-54 | 3.8 | 3.5 | 0.4 | 0.6 | 0.2 | 0.5 |
| 55-59 | 2.0a | 3.9 | 0.4a | 1.3 | 0.0a | 0.5 |
| 60-64 | 2.1 | 3.1 | 0.7 | 0.6 | 0.1 | 0.6 |
| 65 or Older | 1.4 | 1.2 | 0.2 | 0.3 | 0.2 | 0.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 12,521 | 13,200 | 4,497 | 4,746 | 8,024 | 8,453 | 5,629 | 5,629 | 2,395 | 2,824 |
| GENDER | ||||||||||
| Male | 5,572 | 6,269 | 1,735a | 2,101 | 3,837 | 4,168 | 2,746 | 2,867 | 1,091 | 1,301 |
| Female | 6,949 | 6,930 | 2,762 | 2,645 | 4,188 | 4,285 | 2,883 | 2,762 | 1,304 | 1,523 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 10,408 | 11,151 | 3,489 | 3,802 | 6,919 | 7,349 | 4,839 | 4,753 | 2,081 | 2,596 |
| AIAN | 133 | 87 | * | 46 | 53 | 41 | 43 | 33 | * | 8 |
| Asian | 379 | 520 | 146b | 366 | 233 | 154 | 183 | 127 | 50 | 26 |
| Black or African American | 1,423 | 1,702 | 526 | 578 | 897 | 1,123 | 705 | 781 | 193 | 342 |
| NHOPI | 69 | * | * | * | 44 | * | * | * | * | * |
| White | 8,015 | 8,290 | 2,562 | 2,643 | 5,452 | 5,647 | 3,670 | 3,545 | 1,782 | 2,102 |
| Two or More Races | 390 | 471 | 150 | 166 | 239 | 304 | 195 | 239 | 44 | * |
| Hispanic or Latino | 2,114 | 2,049 | 1,008 | 944 | 1,105 | 1,104 | 791 | 877 | 315 | 228 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 5,079 | 5,506 | 1,677 | 1,817 | 3,403 | 3,689 | 2,611 | 3,109 | 791 | 580 |
| Part-Time | 2,204 | 2,584 | 1,222 | 1,336 | 983 | 1,248 | 785 | 774 | 198a | 474 |
| Unemployed | 1,391b | 962 | 586 | 422 | 805a | 541 | 586 | 459 | 218 | 81 |
| Other1 | 3,846 | 4,148 | 1,012 | 1,172 | 2,834 | 2,975 | 1,647 | 1,287 | 1,187 | 1,688 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 4.9 | 5.2 | 13.4 | 13.6 | 3.6 | 3.8 | 5.5 | 5.5 | 2.0 | 2.4 |
| GENDER | ||||||||||
| Male | 4.5 | 5.0 | 10.4 | 12.0 | 3.6 | 3.9 | 5.4 | 5.6 | 1.9 | 2.3 |
| Female | 5.3 | 5.3 | 16.5 | 15.3 | 3.7 | 3.8 | 5.6 | 5.4 | 2.1 | 2.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 4.9 | 5.3 | 13.6 | 14.3 | 3.7 | 4.0 | 6.0 | 5.9 | 2.0 | 2.5 |
| AIAN | 8.1 | 7.0 | * | 22.1 | 4.1 | 4.0 | 7.4 | 5.9 | * | 1.7 |
| Asian | 2.5 | 3.4 | 7.5b | 16.1 | 1.8 | 1.2 | 2.5 | 1.7 | 0.9 | 0.5 |
| Black or African American | 4.6 | 5.5 | 11.6 | 12.4 | 3.4 | 4.3 | 5.3 | 5.8 | 1.5 | 2.7 |
| NHOPI | 6.8 | * | * | * | 5.3 | * | * | * | * | * |
| White | 5.1 | 5.2 | 14.5 | 14.5 | 3.9 | 4.0 | 6.4 | 6.2 | 2.1 | 2.5 |
| Two or More Races | 8.5 | 9.3 | 16.2 | 16.6 | 6.6 | 7.5 | 9.6 | 10.9 | 2.8 | * |
| Hispanic or Latino | 4.9 | 4.6 | 12.9 | 11.4 | 3.1 | 3.1 | 3.7 | 4.1 | 2.2 | 1.6 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 4.4 | 4.7 | 13.2 | 12.9 | 3.3 | 3.5 | 4.1 | 4.7 | 2.1 | 1.5 |
| Part-Time | 7.3 | 7.9 | 15.0 | 15.2 | 4.4 | 5.2 | 7.6 | 6.9 | 1.7a | 3.7 |
| Unemployed | 10.6 | 8.7 | 18.5a | 13.1 | 8.1 | 6.9 | 9.1 | 9.1 | 6.3 | 2.9 |
| Other1 | 4.0 | 4.4 | 10.8a | 13.5 | 3.3 | 3.5 | 7.7 | 6.4 | 1.8 | 2.6 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 3,624 | 3,753 | 1,737 | 1,714 | 1,886 | 2,040 | 1,482 | 1,372 | 405 | 667 |
| GENDER | ||||||||||
| Male | 1,639 | 1,678 | 674 | 717 | 964 | 961 | 752 | 671 | 212 | 290 |
| Female | 1,985 | 2,075 | 1,063 | 997 | 922 | 1,078 | 729 | 701 | 193a | 377 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 2,881 | 3,126 | 1,288 | 1,366 | 1,593 | 1,760 | 1,201 | 1,170 | 392 | 590 |
| AIAN | * | 31 | * | 18 | 7 | 12 | 7 | 8 | * | 5 |
| Asian | 134 | 128 | 56 | 63 | 78 | 65 | 70 | 53 | 8 | 12 |
| Black or African American | 359 | 542 | 187 | 189 | 172a | 353 | 164 | 194 | 8b | 159 |
| NHOPI | 6 | 2 | * | * | * | 0 | * | 0 | * | * |
| White | 2,236 | 2,276 | 946 | 1,013 | 1,290 | 1,262 | 940 | 863 | 349 | 399 |
| Two or More Races | 115 | 148 | 69 | 80 | 47 | 67 | 20 | 52 | * | 15 |
| Hispanic or Latino | 743 | 627 | 449 | 348 | 293 | 279 | 281 | 202 | 13 | 77 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 1,233 | 1,385 | 619 | 587 | 614 | 797 | 546 | 689 | 68 | 108 |
| Part-Time | 655 | 857 | 403 | 499 | 252 | 359 | 250 | 182 | 2b | 176 |
| Unemployed | 527a | 348 | 346a | 177 | 181 | 170 | 150 | 138 | 31 | 32 |
| Other1 | 1,209 | 1,163 | 370 | 450 | 839 | 713 | 535 | 362 | 304 | 351 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 1.4 | 1.5 | 5.2 | 4.9 | 0.9 | 0.9 | 1.4 | 1.3 | 0.3 | 0.6 |
| GENDER | ||||||||||
| Male | 1.3 | 1.3 | 4.0 | 4.1 | 0.9 | 0.9 | 1.5 | 1.3 | 0.4 | 0.5 |
| Female | 1.5 | 1.6 | 6.4 | 5.8 | 0.8 | 0.9 | 1.4 | 1.4 | 0.3a | 0.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1.4 | 1.5 | 5.0 | 5.1 | 0.9 | 0.9 | 1.5 | 1.4 | 0.4 | 0.6 |
| AIAN | * | 2.5 | * | 8.7 | 0.5 | 1.2 | 1.2 | 1.4 | * | 0.9 |
| Asian | 0.9 | 0.8 | 2.9 | 2.8 | 0.6 | 0.5 | 0.9 | 0.7 | 0.1 | 0.2 |
| Black or African American | 1.2 | 1.8 | 4.1 | 4.1 | 0.7a | 1.3 | 1.2 | 1.4 | 0.1b | 1.2 |
| NHOPI | 0.6 | 0.1 | * | * | * | 0.0 | * | 0.0 | * | * |
| White | 1.4 | 1.4 | 5.3 | 5.6 | 0.9 | 0.9 | 1.6 | 1.5 | 0.4 | 0.5 |
| Two or More Races | 2.5 | 2.9 | 7.4 | 8.0 | 1.3 | 1.7 | 1.0 | 2.4 | * | 0.8 |
| Hispanic or Latino | 1.7 | 1.4 | 5.7 | 4.2 | 0.8 | 0.8 | 1.3 | 0.9 | 0.1 | 0.5 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 1.1 | 1.2 | 4.9 | 4.2 | 0.6 | 0.8 | 0.9 | 1.0 | 0.2 | 0.3 |
| Part-Time | 2.2 | 2.6 | 4.9 | 5.7 | 1.1 | 1.5 | 2.4 | 1.6 | 0.0b | 1.4 |
| Unemployed | 4.0 | 3.2 | 10.9b | 5.5 | 1.8 | 2.2 | 2.3 | 2.7 | 0.9 | 1.1 |
| Other1 | 1.3 | 1.2 | 3.9 | 5.2 | 1.0 | 0.8 | 2.5 | 1.8 | 0.5 | 0.5 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 1,811 | 1,623 | 947 | 728 | 864 | 895 | 676 | 485 | 188 | 410 |
| GENDER | ||||||||||
| Male | 771 | 748 | 327 | 297 | 444 | 451 | 390 | 268 | 54 | 183 |
| Female | 1,040 | 875 | 620a | 431 | 420 | 444 | 286 | 217 | 134 | 227 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 1,306 | 1,377 | 647 | 552 | 659 | 826 | 475 | 426 | 184 | 400 |
| AIAN | 20 | 19 | * | 16 | 5 | 3 | 5 | 3 | * | * |
| Asian | 53 | 36 | 37 | 14 | 16 | 22 | 16 | 15 | * | 7 |
| Black or African American | 294 | 289 | 160 | 117 | 134 | 172 | 132 | 134 | 2 | 38 |
| NHOPI | 8 | 1 | * | * | 1 | 0 | * | 0 | * | * |
| White | 887 | 956 | 406 | 356 | 481 | 600 | 323 | 245 | 158 | 355 |
| Two or More Races | 45 | 76 | 22 | 48 | * | 28 | 0b | 28 | * | * |
| Hispanic or Latino | 505b | 245 | 300a | 176 | 205a | 69 | 201a | 59 | 4 | 10 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 603 | 468 | 331 | 223 | 272 | 245 | 253 | 219 | 19 | 25 |
| Part-Time | 308 | 264 | 224 | 167 | 85 | 97 | 85 | 51 | * | 46 |
| Unemployed | 260 | 182 | 161 | 104 | 99 | 79 | 91 | 74 | 8 | 4 |
| Other1 | 639 | 709 | 231 | 235 | 407 | 474 | 246 | 140 | 161 | 334 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 0.7 | 0.6 | 2.8a | 2.1 | 0.4 | 0.4 | 0.7 | 0.5 | 0.2 | 0.3 |
| GENDER | ||||||||||
| Male | 0.6 | 0.6 | 2.0 | 1.7 | 0.4 | 0.4 | 0.8 | 0.5 | 0.1 | 0.3 |
| Female | 0.8 | 0.7 | 3.7a | 2.5 | 0.4 | 0.4 | 0.6 | 0.4 | 0.2 | 0.4 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 0.6 | 0.6 | 2.5 | 2.1 | 0.4 | 0.4 | 0.6 | 0.5 | 0.2 | 0.4 |
| AIAN | 1.2 | 1.5 | * | 7.4 | 0.4 | 0.3 | 0.8 | 0.6 | * | * |
| Asian | 0.4 | 0.2 | 1.9 | 0.6 | 0.1 | 0.2 | 0.2 | 0.2 | * | 0.1 |
| Black or African American | 1.0 | 0.9 | 3.5 | 2.5 | 0.5 | 0.7 | 1.0 | 1.0 | 0.0 | 0.3 |
| NHOPI | 0.8 | 0.1 | * | * | 0.2 | 0.0 | * | 0.0 | * | * |
| White | 0.6 | 0.6 | 2.3 | 1.9 | 0.3 | 0.4 | 0.6 | 0.4 | 0.2 | 0.4 |
| Two or More Races | 1.0 | 1.5 | 2.3 | 4.8 | * | 0.7 | 0.0b | 1.3 | * | * |
| Hispanic or Latino | 1.2b | 0.6 | 3.8a | 2.1 | 0.6a | 0.2 | 0.9a | 0.3 | 0.0 | 0.1 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 0.5 | 0.4 | 2.6a | 1.6 | 0.3 | 0.2 | 0.4 | 0.3 | 0.1 | 0.1 |
| Part-Time | 1.0 | 0.8 | 2.7 | 1.9 | 0.4 | 0.4 | 0.8 | 0.5 | * | 0.4 |
| Unemployed | 2.0 | 1.7 | 5.1 | 3.2 | 1.0 | 1.0 | 1.4 | 1.5 | 0.2 | 0.2 |
| Other1 | 0.7 | 0.8 | 2.5 | 2.7 | 0.5 | 0.6 | 1.2 | 0.7 | 0.2 | 0.5 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 12,521 | 13,200 | 4,497 | 4,746 | 8,024 | 8,453 | 5,629 | 5,629 | 2,395 | 2,824 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 1,703 | 2,087 | 706 | 720 | 997 | 1,367 | 793 | 897 | 204a | 470 |
| Midwest | 2,874 | 2,875 | 1,010 | 978 | 1,864 | 1,897 | 1,356 | 1,219 | 508 | 678 |
| South | 4,649 | 4,691 | 1,616 | 1,744 | 3,032 | 2,947 | 2,198 | 2,032 | 834 | 915 |
| West | 3,296 | 3,546 | 1,165 | 1,304 | 2,131 | 2,242 | 1,282 | 1,482 | 849 | 761 |
| COUNTY TYPE | ||||||||||
| Large Metro | 6,293 | 6,441 | 2,345 | 2,368 | 3,948 | 4,073 | 2,784 | 2,788 | 1,163 | 1,284 |
| Small Metro | 4,173 | 4,828 | 1,515 | 1,753 | 2,658 | 3,075 | 1,925 | 2,056 | 733 | 1,019 |
| Nonmetro | 2,055 | 1,931 | 637 | 625 | 1,418 | 1,306 | 920 | 785 | 499 | 521 |
| Urbanized | 829 | 849 | 306 | 321 | 523 | 528 | 348 | 326 | 175 | 202 |
| Less Urbanized | 1,031 | 923 | 279 | 288 | 752 | 635 | 519 | 400 | 232 | 235 |
| Completely Rural | 195 | 159 | 52 | * | 144 | 143 | 52 | 59 | 92 | * |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 2,782 | 2,786 | 1,084 | 1,049 | 1,697 | 1,737 | 1,223 | 1,149 | 475 | 588 |
| 100-199% | 2,881 | 3,309 | 1,289 | 1,269 | 1,593 | 2,041 | 1,232 | 1,211 | 360a | 830 |
| 200% or More | 6,855 | 7,104 | 2,121 | 2,428 | 4,734 | 4,676 | 3,174 | 3,270 | 1,560 | 1,406 |
| EDUCATION LEVEL | ||||||||||
| < High School | 1,171 | 1,185 | 533 | 553 | 637 | 633 | 403 | 362 | 235 | 271 |
| High School Graduate | 3,208a | 3,931 | 1,500 | 1,702 | 1,709 | 2,228 | 1,146 | 1,449 | 563 | 780 |
| Some College/Associate’s Degree | 5,101 | 4,986 | 2,018 | 1,934 | 3,083 | 3,052 | 2,252 | 2,039 | 831 | 1,013 |
| College Graduate | 3,041 | 3,097 | 446 | 557 | 2,596 | 2,540 | 1,829 | 1,780 | 767 | 760 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 6,374 | 6,988 | 2,536 | 2,780 | 3,839 | 4,208 | 2,602 | 2,886 | 1,237 | 1,322 |
| Medicaid/CHIP | 3,166b | 4,009 | 1,176 | 1,328 | 1,990a | 2,681 | 1,452a | 1,878 | 538 | 803 |
| Other3 | 2,512 | 2,108 | 424 | 357 | 2,088 | 1,751 | 976b | 545 | 1,112 | 1,206 |
| No Coverage | 1,803 | 1,521 | 573 | 567 | 1,230 | 954 | 1,049a | 736 | 181 | 218 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Geographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 4.9 | 5.2 | 13.4 | 13.6 | 3.6 | 3.8 | 5.5 | 5.5 | 2.0 | 2.4 |
| GEOGRAPHIC REGION | ||||||||||
| Northeast | 3.8 | 4.6 | 12.3 | 12.2 | 2.6 | 3.5 | 4.6 | 5.2 | 0.9a | 2.2 |
| Midwest | 5.5 | 5.4 | 14.2 | 13.4 | 4.1 | 4.2 | 6.6 | 5.9 | 2.0 | 2.7 |
| South | 4.8 | 4.8 | 12.7 | 13.1 | 3.6 | 3.5 | 5.6 | 5.2 | 1.9 | 2.0 |
| West | 5.5 | 5.9 | 14.7 | 15.8 | 4.1 | 4.3 | 5.0 | 5.8 | 3.2 | 2.8 |
| COUNTY TYPE | ||||||||||
| Large Metro | 4.6 | 4.6 | 13.3 | 12.4 | 3.3 | 3.3 | 4.8 | 4.7 | 1.9 | 2.0 |
| Small Metro | 5.4 | 5.9 | 13.8 | 15.0 | 4.0 | 4.4 | 6.3 | 6.3 | 2.0 | 2.7 |
| Nonmetro | 5.2 | 5.7 | 13.2 | 15.7 | 4.1 | 4.4 | 6.6 | 7.0 | 2.4 | 2.8 |
| Urbanized | 5.7 | 6.0 | 15.1 | 18.2 | 4.1 | 4.2 | 6.7 | 6.7 | 2.4 | 2.7 |
| Less Urbanized | 5.0 | 5.4 | 11.9 | 14.6 | 4.1 | 4.2 | 7.0 | 7.2 | 2.2 | 2.5 |
| Completely Rural | 4.7 | 6.2 | 11.1 | * | 3.9 | 6.1 | 3.7 | 6.7 | 4.0 | * |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 7.3 | 7.7 | 12.8 | 13.0 | 5.8 | 6.2 | 7.9 | 7.6 | 3.4 | 4.5 |
| 100-199% | 5.7 | 6.6 | 16.1 | 15.0 | 3.7 | 4.9 | 6.1 | 6.3 | 1.6a | 3.8 |
| 200% or More | 4.2 | 4.2 | 12.6 | 13.3 | 3.2 | 3.1 | 4.8 | 4.8 | 1.9 | 1.7 |
| EDUCATION LEVEL | ||||||||||
| < High School | 4.1 | 4.9 | 14.5 | 15.4 | 2.6 | 3.0 | 4.1 | 4.6 | 1.6 | 2.1 |
| High School Graduate | 4.6a | 5.7 | 14.2 | 14.7 | 2.9a | 3.9 | 4.7 | 6.2 | 1.6 | 2.3 |
| Some College/Associate’s Degree | 6.6 | 6.4 | 14.3 | 13.9 | 4.9 | 4.8 | 7.5 | 6.8 | 2.5 | 3.0 |
| College Graduate | 3.9 | 3.6 | 8.8 | 9.8 | 3.5 | 3.2 | 4.7 | 4.3 | 2.2 | 2.0 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 4.1 | 4.5 | 13.4 | 14.0 | 2.8 | 3.1 | 4.2 | 4.5 | 1.7 | 1.8 |
| Medicaid/CHIP | 6.7b | 8.3 | 13.5 | 14.3 | 5.1a | 6.9 | 6.6a | 8.6 | 3.2 | 4.7 |
| Other3 | 3.3 | 2.7 | 16.7 | 12.7 | 2.9 | 2.4 | 10.7b | 5.9 | 1.7 | 1.9 |
| No Coverage | 7.3 | 6.5 | 11.9 | 12.3 | 6.2 | 5.1 | 7.3 | 5.6 | 3.2 | 4.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic/Socioeconomic Characteristic | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 12,521 | 13,200 | 3,624 | 3,753 | 1,811 | 1,623 |
| AGE GROUP | ||||||
| 18-25 | 4,497 | 4,746 | 1,737 | 1,714 | 947 | 728 |
| 26 or Older | 8,024 | 8,453 | 1,886 | 2,040 | 864 | 895 |
| 26-49 | 5,629 | 5,629 | 1,482 | 1,372 | 676 | 485 |
| 50 or Older | 2,395 | 2,824 | 405 | 667 | 188 | 410 |
| GENDER | ||||||
| Male | 5,572 | 6,269 | 1,639 | 1,678 | 771 | 748 |
| Female | 6,949 | 6,930 | 1,985 | 2,075 | 1,040 | 875 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 10,408 | 11,151 | 2,881 | 3,126 | 1,306 | 1,377 |
| AIAN | 133 | 87 | * | 31 | 20 | 19 |
| Asian | 379 | 520 | 134 | 128 | 53 | 36 |
| Black or African American | 1,423 | 1,702 | 359 | 542 | 294 | 289 |
| NHOPI | 69 | * | 6 | 2 | 8 | 1 |
| White | 8,015 | 8,290 | 2,236 | 2,276 | 887 | 956 |
| Two or More Races | 390 | 471 | 115 | 148 | 45 | 76 |
| Hispanic or Latino | 2,114 | 2,049 | 743 | 627 | 505b | 245 |
| HEALTH INSURANCE1 | ||||||
| Private | 6,374 | 6,988 | 1,570a | 1,962 | 711 | 641 |
| Medicaid/CHIP | 3,166b | 4,009 | 1,221 | 1,283 | 644 | 732 |
| Other2 | 2,512 | 2,108 | 627 | 521 | 379 | 338 |
| No Coverage | 1,803 | 1,521 | 629a | 407 | 251 | 192 |
| EMPLOYMENT STATUS | ||||||
| Full-Time | 5,079 | 5,506 | 1,233 | 1,385 | 603 | 468 |
| Part-Time | 2,204 | 2,584 | 655 | 857 | 308 | 264 |
| Unemployed | 1,391b | 962 | 527a | 348 | 260 | 182 |
| Other3 | 3,846 | 4,148 | 1,209 | 1,163 | 639 | 709 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 3 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Demographic/Socioeconomic Characteristic | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 4.9 | 5.2 | 1.4 | 1.5 | 0.7 | 0.6 |
| AGE GROUP | ||||||
| 18-25 | 13.4 | 13.6 | 5.2 | 4.9 | 2.8a | 2.1 |
| 26 or Older | 3.6 | 3.8 | 0.9 | 0.9 | 0.4 | 0.4 |
| 26-49 | 5.5 | 5.5 | 1.4 | 1.3 | 0.7 | 0.5 |
| 50 or Older | 2.0 | 2.4 | 0.3 | 0.6 | 0.2 | 0.3 |
| GENDER | ||||||
| Male | 4.5 | 5.0 | 1.3 | 1.3 | 0.6 | 0.6 |
| Female | 5.3 | 5.3 | 1.5 | 1.6 | 0.8 | 0.7 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 4.9 | 5.3 | 1.4 | 1.5 | 0.6 | 0.6 |
| AIAN | 8.1 | 7.0 | * | 2.5 | 1.2 | 1.5 |
| Asian | 2.5 | 3.4 | 0.9 | 0.8 | 0.4 | 0.2 |
| Black or African American | 4.6 | 5.5 | 1.2 | 1.8 | 1.0 | 0.9 |
| NHOPI | 6.8 | * | 0.6 | 0.1 | 0.8 | 0.1 |
| White | 5.1 | 5.2 | 1.4 | 1.4 | 0.6 | 0.6 |
| Two or More Races | 8.5 | 9.3 | 2.5 | 2.9 | 1.0 | 1.5 |
| Hispanic or Latino | 4.9 | 4.6 | 1.7 | 1.4 | 1.2b | 0.6 |
| HEALTH INSURANCE1 | ||||||
| Private | 4.1 | 4.5 | 1.0a | 1.3 | 0.5 | 0.4 |
| Medicaid/CHIP | 6.7b | 8.3 | 2.6 | 2.7 | 1.4 | 1.5 |
| Other2 | 3.3 | 2.7 | 0.8 | 0.7 | 0.5 | 0.4 |
| No Coverage | 7.3 | 6.5 | 2.5a | 1.7 | 1.0 | 0.8 |
| EMPLOYMENT STATUS | ||||||
| Full-Time | 4.4 | 4.7 | 1.1 | 1.2 | 0.5 | 0.4 |
| Part-Time | 7.3 | 7.9 | 2.2 | 2.6 | 1.0 | 0.8 |
| Unemployed | 10.6 | 8.7 | 4.0 | 3.2 | 2.0 | 1.7 |
| Other3 | 4.0 | 4.4 | 1.3 | 1.2 | 0.7 | 0.8 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 3 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Demographic/Socioeconomic Characteristic | Attempted Suicide (2021) |
Attempted Suicide (2022) |
Received Medical Attention for Suicide Attempt among People Who Attempted Suicide (2021) |
Received Medical Attention for Suicide Attempt among People Who Attempted Suicide (2022) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among People Who Attempted Suicide (2021) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among People Who Attempted Suicide (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 1,811 | 1,623 | 847 | 832 | 554 | 446 |
| AGE GROUP | ||||||
| 18-25 | 947 | 728 | 373 | 304 | 236 | 160 |
| 26 or Older | 864 | 895 | * | 528 | * | * |
| 26-49 | 676 | 485 | * | * | * | 119 |
| 50 or Older | 188 | 410 | * | * | * | * |
| GENDER | ||||||
| Male | 771 | 748 | * | * | * | * |
| Female | 1,040 | 875 | * | 516 | * | 230 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 1,306 | 1,377 | 699 | 749 | 453 | 389 |
| AIAN | 20 | 19 | * | * | * | * |
| Asian | 53 | 36 | * | * | * | * |
| Black or African American | 294 | 289 | * | * | * | * |
| NHOPI | 8 | 1 | * | * | * | * |
| White | 887 | 956 | * | 570 | * | * |
| Two or More Races | 45 | 76 | * | * | * | * |
| Hispanic or Latino | 505b | 245 | * | * | * | * |
| HEALTH INSURANCE1 | ||||||
| Private | 711 | 641 | 312 | * | * | 147 |
| Medicaid/CHIP | 644 | 732 | * | 407 | * | * |
| Other2 | 379 | 338 | * | * | * | * |
| No Coverage | 251 | 192 | * | * | * | * |
| EMPLOYMENT STATUS | ||||||
| Full-Time | 603 | 468 | * | 152 | * | 67 |
| Part-Time | 308 | 264 | * | * | * | * |
| Unemployed | 260 | 182 | * | * | * | * |
| Other3 | 639 | 709 | * | * | * | * |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 3 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Demographic/Socioeconomic Characteristic | Attempted Suicide (2021) |
Attempted Suicide (2022) |
Received Medical Attention for Suicide Attempt among People Who Attempted Suicide (2021) |
Received Medical Attention for Suicide Attempt among People Who Attempted Suicide (2022) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among People Who Attempted Suicide (2021) |
Stayed Overnight or Longer in a Hospital for Suicide Attempt among People Who Attempted Suicide (2022) |
|---|---|---|---|---|---|---|
| TOTAL | 0.7 | 0.6 | 46.8 | 51.3 | 30.6 | 27.5 |
| AGE GROUP | ||||||
| 18-25 | 2.8a | 2.1 | 39.4 | 41.8 | 24.9 | 22.0 |
| 26 or Older | 0.4 | 0.4 | * | 59.0 | * | * |
| 26-49 | 0.7 | 0.5 | * | * | * | 24.6 |
| 50 or Older | 0.2 | 0.3 | * | * | * | * |
| GENDER | ||||||
| Male | 0.6 | 0.6 | * | * | * | * |
| Female | 0.8 | 0.7 | * | 59.0 | * | 26.3 |
| HISPANIC ORIGIN AND RACE | ||||||
| Not Hispanic or Latino | 0.6 | 0.6 | 53.6 | 54.4 | 34.7 | 28.2 |
| AIAN | 1.2 | 1.5 | * | * | * | * |
| Asian | 0.4 | 0.2 | * | * | * | * |
| Black or African American | 1.0 | 0.9 | * | * | * | * |
| NHOPI | 0.8 | 0.1 | * | * | * | * |
| White | 0.6 | 0.6 | * | 59.6 | * | * |
| Two or More Races | 1.0 | 1.5 | * | * | * | * |
| Hispanic or Latino | 1.2b | 0.6 | * | * | * | * |
| HEALTH INSURANCE1 | ||||||
| Private | 0.5 | 0.4 | 43.9 | * | * | 22.9 |
| Medicaid/CHIP | 1.4 | 1.5 | * | 55.6 | * | * |
| Other2 | 0.5 | 0.4 | * | * | * | * |
| No Coverage | 1.0 | 0.8 | * | * | * | * |
| EMPLOYMENT STATUS | ||||||
| Full-Time | 0.5 | 0.4 | * | 32.4 | * | 14.4 |
| Part-Time | 1.0 | 0.8 | * | * | * | * |
| Unemployed | 2.0 | 1.7 | * | * | * | * |
| Other3 | 0.7 | 0.8 | * | * | * | * |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 2 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 3 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Substance | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 6,487 | 7,307 | 2,047 | 2,313 | 1,182 | 942 |
| Marijuana | 5,526a | 6,532 | 1,712 | 1,993 | 934 | 782 |
| Cocaine | 772 | 806 | 294 | 332 | 199 | 138 |
| Crack | * | * | * | * | * | 51 |
| Heroin | * | 141 | 72 | 65 | 55 | 65 |
| Hallucinogens | 1,374 | 1,531 | 461 | 505 | 268 | 228 |
| LSD | 550 | 569 | 235 | 175 | 136 | 71 |
| PCP | * | * | * | * | * | * |
| Ecstasy | 432 | 348 | 178 | 106 | 122 | 58 |
| Inhalants | 328 | 394 | 121 | 143 | 72 | 58 |
| Methamphetamine | 378 | 514 | 198 | 158 | 141 | 116 |
| Misuse of Prescription Psychotherapeutics | 1,992 | 1,954 | 747 | 745 | 446 | 406 |
| Pain Relievers | 1,128 | 1,178 | 471 | 503 | 327 | 278 |
| Stimulants | 576 | 679 | 223 | 254 | 117 | 155 |
| Tranquilizers or Sedatives | 855 | 856 | 351 | 319 | 209 | 199 |
| Tranquilizers | 774 | 693 | 336 | 258 | 198 | 157 |
| Sedatives | 184 | 217 | 71 | 77 | 41 | 53 |
| Benzodiazepines | 645 | 615 | 296 | 250 | 159 | 132 |
| Opioids1 | 1,272 | 1,260 | 515 | 539 | 362 | 303 |
| Central Nervous System Stimulants | 1,426 | 1,609 | 577 | 590 | 368 | 327 |
| Illicit Drugs Other Than Marijuana1,2 | 3,376 | 3,537 | 1,202 | 1,255 | 736 | 584 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING | -- | 6,402 | -- | 1,960 | -- | 869 |
| Tobacco Products | 4,902 | 4,884 | 1,579 | 1,571 | 890 | 678 |
| Cigarettes | 4,207 | 4,029 | 1,370 | 1,410 | 786 | 604 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 542 | 625 | 203 | 193 | 109 | 91 |
| Cigars | 1,569 | 1,858 | 640 | 553 | 322 | 327 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 3,972 | -- | 1,244 | -- | 639 |
| ALCOHOL | 9,691 | 9,995 | 2,748 | 3,038 | 1,365 | 1,251 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL | -- | 1,304 | -- | 553 | -- | 316 |
| Illegally Made Fentanyl | -- | * | -- | * | -- | 39 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Substance | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 11.1 | 11.0 | 3.5 | 3.5 | 2.0a | 1.4 |
| Marijuana | 11.0 | 11.1 | 3.4 | 3.4 | 1.9a | 1.3 |
| Cocaine | 16.3 | 15.4 | 6.2 | 6.3 | 4.2 | 2.6 |
| Crack | * | * | * | * | * | 5.6 |
| Heroin | * | 13.5 | 6.6 | 6.2 | 5.1 | 6.3 |
| Hallucinogens | 19.1 | 18.8 | 6.4 | 6.2 | 3.7 | 2.8 |
| LSD | 23.9 | 26.4 | 10.2 | 8.1 | 5.9 | 3.3 |
| PCP | * | * | * | * | * | * |
| Ecstasy | 20.2 | 17.0 | 8.4 | 5.2 | 5.7 | 2.8 |
| Inhalants | 22.2 | 23.2 | 8.2 | 8.4 | 4.9 | 3.4 |
| Methamphetamine | 14.5 | 19.1 | 7.6 | 5.9 | 5.4 | 4.3 |
| Misuse of Prescription Psychotherapeutics | 14.6 | 14.4 | 5.5 | 5.5 | 3.3 | 3.0 |
| Pain Relievers | 13.5 | 14.6 | 5.7 | 6.2 | 3.9 | 3.4 |
| Stimulants | 16.0 | 16.7 | 6.2 | 6.2 | 3.2 | 3.8 |
| Tranquilizers or Sedatives | 18.7 | 18.2 | 7.7 | 6.8 | 4.6 | 4.2 |
| Tranquilizers | 19.0 | 17.2 | 8.3 | 6.4 | 4.9 | 3.9 |
| Sedatives | 22.0 | 23.3 | 8.5 | 8.2 | 4.9 | 5.7 |
| Benzodiazepines | 17.3 | 17.2 | 7.9 | 7.0 | 4.3 | 3.7 |
| Opioids1 | 14.3 | 14.8 | 5.8 | 6.3 | 4.1 | 3.6 |
| Central Nervous System Stimulants | 15.8 | 16.2 | 6.4 | 6.0 | 4.1 | 3.3 |
| Illicit Drugs Other Than Marijuana1,2 | 15.4 | 15.2 | 5.5 | 5.4 | 3.4 | 2.5 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING | -- | 8.6 | -- | 2.6 | -- | 1.2 |
| Tobacco Products | 7.3 | 7.8 | 2.4 | 2.5 | 1.3 | 1.1 |
| Cigarettes | 8.0 | 8.2 | 2.6 | 2.9 | 1.5 | 1.2 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 5.5 | 7.7 | 2.1 | 2.4 | 1.1 | 1.1 |
| Cigars | 8.5 | 9.9 | 3.5 | 2.9 | 1.8 | 1.7 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 12.6 | -- | 3.9 | -- | 2.0 |
| ALCOHOL | 5.7 | 5.8 | 1.6 | 1.8 | 0.8 | 0.7 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL | -- | 15.1 | -- | 6.4 | -- | 3.7 |
| Illegally Made Fentanyl | -- | * | -- | * | -- | 5.9 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Substance | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 6,487 | 7,307 | 2,047 | 2,313 | 1,182 | 942 |
| Marijuana | 5,526a | 6,532 | 1,712 | 1,993 | 934 | 782 |
| Cocaine | 772 | 806 | 294 | 332 | 199 | 138 |
| Crack | 182 | 169 | 108 | 89 | 89 | 51 |
| Heroin | 232 | 141 | 72 | 65 | 55 | 65 |
| Hallucinogens | 1,374 | 1,531 | 461 | 505 | 268 | 228 |
| LSD | 550 | 569 | 235 | 175 | 136 | 71 |
| PCP | 32 | 73 | 12 | 2 | 12 | 2 |
| Ecstasy | 432 | 348 | 178 | 106 | 122 | 58 |
| Inhalants | 328 | 394 | 121 | 143 | 72 | 58 |
| Methamphetamine | 378 | 514 | 198 | 158 | 141 | 116 |
| Misuse of Prescription Psychotherapeutics | 1,992 | 1,954 | 747 | 745 | 446 | 406 |
| Pain Relievers | 1,128 | 1,178 | 471 | 503 | 327 | 278 |
| Stimulants | 576 | 679 | 223 | 254 | 117 | 155 |
| Tranquilizers or Sedatives | 855 | 856 | 351 | 319 | 209 | 199 |
| Tranquilizers | 774 | 693 | 336 | 258 | 198 | 157 |
| Sedatives | 184 | 217 | 71 | 77 | 41 | 53 |
| Benzodiazepines | 645 | 615 | 296 | 250 | 159 | 132 |
| Opioids1 | 1,272 | 1,260 | 515 | 539 | 362 | 303 |
| Central Nervous System Stimulants | 1,426 | 1,609 | 577 | 590 | 368 | 327 |
| Illicit Drugs Other Than Marijuana1,2 | 3,376 | 3,537 | 1,202 | 1,255 | 736 | 584 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING | -- | 6,402 | -- | 1,960 | -- | 869 |
| Tobacco Products | 4,902 | 4,884 | 1,579 | 1,571 | 890 | 678 |
| Cigarettes | 4,207 | 4,029 | 1,370 | 1,410 | 786 | 604 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 542 | 625 | 203 | 193 | 109 | 91 |
| Cigars | 1,569 | 1,858 | 640 | 553 | 322 | 327 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 3,972 | -- | 1,244 | -- | 639 |
| ALCOHOL | 9,691 | 9,995 | 2,748 | 3,038 | 1,365 | 1,251 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL | -- | 1,304 | -- | 553 | -- | 316 |
| Illegally Made Fentanyl | -- | 126 | -- | 43 | -- | 39 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Substance | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
|---|---|---|---|---|---|---|
| ILLICIT DRUGS1 | 51.8 | 55.4 | 56.5 | 61.6 | 65.3 | 58.1 |
| Marijuana | 44.1a | 49.5 | 47.2 | 53.1 | 51.6 | 48.2 |
| Cocaine | 6.2 | 6.1 | 8.1 | 8.8 | 11.0 | 8.5 |
| Crack | 1.5 | 1.3 | 3.0 | 2.4 | 4.9 | 3.2 |
| Heroin | 1.9 | 1.1 | 2.0 | 1.7 | 3.1 | 4.0 |
| Hallucinogens | 11.0 | 11.6 | 12.7 | 13.5 | 14.8 | 14.0 |
| LSD | 4.4 | 4.3 | 6.5 | 4.7 | 7.5 | 4.4 |
| PCP | 0.3 | 0.6 | 0.3 | 0.0 | 0.7 | 0.1 |
| Ecstasy | 3.4 | 2.6 | 4.9 | 2.8 | 6.7 | 3.6 |
| Inhalants | 2.6 | 3.0 | 3.3 | 3.8 | 4.0 | 3.6 |
| Methamphetamine | 3.0 | 3.9 | 5.5 | 4.2 | 7.8 | 7.1 |
| Misuse of Prescription Psychotherapeutics | 15.9 | 14.8 | 20.6 | 19.9 | 24.6 | 25.0 |
| Pain Relievers | 9.0 | 8.9 | 13.0 | 13.4 | 18.1 | 17.1 |
| Stimulants | 4.6 | 5.1 | 6.1 | 6.8 | 6.5 | 9.5 |
| Tranquilizers or Sedatives | 6.8 | 6.5 | 9.7 | 8.5 | 11.5 | 12.3 |
| Tranquilizers | 6.2 | 5.2 | 9.3 | 6.9 | 10.9 | 9.7 |
| Sedatives | 1.5 | 1.6 | 1.9 | 2.0 | 2.3 | 3.3 |
| Benzodiazepines | 5.2 | 4.7 | 8.2 | 6.7 | 8.8 | 8.2 |
| Opioids1 | 10.2 | 9.5 | 14.2 | 14.4 | 20.0 | 18.7 |
| Central Nervous System Stimulants | 11.4 | 12.2 | 15.9 | 15.7 | 20.3 | 20.2 |
| Illicit Drugs Other Than Marijuana1,2 | 27.0 | 26.8 | 33.2 | 33.4 | 40.6 | 36.0 |
| TOBACCO PRODUCT USE OR NICOTINE VAPING | -- | 48.5 | -- | 52.2 | -- | 53.5 |
| Tobacco Products | 39.1 | 37.0 | 43.6 | 41.9 | 49.2 | 41.8 |
| Cigarettes | 33.6 | 30.5 | 37.8 | 37.6 | 43.4 | 37.2 |
| Daily Cigarettes | -- | -- | -- | -- | -- | -- |
| Smokeless Tobacco | 4.3 | 4.7 | 5.6 | 5.1 | 6.0 | 5.6 |
| Cigars | 12.5 | 14.1 | 17.7 | 14.7 | 17.8 | 20.1 |
| Pipe Tobacco3 | -- | -- | -- | -- | -- | -- |
| Nicotine Vaping | -- | 30.1 | -- | 33.1 | -- | 39.4 |
| ALCOHOL | 77.4 | 75.7 | 75.8 | 80.9 | 75.4 | 77.1 |
| Binge Alcohol Use | -- | -- | -- | -- | -- | -- |
| Heavy Alcohol Use | -- | -- | -- | -- | -- | -- |
| OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL | -- | 9.9 | -- | 14.7 | -- | 19.5 |
| Illegally Made Fentanyl | -- | 1.0 | -- | 1.1 | -- | 2.4 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 For comparison of estimates between 2021 and 2022, these estimates do not include illegally made fentanyl (IMF). 2 Illicit Drugs Other Than Marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. 3 Information about past year use of pipe tobacco was not collected. Estimates for tobacco product use (as well as estimates for tobacco product use or nicotine vaping) in the past year exclude past year pipe tobacco use, but include past month pipe tobacco use. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Substance Use Disorder Status | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
No Serious Thoughts of Suicide (2021) |
No Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Did Not Make Any Suicide Plans (2021) |
Did Not Make Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
Did Not Attempt Suicide (2021) |
Did Not Attempt Suicide (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 12,521 | 13,200 | 241,303b | 243,082 | 3,624 | 3,753 | 250,201b | 252,528 | 1,811 | 1,623 | 252,014b | 254,659 |
| DRUGS OR ALCOHOL1 | 5,779 | 6,249 | 38,604 | 40,244 | 1,899 | 2,018 | 42,484 | 44,476 | 974 | 927 | 43,409 | 45,567 |
| DRUGS1 | 3,983a | 4,674 | 18,588a | 20,743 | 1,423 | 1,591 | 21,148b | 23,826 | 731 | 680 | 21,840b | 24,737 |
| Marijuana | 2,765a | 3,322 | 12,548b | 14,346 | 960 | 1,083 | 14,353b | 16,585 | 517 | 434 | 14,796b | 17,235 |
| Cocaine | 339 | 308 | 1,092 | 1,121 | 170 | 164 | 1,261 | 1,265 | 134 | 55 | 1,297 | 1,374 |
| Heroin | * | 86 | * | 812 | 32 | 32 | 956 | 866 | 16 | 37 | 972 | 861 |
| Hallucinogens | * | * | * | * | * | * | * | * | * | * | * | * |
| Inhalants | * | * | * | * | * | * | * | * | * | * | * | * |
| Methamphetamine | 302 | 415 | 1,302 | 1,403 | 181 | 137 | 1,423 | 1,681 | 127 | 99 | 1,478 | 1,719 |
| Prescription Psychotherapeutics1 | 1,199 | 1,511 | 5,661 | 6,176 | 559 | 599 | 6,301 | 7,088 | 252 | 342 | 6,608 | 7,345 |
| Pain Relievers1 | 720 | 863 | 4,024 | 4,449 | 379 | 388 | 4,366 | 4,924 | 191 | 258 | 4,554 | 5,054 |
| Stimulants1 | 304 | 404 | 962 | 1,165 | 130 | 129 | 1,136 | 1,440 | 81 | 88 | 1,185 | 1,481 |
| Tranquilizers or Sedatives1 | 541 | 496 | 1,569 | 1,724 | 264 | 227 | 1,846 | 1,994 | 107 | 149 | 2,002 | 2,072 |
| Tranquilizers1 | 480 | 371 | 1,127 | 1,360 | 224 | 188 | 1,383 | 1,542 | 96 | 118 | 1,511 | 1,612 |
| Sedatives1 | * | * | * | * | * | 88 | * | 681 | 48 | 69 | 831 | 701 |
| Opioids1 | 789 | 934 | 4,519 | 4,917 | 391 | 407 | 4,917 | 5,444 | 194 | 274 | 5,114 | 5,578 |
| Central Nervous System Stimulants1 | 832 | 971 | 3,100 | 3,276 | 397 | 370 | 3,534 | 3,877 | 275 | 189 | 3,657 | 4,058 |
| ALCOHOL | 3,331 | 3,402 | 25,438 | 25,386 | 1,075 | 1,173 | 27,694 | 27,615 | 552 | 518 | 28,216 | 28,271 |
| BOTH DRUGS AND ALCOHOL1 | 1,534 | 1,826 | 5,422 | 5,885 | 599 | 746 | 6,358 | 6,965 | 310 | 271 | 6,647 | 7,441 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 2,448 | 2,848 | 13,166a | 14,858 | 824 | 844 | 14,790b | 16,861 | 422 | 409 | 15,193b | 17,296 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 1,797 | 1,576 | 20,016 | 19,501 | 477 | 427 | 21,336 | 20,650 | 243 | 247 | 21,570 | 20,830 |
| NO SUBSTANCE USE DISORDER1 | 6,742 | 6,950 | 202,699 | 202,838 | 1,724 | 1,735 | 207,717 | 208,053 | 837 | 696 | 208,605 | 209,092 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
| Substance Use Disorder Status | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
No Serious Thoughts of Suicide (2021) |
No Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Did Not Make Any Suicide Plans (2021) |
Did Not Make Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
Did Not Attempt Suicide (2021) |
Did Not Attempt Suicide (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 4.9 | 5.2 | 95.1 | 94.8 | 1.4 | 1.5 | 98.6 | 98.5 | 0.7 | 0.6 | 99.3 | 99.4 |
| DRUGS OR ALCOHOL1 | 13.0 | 13.4 | 87.0 | 86.6 | 4.3 | 4.3 | 95.7 | 95.7 | 2.2 | 2.0 | 97.8 | 98.0 |
| DRUGS1 | 17.6 | 18.4 | 82.4 | 81.6 | 6.3 | 6.3 | 93.7 | 93.7 | 3.2 | 2.7 | 96.8 | 97.3 |
| Marijuana | 18.1 | 18.8 | 81.9 | 81.2 | 6.3 | 6.1 | 93.7 | 93.9 | 3.4 | 2.5 | 96.6 | 97.5 |
| Cocaine | 23.7 | 21.6 | 76.3 | 78.4 | 11.9 | 11.5 | 88.1 | 88.5 | 9.4 | 3.9 | 90.6 | 96.1 |
| Heroin | * | 9.6 | * | 90.4 | 3.3 | 3.6 | 96.7 | 96.4 | 1.6 | 4.2 | 98.4 | 95.8 |
| Hallucinogens | * | * | * | * | * | * | * | * | * | * | * | * |
| Inhalants | * | * | * | * | * | * | * | * | * | * | * | * |
| Methamphetamine | 18.8 | 22.8 | 81.2 | 77.2 | 11.3 | 7.6 | 88.7 | 92.4 | 7.9 | 5.4 | 92.1 | 94.6 |
| Prescription Psychotherapeutics1 | 17.5 | 19.7 | 82.5 | 80.3 | 8.2 | 7.8 | 91.8 | 92.2 | 3.7 | 4.5 | 96.3 | 95.5 |
| Pain Relievers1 | 15.2 | 16.2 | 84.8 | 83.8 | 8.0 | 7.3 | 92.0 | 92.7 | 4.0 | 4.9 | 96.0 | 95.1 |
| Stimulants1 | 24.0 | 25.8 | 76.0 | 74.2 | 10.3 | 8.2 | 89.7 | 91.8 | 6.4 | 5.6 | 93.6 | 94.4 |
| Tranquilizers or Sedatives1 | 25.6 | 22.4 | 74.4 | 77.6 | 12.5 | 10.2 | 87.5 | 89.8 | 5.1 | 6.7 | 94.9 | 93.3 |
| Tranquilizers1 | 29.9 | 21.4 | 70.1 | 78.6 | 14.0 | 10.9 | 86.0 | 89.1 | 6.0 | 6.8 | 94.0 | 93.2 |
| Sedatives1 | * | * | * | * | * | 11.5 | * | 88.5 | 5.5 | 8.9 | 94.5 | 91.1 |
| Opioids1 | 14.9 | 16.0 | 85.1 | 84.0 | 7.4 | 7.0 | 92.6 | 93.0 | 3.7 | 4.7 | 96.3 | 95.3 |
| Central Nervous System Stimulants1 | 21.2 | 22.9 | 78.8 | 77.1 | 10.1 | 8.7 | 89.9 | 91.3 | 7.0 | 4.5 | 93.0 | 95.5 |
| ALCOHOL | 11.6 | 11.8 | 88.4 | 88.2 | 3.7 | 4.1 | 96.3 | 95.9 | 1.9 | 1.8 | 98.1 | 98.2 |
| BOTH DRUGS AND ALCOHOL1 | 22.1 | 23.7 | 77.9 | 76.3 | 8.6 | 9.7 | 91.4 | 90.3 | 4.5 | 3.5 | 95.5 | 96.5 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 15.7 | 16.1 | 84.3 | 83.9 | 5.3 | 4.8 | 94.7 | 95.2 | 2.7 | 2.3 | 97.3 | 97.7 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 8.2 | 7.5 | 91.8 | 92.5 | 2.2 | 2.0 | 97.8 | 98.0 | 1.1 | 1.2 | 98.9 | 98.8 |
| NO SUBSTANCE USE DISORDER1 | 3.2 | 3.3 | 96.8 | 96.7 | 0.8 | 0.8 | 99.2 | 99.2 | 0.4 | 0.3 | 99.6 | 99.7 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
| Substance Use Disorder Status | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
No Serious Thoughts of Suicide (2021) |
No Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Did Not Make Any Suicide Plans (2021) |
Did Not Make Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
Did Not Attempt Suicide (2021) |
Did Not Attempt Suicide (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 12,521 | 13,200 | 241,303 | 243,082 | 3,624 | 3,753 | 250,201 | 252,528 | 1,811 | 1,623 | 252,014 | 254,659 |
| DRUGS OR ALCOHOL1 | 5,779 | 6,249 | 38,604 | 40,244 | 1,899 | 2,018 | 42,484 | 44,476 | 974 | 927 | 43,409 | 45,567 |
| DRUGS1 | 3,983a | 4,674 | 18,588a | 20,743 | 1,423 | 1,591 | 21,148b | 23,826 | 731 | 680 | 21,840b | 24,737 |
| Marijuana | 2,765a | 3,322 | 12,548b | 14,346 | 960 | 1,083 | 14,353b | 16,585 | 517 | 434 | 14,796b | 17,235 |
| Cocaine | 339 | 308 | 1,092 | 1,121 | 170 | 164 | 1,261 | 1,265 | 134 | 55 | 1,297 | 1,374 |
| Heroin | 145 | 86 | 844 | 812 | 32 | 32 | 956 | 866 | 16 | 37 | 972 | 861 |
| Hallucinogens | 176 | 246 | 281 | 268 | 73 | 125 | 383 | 389 | 55 | 62 | 401 | 452 |
| Inhalants | 101 | 102 | 157 | 159 | 45 | 35 | 214 | 226 | 41 | 9 | 218 | 253 |
| Methamphetamine | 302 | 415 | 1,302 | 1,403 | 181 | 137 | 1,423 | 1,681 | 127 | 99 | 1,478 | 1,719 |
| Prescription Psychotherapeutics1 | 1,199 | 1,511 | 5,661 | 6,176 | 559 | 599 | 6,301 | 7,088 | 252 | 342 | 6,608 | 7,345 |
| Pain Relievers1 | 720 | 863 | 4,024 | 4,449 | 379 | 388 | 4,366 | 4,924 | 191 | 258 | 4,554 | 5,054 |
| Stimulants1 | 304 | 404 | 962 | 1,165 | 130 | 129 | 1,136 | 1,440 | 81 | 88 | 1,185 | 1,481 |
| Tranquilizers or Sedatives1 | 541 | 496 | 1,569 | 1,724 | 264 | 227 | 1,846 | 1,994 | 107 | 149 | 2,002 | 2,072 |
| Tranquilizers1 | 480 | 371 | 1,127 | 1,360 | 224 | 188 | 1,383 | 1,542 | 96 | 118 | 1,511 | 1,612 |
| Sedatives1 | 218 | 190 | 661 | 579 | 93 | 88 | 786 | 681 | 48 | 69 | 831 | 701 |
| Opioids1 | 789 | 934 | 4,519 | 4,917 | 391 | 407 | 4,917 | 5,444 | 194 | 274 | 5,114 | 5,578 |
| Central Nervous System Stimulants1 | 832 | 971 | 3,100 | 3,276 | 397 | 370 | 3,534 | 3,877 | 275 | 189 | 3,657 | 4,058 |
| ALCOHOL | 3,331 | 3,402 | 25,438 | 25,386 | 1,075 | 1,173 | 27,694 | 27,615 | 552 | 518 | 28,216 | 28,271 |
| BOTH DRUGS AND ALCOHOL1 | 1,534 | 1,826 | 5,422 | 5,885 | 599 | 746 | 6,358 | 6,965 | 310 | 271 | 6,647 | 7,441 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 2,448 | 2,848 | 13,166a | 14,858 | 824 | 844 | 14,790b | 16,861 | 422 | 409 | 15,193b | 17,296 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 1,797 | 1,576 | 20,016 | 19,501 | 477 | 427 | 21,336 | 20,650 | 243 | 247 | 21,570 | 20,830 |
| NO SUBSTANCE USE DISORDER1 | 6,742 | 6,950 | 202,699 | 202,838 | 1,724 | 1,735 | 207,717 | 208,053 | 837 | 696 | 208,605 | 209,092 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
| Substance Use Disorder Status | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
No Serious Thoughts of Suicide (2021) |
No Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Did Not Make Any Suicide Plans (2021) |
Did Not Make Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
Did Not Attempt Suicide (2021) |
Did Not Attempt Suicide (2022) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL POPULATION | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| DRUGS OR ALCOHOL1 | 46.2 | 47.3 | 16.0 | 16.6 | 52.4 | 53.8 | 17.0 | 17.6 | 53.8 | 57.1 | 17.2 | 17.9 |
| DRUGS1 | 31.8 | 35.4 | 7.7b | 8.5 | 39.3 | 42.4 | 8.5b | 9.4 | 40.4 | 41.9 | 8.7b | 9.7 |
| Marijuana | 22.1 | 25.2 | 5.2b | 5.9 | 26.5 | 28.9 | 5.7b | 6.6 | 28.5 | 26.7 | 5.9b | 6.8 |
| Cocaine | 2.7 | 2.3 | 0.5 | 0.5 | 4.7 | 4.4 | 0.5 | 0.5 | 7.4 | 3.4 | 0.5 | 0.5 |
| Heroin | 1.2 | 0.7 | 0.3 | 0.3 | 0.9 | 0.9 | 0.4 | 0.3 | 0.9 | 2.3 | 0.4 | 0.3 |
| Hallucinogens | 1.4 | 1.9 | 0.1 | 0.1 | 2.0 | 3.3 | 0.2 | 0.2 | 3.1 | 3.8 | 0.2 | 0.2 |
| Inhalants | 0.8 | 0.8 | 0.1 | 0.1 | 1.2 | 0.9 | 0.1 | 0.1 | 2.3 | 0.6 | 0.1 | 0.1 |
| Methamphetamine | 2.4 | 3.1 | 0.5 | 0.6 | 5.0 | 3.7 | 0.6 | 0.7 | 7.0 | 6.1 | 0.6 | 0.7 |
| Prescription Psychotherapeutics1 | 9.6 | 11.4 | 2.3 | 2.5 | 15.4 | 16.0 | 2.5 | 2.8 | 13.9 | 21.1 | 2.6 | 2.9 |
| Pain Relievers1 | 5.8 | 6.5 | 1.7 | 1.8 | 10.4 | 10.3 | 1.7 | 1.9 | 10.5 | 15.9 | 1.8 | 2.0 |
| Stimulants1 | 2.4 | 3.1 | 0.4 | 0.5 | 3.6 | 3.4 | 0.5 | 0.6 | 4.5 | 5.4 | 0.5 | 0.6 |
| Tranquilizers or Sedatives1 | 4.3 | 3.8 | 0.7 | 0.7 | 7.3 | 6.0 | 0.7 | 0.8 | 5.9 | 9.2 | 0.8 | 0.8 |
| Tranquilizers1 | 3.8 | 2.8 | 0.5 | 0.6 | 6.2 | 5.0 | 0.6 | 0.6 | 5.3 | 7.3 | 0.6 | 0.6 |
| Sedatives1 | 1.7 | 1.4 | 0.3 | 0.2 | 2.6 | 2.4 | 0.3 | 0.3 | 2.7 | 4.2 | 0.3 | 0.3 |
| Opioids1 | 6.3 | 7.1 | 1.9 | 2.0 | 10.8 | 10.9 | 2.0 | 2.2 | 10.7 | 16.9 | 2.0 | 2.2 |
| Central Nervous System Stimulants1 | 6.6 | 7.4 | 1.3 | 1.3 | 11.0 | 9.9 | 1.4 | 1.5 | 15.2 | 11.7 | 1.5 | 1.6 |
| ALCOHOL | 26.6 | 25.8 | 10.5 | 10.4 | 29.7 | 31.3 | 11.1 | 10.9 | 30.5 | 31.9 | 11.2 | 11.1 |
| BOTH DRUGS AND ALCOHOL1 | 12.3 | 13.8 | 2.2 | 2.4 | 16.5 | 19.9 | 2.5 | 2.8 | 17.1 | 16.7 | 2.6 | 2.9 |
| DRUGS ONLY (NO ALCOHOL USE DISORDER)1 | 19.6 | 21.6 | 5.5a | 6.1 | 22.7 | 22.5 | 5.9b | 6.7 | 23.3 | 25.2 | 6.0b | 6.8 |
| ALCOHOL ONLY (NO DRUG USE DISORDER)1 | 14.3 | 11.9 | 8.3 | 8.0 | 13.2 | 11.4 | 8.5 | 8.2 | 13.4 | 15.2 | 8.6 | 8.2 |
| NO SUBSTANCE USE DISORDER1 | 53.8 | 52.7 | 84.0 | 83.4 | 47.6 | 46.2 | 83.0 | 82.4 | 46.2 | 42.9 | 82.8 | 82.1 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Substance use disorder estimates are based on DSM-5 criteria. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||||
| Demographic Characteristic | Total1 (2021) |
Total1 (2022) |
On Probation (2021) |
On Probation (2022) |
Not on Probation (2021) |
Not on Probation (2022) |
|---|---|---|---|---|---|---|
| TOTAL 18 OR OLDER | 12,521 | 13,200 | 348 | 468 | 12,015 | 12,549 |
| AGE GROUP | ||||||
| 18-49 | 10,126 | 10,376 | 299 | 392 | 9,699 | 9,880 |
| 18-25 | 4,497 | 4,746 | 81 | 95 | 4,392 | 4,608 |
| 26-34 | 2,955 | 2,905 | * | 96 | 2,812 | 2,758 |
| 35-49 | 2,674 | 2,724 | * | 201 | 2,494 | 2,514 |
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 5,572 | 6,269 | 203 | 310 | 5,294 | 5,832 |
| Male 18-49 | 4,481 | 4,969 | 202 | 262 | 4,226 | 4,658 |
| Female 18 or Older | 6,949 | 6,930 | * | 158 | 6,721 | 6,717 |
| Female 18-49 | 5,645 | 5,407 | 96 | 131 | 5,473 | 5,221 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 The Total column includes respondents with unknown past year probation status. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Demographic Characteristic | Total1 (2021) |
Total1 (2022) |
On Probation (2021) |
On Probation (2022) |
Not on Probation (2021) |
Not on Probation (2022) |
|---|---|---|---|---|---|---|
| TOTAL 18 OR OLDER | 4.9 | 5.2 | 11.2 | 15.4 | 4.9 | 5.0 |
| AGE GROUP | ||||||
| 18-49 | 7.5 | 7.6 | 13.2 | 17.2 | 7.4 | 7.4 |
| 18-25 | 13.4 | 13.6 | 17.1 | 24.8 | 13.5 | 13.5 |
| 26-34 | 7.4 | 7.2 | * | 11.2 | 7.3 | 7.1 |
| 35-49 | 4.3 | 4.4 | * | 19.4 | 4.1 | 4.2 |
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 4.5 | 5.0 | 9.6 | 14.6 | 4.4 | 4.8 |
| Male 18-49 | 6.6 | 7.2 | 13.1 | 17.2 | 6.5 | 7.0 |
| Female 18 or Older | 5.3 | 5.3 | * | 17.2 | 5.3 | 5.2 |
| Female 18-49 | 8.3 | 7.9 | 13.4 | 17.3 | 8.2 | 7.8 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 The Total column includes respondents with unknown past year probation status. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Demographic Characteristic | Total1 (2021) |
Total1 (2022) |
On Parole/Supervised Release (2021) |
On Parole/Supervised Release (2022) |
Not on Parole/Supervised Release (2021) |
Not on Parole/Supervised Release (2022) |
|---|---|---|---|---|---|---|
| TOTAL 18 OR OLDER | 12,521 | 13,200 | 156 | 212 | 12,215 | 12,806 |
| AGE GROUP | ||||||
| 18-49 | 10,126 | 10,376 | 99 | 169 | 9,906 | 10,105 |
| 18-25 | 4,497 | 4,746 | * | * | 4,438 | 4,669 |
| 26-34 | 2,955 | 2,905 | * | * | 2,887 | 2,831 |
| 35-49 | 2,674 | 2,724 | 32 | * | 2,582 | 2,605 |
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 5,572 | 6,269 | 59 | 123 | 5,438 | 6,019 |
| Male 18-49 | 4,481 | 4,969 | 57 | 98 | 4,371 | 4,823 |
| Female 18 or Older | 6,949 | 6,930 | * | * | 6,776 | 6,787 |
| Female 18-49 | 5,645 | 5,407 | * | * | 5,535 | 5,283 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 The Total column includes respondents with unknown past year parole/supervised release status. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Demographic Characteristic | Total1 (2021) |
Total1 (2022) |
On Parole/Supervised Release (2021) |
On Parole/Supervised Release (2022) |
Not on Parole/Supervised Release (2021) |
Not on Parole/Supervised Release (2022) |
|---|---|---|---|---|---|---|
| TOTAL 18 OR OLDER | 4.9 | 5.2 | 11.2 | 13.8 | 4.9 | 5.1 |
| AGE GROUP | ||||||
| 18-49 | 7.5 | 7.6 | 10.8 | 15.2 | 7.4 | 7.5 |
| 18-25 | 13.4 | 13.6 | * | * | 13.5 | 13.6 |
| 26-34 | 7.4 | 7.2 | * | * | 7.4 | 7.2 |
| 35-49 | 4.3 | 4.4 | 8.6 | * | 4.2 | 4.3 |
| GENDER/AGE GROUP | ||||||
| Male 18 or Older | 4.5 | 5.0 | 6.1 | 10.2 | 4.5 | 4.9 |
| Male 18-49 | 6.6 | 7.2 | 8.4 | 11.9 | 6.6 | 7.2 |
| Female 18 or Older | 5.3 | 5.3 | * | * | 5.3 | 5.2 |
| Female 18-49 | 8.3 | 7.9 | * | * | 8.2 | 7.8 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 The Total column includes respondents with unknown past year parole/supervised release status. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||
| Past Year Mental Health Measure | Full-Time College Students (2021) |
Full-Time College Students (2022) |
Other People Aged 18-221 (2021) |
Other People Aged 18-221 (2022) |
|---|---|---|---|---|
| SUICIDAL THOUGHTS AND BEHAVIOR AND TREATMENT FOR SUICIDE ATTEMPT | ||||
| Had Serious Thoughts of Suicide | 852 | 921 | 2,032 | 2,245 |
| Made Any Suicide Plans | 216 | 291 | 1,014 | 908 |
| Attempted Suicide | 146 | 101 | 561a | 395 |
| Received Medical Attention for Suicide Attempt among People Who Attempted Suicide |
* | * | 195 | 159 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt among People Who Attempted Suicide |
* | * | 139 | 85 |
| LEVEL OF MENTAL ILLNESS2 | ||||
| Any Mental Illness | 2,801 | 2,749 | 4,435 | 4,837 |
| Serious Mental Illness | 918 | 800 | 1,601 | 1,685 |
| Any Mental Illness Excluding Serious Mental Illness | 1,883 | 1,949 | 2,834 | 3,152 |
| No Mental Illness | 4,950 | 4,751 | 9,106 | 9,222 |
| MAJOR DEPRESSIVE EPISODE | 1,636 | 1,661 | 2,688 | 2,719 |
| MENTAL HEALTH TREATMENT3,4 | -- | 2,142 | -- | 3,562 |
| Inpatient | -- | 73 | -- | 398 |
| Outpatient | -- | 1,596 | -- | 2,273 |
| Prescription Medication | -- | 1,210 | -- | 2,403 |
| Telehealth Treatment5 | -- | 1,456 | -- | 2,169 |
| Prison, Jail, or Juvenile Detention Center | -- | 29 | -- | 133 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other People include respondents not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 2 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 3 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 4 Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. 5 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Past Year Mental Health Measure | Full-Time College Students (2021) |
Full-Time College Students (2022) |
Other People Aged 18-221 (2021) |
Other People Aged 18-221 (2022) |
|---|---|---|---|---|
| SUICIDAL THOUGHTS AND BEHAVIOR AND TREATMENT FOR SUICIDE ATTEMPT | ||||
| Had Serious Thoughts of Suicide | 11.0 | 12.3 | 15.0 | 16.0 |
| Made Any Suicide Plans | 2.8 | 3.9 | 7.5 | 6.5 |
| Attempted Suicide | 1.9 | 1.3 | 4.1a | 2.8 |
| Received Medical Attention for Suicide Attempt among People Who Attempted Suicide |
* | * | 34.8 | 40.2 |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt among People Who Attempted Suicide |
* | * | 24.8 | 21.6 |
| LEVEL OF MENTAL ILLNESS2 | ||||
| Any Mental Illness | 36.1 | 36.7 | 32.8 | 34.4 |
| Serious Mental Illness | 11.8 | 10.7 | 11.8 | 12.0 |
| Any Mental Illness Excluding Serious Mental Illness | 24.3 | 26.0 | 20.9 | 22.4 |
| No Mental Illness | 63.9 | 63.3 | 67.2 | 65.6 |
| MAJOR DEPRESSIVE EPISODE | 21.1 | 22.1 | 19.9 | 19.3 |
| MENTAL HEALTH TREATMENT3,4 | -- | 28.6 | -- | 25.3 |
| Inpatient | -- | 1.0 | -- | 2.8 |
| Outpatient | -- | 21.3 | -- | 16.2 |
| Prescription Medication | -- | 16.1 | -- | 17.1 |
| Telehealth Treatment5 | -- | 19.4 | -- | 15.4 |
| Prison, Jail, or Juvenile Detention Center | -- | 0.4 | -- | 0.9 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other People include respondents not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 2 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 3 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 4 Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. 5 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Past Year Mental Health Measure | Full-Time Male College Students (2021) |
Full-Time Male College Students (2022) |
Other Males Aged 18-221 (2021) |
Other Males Aged 18-221 (2022) |
|---|---|---|---|---|
| SUICIDAL THOUGHTS AND BEHAVIOR AND TREATMENT FOR SUICIDE ATTEMPT | ||||
| Had Serious Thoughts of Suicide | 308 | 325 | 744b | 1,081 |
| Made Any Suicide Plans | 61 | 110 | 373 | 396 |
| Attempted Suicide | 43 | 38 | 180 | 154 |
| Received Medical Attention for Suicide Attempt among People Who Attempted Suicide |
* | * | * | * |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt among People Who Attempted Suicide |
* | * | * | * |
| LEVEL OF MENTAL ILLNESS2 | ||||
| Any Mental Illness | 960 | 1,050 | 1,719b | 2,191 |
| Serious Mental Illness | 277 | 237 | 466a | 674 |
| Any Mental Illness Excluding Serious Mental Illness | 683 | 813 | 1,253 | 1,518 |
| No Mental Illness | 2,589 | 2,335 | 5,542 | 5,594 |
| MAJOR DEPRESSIVE EPISODE | 510 | 559 | 971 | 1,125 |
| MENTAL HEALTH TREATMENT3,4 | -- | 586 | -- | 1,482 |
| Inpatient | -- | 21 | -- | 200 |
| Outpatient | -- | 407 | -- | 891 |
| Prescription Medication | -- | 328 | -- | 1,028 |
| Telehealth Treatment5 | -- | 331 | -- | 886 |
| Prison, Jail, or Juvenile Detention Center | -- | 14 | -- | 74 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Males include respondents not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 2 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 3 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 4 Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. 5 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Past Year Mental Health Measure | Full-Time Male College Students (2021) |
Full-Time Male College Students (2022) |
Other Males Aged 18-221 (2021) |
Other Males Aged 18-221 (2022) |
|---|---|---|---|---|
| SUICIDAL THOUGHTS AND BEHAVIOR AND TREATMENT FOR SUICIDE ATTEMPT | ||||
| Had Serious Thoughts of Suicide | 8.7 | 9.6 | 10.2b | 13.9 |
| Made Any Suicide Plans | 1.7 | 3.2 | 5.1 | 5.1 |
| Attempted Suicide | 1.2 | 1.1 | 2.5 | 2.0 |
| Received Medical Attention for Suicide Attempt among People Who Attempted Suicide |
* | * | * | * |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt among People Who Attempted Suicide |
* | * | * | * |
| LEVEL OF MENTAL ILLNESS2 | ||||
| Any Mental Illness | 27.1 | 31.0 | 23.7a | 28.1 |
| Serious Mental Illness | 7.8 | 7.0 | 6.4 | 8.7 |
| Any Mental Illness Excluding Serious Mental Illness | 19.2 | 24.0 | 17.3 | 19.5 |
| No Mental Illness | 72.9 | 69.0 | 76.3a | 71.9 |
| MAJOR DEPRESSIVE EPISODE | 14.4 | 16.5 | 13.4 | 14.5 |
| MENTAL HEALTH TREATMENT3,4 | -- | 17.3 | -- | 19.0 |
| Inpatient | -- | 0.6 | -- | 2.6 |
| Outpatient | -- | 12.0 | -- | 11.5 |
| Prescription Medication | -- | 9.7 | -- | 13.2 |
| Telehealth Treatment5 | -- | 9.8 | -- | 11.4 |
| Prison, Jail, or Juvenile Detention Center | -- | 0.4 | -- | 1.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Males include respondents not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 2 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 3 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 4 Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. 5 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Past Year Mental Health Measure | Full-Time Female College Students (2021) |
Full-Time Female College Students (2022) |
Other Females Aged 18-221 (2021) |
Other Females Aged 18-221 (2022) |
|---|---|---|---|---|
| SUICIDAL THOUGHTS AND BEHAVIOR AND TREATMENT FOR SUICIDE ATTEMPT | ||||
| Had Serious Thoughts of Suicide | 544 | 596 | 1,288 | 1,164 |
| Made Any Suicide Plans | 155 | 182 | 641 | 512 |
| Attempted Suicide | 104 | 63 | 382 | 240 |
| Received Medical Attention for Suicide Attempt among People Who Attempted Suicide |
* | * | * | * |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt among People Who Attempted Suicide |
* | * | * | 34 |
| LEVEL OF MENTAL ILLNESS2 | ||||
| Any Mental Illness | 1,841 | 1,700 | 2,716 | 2,646 |
| Serious Mental Illness | 641 | 564 | 1,135 | 1,011 |
| Any Mental Illness Excluding Serious Mental Illness | 1,200 | 1,136 | 1,582 | 1,634 |
| No Mental Illness | 2,361 | 2,416 | 3,565 | 3,628 |
| MAJOR DEPRESSIVE EPISODE | 1,125 | 1,102 | 1,717 | 1,594 |
| MENTAL HEALTH TREATMENT3,4 | -- | 1,556 | -- | 2,080 |
| Inpatient | -- | 52 | -- | 198 |
| Outpatient | -- | 1,189 | -- | 1,381 |
| Prescription Medication | -- | 883 | -- | 1,374 |
| Telehealth Treatment5 | -- | 1,125 | -- | 1,283 |
| Prison, Jail, or Juvenile Detention Center | -- | 15 | -- | 59 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Females include respondents not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 2 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 3 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 4 Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. 5 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Past Year Mental Health Measure | Full-Time Female College Students (2021) |
Full-Time Female College Students (2022) |
Other Females Aged 18-221 (2021) |
Other Females Aged 18-221 (2022) |
|---|---|---|---|---|
| SUICIDAL THOUGHTS AND BEHAVIOR AND TREATMENT FOR SUICIDE ATTEMPT | ||||
| Had Serious Thoughts of Suicide | 12.9 | 14.5 | 20.5 | 18.5 |
| Made Any Suicide Plans | 3.7 | 4.4 | 10.2 | 8.2 |
| Attempted Suicide | 2.5 | 1.5 | 6.1a | 3.8 |
| Received Medical Attention for Suicide Attempt among People Who Attempted Suicide |
* | * | * | * |
| Stayed Overnight or Longer in a Hospital for Suicide Attempt among People Who Attempted Suicide |
* | * | * | 14.2 |
| LEVEL OF MENTAL ILLNESS2 | ||||
| Any Mental Illness | 43.8 | 41.3 | 43.2 | 42.2 |
| Serious Mental Illness | 15.3 | 13.7 | 18.1 | 16.1 |
| Any Mental Illness Excluding Serious Mental Illness | 28.6 | 27.6 | 25.2 | 26.1 |
| No Mental Illness | 56.2 | 58.7 | 56.8 | 57.8 |
| MAJOR DEPRESSIVE EPISODE | 26.8 | 26.8 | 27.3 | 25.4 |
| MENTAL HEALTH TREATMENT3,4 | -- | 37.8 | -- | 33.2 |
| Inpatient | -- | 1.3 | -- | 3.2 |
| Outpatient | -- | 28.9 | -- | 22.0 |
| Prescription Medication | -- | 21.4 | -- | 21.9 |
| Telehealth Treatment5 | -- | 27.3 | -- | 20.4 |
| Prison, Jail, or Juvenile Detention Center | -- | 0.4 | -- | 0.9 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. NOTE: Estimates in this table exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Other Females include respondents not enrolled in school, enrolled in college part time, enrolled in other grades either full or part time, or enrolled with no other information available. 2 Mental Illness aligns with DSM-IV criteria and is defined as having a diagnosable mental, behavioral, or emotional disorder, other than a developmental or substance use disorder. Estimates of serious mental illness (SMI) are a subset of estimates of any mental illness (AMI) because SMI is limited to people with AMI that resulted in serious functional impairment. These mental illness estimates are based on a predictive model and are not direct measures of diagnostic status. 3 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 4 Respondents could indicate multiple types/locations for receiving mental health treatment; thus, these response categories are not mutually exclusive. 5 Respondents who reported that they received telehealth treatment (i.e., over the phone or through video) were not asked for the type or location of providers for the telehealth treatment they received. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||
| Past Year Mental Health or Substance Use Measure | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
None of These Suicidality Measures (2021) |
None of These Suicidality Measures (2022) |
|---|---|---|---|---|---|---|---|---|
| MAJOR DEPRESSIVE EPISODE STATUS | ||||||||
| Major Depressive Episode | 6,889 | 7,451 | 2,442 | 2,474 | 1,192 | 1,040 | 14,563 | 14,975 |
| No Major Depressive Episode | 5,632 | 5,749 | 1,181 | 1,279 | 619 | 582 | 226,401 | 227,746 |
| MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT SHOULD GET TREATMENT STATUS |
||||||||
| Mental Health Treatment1 | -- | 7,276 | -- | 2,332 | -- | 999 | -- | 48,402 |
| No Mental Health Treatment1 | -- | 5,924 | -- | 1,421 | -- | 624 | -- | 194,318 |
| Sought or Thought Should Get Treatment2 | -- | 2,092 | -- | 577 | -- | 192 | -- | 9,949 |
| Did Not Seek Treatment and Did Not Think Should Get Treatment2 | -- | 3,737 | -- | 782 | -- | 402 | -- | 180,694 |
| SUBSTANCE USE DISORDER STATUS | ||||||||
| Substance Use Disorder3 | 5,779 | 6,249 | 1,899 | 2,018 | 974 | 927 | 38,458 | 40,097 |
| Alcohol Use Disorder4 | 3,331 | 3,402 | 1,075 | 1,173 | 552 | 518 | 25,319 | 25,339 |
| Drug Use Disorder3 | 3,983a | 4,674 | 1,423 | 1,591 | 731 | 680 | 18,474a | 20,627 |
| No Substance Use Disorder3 | 6,742 | 6,950 | 1,724 | 1,735 | 837 | 696 | 202,506 | 202,623 |
| SERIOUS PSYCHOLOGICAL DISTRESS STATUS | ||||||||
| Serious Psychological Distress | 8,963 | 9,700 | 2,950 | 3,140 | 1,467 | 1,245 | 26,472 | 27,550 |
| No Serious Psychological Distress | 3,559 | 3,500 | 673 | 613 | 344 | 378 | 214,492 | 215,170 |
| SUBSTANCE USE TREATMENT STATUS | ||||||||
| Substance Use Treatment5,6 | -- | 1,943 | -- | 677 | -- | 486 | -- | 9,883 |
| No Substance Use Treatment5,6 | -- | 11,256 | -- | 3,076 | -- | 1,137 | -- | 232,837 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 2 Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. 3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. 4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria. 5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment. 6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Past Year Mental Health or Substance Use Measure | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
None of These Suicidality Measures (2021) |
None of These Suicidality Measures (2022) |
|---|---|---|---|---|---|---|---|---|
| MAJOR DEPRESSIVE EPISODE STATUS | ||||||||
| Major Depressive Episode | 32.0 | 33.2 | 11.3 | 11.0 | 5.5 | 4.6 | 67.6 | 66.6 |
| No Major Depressive Episode | 2.4 | 2.5 | 0.5 | 0.5 | 0.3 | 0.2 | 97.5 | 97.4 |
| MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT SHOULD GET TREATMENT STATUS |
||||||||
| Mental Health Treatment1 | -- | 13.0 | -- | 4.2 | -- | 1.8 | -- | 86.7 |
| No Mental Health Treatment1 | -- | 3.0 | -- | 0.7 | -- | 0.3 | -- | 96.9 |
| Sought or Thought Should Get Treatment2 | -- | 17.3 | -- | 4.8 | -- | 1.6 | -- | 82.3 |
| Did Not Seek Treatment and Did Not Think Should Get Treatment2 | -- | 2.0 | -- | 0.4 | -- | 0.2 | -- | 97.9 |
| SUBSTANCE USE DISORDER STATUS | ||||||||
| Substance Use Disorder3 | 13.0 | 13.4 | 4.3 | 4.3 | 2.2 | 2.0 | 86.7 | 86.2 |
| Alcohol Use Disorder4 | 11.6 | 11.8 | 3.7 | 4.1 | 1.9 | 1.8 | 88.0 | 88.0 |
| Drug Use Disorder3 | 17.6 | 18.4 | 6.3 | 6.3 | 3.2 | 2.7 | 81.9 | 81.2 |
| No Substance Use Disorder3 | 3.2 | 3.3 | 0.8 | 0.8 | 0.4 | 0.3 | 96.7 | 96.6 |
| SERIOUS PSYCHOLOGICAL DISTRESS STATUS | ||||||||
| Serious Psychological Distress | 25.2 | 25.9 | 8.3 | 8.4 | 4.1 | 3.3 | 74.3 | 73.5 |
| No Serious Psychological Distress | 1.6 | 1.6 | 0.3 | 0.3 | 0.2 | 0.2 | 98.3 | 98.3 |
| SUBSTANCE USE TREATMENT STATUS | ||||||||
| Substance Use Treatment5,6 | -- | 16.3 | -- | 5.7 | -- | 4.1 | -- | 82.9 |
| No Substance Use Treatment5,6 | -- | 4.6 | -- | 1.3 | -- | 0.5 | -- | 95.3 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 2 Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. 3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. 4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria. 5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment. 6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Past Year Mental Health or Substance Use Measure | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
None of These Suicidality Measures (2021) |
None of These Suicidality Measures (2022) |
|---|---|---|---|---|---|---|---|---|
| MAJOR DEPRESSIVE EPISODE STATUS | ||||||||
| Major Depressive Episode | 6,889 | 7,451 | 2,442 | 2,474 | 1,192 | 1,040 | 14,563 | 14,975 |
| No Major Depressive Episode | 5,632 | 5,749 | 1,181 | 1,279 | 619 | 582 | 226,401 | 227,746 |
| MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT SHOULD GET TREATMENT STATUS |
||||||||
| Mental Health Treatment1 | -- | 7,276 | -- | 2,332 | -- | 999 | -- | 48,402 |
| No Mental Health Treatment1 | -- | 5,924 | -- | 1,421 | -- | 624 | -- | 194,318 |
| Sought or Thought Should Get Treatment2 | -- | 2,092 | -- | 577 | -- | 192 | -- | 9,949 |
| Did Not Seek Treatment and Did Not Think Should Get Treatment2 | -- | 3,737 | -- | 782 | -- | 402 | -- | 180,694 |
| SUBSTANCE USE DISORDER STATUS | ||||||||
| Substance Use Disorder3 | 5,779 | 6,249 | 1,899 | 2,018 | 974 | 927 | 38,458 | 40,097 |
| Alcohol Use Disorder4 | 3,331 | 3,402 | 1,075 | 1,173 | 552 | 518 | 25,319 | 25,339 |
| Drug Use Disorder3 | 3,983a | 4,674 | 1,423 | 1,591 | 731 | 680 | 18,474a | 20,627 |
| No Substance Use Disorder3 | 6,742 | 6,950 | 1,724 | 1,735 | 837 | 696 | 202,506 | 202,623 |
| SERIOUS PSYCHOLOGICAL DISTRESS STATUS | ||||||||
| Serious Psychological Distress | 8,963 | 9,700 | 2,950 | 3,140 | 1,467 | 1,245 | 26,472 | 27,550 |
| No Serious Psychological Distress | 3,559 | 3,500 | 673 | 613 | 344 | 378 | 214,492 | 215,170 |
| SUBSTANCE USE TREATMENT STATUS | ||||||||
| Substance Use Treatment5,6 | -- | 1,943 | -- | 677 | -- | 486 | -- | 9,883 |
| No Substance Use Treatment5,6 | -- | 11,256 | -- | 3,076 | -- | 1,137 | -- | 232,837 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 2 Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. 3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. 4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria. 5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment. 6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Past Year Mental Health or Substance Use Measure | Had Serious Thoughts of Suicide (2021) |
Had Serious Thoughts of Suicide (2022) |
Made Any Suicide Plans (2021) |
Made Any Suicide Plans (2022) |
Attempted Suicide (2021) |
Attempted Suicide (2022) |
None of These Suicidality Measures (2021) |
None of These Suicidality Measures (2022) |
|---|---|---|---|---|---|---|---|---|
| MAJOR DEPRESSIVE EPISODE STATUS | ||||||||
| Major Depressive Episode | 55.0 | 56.4 | 67.4 | 65.9 | 65.8 | 64.1 | 6.0 | 6.2 |
| No Major Depressive Episode | 45.0 | 43.6 | 32.6 | 34.1 | 34.2 | 35.9 | 94.0 | 93.8 |
| MENTAL HEALTH TREATMENT AND SOUGHT OR THOUGHT SHOULD GET TREATMENT STATUS |
||||||||
| Mental Health Treatment1 | -- | 55.1 | -- | 62.1 | -- | 61.5 | -- | 19.9 |
| No Mental Health Treatment1 | -- | 44.9 | -- | 37.9 | -- | 38.5 | -- | 80.1 |
| Sought or Thought Should Get Treatment2 | -- | 35.9 | -- | 42.4 | -- | 32.3 | -- | 5.2 |
| Did Not Seek Treatment and Did Not Think Should Get Treatment2 | -- | 64.1 | -- | 57.6 | -- | 67.7 | -- | 94.8 |
| SUBSTANCE USE DISORDER STATUS | ||||||||
| Substance Use Disorder3 | 46.2 | 47.3 | 52.4 | 53.8 | 53.8 | 57.1 | 16.0 | 16.5 |
| Alcohol Use Disorder4 | 26.6 | 25.8 | 29.7 | 31.3 | 30.5 | 31.9 | 10.5 | 10.4 |
| Drug Use Disorder3 | 31.8 | 35.4 | 39.3 | 42.4 | 40.4 | 41.9 | 7.7b | 8.5 |
| No Substance Use Disorder3 | 53.8 | 52.7 | 47.6 | 46.2 | 46.2 | 42.9 | 84.0 | 83.5 |
| SERIOUS PSYCHOLOGICAL DISTRESS STATUS | ||||||||
| Serious Psychological Distress | 71.6 | 73.5 | 81.4 | 83.7 | 81.0 | 76.7 | 11.0 | 11.4 |
| No Serious Psychological Distress | 28.4 | 26.5 | 18.6 | 16.3 | 19.0 | 23.3 | 89.0 | 88.6 |
| SUBSTANCE USE TREATMENT STATUS | ||||||||
| Substance Use Treatment5,6 | -- | 14.7 | -- | 18.0 | -- | 29.9 | -- | 4.1 |
| No Substance Use Treatment5,6 | -- | 85.3 | -- | 82.0 | -- | 70.1 | -- | 95.9 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Mental health treatment includes treatment for mental health, emotions, or behavior through inpatient treatment/counseling; outpatient treatment/counseling; use of prescription medication; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. 2 Respondents with unknown data for whether they sought or thought they should get mental health treatment were excluded. 3 Substance use disorder estimates are based on DSM-5 criteria. Beginning with the 2021 NSDUH, questions on prescription drug use disorder were asked of all past year users of prescription drugs, regardless of whether they misused prescription drugs. These estimates include prescription drug use disorder data from all past year users of prescription drugs. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details on these changes. 4 Alcohol use disorder (AUD) estimates are based on DSM-5 criteria. 5 Substance use treatment includes treatment for drug or alcohol use through inpatient treatment/counseling; outpatient treatment/counseling; medication-assisted treatment; telehealth treatment; or treatment received in a prison, jail, or juvenile detention center. Substance use treatment questions are asked of respondents who used drugs or alcohol in their lifetime. These estimates include data from respondents who reported that they received any substance use treatment but did not report the substance for which they received treatment. 6 Because of the proportion of respondents in the “substance unspecified” category for treatment, these estimates have added uncertainty. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||
| Demographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 35,608 | 37,465 | 10,548b | 11,496 | 25,060 | 25,970 | 17,694 | 18,187 | 7,366 | 7,782 |
| GENDER | ||||||||||
| Male | 13,234b | 15,409 | 3,840b | 4,696 | 9,394a | 10,713 | 6,822a | 7,907 | 2,571 | 2,806 |
| Female | 22,374 | 22,056 | 6,708 | 6,800 | 15,666 | 15,256 | 10,871 | 10,280 | 4,795 | 4,976 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 29,348a | 31,172 | 8,358a | 8,942 | 20,990 | 22,230 | 14,647 | 15,341 | 6,343 | 6,889 |
| AIAN | 324a | 176 | * | * | 187 | 113 | 92 | 87 | * | 26 |
| Asian | 1,654 | 1,941 | 582 | 772 | 1,072 | 1,169 | 763 | 874 | 309 | 295 |
| Black or African American | 3,779 | 3,863 | 1,162 | 1,107 | 2,617 | 2,757 | 1,824 | 2,095 | 793 | 662 |
| NHOPI | 138 | * | * | * | * | * | * | * | * | * |
| White | 22,334 | 23,799 | 6,052 | 6,541 | 16,282 | 17,258 | 11,334 | 11,682 | 4,947 | 5,576 |
| Two or More Races | 1,119 | 1,174 | 371 | 453 | 748 | 721 | 551 | 504 | 198 | 217 |
| Hispanic or Latino | 6,260 | 6,293 | 2,190a | 2,553 | 4,070 | 3,740 | 3,047 | 2,847 | 1,023 | 893 |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 7,566 | 7,412 | 2,643 | 2,553 | 4,923 | 4,859 | 3,100 | 3,136 | 1,823 | 1,723 |
| 100-199% | 8,385 | 8,582 | 2,752 | 2,919 | 5,632 | 5,663 | 3,780 | 3,652 | 1,852 | 2,011 |
| 200% or More | 19,620a | 21,471 | 5,115b | 6,023 | 14,505 | 15,448 | 10,814 | 11,400 | 3,691 | 4,048 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 18,826a | 20,753 | 6,178a | 6,983 | 12,648 | 13,770 | 9,488 | 10,342 | 3,161 | 3,427 |
| Medicaid/CHIP | 9,710 | 10,680 | 2,675 | 2,920 | 7,036 | 7,759 | 4,887 | 5,251 | 2,148 | 2,508 |
| Other3 | 6,725 | 6,299 | 899 | 875 | 5,825 | 5,423 | 2,063 | 1,858 | 3,763 | 3,566 |
| No Coverage | 4,402 | 3,992 | 1,320 | 1,355 | 3,082 | 2,638 | 2,567a | 2,085 | 515 | 552 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 15,075b | 17,073 | 3,776a | 4,320 | 11,299a | 12,753 | 9,303a | 10,635 | 1,996 | 2,118 |
| Part-Time | 6,087 | 6,372 | 2,934 | 3,400 | 3,153 | 2,973 | 2,409 | 2,114 | 744 | 859 |
| Unemployed | 3,110 | 2,810 | 1,181 | 1,071 | 1,930 | 1,739 | 1,629 | 1,349 | 300 | 390 |
| Other4 | 11,335 | 11,210 | 2,657 | 2,705 | 8,678 | 8,505 | 4,352 | 4,090 | 4,326 | 4,415 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 14.0 | 14.6 | 31.5 | 33.0 | 11.4 | 11.7 | 17.3 | 17.7 | 6.2 | 6.5 |
| GENDER | ||||||||||
| Male | 10.7b | 12.3 | 23.0b | 26.9 | 8.8a | 10.0 | 13.4a | 15.4 | 4.6 | 5.0 |
| Female | 17.2 | 16.8 | 40.1 | 39.3 | 13.8 | 13.4 | 21.1 | 20.0 | 7.7 | 7.9 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 13.9 | 14.7 | 32.6 | 33.7 | 11.3 | 12.0 | 18.1 | 18.9 | 6.1 | 6.6 |
| AIAN | 19.7 | 14.2 | * | * | 14.3 | 11.0 | 15.7 | 15.8 | * | 5.5 |
| Asian | 11.1 | 12.6 | 29.8 | 34.1 | 8.3 | 8.9 | 10.3 | 11.7 | 5.6 | 5.2 |
| Black or African American | 12.3 | 12.5 | 25.6 | 23.7 | 10.0 | 10.5 | 13.7 | 15.6 | 6.2 | 5.2 |
| NHOPI | 13.7 | * | * | * | * | * | * | * | * | * |
| White | 14.1 | 15.0 | 34.2 | 35.8 | 11.6 | 12.3 | 19.8 | 20.5 | 6.0 | 6.7 |
| Two or More Races | 24.5 | 23.3 | 40.0 | 45.2 | 20.5 | 17.8 | 27.0 | 23.1 | 12.3 | 11.6 |
| Hispanic or Latino | 14.5 | 14.2 | 28.0 | 30.9 | 11.5 | 10.4 | 14.3 | 13.2 | 7.3 | 6.2 |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 20.0 | 20.5 | 31.2 | 31.7 | 16.7 | 17.3 | 20.0 | 20.6 | 13.1 | 13.3 |
| 100-199% | 16.5 | 17.2 | 34.3 | 34.4 | 13.2 | 13.7 | 18.7 | 19.0 | 8.2 | 9.1 |
| 200% or More | 11.9 | 12.6 | 30.3a | 33.0 | 9.8 | 10.2 | 16.2 | 16.7 | 4.5 | 4.8 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 12.2a | 13.3 | 32.7a | 35.1 | 9.3 | 10.1 | 15.2 | 16.1 | 4.3 | 4.8 |
| Medicaid/CHIP | 20.5 | 22.2 | 30.7 | 31.5 | 18.2 | 20.0 | 22.4 | 24.2 | 12.7 | 14.7 |
| Other3 | 8.9 | 8.2 | 35.3 | 31.2 | 8.0 | 7.3 | 22.6 | 20.3 | 5.9 | 5.5 |
| No Coverage | 17.8 | 17.2 | 27.5 | 29.3 | 15.4 | 14.2 | 17.9 | 15.8 | 9.2 | 10.2 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 13.2a | 14.4 | 29.7 | 30.7 | 11.1 | 12.2 | 14.5a | 16.0 | 5.3 | 5.6 |
| Part-Time | 20.0 | 19.4 | 35.9 | 38.7 | 14.2 | 12.4 | 23.3a | 18.9 | 6.3 | 6.7 |
| Unemployed | 23.8 | 25.5 | 37.2 | 33.4 | 19.5 | 22.3 | 25.3 | 26.8 | 8.6 | 14.1 |
| Other4 | 11.8 | 11.9 | 28.2 | 31.1 | 10.0 | 10.0 | 20.4 | 20.5 | 6.6 | 6.8 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 19,044 | 20,180 | 6,493 | 6,779 | 12,551 | 13,401 | 8,889 | 9,260 | 3,663 | 4,142 |
| GENDER | ||||||||||
| Male | 7,399b | 9,091 | 2,308b | 2,786 | 5,091b | 6,304 | 3,697a | 4,412 | 1,394 | 1,893 |
| Female | 11,646 | 11,089 | 4,185 | 3,992 | 7,461 | 7,097 | 5,192 | 4,848 | 2,269 | 2,249 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 15,683 | 16,798 | 5,104 | 5,197 | 10,579 | 11,600 | 7,400 | 7,905 | 3,179 | 3,696 |
| AIAN | 244 | 137 | * | * | 134 | 88 | 42 | 66 | * | 22 |
| Asian | 792 | 1,004 | 391 | 500 | 401 | 504 | 326 | 385 | 75 | 119 |
| Black or African American | 2,423 | 2,679 | 793 | 744 | 1,630 | 1,935 | 1,134 | 1,428 | 496 | 507 |
| NHOPI | 102 | * | * | * | * | * | * | * | * | * |
| White | 11,534 | 12,069 | 3,546 | 3,618 | 7,989 | 8,451 | 5,571 | 5,642 | 2,417 | 2,810 |
| Two or More Races | 589 | 728 | 221 | 283 | 368 | 445 | 269 | 312 | 99 | 134 |
| Hispanic or Latino | 3,361 | 3,382 | 1,389 | 1,581 | 1,972 | 1,801 | 1,488 | 1,355 | 484 | 446 |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 4,834 | 5,033 | 1,711 | 1,668 | 3,123 | 3,365 | 2,057 | 2,184 | 1,066 | 1,180 |
| 100-199% | 4,745 | 4,955 | 1,809 | 1,747 | 2,936 | 3,207 | 2,111 | 2,077 | 824 | 1,130 |
| 200% or More | 9,441 | 10,192 | 2,948 | 3,363 | 6,493 | 6,830 | 4,721 | 4,999 | 1,773 | 1,831 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 8,646a | 9,657 | 3,522 | 3,845 | 5,124 | 5,812 | 3,908 | 4,348 | 1,216 | 1,464 |
| Medicaid/CHIP | 6,054 | 6,841 | 1,861 | 1,875 | 4,194a | 4,966 | 3,033 | 3,322 | 1,161 | 1,643 |
| Other3 | 3,804 | 3,759 | 587 | 519 | 3,218 | 3,240 | 1,151 | 1,250 | 2,066 | 1,990 |
| No Coverage | 2,832 | 2,426 | 897 | 912 | 1,935 | 1,514 | 1,556 | 1,252 | 379 | 262 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 6,859a | 7,865 | 2,176 | 2,419 | 4,683a | 5,446 | 3,912a | 4,596 | 771 | 851 |
| Part-Time | 3,303 | 3,469 | 1,728 | 1,944 | 1,574 | 1,526 | 1,182 | 1,099 | 392 | 427 |
| Unemployed | 2,117 | 1,939 | 895 | 729 | 1,222 | 1,210 | 1,016 | 940 | 206 | 270 |
| Other4 | 6,765 | 6,907 | 1,693 | 1,687 | 5,072 | 5,220 | 2,778 | 2,625 | 2,294 | 2,595 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||
| Demographic/Socioeconomic Characteristic | Aged 18+ (2021) |
Aged 18+ (2022) |
Aged 18-25 (2021) |
Aged 18-25 (2022) |
Aged 26+ (2021) |
Aged 26+ (2022) |
Aged 26-49 (2021) |
Aged 26-49 (2022) |
Aged 50+ (2021) |
Aged 50+ (2022) |
|---|---|---|---|---|---|---|---|---|---|---|
| TOTAL | 7.5 | 7.9 | 19.4 | 19.5 | 5.7 | 6.1 | 8.7 | 9.0 | 3.1 | 3.5 |
| GENDER | ||||||||||
| Male | 6.0b | 7.3 | 13.8a | 15.9 | 4.8a | 5.9 | 7.3a | 8.6 | 2.5 | 3.4 |
| Female | 8.9 | 8.5 | 25.0 | 23.1 | 6.6 | 6.2 | 10.1 | 9.5 | 3.7 | 3.6 |
| HISPANIC ORIGIN AND RACE | ||||||||||
| Not Hispanic or Latino | 7.4 | 7.9 | 19.9 | 19.6 | 5.7 | 6.3 | 9.1 | 9.8 | 3.1 | 3.5 |
| AIAN | 14.9 | 11.0 | * | * | 10.2 | 8.6 | 7.1 | 12.0 | * | 4.6 |
| Asian | 5.3 | 6.5 | 20.0 | 22.1 | 3.1 | 3.8 | 4.4 | 5.2 | 1.3 | 2.1 |
| Black or African American | 7.9 | 8.7 | 17.5 | 15.9 | 6.3 | 7.4 | 8.5 | 10.6 | 3.9 | 3.9 |
| NHOPI | 10.1 | * | * | * | * | * | * | * | * | * |
| White | 7.3 | 7.6 | 20.0 | 19.8 | 5.7 | 6.0 | 9.7 | 9.9 | 2.9 | 3.4 |
| Two or More Races | 12.9 | 14.4 | 23.9 | 28.2 | 10.1 | 11.0 | 13.2 | 14.3 | 6.1 | 7.2 |
| Hispanic or Latino | 7.8 | 7.6 | 17.8 | 19.1 | 5.6 | 5.0 | 7.0 | 6.3 | 3.4 | 3.1 |
| POVERTY LEVEL1 | ||||||||||
| Less Than 100% | 12.8 | 13.9 | 20.2 | 20.7 | 10.6 | 12.0 | 13.3 | 14.4 | 7.7 | 9.1 |
| 100-199% | 9.3 | 9.9 | 22.6 | 20.6 | 6.9 | 7.8 | 10.4 | 10.8 | 3.7 | 5.1 |
| 200% or More | 5.7 | 6.0 | 17.5 | 18.4 | 4.4 | 4.5 | 7.1 | 7.3 | 2.2 | 2.2 |
| HEALTH INSURANCE2 | ||||||||||
| Private | 5.6 | 6.2 | 18.6 | 19.3 | 3.8 | 4.3 | 6.3 | 6.8 | 1.7 | 2.0 |
| Medicaid/CHIP | 12.8 | 14.2 | 21.4 | 20.2 | 10.8a | 12.8 | 13.9 | 15.3 | 6.9 | 9.6 |
| Other3 | 5.1 | 4.9 | 23.0 | 18.5 | 4.4 | 4.4 | 12.6 | 13.6 | 3.2 | 3.1 |
| No Coverage | 11.4 | 10.4 | 18.7 | 19.7 | 9.7 | 8.1 | 10.8 | 9.5 | 6.8 | 4.9 |
| EMPLOYMENT STATUS | ||||||||||
| Full-Time | 6.0 | 6.6 | 17.1 | 17.2 | 4.6 | 5.2 | 6.1 | 6.9 | 2.1 | 2.2 |
| Part-Time | 10.9 | 10.6 | 21.2 | 22.1 | 7.1 | 6.3 | 11.5 | 9.8 | 3.3 | 3.3 |
| Unemployed | 16.2 | 17.6 | 28.2 | 22.7 | 12.3 | 15.5 | 15.8 | 18.6 | 5.9 | 9.8 |
| Other4 | 7.0 | 7.3 | 18.0 | 19.4 | 5.9 | 6.1 | 13.0 | 13.1 | 3.5 | 4.0 |
| * = low precision; -- = not available or not comparable due to methodological changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Estimates for 2021 may differ from previously published estimates because the 2021 analysis weights were updated to facilitate between-year comparisons. See the 2022 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. a,b The difference between this estimate and the 2022 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. 1 Respondents aged 18 to 22 who were living in a college dormitory were excluded. 2 Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. 3 Other Health Insurance is defined as having Medicare, military-related health care, or any other type of health insurance. 4 Other Employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2021 and 2022. |
||||||||||